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Abstract
We present three projects linked by our use of continuous flow chem-
istry in the synthesis of organic intermediates. The first is the synthesis
of 1,1’-spirobiindane-7,7’-diol (SPINOL) in 6 steps and 32% overall yield.
The synthesis has been improved over the previous literature protocols
as it is safer, scalable, and higher-yielding, with better robustness and
reproducibility. We introduce two attempts towards the enantioselective
synthesis of SPINOL. In the second project, we have developed a flow
process based on the Vapourtec reactor to synthesise coumalic acid and
methyl coumalate from malic acid in concetrated sulfuric acid. A new
heated rotating flow reactor is also presented for the intensified synthesis
of coumalic acid, a valuable intermediate in organic synthesis derived from
biorenewable sources of malic acid. Methyl coumalate has been used in
two Diels-Alder reactions where the products have applications in molec-
ular electronics and organic light-emitting diodes. Finally, the Darzens
reaction for the synthesis of epoxides is presented here for the first time
in flow, providing access to a range of benzaldehyde-derived products, in-
cluding precursors to the pharmaceutical compound ibuprofen.
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Part I
Synthesis of Spirocyclic
Compounds
1
Chapter 1
Literature Review
Spirocycles are two rings that share a common atom. The spiro motif is increas-
ingly found in drug candidates, and has historically been observed in many nat-
ural products.1 They are also a key structural component in several promising
classes of privileged chiral ligands used in asymmetric synthesis, such as 1,1’-
spirobiindane-7,7’-diol (SPINOL). Restricted rotation and high rigidity at the
spiro centre can assist in improving enantiomeric excess in asymmetric reactions.
However, it is very challenging to synthesise quaternary carbon centres asymmet-
rically,2 and the stereocontrolled preparation of spiro products3–5 adds further
difficulty.
Up until very recently,6 the synthesis of SPINOL has been achiral and ineffi-
cient, due to several poorly-yielding steps and the resolution into enantiomers at
the end of the synthesis.7–10 In this literature review, we will examine how the
use of continuous flow technology may improve the efficiency of this process. We
will also outline several strategies towards an asymmetric synthesis of SPINOL,
which we will re-visit in the Results and Discussion section.
1.1 Flow chemistry
Flow chemistry uses a series of pumps (HPLC, peristaltic or syringe) connected to
tubing to mix reagents in a continuous fashion. Systems can incorporate reactors,
which are coils of tubing or reactor chips which can be temperature-controlled.
It is also possible to customise systems to incorporate glass columns containing,
for example, solid-supported reagents or catalyst-packed bed reactor units. Sys-
tems can be on a micro- (sub-millimetre capillary flow path), meso- (millimetre
to centimetre) or macrofluidic (super-centimetre) scale, with controlled mixing in
chips, static mixers, T-pieces or other mixing elements.11 Flow chemistry is com-
plementary to traditional batch chemistry, and can offer many advantages.12 For
example, photochemistry is a particular beneficiary due to the increased surface-
2
to-volume ratio, exposing reagents to more focused light than can be achieved in
a batch set-up. Chemistry can be more sustainable and systems can be run in
continuous flow mode, facilitating easy scale-up. Flow can enhance reaction opti-
misation by reducing reaction times (often minutes compared to hours, for exam-
ple) and work-up procedures, by incorporating scavenging systems or columns for
purification.13 In-line analysis assists in the monitoring and control of reactions.
One particularly important advantage is increased safety: hazardous or volatile
chemicals such as azides,14–17 diazoketones18 or bromine19–23 can be contained
within the system, reducing the user’s exposure. Reactive intermediates can be
taken forward in multi-step processes without isolation, allowing long reaction
sequences to be built up.
Catalysis in flow
A brief overview of asymmetric catalysis in flow systems will be given below.
Homogeneous catalysis in flow
Homogeneous catalysis requires a catalyst to be dissolved in a solution with the
substrates. It has several advantages over heterogeneous catalysis, including bet-
ter activity and enantioselectivity, and easier preparation and monitoring. How-
ever, the major drawback is the difficulty in removing the catalyst at the end of
a reaction. This can lead to large-scale production problems due to separation
and recycling of the catalyst, as well as product contamination by leaching of the
metal and/ or ligand into the product. Attempting homogeneous catalysis in flow
can speed up catalyst screening and process optimisation. In batch, enantiose-
lective reactions are typically run at lower temperatures to improve enantiomeric
excess whereas flow reactions are typically run at higher temperatures, which in
theory should lead to poorer enantioselectivity. Integrated analysis using IR spec-
troscopy24 or mass spectrometry25 is possible, enabling rapid profiling of reaction
conditions, although monitoring enantioselectivity is still a challenging area and
requires much more research.
Another advantage of homogeneous catalysis in flow is the possibility of per-
forming multi-step transformations without isolating unstable intermediates, as
found in the asymmetric carbolithiation of conjugated enynes, where an organo-
lithium intermediate is generated in a flow microreactor and reacted with an
electrophile before it epimerises (Scheme 1.1).26
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Ligand, -78 °C
H
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1-1 1-2
Scheme 1.1 Carbolithiation of a conjugated enyne.
A further example is highlighted by a tube-in-tube gas-liquid flow reactor
which has been used for homogeneous asymmetric hydrogenation (Scheme 1.2).27
OOHO2C
OMe
OMe
Iridium catalyst
H2 (20-25 bar)
Micro-reactor OOHO2C
OMe
OMe
1-4, up to 75% de
MeOH1-3
Scheme 1.2 Tube-in-tube gas-liquid reactor for asymmetric hydrogenation.
Homogeneous catalysis when used in flow can require lower catalyst loadings
compared to batch reactions, as illustrated in the case of an organocatalysed
asymmetric aldol reaction (Scheme 1.3).28
Ar-CHO
O
DMSO
N
H HN N
N
N
Micro-reactor
Ar
O OH
1-5
1-6
Scheme 1.3 5-(Pyrrolidin-2-yl)tetrazole-catalysed asymmetric aldol reaction.
Heterogeneous catalysis in flow
Many homogeneous catalysts can potentially be immobilised to form a hetero-
geneous catalyst, whilst attempting to retain selectivity and catalyst activity
which are often reduced by immobilisation. Heterogeneous catalysts can be
polymer-supported by covalent bonding between the ligand and the support,
self-supported, or attached to a medium via adsorption, hydrogen bonding or
electrostatic interactions. Other media include ionic liquids29 and supercritical
fluids.30 Advantages over homogeneous catalysts include simultaneous reaction
and separation, as well as improved recyclability which helps reduce costs. In
flow, there is no mechanical stirring, so that the support material is not mechan-
ically degraded. Crucially, the product will not be contaminated by the catalyst
if it is immobilised.
The most common immobilisation strategy is attachment to a polymer sup-
port, which forms a covalent bond between the ligand and the polymer back-
bone support. This requires functionality that can interact with the sup-
port, which can create synthetic challenges in ligand design. An example is a
4
polystyrene-supported proline derivative used in an organocatalytic asymmetric
α-aminoxylation of an aldehyde (Scheme 1.4).31 The immobilised catalyst was
prepared by the Cu(I)-catalysed cycloaddition of azidomethylpolystyrene and a
propargyloxyproline derivative.
O
PhN O
1) Catalyst (10 mol%)
1 h, 0 °C, CHCl 3
2) NaBH4
    30 mins, 0 °C, MeOH
OH
ONHPh
Catalyst = N
NN
O
NH
CO2H
1-8 (80% yield, 93% ee)1-7
Scheme 1.4 α-Aminoxylation of aldehyde with a polystyrene-supported cata-
lyst. Step 1 is in flow.
Metal-organic frameworks can also be used as heterogeneous catalysts. Mix-
ing BINOL-phosphoramidite ligands with [Rh(COD)2]BF4 leads to self-assembly
to form a catalyst which has been used in asymmetric flow hydrogenation
(Scheme 1.5).32
CO2Me
NHAc
CO2Me
NHAc
Catalyst (1 mol%)
H2 (40 atm)
Toluene, RT
Catalyst =
O
OP
N O
O P
N
[Rh]
n
1-10 (97% ee)1-9
Scheme 1.5 Asymmetric hydrogenation with a self-supported Rh-monoPhos
catalyst.
Asymmetric hydrogenation can also be achieved by using a rhodium cat-
alyst immobilised on Al2O3, held in place by simple electrostatic interactions
(Scheme 1.6).33
CO2MeAcHN
[Rh], H2
MonoPhos
Phosphotungstic acid/ 
Al2O3
CO2MeAcHN
*
1-12 (96-97% ee)1-11
Scheme 1.6 Asymmetric hydrogenation using a Rh-monoPhos catalyst immo-
bilised on Al2O3.
Weaker van der Waals’ interactions can be used to hold the support and
catalyst together. This makes immobilisation straightforward, but since binding
is weak, increased catalyst leaching into the product is observed. An example of
this mode of binding is media other than polymers. This increases the ease of
separation and catalyst recovery. These media have been used in hydrogenation,
cyclopropanation and hydroformylation reactions (Scheme 1.7).34,35
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1-13 1-14 1-15
Scheme 1.7 Asymmetric alkene hydroformylation using a supported Rh-
BINAPhos catalyst in supercritical CO2.
1.2 Asymmetric synthesis in organic chemistry
Strategies for the synthesis of chiral compounds
Enantioselective synthesis is defined by IUPAC as a reaction which creates at
least one new element of chirality in a substrate, to give stereoisomeric products
in unequal amounts.36 There are several methods that can be employed to achieve
these results, and these are summarised below.
Chiral pool
The chiral pool approach uses cheap and readily available, mainly naturally-
occurring starting materials such as amino acids or sugars. The chirality of the
starting material is incorporated in full or part into the product.
Chiral auxiliaries
An enantiomerically pure compound is covalently attached to a substrate, which
is followed by a diastereoselective reaction which ideally gives only one enantiomer
of the product. The chiral auxiliary is then removed, and it is sometimes possible
to recycle this auxiliary. Examples include Evans’ oxazolidinone and ephedrine
derivatives (Fig. 1.1).
HN O
O
OH
NHMe
1-16 1-17
Fig. 1.1 An Evans’ oxazolidinone and an ephedrine derivative.
Myers et al. used enolates of pseudoephedrine amides as chiral auxiliaries in
a diastereoselective alkylation with alkyl halides.37 Following asymmetric alky-
lation, pseudoephedrine could be regenerated in excellent yields by a simple ex-
tractive work-up (Scheme 1.8).
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N
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THF
O 1) LDA, LiCl
2) BnBr
0 °C N
OH
O
Bn
HO
O
Bn
H2SO4/dioxane
(1:1)
Reflux
NHMe
OH
1-19, 95% 1-20, 90%, >99% de 1-21, 95%, 97% ee1-18
Scheme 1.8 A pseudoephedrine derivative as a chiral auxiliary in an asymmet-
ric alkylation.
Chiral reagents
A chiral reagent is reacted with an achiral substrate to give a chiral product. The
advantage of this method over the use of chiral auxiliaries is that there are no
addition/ cleavage steps. However, it requires stoichiometric amounts of a chiral
reagent which can be expensive.
An example of a widely-used chiral reagent is l-aspartic acid, which is used
in diastereoselective alkylations.38 An example is shown below (Scheme 1.9).39
HO2C
CO2H
NH2
O
O
CbzHN
1) LDA, THF, -78 °C
2) Br
O
O
CbzHN
CHOEtO2C
1-24, 80%, 76% de1-22 1-23 1-25
Scheme 1.9 l-Aspartic acid as a chiral reagent in a diastereoselective alkylation
reaction.
Asymmetric catalysis
The preferred method to achieve enantioselective synthesis is asymmetric catal-
ysis, where one chiral molecule is used to effect an enantioselective reaction that
gives many molecules of the chiral product, known as chiral amplification. A
chiral catalyst can be formed by the coordination of chiral ligands to a metal
atom.
The Corey-Bakshi-Shibata catalyst, a chiral oxazaborolidine, is a well-known
example. It has been used in an enantioselective catalytic reduction of an achiral
chloromethyl ketone, with borane as a stoichiometric reductant (Scheme 1.10).40
Ph
Cl
O Catalyst (1 mol%)
BH3.THF Ph
Cl
OH
1-27, 97%, 96.5% ee
Catalyst =
N B
O
H
Ph
Ph
O
BN
Ph
Ph
O
PhH2B H
R' OBN
Ph
Ph
O
PhH2B
R'
H
Cl Cl
1-26
Scheme 1.10 The Corey-Bakshi-Shibata oxazaborolidine as a catalyst in an
asymmetric reduction of a ketone.
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Privileged ligand classes
Ligands that catalyse a broad range of enantioselective reactions with high se-
lectivity, requiring little or no change in the ligand structure are also known as
privileged ligands. Many possess a rigid chiral backbone and an axis of chirality
(atropisomerism). The conditions for atropisomerism are the possession of a rota-
tionally stable axis and different substituents on both sides of the axis. Examples
of privileged ligands include chiral salen derivatives, bis(oxazoline)s, cinchona
alkaloid derivatives and the binapthalenes BINAP and BINOL (Fig. 1.2).
NN
OH
R
R HO
R
R
O
N N
O
R R
N
OMe
N
OH
1-28 1-29 1-30
Fig. 1.2 Chiral salen, bis(oxazoline)s and cinchona alkaloid derivatives.
BINOL and BINAP
BINOL and BINAP are biaryl compounds with ortho substituents that are large
enough to prevent free rotation around the C-C single bond. They are highly
versatile ligands for asymmetric synthesis, and their structures are shown below
(Fig. 1.3).
OH
OH
OH
OH
(S)-1-31 (R)-1-32
Fig. 1.3 Structures of (R)- and (S )-BINOL.
BINOL and BINAP can be synthesised via the following route
(Scheme 1.11).41
OH
FeCl3 OH
OH
Tf2O
Pyr
OTf
OTf
PPh2
PPh2
Ph2PH
NiCl2.dppe
DMF
DABCO
1-19 1-18 1-20 1-21
Scheme 1.11 Synthesis of BINOL and BINAP.
BINOL can be resolved into its enantiomers by three different methods. The
first is the addition of N -benzylcinchonidium chloride. The (S )-enantiomer is
a crystalline inclusion compound which dissolves in MeCN whereas the (R)-
enantiomer is not. Alternatively, BINOL can be reacted with pentanoyl chlo-
ride and the enzyme cholesterol esterase added. The enzyme can hydrolyse the
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(S )-diester but not the (R)-diester. Finally, preparative HPLC with a chiral
stationary phase can be used to separate the enantiomers.
BINOL is capable of catalysing a wide variety of reactions, whether as a lig-
and attached to a metal or as an organocatalyst on its own.42,43 Its derivatives
can also be used in reduction and oxidation reactions, and can be used as Lewis
or Brønsted acid catalysts in C-C bond formation (Scheme 1.12), as well as bi-
functional acid/ base catalysts.
MeO
H
N
Bn
HCN
Catalyst (10 mol%)
Toluene, -40 °C, 6 h
MeO
CN
HN
Bn
1-38 (93% ee)
Catalyst =
O
O P
O
OH
Ar
Ar
1-39: Ar = 9-phenanthryl
1-37
Scheme 1.12 An example of using a (R)-BINOL derivative as a Brønsted acid
in an asymmetric Strecker reaction.44
Binapthyl phosphoric acids have been particularly well studied, and their
chirality-inducing behaviour is derived from the steric environment that the two
bulky napthyl groups provide. Viewing from two different angles demonstrates
this perspective in terms of quadrants (Fig. 1.4).45
Ar
Ar
O
O P
O
OH
C2
View 1
View 2
View 1 View 2
C2
P
P OH
OOAr Ar P
O
O
H
O O
Ar
Ar
Empty 
quadrant
Empty 
quadrant
Fig. 1.4 Structures of (View 1: top-down view of BINOL-phosphoric acid; View
2: quadrant view of BINOL phosphoric acid.
This quadrant view can similarly describe BINAP. Examples of reactions
catalysed by BINAP are more common, and include hydrogenations of olefins
and ketones (Scheme 1.13), isomerisation of allylamines, hydroboration, allylic
alkylation, Heck reaction, aldol and Mannich reactions, Michael-type reactions,
conjugate additions using organoboron and Grignard reactions, Diels-Alder reac-
tions, ene reactions, cyclisations and ring-opening reactions.46
O
OMe
O
H2 (750 psi) [Ru(C6H6)Cl2]2 (0.5 mol%)
(R)-BINAP (1.2 mol%) in MeOH
OH
OMe
O
1-41 (98.4% ee)1-40
Scheme 1.13 An example of using (R)-BINAP as a chiral ligand in an asym-
metric hydrogenation of β keto-esters.47
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Axial chirality and bite angles
Many of the privileged ligand classes discussed above exhibit axial chirality, where
the molecules possess an axis of chirality rather than a stereogenic centre. Biaryl
compounds must have ortho substituents that are sufficiently large to prevent
rotation around the C-C single bond, such as in BINOL and BINAP to main-
tain their chirality. The two atropisomers of BINOL, (R)- and (S )-BINOL are
illustrated below (Fig. 1.5).
OH
OH
(R)-BINOL, (R)-1-34
OH
OH
(S)-BINOL, (S)-1-36
Fig. 1.5 Enantiomers (atropisomers) of a an axially chiral binapthyl ligand,
BINOL.
The X-ray crystal structure of (R)-BINOL is shown below (Fig. 1.6).48
Fig. 1.6 (R)-BINOL X-ray crystal structure.
Spirobiindanes also require substituents to restrict rotation and thus render
them chiral. (±)-SPINOL has been re-drawn in 3D to emphasise its rigidity and
lack of rotational ability (Fig. 1.7).
OH
OH
≡
OH
OH
OH
OH
(±)-SPINOL, 1-42 (R)-SPINOL, (R)-1-42 and (S)-SPINOL, (S)-1-42
Fig. 1.7 Racemic SPINOL re-drawn in 3D, with its (R)- and (S )-enantiomers.
The X-ray crystal structure of SPINOL is shown below (Fig. 1.8).49
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Fig. 1.8 SPINOL X-ray crystal structure.
The bite angle, βn, of a bidentate ligand is measured by the X-metal-X angle
(Fig. 1.9).50
X X
βn
PPh2
PPh2 βn (BINAP, 1-21) = 93°
Fig. 1.9 The bite angle, βn, and the bite angle of the BINAP ligand.
A wide bite angle has both steric and electronic effects on a complex: it
increases the bulk of the bidentate ligand, and favours or disfavours certain ge-
ometries of transition metal complexes. BINAP has a relatively wide bite angle.
SPINOL systems have an altered bite angle of bidentate coordination compared
to these binapthyl systems: for example, Zhou et al. reported a bite angle of
87.91◦ for the (S,S )-SIPHOX ligand shown below (Fig. 1.10).51 Changing the bite
angle of a complex can affect the enantioselectivity and rate of a reaction.45,52
PPh2
N
O
iPr
(S,S)-SIPHOX, (S,S)-1-43
Fig. 1.10 A phosphine-oxazoline ligand (SIPHOX) with a bite angle reported
when chelated to an iridium complex.
1.3 1,1’-Spirobiindane-7,7’-diol (SPINOL)
1,1’-Spirobiindane-7,7’-diol (SPINOL) possesses a rigid spirobiindane backbone,
with two phenol groups. When viewed in three dimensions, the phenol groups
are relatively close to each other in space (Fig. 1.11).9
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Fig. 1.11 X-ray crystal structure of 1,1’-spirobiindane-7,7’-diol.
This forms a relatively small bite angle and a sterically differentiated 3D site
for catalysis. The pKa of the phenol groups is substantially lower than that of
free phenol and thus SPINOL is more Lewis acidic than phenol.53
Spirocarbocycles in natural products
Natural products containing the spirocycle motif are well-documented in the lit-
erature, for example as spirooxindoles.54,55 They are also becoming more com-
mon in drugs due to their increased three-dimensionality for potential improved
specificity, and novelty for patenting purposes.56 The total synthesis of natural
products containing spirocarbocycles utilises many reactions including the aldol,
Diels-Alder, and Claisen reactions, as well as ring-closing metathesis and reactions
promoted by acid, base and light.1
Ligands and organocatalysts derived from SPINOL
Once synthesised and resolved, SPINOL can be derivatised to form other useful
compounds which can act as ligands and/ or organocatalysts in asymmetric pro-
cesses. Several of the most common analogues are summarised in the diagram
below (Fig. 1.12).
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Phosphoric acids, 1-44 Phosphoramidites, 1-45 Monophosphites, 1-46
Phosphonites, 1-47 Phosphepines, 1-48
Diphosphines, 1-49 Aminophosphines, 1-50 Bis(oxazolines), 1-51
1-27
Fig. 1.12 Summary of selected derivatives of SPINOL.
Literature syntheses of SPINOL
In 1999, Birman et al. reported the first literature synthesis of SPINOL,7 starting
from 3-methoxybenzaldehyde and proceeding in 28% overall yield over 6 steps
(Scheme 1.14).7
OMe
CHO
O
OMe OMe
Acetone (0.5 equiv.)
NaOH
50% EtOH-H2O
RT, 2 h
O
OMe OMe
H2 (1 atm)
Acetone
RT, 1 day
Raney Ni
O
OMe OMe
Br Br
Br2 (2.5 equiv.)
Pyridine (3.5 equiv.)
CH2Cl2
-10 °C to RT, 4 h
Polyphosphoric acid
105 °C, 5.5 h
Br
OMe
OMe
Br
OMe
OMe 1) n-BuLi (4 equiv.)THF, -78 °C, 1 h
2) EtOH
OH
OH
BBr3 (2.3 equiv.)
CH2Cl2
-78 °C to RT
o/n
1-42
racemic
1-53, 62%
1-56, 57% for 3 steps1-57, 93%
85%
1-52
1-54
1-55
Scheme 1.14 The Birman synthesis of SPINOL.
Since then, there have been various incremental improvements to the syn-
thesis process. Shan et al. used a range of heteropoly acids to spirocyclise
various pentanones, and improved the yield of Br-SPINOMe from 66% to 80%
(Scheme 1.15).8
OBr
OMe
Br
OMe
H3PW12O40 (0.15 equiv.)
Toluene
Reflux, 10 h
Br
OMe
OMe
Br
1-56, 80% yield
1-55
Scheme 1.15 Improved spirocyclisation of 1,5-bis(2-bromo-5-
methoxyphenyl)pentan-3-one using phosphotungstic acid.
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The original synthesis is not asymmetric, and thus requires a final resolving
step to separate the (R)- and (S )-enantiomers of SPINOL. The original paper
used (–)-menthyl chloroformate, followed by separation of the diastereomers by
column chromatography (Scheme 1.16).
O Cl
O
(= R*Cl, 2.4 equiv.)
OH
OH
NEt3 (3.7 equiv.)
DMAP (0.1 equiv.), DCM
RT, 9 h
OH
OH
OH
OH
1-42, racemic
OR*
OR*
Diastereomers, separable by 
column chromatography N2H4.H2O
THF, reflux, 1.5 h
(R)-SPINOL, (R)-1-42
86%
(S)-SPINOL, (S)-1-42
91%
N2H4.H2O
THF, reflux, 1.5 h
1-57
Scheme 1.16 Resolution of SPINOL using (–)-menthyl chloroformate.
In 2002, a simpler and more reproducible method was published by Zhou et al.
that used the co-crystallisation of SPINOL with N -benzyl cinchonidium chloride
(Scheme 1.17).9
N
N+
HO Cl-
OH
OH
Toluene, reflux, 1 h
1-42, racemic
OH
OH
OH
OH
(R)-SPINOL, (R)-1-42
(0.5 equiv.)
From mother liquor
75% yield
From inclusion complex
82% yield
1-58
(S)-SPINOL, (S)-1-42
Scheme 1.17 Resolution of SPINOL with N -benzylcinchonidium chloride.
Two years later, a further method was used to separate the enantiomers of
dibrominated SPINOL (DBSPINOL).10 Transformation with (–)-menthyl chlo-
roformate followed by recrystallisation permitted separation of the dibrominated
products in high yields (Scheme 1.18).
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(R)-DBSPINOL, (R)-1-59
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(S)-DBSPINOL, (S)-1-59
98%
Br
Br
Br
Br
KOH(aq)/EtOH
Reflux
KOH(aq)/EtOH
Reflux
Br
Br
Br
Br
1-57
Scheme 1.18 Resolution of DBSPINOL with (–)-menthyl chloroformate.
1.4 Asymmetric approaches to SPINOL
We were interested in investigating several routes to an asymmetric synthesis of
SPINOL. These included the use of chiral auxiliaries and the asymmetric addition
of an aryl ring to an alkene. A further suggestion not investigated in detail here
is an approach involving the generation of a chiral tight-ion pair (Scheme 1.19).57
OMe OMe
O
OMe OMe
O SiMe3
R
O2S N SO2
R
OMe
OSiMe3
MeO
OMe
OH
MeO
OH
OH
Br Br
Br Br
Br
Br Br
Br
1-421-55
Scheme 1.19 Suggested tight-ion pair approach to SPINOL.
Enantioselective catalysis
There are four key activation modes for asymmetric catalysis: Lewis acid catal-
ysis, hydrogen-bonding catalysis, Brønsted acid catalysis, and chiral anion catal-
ysis.57 In a tight ion pair, there are no solvent molecules between the anion and
cation, and the individual ions keep their stereochemical configuration. In chiral
anion catalysis, an achiral but catalytically active species is combined with a chi-
ral counterion. In a non-polar medium, these species form a tight ion pair, and
the counterion is able to influence the stereochemical outcome of a reaction.
Whether the transition state of the reaction is early or late according to Ham-
mond’s postulate is important in being able to control the stereochemistry of the
product. There are two places to generate chirality in the synthesis of SPINOL:
either through the attack on the original carbonyl in the ketone starting ma-
terial, or by control of the attack on the enantiotopic faces of a carbocation
formed during the reaction. One theoretical mechanism for the spirocyclisation
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is through the formation of a very reactive tertiary benzylic alcohol intermediate
(Scheme 1.20). This represents an earlier transition state.
OBr
OMe
Br
OMe
H
Br
OMe
HO
Br
MeO
H+
Br
OMe
OMe
Br1-55
1-56
Br
OMe
Br
MeO
H OH
Scheme 1.20 Postulated tertiary alcohol intermediate in the synthesis of
SPINOL.
This alcohol is itself a chiral centre which can act to influence the angle of the
subsequent attack on the tertiary carbocation centre by potentially blocking one
of the enantiotopic faces (Scheme 1.21).
Br
OMe
HO
Br
MeO
OH
Br
OMe OH
Br
OMe
or
Scheme 1.21 Postulated ‘blocking’ of one face during addition in the synthesis
of SPINOL.
However, this chiral information may be lost if the alcohol is highly labile.
Its loss would form a tertiary carbocation which can be stabilised by resonance,
through the involvement of the aromatic methoxy group (Scheme 1.22).
Br
OMe
HO
Br
MeO
H+
Br
OMe
OMe
Br
Br
OMe
Br
MeO 1-42
Br
OMe
Br
MeO
Scheme 1.22 Postulated tertiary carbocation transition state in the synthesis
of SPINOL.
At this point, any stereochemical control would depend on being able to
‘choose’ which enantiotopic face of the carbocation is blocked.
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Asymmetric alkene cyclisation
As discussed in the chiral auxiliary route above, we are interested in the tertiary
intermediate during the spirocyclisation process (Fig. 1.13).
Br
OR
HO
Br
RO
Br
OR
Br
RO
H
or
Fig. 1.13 Postulated tertiary intermediates in the synthesis of SPINOL.
We hypothesised that an alkene could be substituted for this intermediate, and
that the subsequent cyclisation can be enantioselectively controlled (Scheme 1.23)
through the use of a chiral acid catalyst. The carbocation can be stabilised
through resonance. If the diphenolic groups are not protected as the dimethoxy
equivalent, autocatalysis may even be possible by harnessing the enhanced acidity
of the resultant diphenolic spiro product.
Br
OR Br
RO
Br
OR
OR
Br
Br
OR Br
RO
MLn
Br
OR
Br
RO
Scheme 1.23 Hypothesised cyclisation of an alkene intermediate in the syn-
thesis of SPINOL.
This alkene could be protonated to generate a carbocation-like intermediate
for cyclisation, for example by Brønsted acid catalysis (Scheme 1.24).58–62
Br
OR Br
RO
ML*
Br
OR Br
RO
ML*
Br
OR Br
RO
ML*
H
Br
OR
OR
Br
Scheme 1.24 Suggested Brønsted acid catalysis in the synthesis of SPINOL.
There is some literature precedent for asymmetric addition to an alkene in
the presence of a chiral ligand.63–65
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Toste et al. have used gold(I)-catalysis for the intramolecular addition of
amines into unactivated alkenes (Scheme 1.25), first using an alkylgold complex,64
and later using gold(I)/menthol cooperative catalysis.63
NHMbs
(R)-DTBM-SEGPHOS(AuCl)2 (3 mol%)
AgBF4 (6 mol%)
(−)-Menthol (2 equiv.)
CH2Cl2, RT, 24 h
N
Mbs
N
Mbs
1-61                            1-62
95% yield
Ratio 1:6.3
e.e. = 95% (1-62)
1-60
O
O
O
O P
P
AuCl
AuCl
OMe
tBu tBu tBu
OMe
tBu
tBu
OMe
tBu
tBu
OMe
tBu
(R)-DTBM-SEGPHOS(AuCl)2 =
Scheme 1.25 Asymmetric Au(I)-catalysed hydroamination of a diene.
Additions to unactivated alkenes have been the topic of a recent review.66
We have seen how the incorporation of continuous flow technology is an im-
portant development in synthetic organic chemistry, and how it may be possible
to influence the mechanism of SPINOL formation to give an asymmetric synthesis
of this valuable compound.
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Chapter 2
Project Aims
The first aim of the project was to synthesise (±)-SPINOL in batch, with the
aim of eventually investigating an enantioselective synthesis.
It was first examined whether it was possible to improve the literature syn-
thesis of SPINOL by incorporating continuous flow technologies. Several or all
of the planned steps may be possible in flow, with a focus on bromination and
hydrogenation as easily translated steps. Two key starting compounds will be
considered, 3-hydroxybenzaldehyde and 3-methoxybenzaldehyde, and the neces-
sity and efficiency of each step will be examined. The spirocyclisation step in
particular will be investigated in detail, exploring the reagents and conditions
required to optimise this crucial step.
Next, approaches to the asymmetric synthesis of SPINOL will be investigated.
These will start with the use of diols derived from amino acids as chiral auxiliaries.
The second route will be via an indanone intermediate, targeting an asymmetric
alkene addition as the spirocyclisation step.
Finally, the chapter will end with the conclusions which can be drawn, and
suggestions for future work.
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Chapter 3
Attempted Synthesis of
(±)-SPINOL from
Hydroxybenzaldehydes
Retrosynthetic analysis of (±)-SPINOL implies that it may be directly synthe-
sised in three steps from 3-hydroxybenzaldehyde and acetone (Scheme 3.1).
OH
OH
OH
O
OH OH
O
OH
H
O
OH
O
1-42 3-1 3-2 3-3
Scheme 3.1 Retrosynthetic analysis of (±)-SPINOL.
3.1 Starting from 3-hydroxybenzaldehyde
The first synthetic route attempted started from 3-hydroxybenzaldehyde. It was
envisaged that the first step would comprise a double aldol condensation, followed
by conjugate reduction and finally the desired spirocyclisation (Scheme 3.2).
OH
OH
OH
O
OHOH
O
OH
H
O
OH
O
3-3 3-2 3-1 1-42
Scheme 3.2 Proposed synthetic route to (±)-SPINOL.
During the synthesis of 1,5-bis(3-hydroxyphenyl)penta-1,4-dien-3-one, a
method was developed by adapting conditions for the synthesis of related com-
pounds by Dolliver67 and Ding.68 This new method used 5 equivalents of 10%
NaOH, and a solvent mixture of EtOH−H2O (ratio 4:5) (Scheme 3.3). The alde-
hyde starting material and acetone were added in two portions, and the mixture
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was heated at 25 ◦C for between 2-4 h, with a longer heating period required for
larger scales. This maximised the conversion of 3-hydroxybenzaldehyde to the
desired pentadienone product.
OH
O
OH
H
O
OH
O
(0.5 equiv.)
10% NaOH/ H2O
EtOH
25 °C
3-2, 64%3-3
Scheme 3.3 Dolliver-Ding aldol condensation of 3-hydroxybenzaldehyde with
acetone.
Recrystallisation of the crude product from IPA gave the pentadienone prod-
uct in 64% overall yield (99% pure by 1H NMR spectroscopy).
After screening many conditions for the conjugate reduction of the α,β-
unsaturated ketone to the pentanone, the most successful was found to be treat-
ment with Pd/C under a 1 bar H2 atmosphere with Ph2S as a catalyst poison
(Scheme 3.5). Without the poison, the over-reduced pentane was observed as the
major product (Scheme 3.4).
OH
O
OHOH
O
OH
Pd/C (10 wt%)
H2 (1 atm)
EtOH
RT, 24 h OH OH
3-2 3-1 3-4
Ratio approx. 2:3 (from LC-MS)
Not isolated
Scheme 3.4 Batch reduction of 1,5-bis(3-hydroxyphenyl)penta-1,4-dien-3-one
using Pd/C.
OH
O
OHOH
O
OH
Pd/C (10 wt%)
H2 (1 atm)
Ph2S (0.01 equiv.)
EtOH
RT, 24 h
3-1, 91%3-2
Scheme 3.5 Batch reduction of 1,5-bis(3-hydroxyphenyl)penta-1,4-dien-3-one
using Pd/C and Ph2S.
The pentanone was obtained as the sole product of hydrogenation, in excellent
yield and with no need for further purification.
The reaction was next transferred to the H-Cube R© reactor, with some screen-
ing of suitable conditions which are summarised in Table 3.1 below. The reaction
was always run using the full H2 production mode,
∗ and with 1 bar pressure
(Scheme 3.6). The conversion values were determined by 1H NMR spectroscopy.
∗Described as approx. 30 mL min−1 at atmospheric pressure in correspondence with
ThalesNano Inc.
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Table 3.1 Screening of conditions for the flow reduction of 1,5-bis(3-
hydroxyphenyl)penta-1,4-dien-3-one, poisoned with Ph2S (0.01 equivalents).
Scheme 3.6 Flow reduction of 1,5-bis(3-hydroxyphenyl)penta-1,4-dien-3-one.
OH
O
OH
H2O O2
H-Cube
H2
Solvent
Catalyst
x mol dm-3, y °C 
z mL min-1, full H2
OH
O
OH
3-2 3-1
Entry Catalyst Solvent Temp.
/◦C
Flow rate
/mL min−1
% Conver-
sion
% Yield
1 10% Pd/C EtOH 20 1.0 100% 81-93%
2 10% Pd/C EtOH 25 1.5 100% 61%
3a 10% Pd/C EtOH 20 2.0 100% 90%
4 10% Pd/C EtOAc 20 2.0 83% -
5b Raney Ni EtOAc 40 2.0 88% -
aCatalyst leaching was observed as discolouration of the product solution, and the amount
of leached palladium could be reduced by stirring with a thiourea immobilised metal scavenger
resin.
bNo catalyst poison used.
At only a few minutes, this reaction time is much shorter than the batch
procedure. Furthermore, using the optimum conditions of 10% Pd/C, EtOH,
20 ◦C and a flow rate of 1.0 mL min−1 enabled the formation of the 1,5-bis(3-
hydroxyphenyl)penta-1,4-dien-3-one in an efficient, safer, and slightly higher yield
than the batch reduction.
An early theory was that it may be possible to spirocyclise the diphenol di-
rectly to the o-SPINOL, potentially avoiding the addition and removal of the
bromides as blocking groups (Scheme 3.7). It should be noted that no mention of
any attempts to previously conduct this chemistry were reported in the literature.
O
OH OH
OH
OH
3-1 1-42
Scheme 3.7 Theoretical spirocyclisation without bromide blocking groups.
In reality, when investigating this route, the phenol groups were unintention-
ally ‘protected’ as the mesylates, and the regioselectivity observed was found to
be exclusively for the para site of the aromatic ring (Scheme 3.8).
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OOH OH
MsO
OMs
HO
OH
3-1 3-5 3-6
Scheme 3.8 Para spirocyclisation and mesylation.
The literature procedure from Birman et al.69 used polyphosphoric acid whilst
heating for 5.5 h at 105 ◦C to spirocyclise a similar starting material (Scheme 3.9).
OH
O
OH
Polyphosphoric acid
105 °C
5.5 h
3-1
Scheme 3.9 Attempted spirocyclisation of 1,5-bis(3-hydroxylphenyl)pentan-3-
one using polyphosphoric acid.
Several attempts were made to spirocyclise 1,5-bis(3-hydroxyphenyl)pentan-3-
one using polyphosphoric acid, but no organic product was successfully extracted
although some unreacted starting material was recovered.
Eaton’s reagent is phosphorous pentoxide-methanesulfonic acid (1:10 by
weight) and is a convenient alternative to phosphoric acid.70 The spirocyclisa-
tion was repeated with Eaton’s reagent at 80 ◦C (Scheme 3.10).
OH
O
OH
Eaton's reagent
80 °C, 3 h
MsO
OMs
3-5, 59%3-1
Scheme 3.10 Spirocyclisation of 1,5-bis(3-hydroxylphenyl)pentan-3-one using
Eaton’s reagent to (p)-SPINOMs.
Comparison with the literature data for (±)-(o)-SPINOL indicated that a
spiro structure had indeed been formed, but the peaks in the aromatic region of
the 1H NMR spectrum did not match exactly. Some of the spectroscopic data
matched the literature, but there were a few conflicting pieces of evidence. The
1H NMR spectrum contained a peak at δ 3.36 ppm (6 protons) which would be
consistent with the methyl protons of the mesyl group, but a D2O shake caused
a broad singlet at 3.57 ppm to disappear. An additional peak was also observed
in the 13C NMR spectrum at 37.8 ppm. The LC-MS spectrum implied that
the compound may be mesyl-protected rather than the free phenol, due to the
observation of a peak at 408 m/z (RT 3.38 mins). Later experiments to synthesise
(p)-SPINOMs by a different route confirmed the identity of this product.
Various attempts were made to try to hydrolyse the mesylate using NaOH, but
none were successful (Scheme 3.11). The 1H NMR spectra of all crude products
obtained matched the starting material in all cases.
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10% NaOH
THF
Reflux, 3 h
MsO
OMs
3-5
Scheme 3.11 Attempted demesylation of (p)-SPINOMs
The first step in the confirmation of the synthesis of p-SPINOMs was the
deprotection of p-(±)-SPINOMe to form p-(±)-SPINOL, following the same pro-
cedure as for the deprotection of o-(±)-SPINOMe (Scheme 3.12).
MeO
OMe
HO
OH
BBr3 in DCM
-78 °C to RT, N 2
DCM
3-5 3-6
Scheme 3.12 Demethylation of p-SPINOMe to form p-SPINOL.
The 1H NMR spectrum of the crude product revealed the absence of the signal
from the methyl protons. The aromatic region of the 1H NMR spectrum also did
not match that of the previously synthesised product. The second step was the
mesylation of the phenols, using mesyl chloride and pyridine (Scheme 3.13).
HO
OH
MsO
OMs
MsCl (2.4 equiv.)
Pyr (5 equiv.)
DCM, N2
0 °C to RT
3-6 3-5
Scheme 3.13 Mesylation of p-SPINOL.
The 1H NMR spectrum of the crude product showed that the aromatic region
contained a doublet at 6.96 ppm, a doublet of doublets at 7.11 and another dou-
blet at 7.29. This matched the data for the originally spirocyclised product, thus
identifying the compound formed with Eaton’s reagent as para-(±)-SPINOMs.
The spirobiindane product o-Br-SPINOMe contains two protecting groups
which needed to be removed to furnish the desired end-product, o-(±)-SPINOL.
The two bromine atoms were installed to act as blocking groups so that only
one isomer of the spirobiindane could form. One literature synthesis of SPINOL
removes these with n-BuLi.
3.2 Starting from
2-bromo-5-hydroxybenzaldehyde
One of the disadvantages of the previous route was the potential for α-
bromination products to form from the ketone.71 This was expected to be-
come a more significant issue upon scale up due to the higher concentration
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of HBr being generated, catalysing enol formation. It would also be possible
for HBr-catalysed spirocyclisation to occur, leading to the para product. Since
the literature procedure incorporates bromine atoms as blocking groups pre-
spirocyclisation, the possibility of changing the order of the reactions starting
from 3-hydroxybenzaldehyde was investigated.
The first step in the alternative sequence was the bromination of the ben-
zaldehyde, which was attempted in both batch and flow.
Various batch methods were attempted for the synthesis of 2-bromo-5-
hydroxybenzaldehyde. The method that gave the highest yield and great-
est proportion of monobrominated product used molecular bromine in DCM
(Scheme 3.14).
OH
H
O
Br2 (1.0 equiv.)
DCM
0 °C to RT
OH
H
OBr
3-8, 78% conversion
65% yield3-3
Scheme 3.14 Batch bromination of 3-hydroxybenzaldehyde.
The maximum conversion reached was 78% as determined by 1H NMR spec-
troscopy, and the crude material was recrystallised from AcOH to give the pure
product in 65% isolated yield.
To mitigate the risks associated with using molecular bromine in batch at
scale, flow methods were also considered. Higher dilutions of solutions were used
to prevent precipitation of product whilst in the flow reactor. DCM, AcOH
and mixtures of these two solvents were considered (Scheme 3.15). The starting
material was less soluble in DCM than AcOH, and the maximum conversion
observed was only approximately 20% by 1H NMR spectroscopy. This value did
not vary according to the flow rate or residence time. It was therefore thought
that the low concentration of starting material may be the limiting factor in
improving the overall conversion.
OH
H
O
Br2 (1.1 equiv.)
0.167-0.500 mL min-1
DCM
23 °C
10 mL OH
H
OBr3-3
0.500-1.50 mL min-1
3-8
Scheme 3.15 Flow bromination of 3-hydroxybenzaldehyde in DCM.
AcOH was also considered as a suitable solvent since it was compatible with
both bromine and the starting material (Scheme 3.16). Conversion to the mono-
brominated product peaked around 60%. As the flow rates were increased, the
ratio of mono- to di-brominated product remained at around 2:1.
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OH
H
O
Br2 (1.1 equiv.)
DCM, 0.500-0.800 mL min-1
23 °C
10 mL OH
H
OBr
AcOH, 1.50-2.40 mL min-1
OH
H
OBr
Br
3-8                      3-9
60% conversion
Ratio 2           :          1
3-3
Scheme 3.16 Flow bromination of 3-hydroxybenzaldehyde in AcOH/DCM.
To improve the solubility of the starting material in DCM, 10% AcOH was
added (Scheme 3.17). The flow rates were varied, and the composition of the
resulting mixture was analysed by 1H NMR spectroscopy. The results are sum-
marised in Fig. 3.1 below.
OH
H
O
Br2 (1.1 equiv.)
DCM, 0.250-0.900 mL min-1
23 °C
10 mL OH
H
OBr
DCM/ AcOH (9:1)
0.750-2.70 mL min-1
OH
H
OBr
Br
3-3
3-8 3-9
Scheme 3.17 Flow bromination of 3-hydroxybenzaldehyde in DCM/AcOH.
Fig. 3.1 Flow bromination of 3-hydroxybenzaldehyde; flow rate vs. composi-
tion.
The maximum conversion (88%) was observed at 2.0 mL min−1, but at this
flow rate dibromination was competitive with the desired monobromination.
In conclusion, the batch method of bromination gave the best yields of 2-
bromo-5-hydroxybenzaldehyde. It would have been preferable to be able to use
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flow chemistry, to reduce user exposure to bromine, but this method gave a higher
proportion of the undesired dibrominated product. In the future, alternative
solvents, dilutions, and reaction temperatures may be considered in flow. One
of the causes of this dibromination may be due to the improved mixing in flow,
which is normally an advantage. Different mixing pieces may reduce this over-
bromination.
Although not optimised in flow, material was prepared allowing the next step
to be tested. Hence the Dolliver-Ding conditions developed in the synthesis of
1,5-bis(3-hydroxyphenyl)penta-1,4-dien-3-one were applied to the condensation
of 2-bromo-5-hydroxybenzaldehyde with acetone (Scheme 3.18).
OH
O
OH
H
O
OH
O
(0.5 equiv.)
10% NaOH
EtOH
25 °C, 3.5 h
3-10, 41%
Br Br Br
3-8
Scheme 3.18 Dolliver-Ding aldol condensation of 2-bromo-5-
hydroxybenzaldehyde with acetone.
The reaction produced the crude product as an orange solid which was re-
crystallised from IPA to give a bright yellow solid.
It was anticipated that the reduction of the brominated pentadienone may
occur with simultaneous loss of the aromatic bromides.
Chemoselective reduction of the brominated pentadienone was attempted
(Scheme 3.19) using the poisoned palladium-based conditions that had pre-
viously proved successful for the reduction of the corresponding 1,5-bis(3-
hydroxyphenyl)penta-1,4-dien-3-one (Pd/C, H2, Ph2S, EtOH).
OH
O
OHOH
O
OH
Pd/C (10 wt%)
H2 (1 atm)
Ph2S (0.01 equiv.)
EtOH
RT, 24 h
Br Br Br Br
3-11, 80% purity
29% isolated yield
3-10
Scheme 3.19 Batch reduction of 1,5-bis(2-bromo-5-hydroxyphenyl)penta-1,4-
dien-3-one.
However, even when using a shorter reaction time of 2 h, a mixture of
the dibrominated, monobrominated and debrominated pentanones was observed.
The reaction time was not shortened further. The quantity of side-products
could be reduced via purification by column chromatography (Hex:EtOAc 1:1
to Hex:EtOAc 0:100), but not completely removed. The desired dibrominated
pentanone was the major product from these reactions (Fig. 3.2), but this was
still an inefficient method of preparation.
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6.506.556.606.656.706.756.806.856.906.957.007.057.107.157.207.257.307.357.407.457.507.557.607.657.707.75
f1 (ppm)
1
2B (dd)
6.57
C (d)
6.73
D (d)
7.32
0.
20
0.
18
0.
16
1,5-Bis(2-bromo-5-hydroxyphenyl)pentan-3-one
Crude product mixture
Fig. 3.2 1H NMR spectra of the desired dibrominated pentanone, compared
with the crude product mixture.
We again hoped that more precise contact time using a packed catalyst bed
flow reactor may lead to better chemoselectivity. Therefore 1,5-bis(2-bromo-5-
hydroxyphenyl)penta-1,4-dien-3-one was dissolved in EtOH to create a stock so-
lution of 0.050 mol dm−3, and passed through a cartridge of 10% Pd/C catalyst
using the H-Cube R© reactor (Scheme 3.20).
OH
O
OH
H2O O2
H-Cube
H210% Pd/C
20 °C, 1.0 mL min -1
Full H2
OH
O
OH OH
O
OH
Br Br
EtOH
Br Br
3-11                              
Minor
Ratio 1                                            4
3-1
Major3-10
Scheme 3.20 Flow reduction of 1,5-bis(2-bromo-5-hydroxyphenyl)penta-1,4-
dien-3-one using 10% Pd/C.
Unfortunately again, mixtures of dibrominated, monobrominated and further-
more the debrominated pentanones were obtained. The mixtures could not easily
be separated but by 1H NMR analysis, the major product was the debrominated
pentanone.
In an attempt to regulate the catalyst activity, the addition of Ph2S as a
catalyst poison with the material being dissolved with the starting material in
the EtOH stock solution was considered (Scheme 3.21).
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OH
O
OH
H2O O2
H-Cube
H210% Pd/C
20 °C, 1.0 mL min -1
Full H2
Ph2S (0.01 equiv.)
EtOH
Br Br
3-10
Scheme 3.21 Flow reduction of 1,5-bis(2-bromo-5-hydroxyphenyl)penta-1,4-
dien-3-one using 10% Pd/C and Ph2S.
This proved somewhat successful but generated a complicated mixture of di-
brominated, monobrominated and debrominated pentadienones, pentanenones
and pentanones which was not separated.
It was thought the Pd catalyst might be more prone to inserting into the C-Br
bond than an alternative catalyst, and so the catalyst was changed to Raney Ni
and a range of reaction temperatures were tested (Scheme 3.22).
OH
O
OH
H2O O2
H-Cube
H2Raney Ni
x °C, 2.0 mL min -1
Full H2
Br Br
EtOH
OH
O
OH
Br Br
3-12, 50% conversion3-10
Scheme 3.22 Flow reduction of 1,5-bis(2-bromo-5-hydroxyphenyl)penta-1,4-
dien-3-one using Raney Ni.
Even at the higher temperatures, approximately only 50% conversion of start-
ing material to the mono-reduced pentaenone could be achieved, but as predicted,
debromination was not observed. More forcing conditions may be required for full
conversion to the di-reduced pentanone, or alternatively recycling the mixture,
or employing a slower flow rate, which may increase the conversion.
Although temporarily put aside, this route was returned to after the publica-
tion in 2016 of an asymmetric synthesis of SPINOL by the Zhou group.72
In collaboration with Lauriane Peyrical, a bromination procedure using
1,5-bis(3-hydroxyphenyl)pentan-3-one as the starting material was developed
(Scheme 3.23).
OH
O
OH OH
O
OH
Br Br
NBS (2.5 equiv.)
MeCN
0 °C, <30 mins
3-11, 94% conversion
88% isolated yield
3-1
Scheme 3.23 Bromination of 1,5-bis(3-hydroxyphenyl)pentan-3-one using
NBS.
Of particular note was that if the temperature and reaction time were not
carefully controlled, dibromination on the aromatic rings was again observed.
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However, maintaining the temperature below 0 ◦C and using 2.5 equivalents of
NBS over a short reaction time allowed excellent conversions and good isolated
yields of the desired product.
In their 2016 paper, Zhou et al. claimed to have used triflic acid to spirocyclise
this brominated substrate. These conditions were thus examined and replicated
(Scheme 3.24).
OH
O
OH
Br Br
Br
OH
OH
Br
Triflic acid (10 mol%)
Dichloroethane (anhydrous)
80 °C, 6 h, N 2
1-59, 100% crude yield3-11
Scheme 3.24 Spirocyclisation of the brominated phenol using triflic acid.
However, although full conversion was achieved, the crude product obtained
contained several side-products, and was of poor quality.
Instead, following previous examples, the 1,5-bis(2-bromo-5-
hydroxyphenyl)pentan-3-one was spirocyclised using polyphosphoric acid
(Scheme 3.25).
OH
O
OH
Br Br
Br
OH
OH
Br
Polyphosphoric acid 
(10 wt x)
105 °C, 6 h
1-59, 72% yield3-11
Scheme 3.25 Spirocyclisation of the brominated phenol using polyphosphoric
acid.
The spirocyclised product was obtained in moderately high yield and high
quality.
Debromination of this compound would give the desired o-SPINOL in 5 steps.
Based upon our previous experiments using palladium catalysis and the ease of
dehalogenation, a palladium-based debromination was attempted (Scheme 3.26).
Br
OH
OH
Br
10% Pd/C (5 mol%)
Et3N (6 equiv.)
H2, THF, H2O
RT, 12 h
1-59
Scheme 3.26 Attempted palladium-based debromination of Br-SPINOL.
Unfortunately a complex mixture of products was obtained, along with a
quantity of the starting material and the desired product, as determined by 1H
NMR spectroscopy. Indeed, despite several attempts to optimise this transfor-
mation, we were unable to improve the outcome. We speculate this may be a
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consequence of the phenolic groups which coordinate to the palladium preventing
dehalogenation.
Further work in this area should concentrate on achieving this step, ideally in
flow. Preliminary experiments were attempted with the H-Cube R© reactor, but
equipment malfunctions meant that conversion was very low.
3.3 Conclusions on the 3-hydroxybenzaldehyde
route
An aldol condensation using 3-hydroxybenzaldehyde and acetone was devel-
oped that gave high yields and purity. The flow reduction of the 1,5-bis(3-
hydroxyphenyl)penta-1,4-dien-3-one was more efficient, safer, and gave higher
yields than the corresponding batch reduction (Table 3.2).
Table 3.2 Comparison of the batch and flow reductions of 1,-bis(3-
hydroxyphenyl)penta-1,4-dien-3-one.
Procedure Batch Flow
Isolated yield 91% 81-93%
Reaction time 24 h 2 min
Throughput 0.033 g h−1 1.62 g h−1
Spirocyclisation of the 1,5-bis(3-hydroxyphenyl)pentan-3-one with polyphos-
phoric acid was not successful. Alternatively, when run with Eaton’s reagent,
a spirobiindane was obtained but this was found to be a mesyl-protected para-
spirobiindane rather than the desired ortho diphenol (Scheme 3.27).
O
OH OH
O
OH OH
Br Br
MsO
OMs
Br
OH
OH
Br
HO
OH
OH
OH
3-1 3-5 3-6
3-11 1-59 1-42
Scheme 3.27 Comparison between regioselectivity of spirocyclisation routes
using hydroxybenzaldehydes.
An alternative sequence was also investigated. When proceeding via 2-bromo-
5-hydroxybenzaldehyde, the batch bromination with Br2/DCM gave superior
yields to the flow set-up, as under flow conditions significant dibromination was
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observed. The equivalent aldol reaction proceeded in lower yields but high pu-
rity to give 1,5-bis(2-bromo-5-hydroxyphenyl)penta-1,4-dien-3-one. With both
the batch and flow reductions of the brominated pentadienone, a mixture of
products was obtained, with some debromination observed as well as the desired
reduction of the unsaturated ketone.
Performing the reduction of the pentadienone before bromination solved this
problem. It has been possible to spirocyclise the brominated pentanone using
polyphosphoric acid and phosphotungstic acid to give Br-SPINOL. The final step
in this preparation of SPINOL would be debromination, which needs further
optimisation.
These routes are summarised in the scheme below (Scheme 3.28).
OH
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OH
OH
O
OH
OH
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OH
O
OH
Br Br
OH
O
H
Br
OH
O
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Br Br
Br
OH
OH
Br
OH
OH
MsO
OMs
HO
OH
3-3 3-2 3-1 3-5
3-8 3-10 3-11 1-59 1-42
3-6
Scheme 3.28 Reactions from 3-hydroxybenzaldehyde to spirobiindanes.
Since it was discovered that the bromine atoms are indeed required as blocking
groups during the spirocyclisation step in order to give the ortho product, the
question arises as to whether bromination should be performed before or after
the reduction of the unsaturated ketone. It was found to be markedly better
to reduce first, and brominate the resulting ketone. It was later found to be
possible to spirocyclise this brominated ketone in high yields and purity using
rapid microwave heating (Section 4.5). The last remaining hurdle to the desired
SPINOL is the debromination of Br-SPINOL to give the final product, believed
to be possible after further experimentation. If successful, this would reduce the
number of steps required to synthesise SPINOL from six to five, and eliminate
the need to use boron tribromide to cleave the methyl protecting groups. At this
point, the route starting from 3-methoxybenzaldehyde was investigated in order
to attempt to improve the literature procedure.
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Chapter 4
Synthesis of (±)-SPINOL from
Methoxybenzaldehydes
One of the the literature syntheses of (±)-SPINOL starts from 3-
methoxybenzaldehyde, and proceeds in 6 steps and 28% overall yield.69 The first
step is an aldol condensation of 3-methoxybenzaldehyde with acetone, followed
by reduction with Raney Ni, then bromination with molecular bromine. The next
step is a low-yielding spirocyclisation with polyphosphoric acid, followed by two
deprotection steps to arrive at the desired product.
Two routes for bromination of the pentanone are described here: the first
builds on work undertaken on 2-bromo-5-hydroxybenzaldehyde by synthesising
2-bromo-5-methoxybenzaldehyde and proceeding, and the other follows the lit-
erature procedure. Improvements to the literature procedure have been made to
five of the six steps to SPINOL and are discussed below.
4.1 Reversing the literature reaction order
A potential route for the synthesis of 1,5-bis(2-bromo-5-methoxyphenyl)penta-
1,4-dien-3-one follows the same pattern as for the synthesis of the diphenol pen-
tadienone, that is, bromination followed by an aldol condensation, followed by
reduction (Scheme 4.1). This differs in order of steps to the sequence found in
the literature, which is an aldol condensation, followed by reduction then bromi-
nation.
OH
OH
OMe
O
OMeOMe
O
OMe
H
O
OMe
H
O
OMe
Br Br Br Br Br
1-52 4-1 4-2 1-55 1-42
Scheme 4.1 Proposed synthetic route to 1,5-bis(2-bromo-5-
methoxyphenyl)pentan-3-one.
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Initial attempts at the bromination of 3-methoxybenzaldehyde used the same
conditions as for the previous bromination of 3-hydroxybenzaldehyde (Br2/DCM)
(Scheme 4.2).
H
O
OMe
H
O
OMe
Br
Br2 (1.0 equiv.)
DCM
0 °C to RT
1-52 4-1
Scheme 4.2 Bromination of 3-methoxybenzaldehyde (Br2/ DCM).
1H NMR spectroscopy showed 70% conversion of the starting material after 4.5
h (63% monobromination product and 7% unknown), demonstrating the slower
reaction of the protected methoxy substrate compared to the phenol.
A literature search was performed to identify a more efficient method, and con-
ditions by Snyder et al. were found that used AcOH as the solvent (Scheme 4.3).73
H
O
OMe
H
O
OMe
Br
Br2 (1.2 equiv.)
AcOH, RT
4-1, 56% isolated yield1-52
Scheme 4.3 Bromination of 3-methoxybenzaldehyde (Br2/ AcOH).
After 24 h, conversion was determined to be 90% by 1H NMR spectroscopy.
The crude yield was 95%, which after recrystallisation from EtOH:H2O (9:1) gave
the desired monobrominated product in 56% yield and >99% purity by 1H NMR
spectroscopy.
In contrast to the polybromination which was seen with 3-
hydroxybenzaldehyde/ Br2/ AcOH, this reaction did not yield any other
product than the monobromination, and proceeded at a substantially slower
rate. Again, the methyl ‘protecting group’ is responsible for this reduction
in reactivity as it makes the oxygen lone pair less available for donation, and
therefore lowers the activation of the aromatic ring.
The aldol condensation of 2-bromo-5-methoxybenzaldehyde with acetone was
attempted in 10% NaOH and EtOH (Scheme 4.4). The starting material was
found to be barely soluble in EtOH/ H2O, but the reaction still proceeded very
rapidly, and precipitation of the product was observed after 10 mins.
OMe
O
OMe
H
O
OMe
O
(0.5 equiv.)
10% NaOH
EtOH
25 °C
4-2, 80%
Br Br Br
4-1
Scheme 4.4 Aldol condensation of 2-bromo-5-methoxybenzaldehyde (Dolliver-
Ding conditions).
34
Large amounts of precipitation were observed from the solution to give a very
high crude yield (96%). The composition of the crude was 87% product and 13%
starting material as determined by 1H NMR spectroscopy. After recrystallisation,
the isolated yield was 80% (95% product).
The yellow 1,5-bis(2-bromo-5-methoxyphenyl)penta-1,4-dien-3-one (95% pure
by 1H NMR spectroscopy) was dissolved in EtOAc, and reduction conditions
were screened using the H-Cube R© reactor. The catalyst used throughout was
Raney Ni, as it had been shown to target the pentadienone C=C rather than
debrominating the aromatic rings.
The initial reduction attempt was performed at 20 ◦C, but after two passes
through the H-Cube R© reactor, TLC (Hex:EtOAc 1:1) showed that only starting
material was present. The temperature was increased in stages through 50 ◦C, 60
◦C, and 70 ◦C and each sample was passed through the H-Cube R© reactor four
times (Scheme 4.5).
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H2O O2
H-Cube
H2Raney Ni
0.050 mol dm-3, x °C
2.0 mL min-1, full H2
Br Br
EtOAc
OMe
O
OMe
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4-2 1-55
Scheme 4.5 Initial reduction of 1,5-bis(2-bromo-5-methoxyphenyl)penta-1,4-
dien-3-one in the H-Cube R© reactor.
Each sample was then dried over Na2SO4, filtered and concentrated in vacuo
before being analysed by 1H NMR spectroscopy to determine the approximate
conversions (Table 4.1). In addition, LC-MS analysis indicated that neither
bromine atom had been lost, as determined by the isotope ratios (Fig. 4.1).
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OMe OMe
Br Br O
OMe OMe
Br Br O
OMe OMe
Br Br
Starting material, 4-2 Intermediate, 4-3 Product, 1-55
Fig. 4.1 Starting material, intermediate and product in the debromination re-
action.
Table 4.1 Composition of product mixture after reduction in the H-Cube R©
reactor depending on reaction temperature.
Entry Temperature
/◦C
% Starting material % Intermediate % Product
1 50 (4 passes) 20 13 68
2 60 (4 passes) 6 10 84
3 70 (4 passes) 2 10 88
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Even at 70 ◦C after four passes through the H-Cube R© reactor, the conver-
sion to the product did not reach 100%. This reaction requires re-visiting with
a new catalyst cartridge to verify the results. It may be that a higher reaction
temperature increases the conversion, but the low concentrations and longer re-
action times make this reaction inefficient for further development as a scaled-up
procedure.
The route with the modified order of reactions is summarised below
(Scheme 4.6).
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Scheme 4.6 Summary of alternative route to 1,5-bis(2-bromo-5-
methoxyphenyl)pentan-3-one.
The first step required 24 h stirring at room temperature, and has only been
tested on a 20 mmol scale. The yield of the crude product was 95% at 90%
purity by 1H NMR spectroscopy. The impurity was the starting material, which
could be removed by recrystallisation from EtOH:H2O 9:1 to give the product in
56% yield and >99% purity as fluffy white needle-like crystals. More material
can also be recovered from the mother liquor. However, the aldol condensation
is a rapid reaction requiring only 10 mins for product formation to be observed.
Problematically, the product precipitation also dissolutions the starting material
meaning the purity of the final material is not high, so that after recrystallisation
the pentadienone was obtained in moderate to high yield. The final reduction step
did not give complete conversion even when employing mildly forcing conditions.
This route was set aside whilst work was performed on the conventional route.
4.2 Aldol condensation of
methoxybenzaldehydes
The synthesis of the non-brominated pentadienone was attempted by two different
methods. The first method followed the literature synthesis of (±)-SPINOL,69
and the second method used the Dolliver-Ding conditions developed during the
synthesis of 1,5-bis(3-hydroxyphenyl)penta-1,4-dien-3-one.
The conditions from Birman et al.69 require 0.5 equivalents of acetone, 2.55
equivalents of sodium hydroxide and EtOH/ H2O as the solvent mixture. The
reaction was performed at room temperature with stirring for 4 h (73 mmol scale)
(Scheme 4.7).
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Scheme 4.7 Aldol condensation of 3-methoxybenzaldehyde (Birman condi-
tions).
The crude product was obtained as a yellow-orange oil, which contained 93%
pentadienone and 7% starting material as determined by 1H NMR spectroscopy.
During the synthesis of 1,5-bis(3-hydroxyphenyl)penta-1,4-dien-3-one, a
method was developed adapting conditions used for the synthesis of related com-
pounds as described by Dolliver67 and Ding.68 This new method used 5 equiva-
lents of 10% NaOH, and a solvent mixture of EtOH-H2O. The starting material
and acetone were added in two portions, and the mixture heated to 25 ◦C for
2-4 h, depending on the scale of the reaction. This maximised the conversion of
3-hydroxybenzaldehyde to the desired pentadienone product at 93%, from where
it did not increase further.
This method was directly applied without alterations to the synthesis of 1,5-
bis(3-methoxyphenyl)penta-1,4-dien-3-one (Scheme 4.8).
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25 °C
1-53, 100% crude
67% purified1-52
Scheme 4.8 Aldol condensation of 3-methoxybenzaldehyde (Dolliver-Ding con-
ditions).
The crude product was a yellow oil, with a higher ratio of product to starting
material (97:3) than was observed with the Birman method, and as a result the
mixture proved much easier to purify. Purification was achieved by flash column
chromatography (Hex:EtOAc 4:1) and gave the product as a yellow oil which
solidified to a sticky yellow solid after several days in 67% yield.
Subsequent attempts at purification included recrystallisations. Attempts us-
ing IPA, H2O, EtOAc, EtOH, MeOH, Et2O, DCM and various combinations
thereof were unsuccessful. However, purification using a solvent gradient of
Hex:EtOAc 9:1 to 2:1 with column chromatography gave the highest isolated
yield of 86%.
This reaction was also monitored by 1H NMR spectroscopy, to give some
additional insight into the rates of intermediate and product formation (Fig. 4.2
and Fig. 4.3).
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Starting material, 1-52
Fig. 4.2 Conversion of 3-methoxybenzaldehyde to 1,5-bis(3-
methoxyphenyl)penta-1,4-dien-3-one via an intermediate
Fig. 4.3 Monitoring of the aldol condensation of 3-methoxybenzaldehyde with
acetone by 1H NMR spectroscopy.
The spectra show that even immediately after all components have been
added, formation of product was observed. The reaction requires longer reac-
tion times to ensure high conversion of the intermediate to the final product.
Therefore the Dolliver-Ding conditions gave a better quality product (97%
product compared to 93% before purification) after a shorter reaction time (2 h
compared to 4 h), thus demonstrating their superiority over the previous literature
conditions.
For analytical purposes, the mono-condensation product 4-(3-
methoxyphenyl)but-3-en-2-one was synthesised.
The Dolliver-Ding conditions that had previously been successful in the di-
condensation were applied to the substrate, this time using one equivalent of
acetone (Scheme 4.9).
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Scheme 4.9 Attempted synthesis of 4-(3-methoxyphenyl)but-3-en-2-one using
the Dolliver-Ding conditions.
The mixture was stirred for 1.5 h at 25 ◦C, then neutralised with 6 M HCl.
The same work-up as previously described was also utilised. 1H NMR spec-
troscopy and LC-MS analysis indicated that the crude mixture contained both
the mono- and di-condensed product, in a ratio of approximately 0.7:1. The
two products were particularly difficult to separate, and column chromatography
(Hex:EtOAc 2:1) was not very successful. Ideally, a synthetic method to form
this product would deliver the mono-condensation product as the overwhelming
major component.
To this end, a literature method by MacMillan et al.74 was selected for
a second attempt. This protocol used acetone in excess as both the reagent
and solvent, with a 1 M NaOH solution added dropwise to a mixture of 3-
methoxybenzaldehyde and acetone (Scheme 4.10).
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4-4, 92% yield
O
1-52
Scheme 4.10 Synthesis of 4-(3-methoxyphenyl)but-3-en-2-one using MacMil-
lan protocol.
1H NMR spectroscopic analysis indicated a single major product, which was
the desired mono-condensation material. Thus no column chromatography or
separation was required, and the product was obtained in 92% yield. The 1H
NMR spectrum was useful in assigning impurity peaks in the spectra of the di-
condensation product.
4.3 Reduction of pentadienones
To obtain the desired pentanone, di-reduction of the conjugated dienone must
occur.
The literature protocol for the reduction of 1,5-bis(3-methoxyphenyl)penta-
1,4-dien-3-one requires stirring with Raney nickel under hydrogen for 24 h.69
This reaction was attempted in acetone, and the reaction was monitored by TLC
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(Hex:EtOAc 1:1) (Scheme 4.11). After 20 h, no starting material remained, and
so the reaction was worked up.
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Raney Ni, H2
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1-54, 86%1-53
Scheme 4.11 Batch reduction of 1,5-bis(3-methoxyphenyl)penta-1,4-dien-3-
one using Raney Ni.
1H NMR spectroscopy of the crude product revealed 100% conversion of the
pentadienone to the pentanone. The literature procedure had observed some
over-reduced pentanol, but this was not present in our reaction mixture.
Raney Ni can be particularly challenging to work with, and poses several
safety issues in regard to its handling and disposal. Thus the H-Cube R© reac-
tor offers an attractive alternative for the reduction of this pentadienone. Both
Raney Ni and Pd catalyst cartridges were examined for efficacy, due to the lower
cost of the palladium cartridges. Various solvents, temperatures, flow rates and
concentrations were examined to find the optimal set-up for maximum conversion
in minimum time.
Since reductions of the diphenol pentadienone had previously been success-
ful successful with palladium on carbon, initial experiments with the methoxy
pentadienone derivative were first performed with a 10% Pd/C catalyst cartridge
(Scheme 4.12).
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1 bar, full H2
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4-5, 38% conversion1-53
Scheme 4.12 Reduction of pentadienone in the H-Cube R© reactor (10% Pd/C,
EtOH).
By LC-MS spectroscopy, the crude product contained both starting material
and the mono-reduced product. By 1H NMR spectroscopy, conversion of starting
material to the mono-reduced compound was 38%. Problematically, the starting
material was not especially soluble in EtOH at room temperature.
Next, the use of Raney nickel catalyst cartridges were considered. The solvent
was also changed to EtOAc because the starting material had a much higher
solubility. The temperature was increased in 20 ◦C intervals and conversion was
monitored by 1H NMR spectroscopy (Scheme 4.13).
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Scheme 4.13 Reduction of pentadienone in the H-Cube R© reactor (Raney Ni,
EtOAc).
The results obtained from this study were somewhat inconsistent, but ex-
hibited a general trend of increasing product formation as the temperature was
increased. Starting from a temperature of 60 ◦C, the flow rate was next reduced
from 2.0 mL min−1 to 1.0 mL min−1 (Scheme 4.14).
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Scheme 4.14 Reduction of the pentadienone using Raney Ni/ EtOAc in the
H-Cube R© reactor.
1H NMR spectroscopy of the crude product showed complete conversion of the
starting material to the di-reduced pentanone and the product could be isolated
as a pale yellow oil.
Subsequent attempts at replicating the success of this experiment were ham-
pered by the intermittent hydrogen production of the H-Cube R© reactor, leading
to a mixture of starting material and product. These could be separated by col-
umn chromatography (Hex:EtOAc 2:1 to Hex:EtOAc 0:100). The problem was
addressed by the addition of a sample collection robot set up to collect 15 mL
samples. Any unreacted starting material present in the vials could be recycled
back through the H-Cube R© reactor. Further reduction of the pentanone to the
alcohol or alkane was not observed.
Over a period of several months, the behaviour of the H-Cube R© reactor be-
came more erratic. Conditions which had previously given full conversion (60
◦C/ 1.0 mL min−1) were no longer sufficient and quantities of starting material
were frequently observed in the crude product. It became necessary to begin
multiple passes through the H-Cube R© reactor to achieve >90% conversion. One
such experiment was followed by 1H NMR spectroscopy, and the spectra from
this are shown below (Fig. 4.4).
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Fig. 4.4 Flow reduction of 1,5-bis(3-methoxyphenyl)penta-1,4-dien-3-one with
multiple passes through the H-Cube R© reactor (Raney Ni, EtOAc, 0.127 mol
dm−3, 60 ◦C, 1.0 mL min−1, full H2).
The conversion of starting material to intermediate required five passes
through the H-Cube R© reactor, and the final two passes through the machine
furnished the product as the major component of the mixture.
To resolve these issues, various fixes were attempted, which included HPLC
pump maintenance, changing catalyst cartridges, increasing temperatures and
varying flow rates. Interestingly, water began to be observed in the product
stream, which indicates a major issue with the membrane and electrolysis cell of
the H-Cube R© reactor. No single fix has yet solved these problems permanently.
When reviewing previous experimental data, the importance of concentration
of the stock solution was considered. It was hypothesised that the concentration of
1,5-bis(3-methoxyphenyl)penta-1,4-dien-3-one may be the most important factor
in determining the conversion.
To this end, an experiment was run with 21 stock solutions of varying concen-
trations. These were run through the H-Cube R© reactor in a single pass (Raney
Ni, EtOAc, 60 ◦C, full H2), and the flow rate was altered. The data are sum-
marised in the graph below (Fig. 4.5).
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Fig. 4.5 Graph of concentration of stock solution versus % conversion to prod-
uct at different flow rates.
When studying the results for the 1.5 mL min−1 flow rate, it becomes appar-
ent that the results are much less predictable, giving less consistent conversions
regardless of the solution concentration. Considering most earlier experiments
were run at the even slower flow rate of 1.0 mL min−1, this could help explain
the erratic conversion results.
When flowing at 2.0 mL min−1, the data becomes more predictable and it was
possible to fit a line of least squares regression to the four data points, giving an
R2 value of 0.99.
It should be noted that to achieve conversions above 90%, it was found to be
far more important to run the reaction at a concentration of 0.100 mol dm−3 or
lower, rather than increasing the flow rate further. At this dilution, there was
little difference in the conversions achieved across the range of flow rates.
Consequently a 0.100 mol dm−3 stock solution of 1,5-bis(3-
methoxyphenyl)penta-1,4-dien-3-one was prepared and was run through
the H-Cube R© reactor at 3.0 mL min−1 (Scheme 4.15).
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60 °C, 3.0 mL min -1
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1-54, 97%1-53
Scheme 4.15 Large-scale flow reduction of 1,5-bis(3-methoxyphenyl)penta-1,4-
dien-3-one in the H-Cube R© reactor.
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After the first pass through the machine, analysis by 1H NMR spectroscopy
indicated that the mixture was composed of 9% starting material, 9% mono-
reduced compound and 82% pentanone product. A second pass resulted in only
2% mono-reduced compound and 98% pentanone product which was deemed
sufficient. This significantly faster flow rate allowed 12.048 g of material to be
processed in 137 mins in a 97% yield (output = 5.17 g/ h) and is thus a far more
efficient method for the reduction of 1,5-bis(3-methoxyphenyl)penta-1,4-dien-3-
one than the literature batch reduction.
4.4 Brominations of pentanones
To block the para position relative to the mexthoxy group, and thus direct spiro-
cyclisation to occur at the ortho positions, it was necessary to install two addi-
tional functional groups. Initially, these were two bromides as in the literature,
but later work considered alternatives such as chlorides since they have a lower
mass and thus reduce waste.
The Birman conditions using pyridine and bromine were applied to
1,5-bis(3-methoxyphenyl)pentan-3-one in the synthesis of 1,5-bis(2-bromo-5-
methoxyphenyl)pentan-3-one (Scheme 4.16).
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OMe OMe
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OMe OMe
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1) Pyr (3.5 equiv.)
DCM, -10 °C
2) Br2 (2.5 equiv.)
-10 °C to RT
1-55, 60-99%1-54
Scheme 4.16 Bromination of 1,5-bis(3-methoxyphenyl)pentan-3-one with pyri-
dine/ Br2.
Following the reaction, the mixture was quenched with 10% Na2S2O3 and
extracted with 1 M HCl and H2O to give an orange oil in high yield (60-99%).
1H NMR spectroscopy of the crude product matched the literature data, and
showed that conversion was complete after 4 h. The largest scale the reaction
was performed on was 18.7 mmol, and during bromine addition a significant
exotherm was observed. The reaction time required also increased to 6 h.
This route to the brominated pentanone removes the need to attempt reduc-
tion of the brominated pentadienone in the H-Cube R© reactor, as this method
gives the product in high purity and the same number of steps. It has the ad-
ditional benefit of making the route divergent, so that it was possible to use the
non-brominated pentanone and the brominated pentanone to investigate spiro-
cyclisations with different conditions. However, the reaction becomes difficult to
perform on a larger scale, due to exotherms and the need for an extended reaction
time.
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Bromination with N -bromosuccinimide (NBS) was attempted, as it is safer
and easier to handle than molecular bromine. The reaction was first attempted
in MeCN (Scheme 4.17).
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NBS (2 equiv.)
MeCN, RT, 20 h
1-55, 33-50%1-54
Scheme 4.17 Synthesis of 1,5-bis(2-bromo-5-methoxyphenyl)pentan-3-one
with NBS.
The lowest yield of 33% was obtained with the shortest reaction time of 30
mins; a 50% yield was obtained after 3 h stirring at RT. Increasing the equivalents
of NBS to 2.1 gave a similar yield of 51% (Scheme 4.18).
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MeCN, RT, 20 h
1-55, 51%1-54
Scheme 4.18 Improved synthesis of 1,5-bis(2-bromo-5-methoxyphenyl)pentan-
3-one with NBS.
This protocol has the advantage of being both safer and quicker, but the draw-
back of a significantly lower yield. The conversion of pentanone to brominated
product was found to be 100% by 1H NMR spectroscopy, but yields of 33-50%
were observed, indicating the work-up was the source of the poor yields. In case
it was the solvent that caused problems in the aqueous work-up, CHCl3 was also
considered (Scheme 4.19).
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CHCl3, RT, 20 h
1-55, 60-61%1-54
Scheme 4.19 Bromination of 1,5-bis(3-methoxyphenyl)pentan-3-one with NBS
in chloroform.
Two reactions were performed at similar concentrations (0.25 mol dm−3, 0.27
mol dm−3) to the reactions in acetonitrile. After work-up, the yields obtained
were consistent, at 60% and 61% respectively. It was noticed in the second reac-
tion that after putting the starting material under high vacuum, approximately
22% of the mass was in fact solvent. This may have been a factor in reducing the
yields of reactions, since less starting material was present than believed. How-
ever, this does not account for all of the ‘missing’ yield: for example, a predicted
increase in yield from 51% to 68% for a reaction above (Scheme 4.18).
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It was considered that potentially the low concentration of the reaction mix-
ture may be a factor in the lower yields. To test this hypothesis, two reactions
were performed in parallel at higher concentrations (0.5 mol dm−3 and 1.0 mol
dm−3) and gave much improved yields of 86% and 91% respectively.
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MeCN, RT, 20 h
1-55, 86-91%1-54
0.5/ 1.0 mol dm-3
Scheme 4.20 Bromination of 1,5-bis(3-methoxyphenyl)pentan-3-one at higher
concentrations in acetonitrile with NBS.
Therefore the problem of lower yields than the bromine/ pyridine reaction has
been solved by running the bromination with NBS at higher concentrations. This
has an added benefit of reducing the solvent volume, thus making the reaction
less wasteful and the work-up easier.
The reaction was sequentially scaled up via 2 g of starting material to 10 g of
starting material in preparation for a much larger-scale reaction. It was observed
that the quenching step with 10% Na2S2O3 was very exothermic at the larger
scales.
In conclusion, an alternative bromination step using 2.1 equivalents of NBS
in MeCN was found preferable to the literature reaction that uses bromine and
pyridine in DCM. Temperature control of the initial addition was not critical.
The required reaction time of the NBS reaction was not as heavily dependent on
scale as the bromine reaction was.
Once the reaction was run at higher concentrations, the yield of the NBS
reaction was consistently higher than with bromine. The product obtained was
of higher purity by 1H NMR spectroscopy, and was less highly coloured (pale
yellow rather than dark orange). Importantly, NBS is a white solid that is easy
to handle, whereas molecular bromine is a highly toxic volatile liquid. Acetonitrile
is a more sustainable solvent than dichloromethane and also less harmful.75
Therefore the NBS reaction was considered preferable to the bromine reaction,
representing an improvement in the synthesis of SPINOL.
4.5 Spirocyclisations of pentanones
The literature synthesis of (±)-SPINOL states that a blocking group para to the
methoxy is required to prevent the para isomer of SPINOL forming preferen-
tially over the desired ortho isomer, but does not investigate this claim further
(Fig. 4.6).
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1-42, o-(±)-SPINOL 3-6, p-(±)-SPINOL
Fig. 4.6 ortho- and para-(±)-SPINOL.
The need for this step has been examined in the previous chapter, but we
will consider it in more depth here. To probe this wasteful step, we investigated
spirocyclisations of the non-brominated pentanones, followed by replication of the
literature procedure which uses brominated pentanones. Finally, we considered
possible improvements to the procedure.
Spirocyclisation of the non-brominated pentanone 1,5-bis(3-
methoxyphenyl)pentan-3-one was attempted with polyphosphoric acid and
heating at 105 ◦C (Scheme 4.21).
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OMe OMe
Polyphosphoric acid
105 °C, 6 h
3-7, 39%
MeO
OMe
1-54
Scheme 4.21 Spirocyclisation of the non-brominated pentanone with polyphos-
phoric acid.
The reaction mixture was quenched with H2O and extracted with Et2O and
DCM, then dry-loaded onto silica and washed through a short plug of silica
(Hex:EtOAc 9:1) to give a yellow oil. The aromatic region of the 1H NMR spec-
trum did not match that of the ortho spirobiindane. Instead, the peak splitting
and COSY spectrum were more consistent with the isolated material being the
para isomer as shown above.
Attempted spirocyclisations with Eaton’s reagent gave a small amount of
crude product, whose 1H NMR spectrum also matched the para isomer. However,
the yield was too low for this to be a viable preparative method (Scheme 4.22).
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80 °C
3-7, <5%
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1-54
Scheme 4.22 Attempted spirocyclisation of 1,5-bis(3-methoxyphenyl)pentan-
3-one with Eaton’s reagent.
The first attempt at the spirocyclisation of the brominated pentanone fol-
lowed the literature conditions using polyphosphoric acid with heating at 105 ◦C
(Scheme 4.23).
47
OMe
OMe
O
OMe OMe
Br Br
Br
Br
Polyphosphoric acid
105 °C, 5 h
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Scheme 4.23 Spirocyclisation of the brominated pentanone with polyphospho-
ric acid (5 h).
After 5 h, the reaction was quenched with H2O and extracted sequentially
with Et2O then DCM.
1H NMR spectroscopy of the crude product identified
both starting material and the spirobiindane product, in the ratio 34:66. The
reaction time was thus deemed insufficient for full conversion.
The reaction was repeated, and monitored by TLC (Hex:EtOAc 9:1)
(Scheme 4.24).
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1-56, 100% conversion
27% yield
1-55
Scheme 4.24 Spirocyclisation of the brominated pentanone with polyphospho-
ric acid (8 h).
After 8 h, TLC showed no starting material remained. The crude purple
product was dry-loaded onto silica and washed through a short plug of silica gel
(Hex:EtOAc 9:1). 1H and 13C NMR spectra of the purified product matched the
literature for the spirocyclic product.
Further attempted spirocyclisations with Eaton’s reagent and subsequent
aqueous/ organic work-up did not allow any organic material to be isolated
(Scheme 4.25). This implies decomposition of the starting material or prod-
uct, or the failure of the work-up to extract any organic material from the acidic
aqueous layer, which seems unlikely based upon previous results.
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1-55
Scheme 4.25 Attempted spirocyclisation of 1,5-bis(2-bromo-5-
methoxyphenyl)pentan-3-one using Eaton’s reagent.
The only modification to the synthesis of SPINOL found in the literature is
an improvement to the spirocyclisation step through the use of heteropoly acids
instead of polyphosphoric acid. These heteropoly acids were considered with a
series of pentanones and the findings are reported below.
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A publication by Shan et al.76 used heteropoly acids to synthesise spiro-
biindanes via bis-cyclisation. Both the brominated and non-brominated
methoxyphenylpentanones were tested, with phosphotungstic, phosphomolybdic
and silicotungstic acids. The optimal conditions were found to be phospho-
tungstic acid (0.15 equiv.) in toluene under Dean-Stark reflux conditions.
The first attempts to replicate these conditions used a hydrated form of phos-
photungstic acid, H3PW12O40 · xH2O. Attempts at using this acid to spirocyclise
the pentanone resulted in only the recovery of starting material. For the next
attempt, the phosphotungstic acid hydrate was dehydrated by heating under vac-
uum to give the heteropoly acid as a fine white solid. It was now possible to use the
literature conditions to synthesise 4,4’-dibromo-7,7’-dimethoxy-1,1’-spirobiindane
(Scheme 4.26).
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1-56, 69%1-55
Scheme 4.26 Spirocyclisation of 1,5-bis(2-bromo-5-methoxyphenyl)pentan-3-
one with phosphotungstic acid.
The NMR spectroscopic data matched the literature for 4,4’-dibromo-7,7’-
dimethoxy-1,1’-spirobiindane, but the compound required further purification
than had been specified in the literature, as the final product was purple in
colour rather than colourless/ white.
Phosphomolybdic acid was dehydrated by heating under vacuum, then used in
an attempt to replicate the literature conditions. However, only starting material
was recovered from the reaction mixture.
In an effort to improve the ease of purification, it was postulated that immo-
bilising the phosphotungstic acid on silica may make it simpler to remove the acid
at the end of the reaction. To this end, phosphotungstic acid was immobilised
on silica, and then used in an attempted spirocyclisation with 1,5-bis(2-bromo-
5-methoxyphenyl)pentan-3-one. Again, only starting material was obtained at
the end of the reaction. Therefore the most successful spirocyclisations used
freshly-dehydrated phosphotungstic acid at a high reaction temperature of 110
◦C.
The final improvement to the synthesis of Br-SPINOMe was to test the spiro-
cyclisation in the microwave (Scheme 4.27).
49
OOMe OMe
Br Br
Br
OMe
OMe
Br
H3PW12O40 (0.15 equiv.)
Toluene, µW
1 h @ 150 °C
1-56, 89% yield1-55
Scheme 4.27 Microwave spirocyclisation using phosphotungstic acid to give
Br-SPINOMe.
There are several advantages to this protocol: the reduced reaction time leads
to lower decomposition and a higher yield of product. The acid also undergoes
less decomposition, so that most of it is still heterogeneous, making it easier to
extract the product into solution. The catalyst could be recovered and recycled
for the same reaction, with no significant loss of activity over five cycles.
Column chromatography (Hex:EtOAc 9:1) following spirocyclisation has been
found to be the best purification step. Unfortunately, this only gave a 35%
recovery of material, but in very high purity. This sample was recrystallised
slowly from DCM to give a single crystal suitable for X-ray crystallography. The
3D structure of Br-SPINOMe is thus given below (Fig. 4.7).
Fig. 4.7 Single crystal X-ray spectrum of 4,4’-dibromo-7,7’-dimethoxy-1,1’-
spirobiindane after recrystallisation (DCM).
The X-ray crystal structure makes the environment around the methoxy
groups clear, and they are closer in space than may be evident from diagrams
representing their structure. The two spirobiindane rings are almost orthogonal
to each other, with the twist at the quaternary spiro carbon.
With these vastly improved conditions, we returned to the original substrate
for the spirocyclisation, 1,5-bis(2-bromo-5-hydroxyphenyl)pentan-3-one. This
was performed with the heteropolyacid, using the same microwave conditions
as above (Scheme 4.28).
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OOH OH
Br Br
Br
OH
OH
Br
H3PW12O40 (0.15 equiv.)
Toluene, µW
1 h @ 150 °C
1-59, 99% yield3-11
Scheme 4.28 Microwave spirocyclisation using phosphotungstic acid to give
Br-SPINOL.
The spirocycle was obtained in an extremely high isolated yield of 99%.
4.6 Debromination of Br-SPINOMe
A double debromination of the spirobiindane was attempted first on a small scale
(0.71 mmol), then later scaled up to 1.38 mmol. The reaction was performed
under N2 with dry solvent, and the starting material was stirred for 1 h at -78
◦C with n-butyllithium (Scheme 4.29). A colour change was observed almost
immediately after the addition of n-BuLi, from pale yellow to dark orange.
OMe
OMe
Br
Br
nBuLi (4 equiv.)
Dry THF, N2
-78 °C, 1 h OMe
OMe
1-57, 60-90%1-56
Scheme 4.29 Debromination of o-BrSPINOMe with BuLi.
The product obtained following work-up was a white solid, and 1H and 13C
NMR spectroscopy showed that the data obtained matched the literature data.
The product was fully assigned by 1H and 13C NMR spectroscopy.
Since it had previously been observed that it was possible to remove aromatic
bromine atoms in the H-Cube R© reactor with a 10% Pd/C catalyst, it was hy-
pothesised that this might form the basis for a more straightforward deprotection
method. The first attempt used a 10% Pd/C catalyst cartridge (Scheme 4.30).
H2O O2
H-Cube
H210% Pd/C
0.056 mol dm-3, 20 °C 
2.0 mL min-1, full H2
OMe
OMe
Br
Br
OMe
OMe
OMe
OMe
Br
EtOAc
1-56 1-57 4-6
Scheme 4.30 Debromination of Br-SPINOMe using the H-Cube R© reactor.
When analysed, 39% of the mixture obtained was determined to be starting
material by 1H NMR spectroscopy. The remaining 61% was made up of product
(39%) and monobrominated intermediate (22%). Therefore more forcing con-
ditions and/ or additional passes through the H-Cube R© reactor were deemed
necessary.
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Later attempts considered a range of temperatures, and varied the number of
passes through the H-Cube R© reactor (Scheme 4.31).
H2O O2
H-Cube
H210% Pd/C
x mol dm-3, y °C 
2.0 mL min-1, full H2
OMe
OMe
Br
Br
OMe
OMe
OMe
OMe
Br
EtOAc
1-56 1-57 4-6
Scheme 4.31 Screening conditions for the debromination of Br-SPINOMe us-
ing the H-Cube R© reactor.
The results are summarised in the table (Table 4.2) and graph below (Fig. 4.8).
Table 4.2 Removal of bromides from Br-SPINOMe in the H-Cube R© reactor.
Entry Concentration/
mol dm−3
Temperature/
◦C
Number
of
passes
% Start-
ing ma-
terial
% Inter-
mediate
% Prod-
uct
1 0.054 30 1 0 78 22
2 0.055 30 1 0 85 15
3 0.055 30 2 0 37 63
4 0.055 30 3 0 17 83
5 0.055 30 4 0 18 82
6 0.054 50 1 0 35 65
7 0.024 60 1 0 93 7
8 0.024 60 2 0 90 10
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Fig. 4.8 Ratios between intermediate and product in the debromination of Br-
SPINOMe. No starting material was observed in any of these reactions.
By increasing the temperature to >30 ◦C, it can be seen that no unreacted
starting material was left. Further optimisation of concentration and temperature
is required to maximise the conversion to product, but the above results are
promising.
4.7 Deprotection of SPINOMe
The final step in the synthesis of o-(±)-SPINOL is the deprotection of the two
methoxy groups.
Following the existing literature procedures, this reaction required the use of
boron tribromide, which is a particularly unpleasant reagent to work with, due to
the release of HBr fumes when exposed to air. The reaction was first attempted
on a small scale (0.21 mmol), then later scaled up to 0.50 mmol (Scheme 4.32).
OMe
OMe
OH
OH
BBr3 (1 M in DCM) (2.5 equiv.)
-78 °C to RT, 20 h
N2, DCM
1-42, 38%1-57
Scheme 4.32 Deprotection of SPINOMe with BBr3 to give o-(±)-SPINOL.
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Work-up was easier at the smaller scale, as the organic solution had to be
washed with a large volume of water (approx. 500 mL for even the 0.21 mmol
scale) to remove any acidic reagents. This led to a higher yield of 38% as opposed
to around 20% for the larger scale reaction. The product was obtained as a
pale yellow oil, which was fully assigned by 1H and 13C NMR spectroscopy and
confirmed as o-(±)-SPINOL by comparison with literature data.
4.8 Conclusions on the
3-methoxybenzaldehyde route
Reversing the literature reaction order did not provide any significant benefits
over the previous route but several successful reactions were identified.
The aldol reaction was improved on by using the Dolliver-Ding conditions
developed during the synthetic route starting from 3-hydroxybenzaldehyde. It
gave a better quality product after a shorter reaction time.
After optimisation of the reduction step using the H-Cube R© reactor, condi-
tions allowed 12.048 g of material to be processed in 137 mins in a 97% yield.
This is therefore a far more efficient method for the reduction of 1,5-bis(3-
methoxyphenyl)penta-1,4-dien-3-one than the literature batch reduction. It is
also safer, as the Raney Ni was sealed in a catalyst cartridge and thus required
no handling by the user.
A more successful bromination method was developed using NBS rather than
molecular bromine as was used in the literature procedure. The time of the NBS
reaction was not as heavily dependent on scale as the bromine reaction and once
the reaction was run at higher concentrations, the yield of the NBS reaction was
higher than with bromine. The product obtained was of higher purity by 1H NMR
spectroscopy. Finally, NBS and acetonitrile are safer to handle than bromine and
DCM.
In agreement with the existing literature on the spirocyclisation of the pen-
tanone, phosphotungstic acid was found to be more successful than polyphos-
phoric acid as the reagent. Eaton’s reagent was not useful in this context. It
was found that the bromine substitution on the aromatic rings was necessary to
ensure the desired ortho regioselectivity during spirocyclisation.
Double debromination of the spirocycle was attempted in the H-Cube R© re-
actor, and whilst further work is required to optimise the concentration and tem-
perature to maximise the conversion to product, the initial results are promising.
As yet, the only demethylation procedure attempted replicates the literature
method which uses BBr3. It would be highly desirable to substitute this reagent
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for something milder, and so future work will be performed in this area.
The overall route is shown in the scheme below (Scheme 4.33).
OMe
CHO
O
OMe OMe
Acetone (0.5 equiv.)
10% NaOH
EtOH
25 °C
O
OMe OMe
10% Pd/ C or
Raney Ni
O
OMe OMe
Br Br
NBS (2.5 equiv.)
Br
OMe
OMe
Br
OMe
OMe1) nBuLi (4 equiv.)
THF, -78 °C
2) EtOH OH
OHBBr3 (2.5 equiv.)
CH2Cl2
racemic
1-53, 100% crude
(67% purified)
1-56
89% yield
1-57, 75-90% 1-42, 73%
MeCN, RT
-78 °C to RT
1-54, 97%1-55, 100%
EtOAc
H2O O2
H-Cube H2
3.0 mL min-1, 60 °C
1 bar, full H2, 0.05 mol dm-3
H3PW12O40 
(0.15 equiv.)
Toluene, µW
1-52
Scheme 4.33 Overall reaction scheme to o-(±)-SPINOL. Reagents shown in
red are safer or more scalable than their equivalent in the literature procedure.
Reagents in purple remain problematic.
The benefits of this route are that in proceeds in 6 steps and 32% overall yield
(c.f. literature route: 6 steps, 28% overall yield). It incorporates flow technology
and is safer, with improved yields, robustness and reproducibility. It is also more
easily scaled.
55
Chapter 5
Synthesis of SPINOL using
Chiral Diols as Auxiliaries
5.1 Introduction
Since the ketone functional group is the site of intramolecular Friedel-Crafts ad-
dition by two aromatic rings, it was suggested that modification of the ketone to
create diastereoselectivity in the intermediate may lead to overall enantioselec-
tivity during this spirocyclisation step. The two obvious derivatives are imines
(formed by the reaction of the ketone with an amine) and acetals (formed by the
reaction of the ketone with a diol).
The imine route was envisaged as shown below (Scheme 5.1).
OR
O
OR OR OR
OH
OH
N
R'
OR
OR
OR
NHR'
OR
X X X X
X
X
X
X
diastereomeric
*
*
chiral, non-racemic
*
1-42
Scheme 5.1 Postulated imine-based spirocyclisation.
Early investigations into the feasibility of imine formation identified some
issues. It was not possible to analyse the postulated imine product by 1H
NMR spectroscopy as the shift values of protons did not change sufficiently
(Scheme 5.2). Instead, IR spectroscopy had to be used to confirm the identity of
the product.
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OBr
OMe
Br
OMe
Ph NH2
(1 equiv.)
Toluene, reflux
NBr
OMe
Br
OMe
Ph
1-55 5-1
Scheme 5.2 Synthesis of the imine.
Subsequent attempts at spirocyclisation of the imine intermediate using p-
TsOH were not successful, and in most cases simply led to regeneration of the
ketone starting material.
Therefore instead of investing more time working on this reaction, acetal for-
mation was considered as a more promising alternative. As a simple model process
ethylene glycol was used as a test diol substrate (Scheme 5.3).
Br
OMe
O Br
OMe
HO OH
Camphorsulfonic acid 
(0.43 equiv.)
Toluene
Reflux
(5 equiv.)
Br
OMe
Br
OMe
OO
5-2, 70-90%1-55
Scheme 5.3 Formation of an acetal using ethylene glycol.
Under typical acetal-forming conditions, the resulting acetal was synthesised
in 70-90% yield without purification. It was also possible to perform the acetali-
sation in the microwave (Scheme 5.4), and the reaction was optimised by reducing
the equivalents of ethylene glycol (Table 5.1).
Table 5.1 Reducing the equivalents of ethylene glycol during microwave acetal-
isation
Scheme 5.4 Microwave formation of an acetal using ethylene glycol.
Br
OMe
Br
OMe
O
HO OH (x equiv.)
CSA (0.43 equiv.)
Toluene
µW, 130 °C, 30 mins
Br
OMe
Br
OMe
OO
1-55 5-2
Entry x equivalents of EG Conversion by 1H NMR spectroscopy (no in-
ternal standard)
1 5 58%
3 1.5 61%a
3 1.5 82%
a20 mins of heating instead of 30.
The acetal underwent spirocyclisation both in batch and the microwave to
give Br-SPINOMe in moderate yields as shown below (Scheme 5.5).
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Br
OMe
Br
OMe
OO
Br
OMe
OMe
Br
H3PW12O40 
(0.15 equiv.)
Toluene, reflux
1-56, 70% conversion
57% yield
5-2
Scheme 5.5 Spirocyclisation of the acetal in batch.
The diols required for acetal formation must be chiral to impart chirality into
the intermediate, which has previously been achiral. α-Amino acids (judiciously
chosen) can be derivatised to give chiral diols (Fig. 5.1).
HO OH
R
HO OH
R
O
HO NH2
R
O
Fig. 5.1 Retrosynthesis of a chiral diol to identify an amino acid as a suitable
substrate.
They have the advantage of the enantiopure l-amino acid being relatively
cheap, and readily available. A variety of diols could be synthesised from a range
of amino acids. Specific amino acids were selected by applying the following
criteria:
1. Amino acid must be chiral
2. R-group must not contain -XH groups
3. R-group must be non-charged
4. R-group must be non-aromatic
5. R-group must be ‘sufficiently’ sterically bulky
The last of these is deliberately left somewhat open to interpretation. Of
the twenty naturally-occurring α-amino acids, these criteria eliminate all but
isoleucine, leucine, valine and phenylalanine. Isoleucine was unavailable in the
laboratory at the time, and so the other three became the focus of investigation.
Phenylalanine breaks the fourth criterion above, but was included for testing re-
gardless, since it is thought to be unlikely that the aromatic C-H bonds will be
correctly oriented to cause side-reactions during the Friedel-Crafts step (Fig. 5.2).
HO
O
NH2
HO
O
NH2
HO
O
NH2
L-Valine, 5-3 L-Leucine, 5-4 L-Phenylalanine, 5-5
Fig. 5.2 Amino acids selected for diol synthesis.
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Amino acids will be considered as both the racemic starting material and the
enantiopure l-amino acid. The first step in derivatisation is the conversion of
the amine group to an alcohol. There is literature precedent for the reaction of
valine77 with sodium nitrite to give the desired α-hydroxy acid (Scheme 5.6).
HO
O
NH2
HO
O
OH
NaNO2
H2SO4, H2O
5-3 5-6
Scheme 5.6 Literature conversion of valine to the α-hydroxy acid.
The second step is the reduction of the carboxylic acid to the corresponding
alcohol, which there is again literature precedent for when using NaBH4 and I2
(Scheme 5.7).78
HO
O
OH
HO
OH
NaBH4, I2
THF
5-6 5-12
Scheme 5.7 Literature reduction of the α-hydroxy acid to the diol.
The different amino acids will be discussed below.
5.2 L-Amino acids
The mechanism of Step 1 proceeds via two inversion steps so that the overall
stereochemistry is retained. However, racemisation may occur and so the prod-
uct’s enantiopurity was confirmed. The first approach was to use chiral amines
to form a diastereomeric salt and assessment by 1H NMR spectroscopy.
Further attempts were made to directly measure the enantiopurity of the
amino acid derivatives by chiral HPLC but this was not successful. After a liter-
ature search, work by Ley et al. identified the possibility of derivatisation of the
α-hydroxy acids as benzyl esters, followed by chiral HPLC as a method of deter-
mining the e.e.79 Both the enantiopure and racemic derivatives were synthesised
to enable comparison of the chiral HPLC results.
To determine the enantiopurity of the α-hydroxy acid, it was converted to the
benzyl ester and submitted for chiral HPLC (Scheme 5.8).
HO
O
OH
BnO
O
OH
BnBr (1.1 equiv.)
Cs2CO3 (1.5 equiv.)
Dry DMF
0 °C to RT
5-10, 32%5-7
Scheme 5.8 Synthesis of the leucine-derived benzyl ester.
59
Salt formation was attempted with both (R)-(+)- and (S )-(–)-α-
methylbenzylamines in parallel (Scheme 5.9).
HO
O
OH
NH2
(1 equiv.)
D2O, RT, 1 h
NH2 .HO
O
OH
5-22 5-33
Scheme 5.9 Formation of a salt with (R)-(+)-α-methylbenzylamine.
Analysis of the 1H NMR spectra of the two compounds confirmed salt forma-
tion due to the shifting of several important peaks, and only one diastereomer was
observed. This was evidence that the original α-hydroxy acid was enantiomeri-
cally pure and had formed without scrambling of stereochemical information.
The first attempt at reduction of l-Val-ol used NaBH4 and I2, following a liter-
ature procedure;80 however, no conversion was observed. The reduction was suc-
cessfully completed by using lithium aluminium hydride. The yield was improved
from around 20% to >40% by altering the work-up from an ethanol quench, evap-
oration and extraction with DCM/NaCl(aq). Feiser work-up conditions use a
sodium hydroxide wash and magnesium sulfate to prevent contamination of the
product with lithium salts.81 The resulting diol was then reacted with the pen-
tanone. After purification by column chromatography, the acetal was obtained
in low yield but was fully characterised. The acetal-forming reaction was also
performed in the microwave. Once formed, the acetal was reacted to undergo
spirocyclisation in the microwave with the heteropoly acid H3PW12O40.
The procedure was repeated, substituting l-valine for l-leucine, and subse-
quently for l-phenylalanine. The results are summarised in the scheme below
(Scheme 5.10).
O
HO
R
NH2
NaNO2 (6 equiv.)
0.5 M H2SO4
H2O, 0 °C to RT, o/n O
HO
R
OH
BnO
O
R
OH
BnBr (1.1 equiv.)
Cs2CO3 (1.5 equiv.)
Dry DMF
0 °C to RT
HO
R
OH
LiAlH4 (2.5 equiv.)
Et2O
0 °C to RT
+ Feiser work-up
Br
OMe
Br
OMe
OO
R
Br
OMe
Br
OMe
O
Camphorsulfonic acid 
(0.43 equiv.)
Toluene
Reflux o/n
   OR
µW, 30 mins at 130 °C
Val, 5-15: 28% (batch); 67% (crude; µW)
Leu, 5-16: 89% (batch)
Phe, 5-17: quantitative (batch)
(0.67 equiv.)
Val, 5-6: 47%
Leu, 5-7: 65-71%
Phe, 5-8: 69-74%
Val, 5-9: 57% (crude)
Leu, 5-10: 32%
Phe, 5-11: 28%
Val, 5-12: 65%
Leu, 5-13: 58%
Phe, 5-14: 56%
Br
OMe
OMe
Br
H3PW12O40 (0.15 equiv.)
Toluene
Reflux o/n
OR
µW, 60 mins at 150 °C
Val: 49% (µW)
Leu: 21% (batch); 48% (µW)
Phe: 79% (batch)
Val, 5-3 
Leu, 5-4
Phe, 5-5
1-41
1-40
Scheme 5.10 Reactions involving l-amino acids discussed here.
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5.3 Racemic Amino Acids
The synthetic protocol was repeated, using racemic valine, leucine and phenylala-
nine for comparison purposes. The results are summarised in the scheme below
(Scheme 5.11).
O
HO
R
NH2
NaNO2 (6 equiv.)
0.5 M H2SO4
H2O, 0 °C to RT, o/n O
HO
R
OH
BnO
O
R
OH
BnBr (1.1 equiv.)
Cs2CO3 (1.5 equiv.)
Dry DMF
0 °C to RT
HO
R
OH
LiAlH4 (2.5 equiv.)
Et2O
0 °C to RT
+ Feiser work-up
Br
OMe
Br
OMe
OO
R
Br
OMe
Br
OMe
O
Camphorsulfonic acid 
(0.43 equiv.)
Toluene, reflux o/n
Val, 5-30: 28%
Leu, 5-31: 89%
Phe, 5-32: quantitative
(0.67 equiv.)
Val, 5-21: 47%
Leu, 5-22: 60%
Phe, 5-23: 57%
Val, 5-24: 21%
Leu, 5-25: 50%
Phe, 5-26: 41%
Val, 5-27: 23%
Leu, 5-28: 56%
Phe, 5-29: 56%
Val, 5-18
Leu, 5-19
Phe, 5-20
1-40
Scheme 5.11 Reactions involving racemic amino acids discussed here.
5.4 Chiral HPLC results
Chiral HPLC was performed on a number of samples of the benzyl hydroxy esters,
varying the solvent conditions to obtain the optimum separation.
The benzyl ester amino acid derivatives were analysed by chiral chromatog-
raphy (80% hexanes, 10% ethanol, 10% dichloromethane). The results did not
allow meaningful conclusions to be drawn. Poor results were obtained from the
chiral HPLC with the selected column. Other columns and solvent systems still
require testing.
The enantiomers of Br-SPINOMe have previously been separated by analyt-
ical chiral HPLC. We were therefore able to use the same procedures to analyse
our reaction products (Table 5.2).
Table 5.2 Outcomes of chiral HPLC of spirocycles
Starting material Heating method Outcome of chiral HPLC
Ketone Batch and/ or mi-
crowave
ee = 1.7%
(Hexane:dCM 99.25:0.75)
Phe-acetal Batch ee = -9.7% (Hexane:DCM 98:2) a
Leu-acetal Batch ee = -18.2% (Hexane:DCM 98:2)
Leu-acetal Microwave ee = -10.1% (Hexane:DCM 98:2), -
7.1% (Hexane:DCM 99.25:0.75)
Val-acetal Microwave ee = -8.4% (Hexane:DCM 98:2)
aPoor quality
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5.5 Conclusions
A variety of chiral diol derivatives were synthesised from the naturally-occurring
l-amino acids, valine, leucine and phenylalanine. These derivatives were used in
acetalisation reactions with 1,5-bis(2-bromo-5-methoxyphenyl)pentan-3-one. The
acetal products were subjected to spirocyclisation reaction conditions using a het-
eropoly acid, with either microwave or standard hot-plate heating. Chiral HPLC
data was not reliable enough to be able to determine whether enantioselectivity
has been induced in the spirocycle product.
Since this work was performed, a report was published6 which synthesised a
wider range of acetals than was possible here. Some of these were used to induce
enantioselectivity in the spirocyclisation reaction, proving that our concept was
viable.
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Chapter 6
Synthesis of SPINOL via an
indanone intermediate
6.1 Introduction and rationale
Retrosynthetic analysis implies that an alkene intermediate could be synthesised
from 3-methoxybenzaldehyde by the following route involving a key Wittig cou-
pling reaction (Scheme 6.1).
Br
OMe Br
MeO
Br
OMe O
Br
OMe
X
+
Br
OMe
X
O
Br
OMe
X
O Br
OMe
H
O
OMe
H
O
4-1 1-52
Scheme 6.1 Retrosynthesis of the alkene.
The corresponding forward synthetic route could proceed as shown below
being divergent from the intermediate bromide (Scheme 6.2).
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OMe Br
MeO
Br
OMe O
Br
OMe
Br
OMe
OR
OBr
OMe
OR
OBr
OMe
H
O
OMe
H
O
OR
Br
OMe
Br
1-52 4-1 6-2
6-1
Scheme 6.2 Synthesis of the alkene, starting from 3-methoxybenzaldehyde.
The shared propanoic acid intermediate is an appealing feature of this syn-
thetic route.
6.2 Horner-Wadsworth-Emmons reactions of
3-methoxybenzaldehyde
The first step in this second route is the bromination of 3-methoxybenzaldehyde
(Scheme 6.3). This reaction had been attempted previously (Section 4.1), but a
new method was attempted during this project which gave higher yields and a
product of improved quality.82
OMe
H
O
NBS (1.68 equiv.)
DMF, RT
OMe
H
OBr
4-1, 76%1-52
Scheme 6.3 Bromination of 3-methoxybenzaldehyde.
The crude product was recrystallised from IPA to give sparkly, needle-like
white crystals. The same reaction was repeated on a larger scale to give a 94%
yield of crude product which gave a 55% recovery following recrystallisation.
3-Methoxybenzaldehyde and 2-bromo-5-methoxybenzaldehyde were reacted
with triethylphosphonoacetate using a Horner-Wadsworth-Emmons reaction to
give the corresponding propenoates. The propenoates were then reduced using
tosyl hydrazide in a biphasic reaction mixture (Scheme 6.4).
OMe
H
O EtO P
O
OEt
O
EtO
(2.44 equiv.)
LiBr (2.87 equiv.)
DBU (2.44 equiv.)
MeCN, RT OMe
OEt
O
X = H, 6-3; 94%
X = Br, 6-4; 99%
X
OMe
OEt
O
TsNHNH2 (3 equiv.)
NaOAc (4.5 equiv.)
THF:H2O 1:1
Reflux
X = H, 6-5; 88%
X = Br, 6-6; 82-98%
X X
X = H, 1-52
X = Br, 4-1
Scheme 6.4 Horner-Wadsworth-Emmons reaction with 3-
methoxybenzaldehyde or 2-bromo-5-methoxybenzaldehyde, followed by reduction
of the resulting propenoate.
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After purification by column chromatography (pet. ether:EtOAc 4:1), the
non-brominated propenoate was obtained as a pale yellow oil in excellent yield,
whereas the brominated propenoate was obtained as a white solid with a melting
point close to room temperature. After purification by column chromatography
(hexanes:EtOAc 8:2), the non-brominated propanoate was obtained as a colour-
less oil in excellent yield whilst the brominated propanoate was found to exist as
a waxy white solid.
Previous attempts at saponification of the propanate undertaken by an under-
graduate student∗ had used 8 equivalents of NaOH, refluxing in EtOH to obtain
the acid product. Milder conditions were also found to furnish the product in a
similar yield and reaction time (Scheme 6.5).
OMe
OEt
OBr
OMe
OH
OBr
6-7, 74%
NaOH (4.0 equiv.)
EtOH, RT
6-6
Scheme 6.5 Saponification of the ester to give the acid.
In addition, the product was of a higher quality than the material isolated
under the previous harsher conditions, and after recrystallisation furnished a
sparkly, needle-like white crystalline solid where it had previously been orange.
However, it was discovered that the reaction required wet NaOH. Wet NaOH
may have been the source of water in previously successful reactions, and thus
reducing the amount of NaOH had inadvertently reduced the amount of water
present. Various cyclisation reactions were attempted (Scheme 6.6), and the
results are summarised in the table below (Table 6.1).
The reaction of the acid with Eaton’s reagent gave a mixture of two prod-
ucts by 1H NMR spectroscopy, in the ratio 56:44 (Fig. 6.1). The major product
was identified as the desired indanone by comparison. The unknown product
was thought to be due to a side-reaction between the acid starting material and
methanesulfonic acid. It appears to contain three aromatic protons from the
1H NMR spectrum, and thus has not cyclised. When repeated, heating for an
additional hour gave a mixture of these same products in the ratio 72:28 (in-
danone:impurity). The impurity was removed via purification by column chro-
matography (Hex:EtOAc 1:1) to give the indanone product in 50% isolated yield.
∗Joshua Goswell, Durham University, 2014-15
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Table 6.1 Screening conditions for the synthesis of 1-indanone
Scheme 6.6 Cyclisation of the acid or ester to 1-indanone.
OMe
OR
OBr
Reagent
Temperature
OMe
Br
O
R = H; 6-7
R = Et, 6-6
6-1
Entry Starting
material
Reagent % Conversion to indanone
1 Acid Polyphosphoric acid 100a
2 Acid Eaton’s reagent See Fig. 6.1
3 Acid H2SO4 100
b
4 Acid H3PW12O40 0
5 Ester Polyphosphoric acid 5
6 Ester Eaton’s reagent 6
7 Ester H3PW12O40 0
a32-47% isolated yield
b<10% isolated yield
6.556.606.656.706.756.806.856.906.957.007.057.107.157.207.257.307.357.407.457.507.557.607.657.707.757.80
f1 (ppm)
1
2
3
D (dd)
6.68
E (d)
6.85
F (d)
7.44
0.
62
0.
65
0.
57
Indanone product
Acid starting material
Crude mixture from reaction of acid with Eaton's reagent
Fig. 6.1 Comparison between starting material, target compound and the crude
mixture obtained from the reaction of the acid with Eaton’s reagent.
The reduction of the ester to the corresponding alcohol has been attempted
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several times, and gave the alcohol in high yields without the need for further
purification. The Appel reaction was then utilised to convert the alcohol to the
bromide as shown below (Scheme 6.7).
OEt
OBr
OMe
LiAlH4 (1.0 equiv.)
THF, 0 °C to RT
OH
Br
OMe
6-8, 90%, 98%6-6
PPh3 (1.2 equiv.)
CBr4 (1.1 equiv.)
DCM
0 °C to RT, o/n
Br
Br
OMe
6-2, 81%, 84%
Scheme 6.7 Reduction of the ester followed by conversion of the alcohol to the
corresponding bromide.
The reaction gave the corresponding bromide product in high yields after
purification by column chromatography.
The subsequent transformation to the phosphonium bromide salt was readily
realised and was performed several times by refluxing the bromide in toluene with
PPh3 (Scheme 6.8). Upon cooling the product precipitated from the organic
solvent, and thus was easy to perform on a larger scale. The crude solid was
purified by recrystallisation from H2O to give an isolated yield of 51%.
PPh3 (1.0 equiv.)
Toluene, refluxBr
Br
OMe
6-9, 51%
PPh3
Br
OMe
Br-
6-2
Scheme 6.8 Formation of the phosphonium bromide salt.
Having successfully prepared the phosphonium salt, we next screened reac-
tion conditions for the formation of the ylid based upon literature conditions for
related compounds.83 Our first attempts were with BuLi.
Br
OMe
PPh3
Br
OMe
Br-
O
Br
OMe
Br
OMe
15% conversion
2) 6-1
(1.0 equiv.)
1) BuLi (1.0 equiv.)
THF, 0 °C to RT
6-9
Scheme 6.9 First attempt at the Wittig reaction.
After 20 mins, 1H NMR spectroscopy of the crude material (column,
Hex:EtOAc 9:1) indicated the presence of an alkene but significant amounts of
starting materials. The reaction was therefore attempted again with a longer
running time. The starting materials were not very soluble in THF so a change
of solvent could be more successful.
As a precaution, the BuLi was titrated against N−benzylbenzamide. The
concentration was found to be 2.45 M, close to the quoted 2.5 M. This could
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therefore not be the source of the low conversions. The equivalents of BuLi were
increased to 1.2 from 1.0 and the reaction was repeated, giving the same result.
Next, to test whether ylid formation from the combination of the phosphonium
bromide with BuLi was the issue, the reaction was attempted with a longer
incubation time of these reagents. A model acceptor system was also employed,
using benzaldehyde as a more reactive capture agent and varying the number of
equivalents.
Assessment of the 1H NMR spectrum indicated low conversion of the ben-
zaldehyde to the alkene (<20%), as well as formation of additional side-products.
We considered that perhaps butyllithium as a base may be too strong and
may be causing decomposition and side-reactions. It was therefore exchanged for
potassium tert-butoxide, and the reaction repeated (Scheme 6.10).
Br
OMe O
Br
OMe
PPh3
6-10, (1.1 equiv.)
KOtBu (1.1 equiv.)
Et2O
0 °C to RT
6-1
Scheme 6.10 Attempted Wittig reaction using potassium tert-butoxide.
However, analysis of the crude reaction mixture indicated only the indanone
and the phosphonium starting materials.
It was hypothesised that the phosphonium bromide could be responsible for
preventing the successful Wittig reaction. An alternative approach is the Horner-
Wadsworth-Emmons reaction, a variant of the Wittig reaction that uses a phos-
phonate ester as a starting material.
The phosphonate ester was therefore synthesised from the bromide by the
Arbuzov reaction (Scheme 6.11).
Br
OMe
Br P(OEt)3 (1 equiv.)
Reflux, 150 °C
24 h
Br
OMe
P
O
EtO OEt
6-10, 100% crude yield6-2
Scheme 6.11 Arbuzov reaction in the synthesis of the phosphonate ester
derivative.
The phosphonate ester synthesised above was then reacted with cyclopen-
tanone as a model substrate (Scheme 6.12).
O
Br
OMe
P
6-10 (1.1 equiv.)
BuLi (1.2 equiv.)
Dry THF
-78 °C to RT
O
EtO OEt
6-11
Scheme 6.12 Attempted Horner-Wadsworth-Emmons reaction using the phos-
phonate ester and cyclopentanone.
68
No conversion to the alkene was observed by 1H NMR spectroscopy.
6.3 Alternative route to the propenoate
Whilst searching for an improved method to synthesise the unsaturated ester, it
became apparent that the Knoevenagel condensation would provide a ‘shortcut’
to the unsaturated acid, giving the product in fewer steps and therefore poten-
tially higher overall yield. The success of this route depended on whether it was
still possible to reduce the unsaturated acid to the saturated acid, and whether
it was easy to subsequently reduce the saturated acid to the necessary alcohol.
If this were true, the saturated acid could act as the common intermediate in
the overall reaction scheme. Furthermore, the saponification of the equivalent
ester had been troublesome, and so this would also circumvent this reaction. The
Knoevenagel condensation using the Doebner modification proceeded as shown
below (Scheme 6.13).
R H
O OR1
O
R1O
O
Base R OR1
O
OR1O
OH-
R OH
O
Scheme 6.13 Knoevenagel/Doebner reaction.
The mechanism applied to this reaction is illustrated below (Scheme 6.14).
HO OH
OO B
HO OH
O-O
H
N
O
H
Br
OMe
N+
H
Br
OMe
HO OH
O-O
+
H
NBr
OMe
O
OH
OHO
H
Br
OMe
O
O
OHO H
-CO2
Br
OMe
C
OH
OH
Br
OMe
OH
O
H
N
6-12
6-13 4-1
6-14
Scheme 6.14 Mechanism of the Knoevenagel/Doebner reaction.
This reaction was attempted several times and gave yields from 69-94% after
purification by extraction with EtOAc to give the product as a fluffy white solid
(Scheme 6.15).84
OH
O
H
OBr
OMe
HO OH
O O Piperidine
Br
OMe
Pyridine
Reflux
- CO2
6-14, >69% yield4-1 6-12
Scheme 6.15 Knoevenagel/Doebner reaction.
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This protocol was also successfully employed with 2-bromo-5-
hydroxybenzaldehyde as the starting material (Scheme 6.16).
OH
O
H
OBr
OH
HO OH
O O Piperidine
Br
OH
Pyridine
Reflux
- CO2
6-14, 95% crude4-1 6-12
Scheme 6.16 Knoevenagel/Doebner reaction.
The product was obtained in 95% yield without purification.
The biphasic reduction conditions that use tosyl hydrazide were also success-
fully applied to the reduction of the unsaturated acid (Scheme 6.17).
TsNHNH2 (3 equiv.)
NaOAc (4.5 equiv.)
THF:H2O (1:1)
Reflux
OH
OBr
OMe
6-7, 86% yield
OH
OBr
OMe
6-14
Scheme 6.17 Conjugate reduction.
Gratifyingly, the reaction was successful and thus repeated several times, on
increasing scales. The product was obtained in high yields (86%, quantitative)
after purification by column chromatography.
The initial attempt at the reduction of the saturated acid used 1.0 equivalents
of LiAlH4 as in the ester reduction (Scheme 6.18). The alcohol was obtained in
88% yield.
OH
OBr
OMe
LiAlH4 (1.0 equiv.)
Dry THF, RT
OH
Br
OMe
6-8, 88% yield6-7
Scheme 6.18 Reduction.
When repeated with purification to remove lithium salts, the yield decreased
to 49%. Increasing the equivalents of LiAlH4 from 1.0 to 3.0 gave the alcohol and
an undesired by-product (unidentified) and thus was significantly less successful.
6.4 Conclusions on Route 2
Several different approaches to the precursors to the Wittig reaction have been
successfully completed. Several steps proceed in excellent yield, and have given
access to previously undocumented compounds. Several common intermediates
were identified: first, the ethyl ester, and later, the propanoic acid, from which
the syntheses branched out (Scheme 6.19).
70
OMe
H
O Br
OMe
H
O
NBS (1.68 equiv.)
4-1, 76%
DMF, RT, 18 h
EtO P
O
OEt
O
EtO
(2.44 equiv.)
LiBr (2.87 equiv.)
DBU (2.44 equiv.)
MeCN, RT OMe
Br
OEt
O
6-3, 99%
OMe
OEt
O
TsNHNH2 (3 equiv.)
NaOAc (4.5 equiv.)
THF:H2O 1:1
Reflux
Br
6-6, 95%
OMe
OH
OBr
6-7, 77%
NaOH (8.0 equiv.)
EtOH, reflux
OMe
OH
Br
OMe
Br
Br
Br
OMe O
Polyphosphoric acid
OMe
PPh3
Br
Br-
Br
OMe Br
OMe
Br
OMe
OMe
Br
OH
OH
6-8, 98%
6-2, 84%6-9, 51%
6-1, 47%
LiAlH4 (1.0 equiv.)
THF
0 °C to RT
CBr4 (1.1 equiv.)
PPh3 (1.2 equiv.)
DCM
0 °C to RT
PPh3 (1.0 equiv.)
Toluene
Reflux
BuLi (1.0 equiv.)
THF
0 ° to RT
60 °C
Approx. 15% conversion
1-52
1-56
1-42
Scheme 6.19 Route 2 to SPINOL.
This project may yet yield the spirocyclic product. Work is required to de-
velop the Wittig reaction into a successful procedure with higher conversions than
observed here. Once this is complete, enantioselective cyclisations using metal
catalysts with chiral ligands can be investigated.
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Chapter 7
Conclusions
The synthesis of 1,1’-spirobiindane-7,7’-diol has been improved over the litera-
ture protocols. Key to this success is the use of continuous flow technologies: the
H-Cube R© has been used to great effect in this synthesis, removing the need
for handling dangerous Raney nickel. Interconversions between related com-
pounds have opened up new avenues of discovery. It is possible to synthesise
SPINOL from a range of starting materials, proceeding via different routes. 3-
Hydroxybenzaldehyde has been demonstrated to be a viable starting material for
the synthesis of Br-SPINOL, from which it should be theoretically possible to
reach SPINOL. These procedures have been thoroughly tested, and shown to be
more reliable and reproducible than those already published.
These findings are summarised in the diagram below.
OH
CHO
O
OH OH
Acetone (0.5 equiv.)
10% NaOH
EtOH
25 °C
O
OH OH
10% Pd/ C or
Raney Ni
O
OH OH
Br Br
NBS (2.5 equiv.)
Br
OH
OH
Br
OH
OH
3-2, 100% crude
(64% purified)
1-59, 99% yield
MeCN, 0 °C
3-1, 90%3-12, 88%
EtOH
H2O O2
H-Cube H2
2.0 mL min-1, 20 °C
1 bar, full H2
H3PW12O40 
(0.15 equiv.)
Toluene, µW
1 h @ 150 °C
3-3
1-42
Scheme 7.1 Overall reaction scheme to o-(±)-Br-SPINOL. Reagents shown in
red are safer or more scalable than their equivalent in the literature procedure.
The literature route to SPINOL has also been improved, and these are sum-
marised in the scheme below.
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OMe
CHO
O
OMe OMe
Acetone (0.5 equiv.)
10% NaOH
EtOH
25 °C
O
OMe OMe
10% Pd/ C or
Raney Ni
O
OMe OMe
Br Br
NBS (2.5 equiv.)
Br
OMe
OMe
Br
OMe
OMe1) nBuLi (4 equiv.)
THF, -78 °C
2) EtOH OH
OHBBr3 (2.5 equiv.)
CH2Cl2
racemic
1-53, 100% crude
(67% purified)
1-56
89% yield
1-57, 75-90% 1-42, 73%
MeCN, RT
-78 °C to RT
1-54, 97%1-55, 100%
EtOAc
H2O O2
H-Cube H2
3.0 mL min-1, 60 °C
1 bar, full H2, 0.05 mol dm-3
H3PW12O40 
(0.15 equiv.)
Toluene, µW
1-52
Scheme 7.2 Overall reaction scheme to o-(±)-SPINOL. Reagents shown in
red are safer or more scalable than their equivalent in the literature procedure.
Reagents in purple remain problematic.
This route proceeds in 6 steps and 32% overall yield (c.f. literature route: 6
steps, 28% overall yield).
When attempting to enantioselectively synthesise SPINOL, two approaches
were considered: using amino acid-derived chiral diols in a chiral auxiliary-based
strategy, and cyclisation of an alkene. Ultimately, neither were successful in se-
lectively synthesising (+)- or (–)-SPINOL, but progress was made in both cases.
In the chiral diol work, another group were later able to enantioselectively syn-
thesise SPINOL using a very similar approach, demonstrating that our concept
was sound. More work is required on the alkene-based indanone route, and it
may still be possible to synthesise SPINOL by this approach.
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Chapter 8
Future Work
If the debromination of Br-SPINOL were completed, it would be possible to
access SPINOL from 3-hydroxybenzaldehyde in fewer steps than the equivalent
synthesis from 3-methoxybenzaldehyde. Early attempts have been made, but an
extensive testing of conditions has not been completed. If this were not possible,
the most crucial step to improve would be the demethylation from SPINOMe to
SPINOL, due to the hazardous nature of BBr3 and the low-yielding procedure.
The ‘chiral diols’ approach held promise. The related results from the Zhou
group6 need to be verified and compared to this route. The ‘indanone/alkene’
approach requires successful synthesis of the alkene intermediate, followed by
cyclisation.
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Chapter 9
Experimental
9.1 1,1’-Spirobiindane-7,7’-diol (o-SPINOL),
Compound 1-42
OH
OH
1
2
34
56
7
8
9
Chemical Formula: C17H16O2
Exact Mass: 252.12
10
Procedure:69
7,7’-Dimethoxy-1,1’-spirobiindane (o-SPINOMe, 1-57) (0.080 g, 0.29 mmol) was
charged to an oven-dried 50 mL RBF, which was then fitted with a stirrer bar and
septum. Dry DCM (2.0 mL) was charged to the RBF, which was then flushed
with N2. The solution was cooled to -78
◦C and stirred for 10 mins. BBr3 in DCM
(1.0 mL) was charged to the RBF, which was allowed to warm to RT and stirred
for 18 h. The solution was diluted with DCM (10 mL) and washed with H2O
until the washings were neutral (approximately 200 mL H2O). The pale yellow
organic solution was dried over Na2SO4, filtered and concentrated in vacuo to
give a pale yellow film.
Isolated yield: 0.027 g (0.11 mmol, 38%)
1H NMR (700 MHz, CDCl3): δ/ppm 2.16-2.22 (2 H, m, H2), 2.29-2.32 (2 H, m,
H2), 2.98-3.08 (4 H, m, H3), 4.63 (2 H, br s, H10), 6.68 (2 H, d, J = 8.0 Hz,
H7), 6.89 (2 H, d, J = 8.1 Hz, H9), 7.17 (2 H, t, J = 7.7 Hz, H8);
13C NMR (176 MHz, CDCl3): δ/ppm 31.2 (C3), 37.4 (C2), 57.5 (C1), 114.3
(C7), 117.7 (C9), 129.9 (C8), 130.5 (C4), 145.8 (C5), 152.9 (C6).
IR (neat) ν = 3327.2 (OH, br), 1230.6 (C-O, s), 997.4 (m), 778.1 (s) cm−1.
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LC-MS: Rt = 3.16 min, m/z 253.2 [MH]
+; HR-MS calculated for C17H17O2 at
253.1229, found 253.1227 (∆ = -0.8 ppm).
Reference6,69,85
76
9.2 1,5-Bis(3-methoxyphenyl)penta-1,4-dien-3-
one, Compound
1-53
OMe
O
OMe
Chemical Formula: C19H18O3
Exact Mass: 294.13
12
3
4
5
6
7
8
9
Procedure:67–69
NaOH (25.033 g, 625.8 mmol) was charged to a 1 L RBF fitted with a stirrer bar,
followed by H2O (250 mL) and the resulting solution was stirred until all the base
had dissolved. EtOH (200 mL) was charged to the RBF, and the mixture was
heated to 25 ◦C. Next 3-methoxybenzaldehyde (1-52, 15.23 mL, 125.0 mmol)
followed by acetone (4.60 mL, 62.6 mmol) were charged to the RBF and the
solution was stirred for 15 mins, after which time formation of a yellow oil was
observed. A second aliquot of 3-methoxybenzaldehyde (1-52, 15.23 mL, 125.0
mmol) then acetone (4.60 mL, 62.6 mmol) were charged to the RBF and the
solution was again stirred for 2.5 h. The solution was extracted with DCM (100
mL x 3), and the resulting organic layers were combined and washed with H2O
(100 mL x 3). The organic solution was dried over Na2SO4, filtered, and the
solvent removed in vacuo to give a yellow oil which was 97% product by 1H NMR
spectroscopy. Purification by flash column chromatography (Hex:EtOAc 80:20 to
0:100) gave the product as a bright yellow oil.
Isolated yield: 31.702 g (107.8 mmol, 86%)
1H NMR (700 MHz, CDCl3): δ/ppm 3.85 (6 H, s, H10), 6.96 (2 H, dd, J = 2.5,
8.2 Hz, H8), 7.06 (2 H, d, J = 15.9 Hz, H2), 7.13 (2 H, m, H5), 7.21 (2 H, d, J
= 7.6 Hz, H9), 7.32 (2 H, t, J = 7.9 Hz, H7), 7.70 (2 H, d, J = 15.9 Hz, H3);
13C NMR (176 MHz, CDCl3): δ/ppm 55.4 (C10), 113.3 (C5), 116.4 (C8), 121.1
(C9), 125.7 (C2), 130.0 (C7), 136.2 (C4), 143.3 (C3), 160.0 (C6), 188.9 (C1).
IR (neat) ν = 1620.7 (m, C=O), 1578.0 (s), 1593.0 (s), 1256.6 (s, C-O), 1043.3
(m, C-O), 985.0 (s), 859.8 (s), 763.8 (s), 705.8 (s), 665.6 (s) cm−1.
LC-MS: Rt = 3.77 min, m/z 295.2 [MH]
+; HR-MS calculated for C19H19O3 at
295.1334, found 295.1341 (∆ = +2.4 ppm).
Reference69,86–89
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9.3 1,5-Bis(3-methoxyphenyl)pentan-3-one,
Compound 1-54
OMe
O
OMe
Chemical Formula: C19H22O3
Exact Mass: 298.16
12
3
4
5
6
7
8
9
Flow procedure:
A stock solution was prepared from 1,5-bis(3-methoxyphenyl)penta-1,4-dien-3-
one (1-53, 12.048 g, 40.96 mmol) was dissolved in EtOAc (410 mL, 0.100 mol
dm−3). The yellow solution was passed twice through the Thales Nano H-Cube R©
reactor (Raney Ni, 3.0 mL min−1, 60 ◦C, full H2) to give 100% conversion by
1H
NMR spectroscopy. The solvent was removed in vacuo to give the product as a
pale yellow oil.
Isolated yield: 11.786 g (39.53 mmol, 97%)
Batch procedure:69
First, 1,5-bis(3-methoxyphenyl)penta-1,4-dien-3-one (1-53, 0.980g, 3.33 mmol)
was charged to a 3-necked 100 mL RBF fitted with an overhead stirrer and two
septa. Acetone (20 mL) was charged to the RBF, and the solution was degassed
with N2. Raney Ni was charged to the flask, which was then stirred for 20 mins
at RT under N2. An H2 balloon was fitted to the flask, which was then stirred at
RT for 20 h. The flask was flushed with N2, then filtered through Celite over a
scinter and rinsed with acetone. The solution was concentrated in vacuo to give
a pale yellow oil, which was 100% pentanone by 1H NMR spectroscopy, with no
over-reduced alcohol present.
Isolated yield: 0.851 g (2.85 mmol, 86%).
1H NMR (700 MHz, CDCl3): δ/ppm 2.71 (4 H, t, J = 7.6 Hz, H2), 2.87 (4 H, t,
J = 7.6 Hz, H3), 3.79 (6 H, s, H10), 6.75 (6 H, m, H7/8/9), 7.20 (2 H, t, J =
7.8 Hz, H5);
13C NMR (176 MHz, CDCl3): δ/ppm 29.8 (C3), 44.4 (C2), 55.1 (C10), 111.4
(C7/8/9), 114.1 (C7/8/9), 120.6 (C7/8/9), 129.5 (C5), 142.6 (C4), 159.7 (C6),
209.0 (C1).
IR (neat) ν = 1711.8 (C=O, m), 1583.9 (C=O, s), 1256.6 (C-O, s), 1152.5
(C-O, s), 1042.1 (m), 779.6 (m), 729.8 (m), 695.3 (s) cm−1.
LC-MS: Rt = 3.73 min, m/z 321 [M+Na]
+; HR-MS calculated for
C19H22O3
23Na at 321.1467, found 321.1477 (∆ = +3.1 ppm).
Reference69,87
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9.4 1,5-Bis(2-bromo-5-methoxyphenyl)pentan-
3-one, Compound
1-55
OMe
O
OMe
Chemical Formula: C19H20Br2O3
Exact Mass: 453.98
12
3
4
5
6
7
8
9
Br Br
Batch procedure with Br2:
69
First, 1,5-bis(3-methoxyphenyl)pentan-3-one (1-54, 0.823 g, 2.76 mmol) then
DCM (10 mL) were charged to a 100 mL RBF fitted with a stirrer bar. Pyridine
(0.78 mL, 9.64 mmol) was charged to the RBF, which was cooled to -10 ◦C in an
ice/ salt bath and stirred for 10 mins. A solution of Br2 (0.36 mL, 6.99 mmol) in
DCM (3 mL) was added dropwise to the RBF, and an exotherm was observed.
The solution was warmed to RT, and stirred for 4 h. The reaction was quenched
with 10% Na2S2O3 (10 mL), then washed with 1 M HCl (15 mL x 3). The orange
organic extract was washed with H2O (20 mL x 2), dried over Na2SO4 and filtered.
The solvent was removed in vacuo to give an orange oil which solidified to a pale
yellow wax overnight.
Isolated yield: 1.007 g (2.22 mmol, 80%)
Batch procedure with NBS:
First, 1,5-bis(3-methoxyphenyl)pentan-3-one (1-54, 0.298 g, 0.99 mmol) was
charged to a 50 mL RBF fitted with a stirrer bar. MeCN (4 mL) was charged to
the RBF to give a pale yellow solution. NBS (0.360 g, 2.02 mmol) was charged
to the RBF, which was stirred at RT for 30 mins. The reaction was quenched
with 10% Na2S2O3 (10 mL), then extracted with Et2O (10 mL), 10% Na2S2O3
(10 mL) followed by H2O (10 mL). The organic extracts were combined and dried
over Na2SO4, filtered and concentrated in vacuo to give a pale yellow oil.
Isolated yield: 0.228 g (0.50 mmol, 50%)
Flow procedure:
1,5-Bis(2-bromo-5-hydroxyphenyl)penta-1,4-dien-3-one (3-10, 0.0913 g, 0.203
mmol) was dissolved in EtOAc (6 mL, 0.034 mol dm−3) and passed through
the Thales Nano H-Cube R© reactor (Raney Ni catalyst, 2.0 mL min−1, 70 ◦C, 1
atm, full H2 mode) six times. The solution was concentrated in vacuo to give the
product.
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Isolated yield: 0.030 g (0.066 mmol, 33%)
1H NMR (700 MHz, CDCl3): δ/ppm 2.73 (4 H, t, J = 7.7 Hz, H2), 2.96 (4 H, t,
J = 7.7 Hz, H3), 3.76 (6 H, s, H10), 6.63 (2 H, dd, J = 8.7, 3.1 Hz, H7), 6.77 (2
H, d, J = 3.0 Hz, H5), 7.39 (2 H, t, J = 8.7 Hz, H8);
13C NMR (176 MHz, CDCl3): δ/ppm 30.6 (C3), 42.5 (C2), 55.4 (C10), 113.6
(C7), 114.6 (C9), 116.2 (C5), 133.4 (C8), 141.2 (C4), 159.0 (C6), 208.4 (C1).
IR (neat) ν = 1700.6 (C=O, m), 1571.9 (C=O, m), 1471.0 (s), 1240.1 (C-O, s),
1163.2 (C-O, s), 790.7 (s), 599.5 (s) cm−1.
LC-MS: Rt = 4.18 min, m/z 477:479:481 (1:2:1) [M+Na]
+; HR-MS calculated
for C19H20O3Br2
23Na at 476.9677, found 476.9676 (∆ = -0.21 ppm).
Reference69
80
9.5 4,4’-Dibromo-7,7’-dimethoxy-1,1’-
spirobiindane (Br-SPINOMe), Compound
1-56
Br
OMe
OMe
Br
1
2
34
56
7
8
9
10
Chemical Formula: C19H18Br2O2
Exact Mass: 435.97
Polyphosphoric acid procedure:69
First, 1,5-bis(2-bromo-5-methoxyphenyl)pentan-3-one (1-55, 0.768 g, 1.69 mmol)
was charged to a 50 mL RBF fitted with a stirrer bar. Polyphosphoric acid
(4.250 g) was charged to the RBF, which was heated at 105 ◦C for 8 h. 1H NMR
spectroscopy after 6 h indicated 74% conversion. The dark brown solution was
poured into H2O (50 mL), then extracted with Et2O (20 mL x 2), then DCM
(20 mL x 2). The solution was decanted to remove brown solid, then the solvent
removed in vacuo. The pale brown foam obtained was dry-loaded onto silica,
then filtered through a 2 cm plug of silica (Hex:EtOAc 9:1). The solution was
concentrated in vacuo to give a pale yellow solid.
Isolated yield: 0.199 g (0.46 mmol, 27%).
Heteropoly acid procedure:76
First, 1,5-bis(2-bromo-5-methoxyphenyl)pentan-3-one (1-55, 2.331 g, 5.13 mmol)
was charged to a 100 mL RBF fitted with a stirrer bar. Toluene (20 mL) was
charged to the flask, which was stirred until the solid dissolved to give an orange
solution. H3PW12O40 (2.123 g, 0.74 mmol) was charged to the flask, and the
resulting mixture was stirred under Dean-Stark reflux conditions for 14 h. The
dark-brown solution was allowed to cool to RT then filtered through a scinter
and washed with CHCl3 (20 mL). The solution was concentrated in vacuo, and
the purple solid was purified by flash column chromatography (Hex:EtOAc 9:1)
to give a white solid.
Isolated yield: 1.025 g (2.35 mmol, 46%).
1H NMR (700 MHz, CDCl3): δ/ppm 2.13-2.17 (2 H, m, H2), 2.28-2.33 (2 H, m,
H2), 2.92-2.96 (2 H, m, H3), 3.03-3.07 (2 H, m, H3), 3.51 (6 H, s, H10), 6.51 (2
H, d, J = 8.6 Hz, H7), 7.25 (2 H, m, H8);
13C NMR (176 MHz, CDCl3): δ/ppm 33.1 (C3), 37.9 (C2), 55.4 (C10), 61.9
(C1), 110.5 (C9), 110.8 (C7), 130.3 (C8), 138.0 (C5), 144.8 (C4), 155.6 (C6).
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IR (neat) ν = 1472.1 (m), 1260.9 (C-O, s), 1077.2 (m), 1054.2 (m), 795.8 (s)
cm−1.
LC-MS (ASAP): Rt = 0.72 min, m/z 437:439:441 (1:2:1) [MH]
+; HR-MS (AP+)
calculated for C19H18Br2O2 at 436.9752, found 436.9756 (∆ = +0.9 ppm).
GC-MS: 7.87 min, m/z 436:438:440 (1:2:1) [M]+.
CHN analysis: calculated for C19H18Br2O2 at C 52.08%, H 4.14%, N 0.00%;
found C 52.13%, H 4.12%, N -0.02%.
The structure and connectivity were confirmed by single crystal X-ray
crystallography, performed by Dr Dmitry S. Yufit of the Durham University
X-Ray Crystallography Service and has the unique identifier of ‘14srv270’.
Space group P-1
a/ A˚ 7.5094(4)
b/ A˚ 10.4475(6)
c/ A˚ 12.0959(6)
α/ ◦ 107.731(5)
β/ ◦ 106.488(5)
γ/ ◦ 97.534(4)
Reference69,76,90
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9.6 7,7’-Dimethoxy-1,1’-spirobiindane
(o-SPINOMe), Compound 1-57
OMe
OMe
1
2
34
56
7
8
9
10
Chemical Formula: C19H20O2
Exact Mass: 280.15
Batch procedure:69
First, 4,4’-dibromo-7,7’-dimethoxy-1,1’-spirobiindane (Br-SPINOMe, 1-56)
(0.205 g, 0.47 mmol) was charged to an oven-dried 100 mL RBF, which was
then fitted with a stirrer bar and septum. The flask was flushed with N2, and
dry THF (8.0 mL) was charged to the RBF. The solution was cooled to -78 ◦C
and stirred for 10 mins. nBuLi (3.0 mL, 3.30 mmol) was added dropwise to the
RBF, and the solution changed colour from pale yellow to orange. After 1 h,
the solution was quenched with EtOH (1.0 mL) and left to warm to RT. The
solution was extracted with H2O (15.0 mL x 3) and DCM (10.0 mL x 2). The
pale yellow solution was dried over Na2SO4, filtered and concentrated in vacuo
to give a white solid.
Isolated yield: 0.117 g (0.42 mmol, 89%)
Flow procedure:
First, 4,4’-dibromo-7,7’-dimethoxy-1,1’-spirobiindane (1-56, 0.098 g, 0.22 mmol)
was dissolved in EtOAc (4 mL, 0.056 mol dm−3) and passed through the Thales
Nano H-Cube R© reactor (10% Pd/C catalyst, 2.0 mL min−1, 20 ◦C, 1 atm, full
H2 mode). The solution was concentrated in vacuo to give a mixture of products
as a pale yellow oil.
1H NMR (700 MHz, CDCl3): δ/ppm 2.15-2.19 (2 H, m, H2), 2.32-2.36 (2 H, m,
H2), 2.97-3.01 (2 H, m, H3), 3.04-3.08 (2 H, m, H3), 3.53 (6 H, s, H10), 6.62 (2
H, d, J = 8.0 Hz, H7), 6.86 (2 H, d, J = 7.4 Hz, H9), 7.13 (2 H, t, J = 7.7 Hz,
H8);
13C NMR (176 MHz, CDCl3): δ/ppm 31.6 (C3), 38.8 (C2), 55.2 (C10), 59.2
(C1), 108.6 (C7), 116.8 (C9), 127.5 (C8), 136.9 (C5), 145.3 (C4), 156.5 (C6).
IR (neat) ν = 1585.3 (m), 1473.5 (m), 1261.8 (m), 1060.4 (m), 771.9 (s) cm−1.
LC-MS: Rt = 3.71 min, m/z 281.2 [MH]
+; HR-MS calculated for C19H21O2 at
281.1542, found 281.1548 (∆ = +2.1 ppm).
Reference69
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9.7 4,4’-Dibromo-2,2’,3,3’-tetrahydro-1,1’-
spirobi[indene]-7,7’diol (Br-SPINOL),
Compound 1-59
Br
OH
OH
Br
Chemical Formula: C17H14Br2O2
Exact Mass: 407.94
1 2
34
56
7
8
9
10
Procedure:
First, 1,5-bis(2-bromo-5-hydroxyphenyl)pentan-3-one (3-11, 0.100 g, 0.23 mmol)
then H3PW12O40 (0.105 g, 0.037 mmol) were charged to a 5 mL microwave vial,
followed by toluene (3 mL) and a stirrer bar. The vial was capped and sealed,
then heated in the micrwoave with 5 mins’ pre-stirring at 150 ◦C for 60 mins. The
vial was uncapped and the crude mixture filtered over a silica/ cotton wool plug,
washing with CHCl3 (5 mL). Concentration in vacuo gave the crude product as a
pale yellow solid. Purification by column chromatography (Hex:EtOAc 9:1) gave
the product as a white solid.
Isolated yield: 0.095 g (0.23 mmol, 99%)
1H NMR (700 MHz, CDCl3): δ/ppm 2.14-2.36 (4 H, m, H2), 2.91=3.10 (4 H, m,
H3), 4.51 (2 H, s, H10), 6.58 (2 H, d, J = 8.5 Hz, H7), 7.29 (2 H, d, J = 8.5 Hz,
H8);
13C NMR (126 MHz, CDCl3): δ/ppm 32.7 (C3), 36.7 (C2), 60.3 (C1), 111.0
(C9), 116.6 (C7), 132.1 (C5), 132.6 (C8), 145.4 (C4), 151.9 (C6).
IR (neat) ν = 3522.3 (O-H, br w), 1466.4 (s), 1274.8 (m), 804.7 (s), 655.0 (m)
cm−1.
LC-MS: Rt = 3.46 min, m/z 407.5:409.5:411.5 (1:2:1) [M]
−; HR-MS calculated
for C79H13O2Br2 at 406.9282, found 406.9282 (∆ = 0.0 ppm).
Reference6
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9.8 1,5-Bis(3-hydroxyphenyl)pentan-3-one,
Compound 3-1
OH
O
OH
Chemical Formula: C17H18O3
Exact Mass: 270.13
12
3
4
5
6
7
8
9
Procedure:91
First, 1,5-bis(3-hydroxyphenyl)penta-1,4-dien-3-one (3-2, 0.801 g, 3.01 mmol)
and 10% Pd/C (0.0812 g, 10 wt%) were charged to a 50 mL RBF fitted with a
stirrer bar which was flushed with N2. EtOH (12 mL) then Ph2S (5.0 L, 0.0299
mmol) were charged to the flask under N2. The flask was put under vacuum then
back-filled with H2 twice, and stirred at room temperature under a H2 balloon for
5 h. The flask was flushed with N2 (15 mins), then the solution filtered through
Celite and rinsed with EtOH (5 mL x 3). The solvent was removed in vacuo to
give a pale yellow oil which solidified on standing.
Isolated yield: 0.737 g (2.73 mmol, 91%)
1H NMR (700 MHz, d6−DMSO): δ/ppm 2.69 (4 H, m, H2/3), 6.57 (3 H, m,
H5/7/8/9), 7.04 (1 H, t, J = 8.0 Hz, H5/7/8/9), 9.28 (1 H, br s, Ar-OH);
13C NMR (176 MHz, d6−DMSO): δ/ppm 29.5 (C2/3), 43.8 (C2/3), 113.3 (CH),
115.6 (CH), 119.2 (CH), 129.7 (CH), 143.0 (C4), 157.7 (C6), 209.5 (C1).
IR (neat) ν = 3325.9 (OH, br), 1698.8 (C=O, s), 1585.6 (s), 1249.9 (C-O, m),
1231.1 (C-O, s), 769.8 (m), 690.0 (s), 644.1 (m) cm−1.
LC-MS: Rt = 2.52 min, m/z 269 [M-H]
−; HR-MS calculated for C17H17O3 at
269.1178, found 269.1189 (∆ = +4.1 ppm).
Reference6
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9.9 1,5-Bis(3-hydroxyphenyl)penta-1,4-dien-3-
one, Compound
3-2
OH
O
OH
Chemical Formula: C17H14O3
Exact Mass: 266.09
12
3
4
5
6
7
8
9
Procedure:68,92
10% NaOH (14.928 g, 373 mmol, 150 mL) was charged to a 500 mL RBF, fol-
lowed by EtOH (120 mL) and the solution was heated at 25 ◦C with stirring.
3-Hydroxybenzaldehyde (3-3, 9.129 g, 74.8 mmol) was charged to the flask, fol-
lowed by acetone (2.75 mL, 37.5 mmol), and the solution was stirred for a fur-
ther 15 mins. The colour changed from yellow to red. A further portion of
3-hydroxybenzaldehyde (3-3, 9.123 g, 74.7 mmol) and acetone (2.80 mL, 38.1
mmol) were charged to the RBF. The resulting solution was stirred for 3.5 h at
25 ◦C. An aqueous solution of 6 M HCl was added until the solution was neutral,
and a yellow precipitate had formed. The solution was filtered, dried in vacuo,
then recrystallised from IPA to give a fine bright yellow powder.
Isolated yield: 11.902 g (44.7 mmol, 60%)
1H NMR (700 MHz, d4−MeOD): δ/ppm 6.85 (1 H, d, J = 8.0 Hz, H2), 7.10 (1
H, s), 7.15-7.18 (2 H, m), 7.24 (1 H, t, J = 7.8 Hz), 7.69 (1 H, d, J = 15.9 Hz,
H3);
13C NMR (176 MHz, d4−MeOD): δ/ppm 114.3 (CH), 117.5 (C2), 119.8 (CH),
124.8 (CH), 129.6 (CH), 136.1 (C4), 143.9 (C3), 157.7 (C6), 190.1 (C1).
IR (neat) ν = 3229.8 (OH, br), 1618.2 (C=O, s), 1579.2 (s), 1561.1 (s), 1213.3
(s), 1105.0 (s), 982.0 (s), 863.5 (s), 782.2 (s) cm−1.
LC-MS: Rt = 2.49 min, m/z 265.1 [M-H]
−; HR-MS (ES+) calculated for
C17H15O3 at 267.1021, found 267.1029 (∆ = +3.0 ppm).
Melting point: decomposed to black solid by 202 ◦C (IPA).
Reference93,94
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9.10 5,5’-Dimesylate-1,1’-spirobiindane
(p-SPINOMs), Compound 3-5
1
2
34
5
6
7
8
9
Chemical Formula: C19H20O6S2
Exact Mass: 408.07
10 O
O
S
S
O O
O O
Procedure with Eaton’s reagent:
1,5-Bis(3-hydroxyphenyl)pentan-3-one (3-1, 0.342 g, 1.27 mmol) was charged to
a 50 mL RBF fitted with a stirrer bar. Eaton’s reagent70 (8.701 g, 25:1 by wt) was
charged to the flask, which was heated at 60 ◦C for 2 h. The flask was transferred
to an ice bath, and H2O (40 mL) was charged to the flask slowly, followed by
gradual addition of NaHCO3 (100 mL) due to the exotherm. The solution was
extracted twice with Et2O (100 mL, then 50 mL), then the solvent removed in
vacuo to give a colourless oil with some purple discolouration. The crude product
was dissolved in DCM, then filtered through a 1 cm plug of silica, followed by
solvent removal in vacuo to give the product as a solid foam.
Isolated yield: 0.198 g (0.785 mmol, 62%)
Procedure from p-SPINOL:95
1,1’-Spirobiindane-5,5’-diol (p-SPINOL, 3-6) (0.050 g, 0.20 mmol) was charged
to a 25 mL RBF fitted with a stirrer bar and a septum. The starting material
was dissolved in dry DCM (0.4 mL) to give a pale yellow solution which was
flushed with N2. Dry pyridine (0.08 mL, 0.99 mmol) was charged to the RBF
and the solution cooled to 0 ◦C and stirred for 10 mins. MsCl (0.10 mL, 1.29
mmol) was charged to the RBF and the solution was stirred in an ice bath for
3 h, then warmed to RT for 5 h. The solution was quenched with H2O and the
organic phase extracted. The aqueous layer was washed with DCM (3 x 2 mL).
All the organic extracts were combined, washed with 1 M HCl (2 x 5 mL), then
brine (2 x 4 mL), dried over Na2SO4, filtered and concentrated in vacuo to give
a pale yellow oil.
Isolated yield: 0.054 g (0.13 mmol, 74%)
1H NMR (400 MHz, CDCl3): δ/ppm 2.15-2.23 (2 H, m, H2/3), 2.34-2.40 (2 H,
m, H2/3), 3.02-3.06 (4 H, m, H2/3), 3.16 (3 H, s, H10), 6.93 (2 H, d, J = 8.2
Hz, H6), 7.05 (2 H, dd, J = 8.2, 2.3 Hz, H7), 7.21 (2 H, d, J = 2.1 Hz, H9);
13C NMR (125 MHz, CDCl3): δ/ppm 30.7 (C2/3), 37.8 (C10), 40.8 (C2/3), 59.7
(C1), 118.8 (Ar CH), 121.2 (Ar CH), 124.6 (Ar CH), 146.0 (Ar C), 148.7 (Ar
87
C), 149.2 (Ar C).
IR (neat) ν = 2939.5 (w), 1359.5m, 1175.5 (C-O, s), 1121.6 (C-O, m), 923.2 (s),
804.2 (m) cm−1.
LC-MS: Rt = 3.31 min, m/z 409.6 [MH]
+; HR-MS calculated for C19H21O6S2 at
409.0780, found 409.0768 (∆ = -2.4 ppm).
No literature data available.
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9.11 1,1’-Spirobiindane-5,5’-diol (p-SPINOL),
Compound 3-6
1
2
34
56
7
8
9
Chemical Formula: C17H16O2
Exact Mass: 252.12
10
HO
OH
Procedure:
5,5’-Dimethoxy-1,1’-spirobiindane (p-SPINOMe, 3-7) (0.538 g, 1.92 mmol) was
dissolved in dry DCM (10 mL) and transferred to a dry 50 mL RBF fitted with
a stirrer bar and septum. The RBF was flushed with N2, and the solution cooled
to -78 ◦C. BBr3 in DCM (4.50 mL, 4.50 mmol) was transferred to the RBF, and
the colour of the solution changed from pale yellow to dark red. The solution was
then allowed to warm to RT and stirred for 20 h. The solution was diluted with
DCM (10 mL) and vented to the atmosphere. The solution was washed with H2O
until the washings were neutral, and the organic layers were dried over Na2SO4
and then filtered and concentrated in vacuo to give a foam.
Isolated yield: 0.045 g (0.18 mmol, 9%)
1H NMR (400 MHz, CDCl3): δ/ppm 2.11-2.19 (2 H, m, H2), 2.26-2.37 (2 H, m,
H2), 2.93-3.05 (4 H, m, H3), 4.92 (2 H, br s, H10), 6.63 (2 H, dd, J = 8.1, 2.5
Hz, Ar H), 6.77-6.81 (4 H, m, Ar H);
13C NMR (101 MHz, CDCl3): δ/ppm 30.8 (C2/C3), 40.1 (C2/C3), 59.2 (C1),
111.2 (CH), 113.7 (CH), 124.1 (CH), 143.0 (C4/5), 145.5 (C4/5), 154.7 (C8);
IR (neat) ν = 3278.1 (O-H, br m), 1609.8 (m), 1490.1 (m), 1450.6 9s), 1247.7
(s), 1215.5 (C-O, s), 1156.7 (s), 1095.7 (m), 722.5 (m), 857.0 (s), 592.9 (s) cm−1.
Reference6,96
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9.12 5,5’-Dimethoxy-1,1’-spirobiindane
(p-SPINOMe), Compound 3-7
1
2
34
56
7
8
9
Chemical Formula: C19H20O2
Exact Mass: 280.15
10
MeO
OMe
Procedure with polyphosphoric acid:
1,5-Bis(3-methoxyphenyl)pentan-3-one (1-54, 0.951 g, 3.19 mmol) was charged
to a 100 mL RBF fitted with a stirrer bar. Polyphosphoric acid (8.174 g, 8.6 wt)
was charged to the RBF, and the resulting viscous solution was heated to 105
◦C for 6 h. The solution was quenched with H2O (50 mL), then extracted with
Et2O (30 mL x 2), then extracted with DCM (20 mL x 2). The organic layers
were concentrated in vacuo, and then dry-loaded onto silica. The crude product
was purified by column chromatography (Hex:EtOAc 9:1) to give a yellow oil.
Isolated yield: 0.347 g (1.24 mmol, 39%)
Procedure with heteropoly acid:
1,5-Bis(3-methoxyphenyl)pentan-3-one (1-54, 1.075 g, 3.61 mmol) was charged
to a 50 mL RBF fitted with a stirrer bar. Toluene (10 mL) was charged to the
RBF and the mixture was stirred until all the solid dissolved to give an orange
solution. H3PW12O40 (1.552 g, 0.539 mmol) was charged to the RBF, which was
heated under reflux with a Dean-Stark head for 20 h. The reaction was allowed to
cool to RT, then filtered through a scinter and rinsed with CHCl3. The solution
was concentrated in vacuo to give an orange oil (0.833g, 2.97 mmol, 82% crude
yield). The crude oil was purified by flash column chromatography (Hex:EtOAc
9:1) to give a white solid.
Isolated yield: 0.730 g (2.61 mmol, 72%).
1H NMR (700 MHz, CDCl3): δ/ppm 2.16 (2 H, m, H2), 2.29 (m, 2H, H2), 2.97
(m, 4H, H3), 3.80 (s, 6H, H10), 6.70 (dd, J = 8.5, 2.3 Hz, 2H, H6/7/9), 6.83 (m,
4H, H6/7/9);
13C NMR (176 MHz, CDCl3): δ/ppm 31.0 (C3), 41.1 (C2), 55.4 (C10), 59.3
(C1), 109.6 (C6/7/9), 112.6 (C6/7/9), 123.9 (C6/7/9), 142.9 (C4/5), 145.2
(C4/5), 158.9 (C8).
IR (neat) ν = 2934.9 (m), 1606.0 (m), 1492.1 (s), 1464.0 (m), 1247.2 (C-O, s),
1031.3 (C-O, m), 834.8 (s) cm−1.
LC-MS: Rt = 3.66 min, m/z 281 [MH]
+.
Reference76,96
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9.13 2-Bromo-5-hydroxybenzaldehyde,
Compound 3-8
OH
CHO
Br
Chemical Formula: C7H5BrO2
Exact Mass: 199.95
Procedure:
3-Hydroxybenzaldehyde (3-3, 2.465 g, 20.2 mmol) was charged to a 250 mL RBF
fitted with a stirrer bar. DCM (80 mL) was charged to the flask and the resultant
mixture was stirred in an ice bath (15 mins). A solution of Br2 (1.1 mL, 21.4
mmol) in DCM (10 mL) was added dropwise over 5 mins. The solution was
removed from the ice bath and allowed to warm to room temperature. After 30
mins, precipitation was observed and the heterogeneous solution changed colour
from brown to orange. After 4 h stirring at room temperature, conversion to
the product was 78% as determined by 1H NMR spectroscopy and the flask was
cooled in an ice bath for 30 mins. The solution was filtered and the solid left to
air-dry. Recrystallisation from AcOH gave the product as fluffy white needles.
Isolated yield: 2.633 g (13.2 mmol, 65%)
1H NMR (700 MHz, CDCl3): δ/ppm 5.23 (1 H, br s, OH), 7.00 (1 H, dd, J =
8.6, 3.2 Hz), 7.38 (1 H, d, J = 3.2 Hz), 7.52 (1 H, d, J = 8.6 Hz), 10.29 (1 H, s,
CHO);
13C NMR (176 MHz, CDCl3): δ/ppm 115.7 (CH), 117.8 (C), 123.3 (CH), 134.1
(C), 134.9 (CH), 155.5 (C), 191.9 (CHO).
IR (neat) ν = 3461.4 (OH, s), 1674.8 (C=O, s), 1590.9 (s), 1475.7 (m), 1428.1
(m), 1384.2 (m), 1298.0 (m), 1165.9 (s), 876.4 (m), 828.5 (m) cm−1.
LC-MS: Rt = 2.35 min, m/z 198,8 [M-H]
−; HR-MS calculated for C7H4BrO2 at
198.9395, found 198.9396 (∆ = +0.5 ppm).
CHN analysis: calculated for C7H5BrO2 at C 41.82%, H 2.51%, N 0.00%; found
C 41.93%, H 2.52%, N -0.02%.
Melting point: 133.7-134.5 ◦C (AcOH), literature97 = 133 ◦C.
Reference97
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9.14 1,5-Bis(2-bromo-5-hydroxyphenyl)penta-
1,4-dien-3-one, Compound
3-10
OH
O
OH
Chemical Formula: C17H12Br2O3
Exact Mass: 421.92
12
3
4
5
6
7
8
9
Br Br
Procedure:68,92
10% NaOH (0.494 g, 12.4 mmol) was charged to a 100 mL RBF, followed by
EtOH (4.0 mL). The solution was heated to 25 ◦C with stirring. 2-Bromo-5-
hydroxybenzaldehyde (3-8, 0.509 g, 2.55 mmol) and acetone (0.092 mL, 1.25
mmol) were charged to the RBF, then the resulting solution was stirred for 15
mins. The colour changed from yellow to red. A second portion of 2-bromo-5-
hydroxybenzaldehyde (3-8, 0.509 g, 2.55 mmol) was charged to the flask, followed
by acetone (0.092 mL, 1.25 mmol). The solution was stirred for 3.5 h at 25 ◦C.
An aqueous solution of 6 M HCl was added until the solution was neutral, with an
orange precipitate. The solution was filtered, dried in vacuo, then recrystallised
from IPA to give a fine bright yellow powder.
Isolated yield: 0.440 g (1.04 mmol, 41%)
1H NMR (700 MHz, d4−MeOD): δ/ppm 6.79 (1 H, dd, J = 8.7, 3.0 Hz, H4),
7.10 (1 H, d, J = 15.9 Hz, H8), 7.26 (1 H, d, J = 2.9 Hz, H6), 7.45 (1 H, d, J =
8.7 Hz, H3), 8.02 (1 H, d, J = 15.9 Hz, H7);
13C NMR (176 MHz, d4−MeOD): δ/ppm 113.9 (C5), 114.3 (C9), 119.5 (C7),
127.0 (C2), 133.7 (C8), 134.8 (C4), 142.0 (C3), 157.5 (C6), 189.1 (C1).
IR (neat) ν = 3301.9 (OH, br), 1615.0 (C=O, s), 1566.2 (s), 1464.4 (s), 1351.0
(s), 1311.8 (s), 1117.4 (s), 980.4 (s), 817.7 (s) cm−1.
LC-MS: Rt = 3.62 min, m/z 420.8 [M-H]
−; HR-MS (ES+) calculated for
C17H13O3
79Br2 at 422.9231, found 422.9234 (∆ = +0.7 ppm).
Melting point: decomposed to black solid by 197 ◦C (IPA).
Reference6
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9.15 1,5-Bis(2-bromo-5-
hydroxyphenyl)pentan-3-one, Compound
3-11
Br
OH
O Br
OH
Chemical Formula: C17H16Br2O3
Exact Mass: 425.95
1
2
3
4
5
6
7
8
9
10
Procedure:
First, 1,5-bis(3-hydroxylphenyl)pentan-3-one (3-1, 1.00 g, 3.70 mmol) was dis-
solved in MeCN (15 mL) in a 50 mL RBF fitted with a stirrer bar. The RBF was
then lowered into an ice bath. NBS (1.65 g, 9.25 mmol) was added slowly. The
reaction was followed by TLC. After 30 mins, the reaction had reached 92% con-
version. The reaction was quenched with 10% Na2S2O3 (10 mL), then extracted
with Et2O (10 mL), 10% Na2S2O3 (10 mL) followed by H2O (10 mL). The or-
ganic extracts were combined and dried over Na2SO4, filtered and concentrated
in vacuo to give the product as a white powder.
Isolated yield: 1.32 g (3.09 mmol, 91%)
1H NMR (400 MHz, d6−DMSO): δ/ppm 2.75 (8 H, h, J = 6.8, 6.4 Hz, H2/3),
6.57 (2 H, dd, J = 8.6 H, 3.0 Hz, H7), 6.73 (2 H, d, J = 2.9 Hz, H5), 7.32 (2 H,
d, J = 8.6 Hz, H8), 9.62 (2 H, s, H10);
13C NMR (101 MHz, d6−DMSO): δ/ppm 30.1 (C3), 42.1 (C2), 112.5 (C9),
115.8 (C7), 133.4 (C8), 141.3 (C4), 157.4 (C6), 208.6 (C1).
IR (neat) ν = 3422.1 (O-H, br w), 1686.6 (C=O, s), 1591.5 (m), 1579.3 (m),
1471.7 (m), 1434.0 (s), 1222.3 (C-O, s), 1166.7 (s), 1030.3 (m), 858.9 (m), 797.2
(m), 706.9 (m), 601.2 (s) cm−1.
LC-MS: Rt = 2.70 min, m/z 425:427:429 (1:2:1) [M]
−.
Reference6
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9.16 2-Bromo-5-methoxybenzaldehyde,
Compound 4-1
Br
OMe
CHO
Chemical Formula: C8H7BrO2
Exact Mass: 213.96
123
4
5
6
7
8
Procedure using Br2:
98
3-Methoxybenzaldehyde (1-52, 2.45 mL, 20.1 mmol) was charged to a 50 mL RBF
fitted with a stirrer bar, followed by AcOH (5 mL). All the starting material
dissolved to give a pale yellow solution. Neat Br2 (1.25 mL, 24.4 mmol) was
charged slowly to the RBF with stirring to give a dark orange solution. An
exotherm was observed. After 24 h, substantial solid formation was observed and
the reaction was stopped by the addition of 10% Na2S2O3 (30 mL). The solution
was poured into H2O (30 mL) and extracted with Et2O (30 mL x 4). The organic
layers were combined and washed with H2O (30 mL x 2) then sat. aqueous NaCl
(30 mL), followed by drying over MgSO4 and filtration. Removal of the solvent
in vacuo gave the crude product as a pale yellow solid (4.076 g, 19.05 mmol, 95%
crude yield) which was 90% product by 1H NMR spectroscopy. Recrystallisation
from EtOH:H2O (9:1) followed by rinsing with cold EtOH gave the product as
sparkly white fluffy needles.
Isolated yield: 2.683 g (12.5 mmol, 63%)
Procedure using NBS:99
3-Methoxybenzaldehyde (1-52, 10.0 mL, 81.9 mmol) was charged to a 500 mL
RBF fitted with a stirrer, followed by DMF (65 mL). The RBF was lowered into
an ice bath, and NBS (24.4 g, 133.3 mmol) was added slowly over 20 mins. The
RBF was removed from the ice bath and allowed to warm to RT, turning an
orange colour. After stirring overnight at RT, the solution was poured into a
mixture of ice and water to quench the reaction, and stirred until the ice had
melted. Formation of a yellow-white precipitate was observed immediately. The
slurry was filtered and washed with H2O (50 mL x 2). Recrystallisation from IPA
gave the product as white, flaky crystals.
Isolated yield: 13.362 g (62.5 mmol, 76%)
1H NMR (700 MHz, CDCl3): δ/ppm 3.83 (1 H, s, H7), 7.03 (1 H, dd, J = 8.8,
3.2 Hz, H4), 7.41 (1 H, d, J = 3.2 Hz, H3), 7.52 (1 H, d, J = 8.8 Hz, H6), 10.30
(1 H, s, H8);
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13C NMR (176 MHz, CDCl3): δ/ppm 55.7 (C7), 112.6 (C3), 118.0 (C2), 123.1
(C4), 134.0 (C1), 134.5 (C6), 159.2 (C5), 191.8 (C8).
IR (neat) ν = 1674.9 (m), 1569.5 (m), 1278.3 (m), 1197.8 (m), 931.9 (s), 865.0
(m), 819.7 (s), 647.1 (s), 597.5 (s) cm−1.
LC-MS: Rt = 2.88 min, m/z 215 [MH]
+; HR-MS calculated for C8H8
79BrO2 at
214.9708, found 214.9715 (∆ = +3.3 ppm).
CHN analysis: calculated for C8H7BrO2 at C 44.68%, H 3.28%, N 0.00%; found
C 44.61%, H 3.28%, N -0.03%.
Melting point: 74.5-75.5 ◦C (EtOH:H2O 9:1), literature = 74.5-75.5
◦C (EtOH).
Reference100
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9.17 4-(3-Methoxyphenyl)but-3-en-2-one,
Compound 4-4
OMe
O
Chemical Formula: C11H12O2
Exact Mass: 176.08
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Procedure:74
3-Methoxybenzaldehyde (1-52, 2.44 mL, 20.0 mmol) was charged to a 100 mL
RBF fitted with a stirrer bar. Acetone (14.70 mL, 200 mmol) was charged to the
RBF, whereupon the starting material dissolved to give a pale yellow solution.
NaOH (1.645 g, 41.1 mmol) was dissolved in H2O (41 mL) to give a 1 M solution
which was then charged dropwise to the RBF over 15 mins. An exotherm was
observed, and the solution darkened to a yellow colour. The solution was stirred
at RT for 2 h, and droplets of a yellow oil were observed to form during this time.
The solution was neutralised with an aqeous solution of 6 M HCl, which forced
the solution to separate into two phases. The solution was extracted with EtOAc
(50 mL x 2), and the organic extracts were combined and washed with brine (50
mL), then dried over Na2SO4, filtered and concentrated in vacuo to give a yellow
oil.
Isolated yield: 3.254 g (18.5 mmol, 92%)
1H NMR (700 MHz, CDCl3): δ/ppm 2.34 (3 H, s, H1), 3.79 (3 H, s, H11), 6.66
(1 H, d, J = 16.2, H3), 6.91 (1 H, d, J = 8.2, H8), 7.02 (1 H, s, H6), 7.09 (1 H,
d, J = 7.2, H10), 7.27 (1 H, t, J = 7.9, H9), 7.44 (1 H, d, J = 16.3, H4);
13C NMR (176 MHz, CDCl3): δ/ppm 27.4 (C1), 55.3 (C11), 113.0 (C6), 116.4
(C8). 120.9 (C10), 127.4 (C3), 129.9 (C9), 137.8 (C5), 143.3 (C4), 159.9 (C7),
198.3 (C2).
IR (neat) ν = 1667.0 (m), 1608.2 (m), 1578.0 (m), 1256.3 (s), 1232.2 (s), 1158.9
(m), 1039.2 (m), 974.9 (m), 776.7 (m), 685.6 (m) cm−1.
LC-MS: Rt = 3.11 min, m/z 177.1 [MH]
+.
Reference101–103
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9.18 2,2-Bis[2-(2-bromo-5-
methoxyphenyl)ethyl]-1,3-dioxolane,
Compound 5-2
Br
OMe
OO Br
OMe
Chemical Formula: C21H24Br2O4
Exact Mass: 498.00
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Procedure:
1,5-Bis(2-bromo-5-methoxyphenyl)pentan-3-one (1-55, 0.116 g, 0.26 mmol),
ethylene glycol ( 40 µL, 0..75 mmol), camphorsulfonic acid (0.026 g, 0.11 mmol)
and toluene (3 mL) were charged to a microwave vial fitted with a stirrer bar.
The solution underwent microwave heating at 130 ◦C for 30 mins with 5 mins
pre-stirring. The solution was allowed to cool to RT, then filtered through a mini
column (silica/ cotton wool) and rinsed through with CHCl3. The yellow solution
was concentrated in vacuo to give a yellow oil (0.092 g). Purification by column
chromatography (Hex:EtOAc 8:2) gave the product as a colourless oil.
Isolated yield: 0.061 g (0.12 mmol, 48%)
1H NMR (700 MHz, CDCl3): δ/ppm 1.95-2.00 (2 H, m, H11), 2.72 (2 H, t, J =
7.7 Hz, H2), 2.84-2.88 (2 H, m, H11), 2.95 (2 H, t, J = 7.7 Hz, H3), 3.76 (6 H,
d, J = 7.5 Hz, H10), 6.62 (2 H, dt, J = 8.7, 2.5 Hz, H7), 6.78 (2 H, dd, J =
16.7, 3.0 Hz, H5), 7.38 (2 H, dd, J = 8.7, 6.9 Hz, H8);
13C NMR (126 MHz, CDCl3): δ/ppm 30.6 (C11), 31.05 (C3), 37.1 (C11), 42.4
(C2), 55.4 (C10), 65.1 (C1), 113.3/113.6 (C7 - d), 114.6/114.8 (C9 - d),
115.9/116.1 (C5 - d), 133.26/133.33 (C8 - d), 141.2/142.4 (C4 - d), 159.0 (C6).
IR (neat) ν = 2936.3 (w), 1714.0 (w), 1594.0 (w), 1571.3 (m), 1470.3 (s), 1414.9
(w), 1277.4 (m), 1239.2 (s), 1162.2 (m), 1137.7 (m), 1049.9 (s), 1013.8 (s), 853.6
(w), 800.3 (m), 599.6 (s) cm−1.
LC-MS: Rt = 0.941 min, m/z 499.01 [MH]
+.
No literature data available.
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9.19 (2S)-2-Hydroxy-3-methylbutanoic acid,
2-hydroxy-3-methylbutanoic acid,
Compounds 5-6 and 5-21
HO
O
OH
Chemical Formula: C5H10O3
Exact Mass: 118.06
1 2 3
4
5
HO
O
OH
Chemical Formula: C5H10O3
Exact Mass: 118.06
1 2 3
4
5
Procedure with l-valine, adapted from literature:104
l-Valine (7.034 g, 60 mmol) was charged to a 500 mL RBF fitted with a stirrer
bar. An aqueous solution of 0.5 M H2SO4 (240 mL) was charged to the RBF and
stirred for 15 mins at 0 ◦C until all the solid dissolved. NaNO2 (24.8 g, 360 mmol)
was dissolved in H2O (90 mL) and the resulting solution was charged dropwise
over 2 h. The RBF was removed from the ice bath and allowed to warm to RT,
stirring overnight. The solution was extracted with Et2O (3 x 50 mL), and the
combined organic layers were washed with a saturated solution of NaCl(aq) (2 x
50 mL), dried over Na2SO4, filtered and concentrated in vacuo to give the crude
product as a pale yellow oil.
Isolated yield: 3.310 g (28.0 mmol, 47%)
Procedure with rac-valine:
dl-Valine (0.584 g, 4.99 mmol) was charged to a 100 mL RBF fitted with a stirrer
bar. An aqueous solution of 0.5 M H2SO4 (20 mL) was charged to the RBF and
stirred for 15 mins at 0 ◦C until all the solid dissolved. NaNO2 (2.1 g, 30 mmol)
was dissolved in H2O (7.5 mL) and the resulting solution was charged dropwise
over 2 h. The RBF was removed from the ice bath and allowed to warm to RT,
stirring overnight. The solution was extracted with Et2O (3 x 5 mL), and the
combined organic layers were washed with a saturated solution of NaCl(aq) (2 x
5 mL), dried over Na2SO4, filtered and concentrated in vacuo to give the crude
product as a pale yellow oil. Purification from toluene/Et2O gave the product as
colourless, needle-like crystals.
Isolated yield: 0.279 g (2.36 mmol, 47 %)
1H NMR (700 MHz, D2O): δ/ppm 0.76 (3 H, d, J = 6.9 Hz, H4/5), 0.85 (3 H,
d, J = 7.0 Hz, H4/5), 1.95 (1 H, pd, J = 6.9, 4.2 Hz, H3), 3.98 (1 H, d, J = 4.2
Hz, H2);
13C NMR (126 MHz, D2O): δ/ppm 15.7 (C4/5), 17.9 (C4/5), 31.4 (C3), 75.1
98
(C2), 177.6 (C1).
IR (neat) ν = 3419.1 (w), 2966.5 (w), 1704.0 (C=O, s), 1258.0 (m), 1213.1 (m),
1135.0 (m), 1027.4 (s), 891.3 (m) cm−1.
LC-MS: Rt = 1.06 min, m/z 117.5 [M]
−; HR-MS calculated for C5H9O3 at
117.0552, found 117.0553 (∆ = +0.9 ppm).
Reference105
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9.20 (2S)-2-Hydroxy-4-methylpentanoic acid,
2-hydroxy-4-methylpentanoic acid,
Compounds 5-7 and 5-22
HO
OH
O
Chemical Formula: C6H12O3
Exact Mass: 132.08
1 2
3 4
5
6
HO
OH
O
Chemical Formula: C6H12O3
Exact Mass: 132.08
1 2
3 4
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Procedure with l-leucine:104
l-Leucine (7.864 g, 60 mmol) was charged to a 500 mL RBF fitted with a stirrer
bar. An aqueous solution of 0.5 M H2SO4 (240 mL) was charged to the RBF and
stirred for 15 mins at 0 ◦C until all the solid dissolved. NaNO2 (24.9 g, 360 mmol)
was dissolved in H2O (90 mL) and the resulting solution was charged dropwise
over 2 h. The RBF was removed from the ice bath and allowed to warm to RT,
stirring overnight. The solution was extracted with Et2O (3 x 50 mL), and the
combined organic layers were washed with a saturated solution of NaCl(aq) (2 x
50 mL), dried over Na2SO4, filtered and concentrated in vacuo to give the crude
product as a pale yellow oil.
Isolated yield: 5.168 g (39.1 mmol, 65%)
Procedure with rac-leucine:104
dl-Leucine (0.660 g, 5.04 mmol) was charged to a 100 mL RBF fitted with a
stirrer bar. An aqueous solution of 0.5 M H2SO4 (20 mL) was charged to the
RBF and stirred for 15 mins at 0 ◦C until all the solid dissolved. NaNO2 (2.1 g,
xx mmol) was dissolved in H2O (90 mL) and the resulting solution was charged
dropwise over 2 h. The RBF was removed from the ice bath and allowed to warm
to RT, stirring overnight. The solution was extracted with Et2O (3 x 5 mL), and
the combined organic layers were washed with a saturated solution of NaCl(aq)
(2 x 5 mL), dried over Na2SO4, filtered and concentrated in vacuo to give the
crude product as a white solid (0.462 g). Recrystallisation (toluene/Et2O) gave
the product as white needle-like crystals.
Isolated yield: 0.397 g (3.01 mmol, 60%)
1H NMR (700 MHz, D2O): δ/ppm 0.79 (6 H, dd, J = 6.7, 2.9 Hz, H5+6),
1.43-1.51 (2 H, m, H3) 1.62-1.66 (1 H, m, H4), 4.17 (1 H, dd, J = 9.2, 4.4 Hz,
H2);
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13C NMR (126 MHz, D2O): δ/ppm 20.6 (C5/6), 22.4 (C5/6), 23.8 (C4), 42.3
(C3), 68.8 (C2), 178.8 (C1).
IR (neat) ν = 3418.2 (m), 2958.2 (m), 1699.9 (C=O, s), 1266.3 (s), 1226.7 (m),
1136.4 (m), 1075.7 (s), 895.9 (s), 688.4 (m), 521.0 (m) cm−1.
LC-MS: Rt = 1.67 min, m/z 131 [M]
−; HR-MS calculated for C6H11O3 at
131.0708, found 131.0704 (∆ = -3.1 ppm).
Reference79
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9.21 (2S)-2-Hydroxy-3-phenylpropanoic acid,
2-hydroxy-3-phenylpropanoic acid,
Compounds 5-8 and 5-23
HO
O
OH
Chemical Formula: C9H10O3
Exact Mass: 166.06
1 2 3 4 5
6
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O
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Chemical Formula: C9H10O3
Exact Mass: 166.06
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Procedure with l-phenylalanine adapted from literature:104
l-Phenylalanine (9.9 g, 60 mmol) was charged to a 500 mL RBF fitted with a
stirrer bar. An aqueous solution of 0.5 M H2SO4 (240 mL) was charged to the
RBF and stirred for 15 mins at 0 ◦C until all the solid dissolved. NaNO2 (25.0 g,
360 mmol) was dissolved in H2O (90 mL) and the resulting solution was charged
dropwise over 2 h. The RBF was removed from the ice bath and allowed to warm
to RT, stirring overnight. The solution was extracted with Et2O (3 x 50 mL), and
the combined organic layers were washed with a saturated solution of NaCl(aq)
(2 x 50 mL), dried over Na2SO4, filtered and concentrated in vacuo to give the
crude product as a white solid which could be recrystallised from toluene:Et2O
(1:1) to give the product as sparkly white fluffy crystals.
Isolated yield: 6.841 g (41.2 mmol, 69%)
Procedure with rac-phenylalanine:104
dl-Phenylalanine (0.826 g, 5.01 mmol) was charged to a 100 mL RBF fitted with
a stirrer bar. An aqueous solution of 0.5 M H2SO4 (20 mL) was charged to the
RBF and stirred for 15 mins at 0 ◦C until all the solid dissolved. NaNO2 (2.1 g,
30 mmol) was dissolved in H2O (90 mL) and the resulting solution was charged
dropwise over 2 h. The RBF was removed from the ice bath and allowed to
warm to RT, stirring overnight. The solution was extracted with Et2O (3 x 20
mL), and the combined organic layers were washed with a saturated solution of
NaCl(aq) (2 x 20 mL), dried over Na2SO4, filtered and concentrated in vacuo to
give the crude product as a yellow oil (0.672 g). Purification by recrystallisation
(toluene/Et2O) gavethe product as a fluffy, sparkly white solid.
Isolated yield: 0.478 g (2.88 mmol, 57%)
1H NMR (700 MHz, D2O): δ/ppm 2.86 (2 H, dd, J = 14.1, 4.8 Hz, H3), 4.40 (1
H, dd, J = 7.7, 4.8 Hz, H2), 7.17-7.26 (5 H, m, H5-9);
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13C NMR (126 MHz, D2O): δ/ppm 39.5 (C3), 71.2 (C2), 126.9 (C5/6/7/8/9),
128.5 (C5/6/7/8/9), 129.0 (C5/6/7/8/9), 129.4 (C5/6/7/8/9), 136.7 (C4), 177.1
(C1).
IR (neat) ν = 3441.7 (m), 1723.3 (C=O, m), 1240.6 (m), 1191.5 (m), 1090.3 (s),
1066.6 (m), 794.3 (m), 739.2 (m), 699.5 (s), 621.9 (m), 488.1 (m) cm−1.
LC-MS: Rt = 1.31 min, m/z 165 [M]
−; HR-MS calculated for C9H9O3 at
165.0552, found 165.0547 (∆ = -3.0 ppm).
Melting point: 122.0-123.3 ◦C (toluene:Et2O 1:1).
Reference79
103
9.22 Benzyl
(2S)-2-hydroxy-3-methylbutanoate,
benzyl 2-hydroxy-3-methoylbutanoate,
Compounds 5-9 and 5-24
O
O
OH
Chemical Formula: C12H16O3
Exact Mass: 208.11
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Chemical Formula: C12H16O3
Exact Mass: 208.11
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Procedure for benzyl (2S )-2-hydroxy-3-methylbutanoate (5-9):79
(2S )-2-Hydroxy-3-methylbutanoic acid (5-6, 0.120 g, 1.0 mmol) was charged to
an oven-dried 25 mL RBF fitted with a stirrer bar and septum. Dry DMF (0.7
mL), was charged to the RBF at 0 ◦C. Cs2CO3 (0.500 g, 1.5 mmol) was charged
to the RBF in two portions, and the resulting slurry was stirred at 0 ◦C for 20
mins. BnBr (0.13 mL, 1.1 mmol) was added dropwise to the RBF, which was
allowed to warm to RT overnight. A white precipitate was observed, which was
removed by filtration and washed with Hex:EtOAc (8:2), and then discarded. The
filtrate was extracted with half-saturated NH4Cl (3 x 5 mL) then half-saturated
NaHCO3 (10 mL). The organic layers were combined, dried over Na2SO4, filtered
and concentrated in vacuo to give a pale yellow oil (0.121 g). The crude material
was purified by column chromatography (Hex:EtOAc 8:2) to give the product as
a colourless oil.
Isolated yield: 0.039 g (0.187 mmol, 19%)
Procedure for benzyl 2-hydroxy-3-methylbutanoate (5-24):79
2-Hydroxy-3-methylbutanoic acid (5-21, 0.120 g, 1.0 mmol) was charged to an
oven-dried 25 mL RBF fitted with a stirrer bar and septum. Dry DMF (0.7 mL),
was charged to the RBF at 0 ◦C. Cs2CO3 (0.499 g, 1.5 mmol) was charged to
the RBF in two portions, and the resulting slurry was stirred at 0 ◦C for 20
mins. BnBr (0.13 mL, 1.1 mmol) was added dropwise to the RBF, which was
allowed to warm to RT overnight. A white precipitate was observed, which was
removed by filtration and washed with Hex:EtOAc (8:2), and then discarded. The
filtrate was extracted with half-saturated NH4Cl (3 x 5 mL) then half-saturated
NaHCO3 (10 mL). The organic layers were combined, dried over Na2SO4, filtered
and concentrated in vacuo to give a colourless oil (0.176 g). The crude material
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was purified by column chromatography (Hex:EtOAc 8:2) to give the product as
a colourless oil.
Isolated yield: 0.043 g (0.207 mmol, 21%)
1H NMR (700 MHz, CDCl3): δ/ppm 0.82 (3 H, d, J = 6.9 Hz, H4), 1.00 (3 H,
d, J = 7.0 Hz, H4), 2.08 (1 H, ddt, J = 10.3, 6.9, 3.4 Hz, H3), 2.71 (1 H, d, J =
6.1 Hz, H10), 4.07-4.08 (1 H, m, H2), 5.18-5.24 (2 H, m, H5), 7.33-7.37 (5 H, m,
H7-9);
13C NMR (126 MHz, CDCl3): δ/ppm 15.9 (C4), 18.8 (C4), 32.2 (C3), 67.3 (C5),
75.0 (C2), 128.4 (C7/8/9), 128.5 (C7/8/9), 128.6 (C7/8/9), 135.2 (C6), 174.8
(C1).
LC-MS: Rt = 2.93 min, m/z 231.4 [M+Na]
+; HR-MS calculated for C12H17O3
at 209.1178, found 209.1185 (∆ = +3.3 ppm).
Reference79
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9.23 Benzyl
(2S)-2-hydroxy-4-methylpentanoate,
benzyl 2-hydroxy-4-methylpentanoate,
Compounds 5-10 and 5-25
O
OH
O
Chemical Formula: C13H18O3
Exact Mass: 222.13
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Chemical Formula: C13H18O3
Exact Mass: 222.13
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Procedure for benzyl (2S )-2-hydroxy-4-methylpentanoate (5-10):79
(2S )-2-Hydroxy-4-methylpentanoic acid (5-7, 0.133 g, 1.0 mmol) was charged to
an oven-dried 25 mL RBF fitted with a stirrer bar and septum. Dry DMF (0.7
mL), was charged to the RBF at 0 ◦C. Cs2CO3 (0.487 g, 1.5 mmol) was charged
to the RBF in two portions, and the resulting slurry was stirred at 0 ◦C for 20
mins. BnBr (0.13 mL, 1.1 mmol) was added dropwise to the RBF, which was
allowed to warm to RT overnight. A white precipitate was observed, which was
removed by filtration and washed with Hex:EtOAc (8:2), and then discarded. The
filtrate was extracted with half-saturated NH4Cl (3 x 5 mL) then half-saturated
NaHCO3 (10 mL). The organic layers were combined, dried over Na2SO4, filtered
and concentrated in vacuo to give a pale yellow oil (0.208 g). The crude material
was purified by column chromatography (Hex:EtOAc 8:2) to give the product as
a colourless oil.
Isolated yield: 0.071 g (0.320 mmol, 32%)
Procedure for benzyl (2-hydroxy-4-methylpentanoate (5-25):79
2-Hydroxy-4-methylpentanoic acid (5-22, 0.129 g, 1.0 mmol) was charged to an
oven-dried 25 mL RBF fitted with a stirrer bar and septum. Dry DMF (0.7 mL),
was charged to the RBF at 0 ◦C. Cs2CO3 (0.487 g, 1.5 mmol) was charged to
the RBF in two portions, and the resulting slurry was stirred at 0 ◦C for 20
mins. BnBr (0.13 mL, 1.1 mmol) was added dropwise to the RBF, which was
allowed to warm to RT overnight. A white precipitate was observed, which was
removed by filtration and washed with Hex:EtOAc (8:2), and then discarded. The
filtrate was extracted with half-saturated NH4Cl (3 x 5 mL) then half-saturated
NaHCO3 (10 mL). The organic layers were combined, dried over Na2SO4, filtered
and concentrated in vacuo to give a colourless oil.
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Crude yield: 0.110 g (0.495 mmol, 50%)
1H NMR (700 MHz, CDCl3): δ/ppm 0.93 (6 H, t, J = 7.6 Hz, H5), 1.55-1.58 (2
H, m, H3), 1.86-1.90 (1 H, m, H4), 2.66 (1 H, d, J = 6.0 Hz, H11), 4.24 (1 H, dt,
J = 10.1, 5.3 Hz, H2), 5.20 (2 H, d, J = 3.4 Hz, H6), 7.30-7.38 (5 H, m, H8-10);
13C NMR (126 MHz, CDCl3): δ/ppm 21.5 (C5), 23.2 (C5), 24.4 (C4), 43.4 (C3),
67.3 (C6), 69.2 (C2), 128.3 (C8/9/10), 128.5 (C8/9/10), 128.6 (C8/9/10), 135.2
(C7), 175.7 (C1).
IR (neat) ν = 2957.3 (w), 1733.0 (s), 1456.0 (w), 1368.6 (w), 1266.3 (m), 1192.5
(m), 1138.1 (s), 1082.9 (m), 1003.0 (m), 745.3 (m), 695.8 (s), 602.8 (w) cm−1.
LC-MS: Rt = 3.16 min, m/z 245.4 [M+Na]
+; HR-MS calculated for C13H19O3
at 223.1334, found 223.1340 (∆ = +2.7 ppm).
Reference79
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9.24 Benzyl
(2S)-2-hydroxy-3-phenylpropanoate,
benzyl 2-hydroxy-3-phenylpropanoate,
Compounds 5-11 and 5-26
O
O
OH
Chemical Formula: C16H16O3
Exact Mass: 256.11
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Chemical Formula: C16H16O3
Exact Mass: 256.11
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Procedure for benzyl (2S )-2-hydroxy-3-phenylpropanoate (5-11):79
Recrystallised (2S )-2-hydroxy-3-phenylpropanoic acid (5-8, 0.165 g, 1.0 mmol)
was charged to an oven-dried 25 mL RBF fitted with a stirrer bar and septum.
Dry DMF (1.0 mL), was charged to the RBF at 0 ◦C. Cs2CO3 (0.489 g, 1.5 mmol)
was charged to the RBF in two portions, and the resulting slurry was stirred at
0 ◦C for 30 mins. BnBr (0.13 mL, 1.1 mmol) was added dropwise to the RBF,
which was allowed to warm to RT overnight. A white precipitate was observed,
which was removed by filtration and washed with Hex:EtOAc (8:2), and then
discarded. The filtrate was extracted with half-saturated NH4Cl (3 x 5 mL) then
half-saturated NaHCO3 (10 mL). The organic layers were combined, dried over
Na2SO4, filtered and concentrated in vacuo to give a pale yellow oil (0.164 g).
The crude material was purified by column chromatography (Hex:EtOAc 8:2) to
give the product as a pale yellow oil.
Isolated yield: 0.072 g (0.281 mmol, 28%)
Procedure for benzyl 2-hydroxy-3-phenypropanoate (5-26):79
Recrystallised 2-hydroxy-3-phenylpropanoic acid (5-23, 0.167 g, 1.0 mmol) was
charged to an oven-dried 25 mL RBF fitted with a stirrer bar and septum. Dry
DMF (1.0 mL), was charged to the RBF at 0 ◦C. Cs2CO3 (0.489 g, 1.5 mmol)
was charged to the RBF in two portions, and the resulting slurry was stirred at
0 ◦C for 30 mins. BnBr (0.13 mL, 1.1 mmol) was added dropwise to the RBF,
which was allowed to warm to RT overnight. A white precipitate was observed,
which was removed by filtration and washed with Hex:EtOAc (8:2), and then
discarded. The filtrate was extracted with half-saturated NH4Cl (3 x 5 mL) then
half-saturated NaHCO3 (10 mL). The organic layers were combined, dried over
Na2SO4, filtered and concentrated in vacuo to give a colourless oil (0.199 g). The
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crude material was purified by column chromatography (Hex:EtOAc 8:2) to give
the product as a colourless oil.
Isolated yield: 0.105 g (0.410 mmol, 41%)
1H NMR (700 MHz, CDCl3): δ/ppm 2.70 (1 H, br s, H13), 2.97 (1 H, dd, J =
140., 6.5 Hz, H3), 3.12 (1 H, dd, J = 13.9, 4.7 Hz, H3), 4.49 (1 H, d, J = 5.3
Hz, H2), 5.17 (2 H, d, J = 3.1 Hz, H8), 7.13-7.15 (2 H, m, H5+6+7), 7.21-7.25
(3 H, m, H5+6+7), 7.31-7.38 (5 H, m, H10+11+12);
13C NMR (126 MHz, CDCl3): δ/ppm 40.5 (C3), 67.4 (C8), 71.2 (C2), 126.8
(C5/6/7), 128.4 (C5/6/7), 128.59 (C10/11/12), 128.62 (C10/11/12), 128.64
(C10/11/12), 129.5 (C5/6/7), 135.0 (C), 136.1 (C4), 174.0 (C1).
IR (neat) ν = 3474.4 (br, w), 3031.2 (w), 1733.0 (C=O, m), 1497.1 (w), 1454.7
(w), 1262.7 (w), 1187.2 (m), 1090.9 (m), 1029.8 (w), 909.8 (w), 742.9 (m), 695.4
(s), 60.1 (w), 487.7 (m) cm−1.
LC-MS: Rt = 3.14 min, m/z 279.4 [M+Na]
+; HR-MS calculated for C16H16O3
at 257.1178, found 257.1173 (∆ = -1.9 ppm).
Reference79
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9.25 (2S)-3-Methylbutane-1,2-diol,
3-Methylbutane-1,2-diol, Compounds
5-12 and 5-27
HO
OH
Chemical Formula: C5H12O2
Exact Mass: 104.08
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4
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5
HO
OH
Chemical Formula: C5H12O2
Exact Mass: 104.08
1
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Procedure for (2S )-3-methylbutane-1,2-diol (5-12):
LiAlH4 (0.974 g, 25 mmol) was charged under N2 to an oven-dried 250 mL RBF
fitted with a stirrer bar and septum at 0 ◦C. Dry Et2O (10 mL) was charged
to the RBF. (2S )-2-Hydroxy-3-methylbutanoic acid (5-6, 1.188 g, 10 mmol) was
dissolved in dry Et2O (10 mL), then charged dropwise to the LiAlH4 solution at
0 ◦C. The RBF was allowed to warm to RT overnight with stirring. The solution
was diluted with Et2O (5 mL) and cooled to 0
◦C, then quenched with H2O (1
mL). The subsequent work-up followed a procedure by Fieser81 which begins with
the addition of 15% NaOH (1 mL). The solution is further diluted with H2O (3
mL), then warmed to RT and stirred for 15 mins. MgSO4 (approx. 1 g) was
added, followed by further Et2O (5 mL), and the resulting slurry was stirred for
15 mins. The slurry was filtered over Celite and rinsed through with Et2O. The
filtrate was concentrated in vacuo to give the product as a pale yellow oil.
Isolated yield: 0.677 g (6.50 mmol, 65%)
Procedure for 3-methylbutane-1,2-diol (5-27):
LiAlH4 (0.096 g, 2.5 mmol) was charged under N2 to an oven-dried 25 mL RBF
fitted with a stirrer bar and septum at 0 ◦C. Dry THF (1.0 mL) was charged
to the RBF. 2-Hydroxy-3-methylbutanoic acid (5-21, 0.114 g, 1.0 mmol) was
dissolved in dry THF (1.0 mL), then charged dropwise to the LiAlH4 solution at
0 ◦C. The RBF was allowed to warm to RT overnight with stirring. The solution
was diluted with THF (1 mL) and cooled to 0 ◦C, then quenched with H2O (1
mL). The subsequent work-up followed a procedure by Fieser81 which begins with
the addition of 15% NaOH (1 mL). The solution is further diluted with H2O (3
mL), then warmed to RT and stirred for 15 mins. MgSO4 (approx. 0.5 g) was
added, followed by further Et2O (5 mL), and the resulting slurry was stirred for
15 mins. The slurry was filtered over Celite and rinsed through with THF. The
filtrate was concentrated in vacuo to give the product as a pale yellow oil.
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Isolated yield: 0.024 g (0.231 mmol, 23%)
1H NMR (700 MHz, D2O): δ/ppm 0.76 (3 H, d, J = 3.8 Hz, H4/5), 0.77 (3 H,
d, J = 3.8 Hz, H4/5), 1.58 (1 H, dq, J = 13.6, 6.8 Hz, H3), 3.29 (1 H, ddd, J =
7.4, 6.2, 3.5 Hz, H2), 3.38 (1 H, dd, J = 11.7, 7.5 Hz, H1), 3.53 (1 H, dd, J =
11.7, 3.5 Hz, H1);
13C NMR (126 MHz, D2O): δ/ppm 16.9 (C4/5), 18.1 (C4/5), 29.9 (C3), 63.7
(C1), 76.9 (C2).
IR (neat) ν = 3344.1 (br, m), 2960.2 (m), 1467.8 (w), 1386.6 (w), 1061.8 (s),
1008.1 (s), 867.2 (m) cm−1.
Reference106
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9.26 (2S)-4-Methylpentane-1,2-diol,
4-methylpentane-1,2-diol, Compounds
5-13 and 5-28
HO
OH
Chemical Formula: C6H14O2
Exact Mass: 118.10
3 4
5
51
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OH
Chemical Formula: C6H14O2
Exact Mass: 118.10
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Procedure for (2S )-4-methylpentane-1,2-diol (5-13):
LiAlH4 (0.964 g, 24 mmol) was charged under N2 to an oven-dried 250 mL RBF
fitted with a stirrer bar and septum at 0 ◦C. Dry Et2O (10 mL) was charged to
the RBF. (2S )-2-Hydroxy-4-methylpentanoic acid (5-7, 1.320 g, 10 mmol) was
dissolved in dry Et2O (10 mL), then charged dropwise to the LiAlH4 solution at
0 ◦C. The RBF was allowed to warm to RT overnight with stirring. The solution
was diluted with Et2O (5 mL) and cooled to 0
◦C, then quenched with H2O (1
mL). The subsequent work-up followed a procedure by Fieser81 which begins with
the addition of 15% NaOH (1 mL). The solution is further diluted with H2O (3
mL), then warmed to RT and stirred for 15 mins. MgSO4 (approx. 1 g) was
added, followed by further Et2O (5 mL), and the resulting slurry was stirred for
15 mins. The slurry was filtered over Celite and rinsed through with Et2O. The
filtrate was concentrated in vacuo to give the product as a colourless oil.
Isolated yield: 0.681 g (5.77 mmol, 58%)
Procedure for 4-methylpentane-1,2-diol (5-28):
LiAlH4 (0.097 g, 2.5 mmol) was charged under N2 to an oven-dried 25 mL RBF
fitted with a stirrer bar and septum at 0 ◦C. Dry THF (1.0 mL) was charged
to the RBF. 2-Hydroxy-4-methylpentanoic acid (5-22, 0.135 g, 1.0 mmol) was
dissolved in dry THF (1.0 mL), then charged dropwise to the LiAlH4 solution at
0 ◦C. The RBF was allowed to warm to RT overnight with stirring. The solution
was diluted with THF (0.5 mL) and cooled to 0 ◦C, then quenched with H2O
(1 mL). The subsequent work-up followed a procedure by Fieser81 which begins
with the addition of 15% NaOH (1 mL). The solution is further diluted with H2O
(3 mL), then warmed to RT and stirred for 15 mins. MgSO4 (approx. 0.5 g) was
added, followed by further Et2O (5 mL), and the resulting slurry was stirred for
15 mins. The slurry was filtered over Celite and rinsed through with THF. The
filtrate was concentrated in vacuo to give the product as a colourless oil.
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Isolated yield: 0.087 g (0.572 mmol, 56%)
1H NMR (700 MHz, D2O): δ/ppm 0.77 (6 H, dd, J = 11.5, 6.6 Hz, H5+6),
1.10-1.14 (1 H, ddd, J = 4.5, 9.0, 18.4 Hz, H3), 1.18-1.20 (1 H, ddd, J = 5.5,
9.2, 14.4 Hz, H3), 1.53-1.60 (1 H, m, H4), 3.29-3.32 (1 H, dd, J = 11.6, 3.9 Hz,
H1), 3.41-3.44 (1 H, dd, J = 11.7, 6.9 Hz, H1), 3.62-3.66 (1 H, ddt, J = 8.7, 6.9,
4.2 Hz, H2);
13C NMR (126 MHz, D2O): δ/ppm 21.1 (C5/6), 22.6 (C5/6), 23.7 (C4), 41.3
(C3), 65.8 (C1), 70.0 (C2).
IR (neat) ν = 3339.6 (O-H, br), 2954.9 (s), 2927.6 (m), 2870.6 (m), 1468.5 (m),
1367.5 (m), 1065.7 (C-O, s), 1025.7 (C-O, s), 881.1 (m) cm−1.
LC-MS: Rt = 1.59 min, m/z 141 [M+Na]
+.
Reference107
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9.27 (2S)-3-Phenylpropane-1,2-diol,
3-phenylpropane-1,2-diol, Compounds
5-14 and 5-29
HO
OH
Chemical Formula: C9H12O2
Exact Mass: 152.08
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Chemical Formula: C9H12O2
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Procedure for (2S )-3-phenylpropane-1,2-diol (5-14):
LiAlH4 (0.974 g, 25 mmol) was charged under N2 to an oven-dried 250 mL RBF
fitted with a stirrer bar and septum at 0 ◦C. Dry Et2O (10 mL) was charged to
the RBF. (2S )-2-Hydroxy-3-phenylpropanoic acid (5-8, 1.654 g, 10 mmol) was
dissolved in dry Et2O (10 mL), then charged dropwise to the LiAlH4 solution at
0 ◦C. The RBF was allowed to warm to RT overnight with stirring. The solution
was diluted with Et2O (5 mL) and cooled to 0
◦C, then quenched with H2O (1
mL). The subsequent work-up followed a procedure by Fieser81 which begins with
the addition of 15% NaOH (1 mL). The solution is further diluted with H2O (3
mL), then warmed to RT and stirred for 15 mins. MgSO4 (approx. 1 g) was
added, followed by further Et2O (5 mL), and the resulting slurry was stirred for
15 mins. The slurry was filtered over Celite and rinsed through with Et2O. The
filtrate was concentrated in vacuo to give the product as a colourless oil.
Isolated yield: 0.846 g (5.56 mmol, 56%)
Procedure for 3-phenylpropane-1,2-diol (5-29):
LiAlH4 (0.110 g, 2.5 mmol) was charged under N2 to an oven-dried 250 mL RBF
fitted with a stirrer bar and septum at 0 ◦C. Dry THF (1.0 mL) was charged
to the RBF. 2-Hydroxy-3-phenylpropanoic acid (5-23, 0.170 g, 1.0 mmol) was
dissolved in dry THF (1.0 mL), then charged dropwise to the LiAlH4 solution at
0 ◦C. The RBF was allowed to warm to RT overnight with stirring. The solution
was diluted with THF (0.5 mL) and cooled to 0 ◦C, then quenched with H2O
(1 mL). The subsequent work-up followed a procedure by Fieser81 which begins
with the addition of 15% NaOH (1 mL). The solution is further diluted with H2O
(3 mL), then warmed to RT and stirred for 15 mins. MgSO4 (approx. 0.5 g) was
added, followed by further Et2O (5 mL), and the resulting slurry was stirred for
15 mins. The slurry was filtered over Celite and rinsed through with THF. The
filtrate was concentrated in vacuo to give the product as a colourless oil.
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Isolated yield: 0.846 g (5.56 mmol, 56%)
1H NMR (700 MHz, D2O): δ/ppm 2.55 (1 H, dd, J = 13.9, 8.4 Hz, H3), 2.74 (1
H, dd, J = 13.9, 5.1 Hz, H3), 3.37 (1 H, dd, J = 11.7, 6.7 Hz, H1), 3.49 (1 H,
dd, J = 11.7, 3.9 Hz, H1) 3.82-3.84 (1 H, m, H2), 7.15-7.18 (3 H, m,
H5/6/7/8/9), 7.23-7.26 (2 H, m, H5/6/7/8/9);
13C NMR (126 MHz, D2O): δ/ppm 38.7 (C3), 64.9 (C1), 72.8 (C2), 126.4
(C5/6/7/8/9), 128.5 (C5/6/7/8/9), 129.3 (C5/6/7/8/9), 138.3 (C4).
IR (neat) ν = 3234.6 (O-H, br), 2923.8 (w), 1494.9 (w), 1455.2 (w), 1092.0 (m),
1071.8 (m), 1040.9 (s), 898.2 (m), 748.0 (m), 695.7 (s), 549.3 (s) cm−1.
LC-MS: Rt = 1.70 min, m/z 175.3 [M+Na]
+; HR-MS calculated for
C9H12O2
23Na at 175.0735, found 175.0742 (∆ = +4.0 ppm).
Reference108
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9.28 2,2-Bis[2-(2-bromo-5-
methoxyphenyl)ethyl]-4-(propan-2-yl)-1,3-
dioxolane, Compound
5-15/5-30
Br
OMe
OO Br
OMe
Chemical Formula: C24H30Br2O4
Exact Mass: 540.05
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Procedure:
1,5-Bis(2-bromo-5-methoxyphenyl)pentan-3-one (1-55, 0.225 g, 0.5 mmol), (2S )-
3-methylbutane-1,2-diol (5-12, 0.079 g, 0.8 mmol), camphorsulfonic acid (0.050
g, 0.2 mmol) and toluene (3 mL) were charged to a microwave vial fitted with a
stirrer bar. The solution underwent microwave heating at 130 ◦C for 45 mins with
5 mins pre-stirring. The solution was extracted with NaHCO3 (3 x 5 mL) and
washed with a saturated solution of NaCl(aq) (5 mL), then dried over Na2SO4
and filtered. The solution was concentrated in vacuo to give the crude product
as an orange oil.
Isolated yield: 0.122 g (0.2 mmol, 46%)
1H NMR (700 MHz, CDCl3): δ/ppm 0.89 (3 H, d, J = 6.8 Hz, H14/15), 1.05 (3
H, d, J = 6.7 Hz, H14/15), 1.80 (1 H, dq, J = 13.5, 6.8 Hz, H13), 1.89-2.03 (4
H, m, H2), 2.74-2.90 (4 H, m, H3), 3.65 (1 H, t, J = 8.0 Hz, H11), 3.77 (6 H, d,
J = 2.6 Hz, H10), 3.86 (1 H, q, J = 7.9 Hz, H12), 4.10 (1 H, dd, J = 7.8, 6.3
Hz, H11), 6.62 (2 H, dt, J = 8.7, 3.0 Hz, H7), 6.79 (2 H, dd, J = 9.6, 3.0 Hz,
H5), 7.39 (2 H, dd, J = 8.7, 3.8 Hz, H8);
13C NMR (126 MHz, CDCl3): δ/ppm 18.2 (C14/15), 19.3 (C14/15), 30.9 (C3),
31.3 (C3), 31.8 (C13), 37.5d (C2), 55.4 (C10), 68.6 (C11), 81.9 (C12), 110.8
(C1), 113.2d (C7), 114.9d (C9), 115.9 (C5), 133.2 (C8), 142.6d (C4), 159.0 (C6).
IR (neat) ν = 2959.7 (w), 1571.5 (w), 1471.1 (s), 1368.0 (w), 1283.0 (m), 1239.6
(s), 1162.4 (s), 1162.4 (m), 1129.6 (m), 1052.7 (s), 1013.8 (s), 799.4 (m), 601.1
(m) cm−1.
No literature data available.
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9.29 2,2-Bis[2-(2-bromo-5-
methoxyphenyl)ethyl]-4-(2-methylpropyl)-
1,3-dioxolane, Compound
5-16/5-31
Br
OMe
OO Br
OMe
Chemical Formula: C25H32Br2O4
Exact Mass: 554.07
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Procedure:
1,5-Bis(2-bromo-5-methoxyphenyl)pentan-3-one (1-55, 0.912 g, 2.0 mmol), (2S )-
4-methylpentane-1,2-diol (5-13, 0.354 g, 3.0 mmol), camphorsulfonic acid (0.201
g, 0.86 mmol) and toluene (10 mL) were charged to a 50 mL RBF fitted with
a stirrer bar. The solution was heated under Dean-Stark reflux conditions with
stirring overnight. The solution was allowed to cool to RT, then extracted with
NaHCO3 (3 x 10 mL) and washed with a saturated solution of NaCl(aq) (10 mL),
then dried over Na2SO4 and filtered. The solution was concentrated in vacuo
to give the crude product as an orange oil (0.784 g). Purification by column
chromatography (Hex:EtOAc 1:1) gave the product as a yellow oil.
Isolated yield: 0.596 g (1.08 mmol, 54%)
1H NMR (700 MHz, CDCl3): δ/ppm 0.95 (6 H, dd, J = 11.3, 6.7 Hz, H15+16),
1.38 (2 H, m, H13), 1.77 (1 H, m, H14), 1.98 (4 H, m, H2), 2.81 (4 H, m, H3),
3.53 (1 H, t, J = 8.0 Hz, H11), 3.77 (6 H, d, J = 3.3 Hz, H10), 4.15-4.25 (2 H,
m, H11+12), 6.61 (2 H, dt, J = 8.8, 3.1 Hz, H7), 6.79 (2 H, dd, J = 10.6, 3.0
Hz, H5), 7.39 (2 H, dd, J = 8.8, 3.9 Hz, H8);
13C NMR (126 MHz, CDCl3): δ/ppm 22.6 (C15/16), 23.2 (C15/16), 25.6 (C14),
30.9 (C3), 31.3 (C3), 37.7 (C2), 37.8 (C2), 42.6 (C13), 55.4 (C10), 70.7 (C11),
75.2 (C12), 110.6 (C1), 113.2 (C7), 114.6 (C9), 115.9 (C5), 132.2 (C8), 141.2
(C4), 159.0 (C6).
IR (neat) ν = 2955.0 (w), 1593.8 (w), 1571.6 (m), 1468.6 (s), 1239.1 (s), 1162.4
(m), 1135.0 (m), 1049.5 (s), 1013.5 (s), 906.2 (w), 851.9 (w), 798.6 (m), 600.3
(s) cm−1.
No literature data available.
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9.30 4-Benzyl-2,2-bis[2-(2-bromo-5-
methoxyphenyl)ethyl]-1,3-dioxolane,
Compound 5-17/5-32
Br
OMe
OO Br
OMe
Chemical Formula: C28H30Br2O4
Exact Mass: 588.05
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Procedure:
1,5-Bis(2-bromo-5-methoxyphenyl)pentan-3-one (1-55, 0.115 g, 0.3 mmol), (2S )-
3-phenylpropane-1,2-diol (5-14, 0.087 g, 0.6 mmol), camphorsulfonic acid (0.029
g, 0.1 mmol) and toluene (2 mL) were charged to a microwave vial fitted with a
stirrer bar. The solution underwent microwave heating at 130 ◦C for 30 mins with
5 mins pre-stirring. The solution was extracted with NaHCO3 (3 x 5 mL) and
washed with a saturated solution of NaCl(aq) (5 mL), then dried over Na2SO4
and filtered. The solution was concentrated in vacuo to give the crude product
as an orange oil.
Isolated yield: 0.142 g (0.2 mmol, 95%)
1H NMR (700 MHz, CDCl3): δ/ppm 1.94-2.03 (4 H, m, H2), 2.77-2.84 (6 H, m,
H3+H13), 3.10 (1 H, dd, J = 13.8, 6.2 Hz, H13), 3.71 (1 H, t, J = 7.9 Hz,
H11), 3.76 (6 H, d, J = 15.7 Hz, H10), 4.09 (1 H, dd, J = 8.0, 6.0 Hz, H11),
4.43 (1 H, dt, J = 13.2, 6.3 Hz, H12), 6.62 (2 H, ddd, J = 15.0, 8.8, 3.1 Hz,
H7), 6.78 (2 H, dd, J = 26.2, 3.1 Hz, H5), 7.21-7.31 (5 H, m, H15-19), 7.39 (2
H, dd, J = 19.0, 8.7 Hz, H8);
13C NMR (126 MHz, CDCl3): δ/ppm 30.9 (C2), 31.3 (C2), 37.5 (C3), 37.7 (C3),
40.0 (C13), 55.4 (C10), 69.8 (C11), 77.1 (C12), 111.2 (C1), 113.2 (C7 - d), 114.9
(C9 - d), 115.9 (C5 - d), 126.6 (C15/16/17/18/19), 128.5 (C15/16/17/18/19),
129.2 (C15/16/17/18/19), 133.3 (C8), 137.4 (C14), 142.4 (C4 - d), 159.0 (C6).
IR (neat) ν = 2935.0 (w), 1574.5 (w), 1470.2 (s), 1436.4 (m), 1261.8 (s), 1172.6
(m), 1080.6 (m), 1056.3 (m), 797.3 (s) cm−1.
No literature data available.
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9.31 4-Bromo-7-methoxy-2,3-dihydro-1H-
inden-1-one, Compound
6-1
O
Br
OMe
Chemical Formula: C10H9BrO2
Exact Mass: 239.98
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Procedure:
3-(2-Bromo-5-methoxyphenyl)propanoic acid (6-7, 0.641 g, 2.48 mmol) and
polyphosphoric acid (10.652 g, 16.6 wt/wt) were charged to a 50 mL RBF fitted
with a stirrer bar. The resulting viscous solution was heated to 60 ◦C for 1 h,
after which it was removed from the heat and allowed to cool to RT. The dark red
solution was quenched with H2O (10 mL) then diluted with DCM (10 mL) and
extracted with DCM (15 mL x 2). The combined organic extracts were washed
with H2O (15 mL), NaHCO3 (15 mL) and a saturated solution of NaCl(aq) (15
mL), dried over Na2SO4, filtered and concentrated in vacuo to give a yellow solid
(0.398 g, 1.66 mmol). The crude material was purified by column chromatography
(hexanes:EtOAc 1:1) to give the product as a yellow solid.
Isolated yield: 0.283 g (1.18 mmol, 47%)
1H NMR (700 MHz, CDCl3): δ/ppm 2.68-2.70 (2 H, m, H2), 2.99-3.01 (2 H, m,
H3), 3.93 (3 H, s, H10), 6.72 (1 H, d, J = 8.7 Hz, H7), 7.64 (1 H, d, J = 8.6 Hz,
H8);
13C NMR (126 MHz, CDCl3): δ/ppm 26.9 (C3), 36.6 (C2), 56.1 (C10), 111.2
(C7), 111.8 (C9), 127.0 (C5), 138.6 (C8), 156.7 (C4), 157.4 (C6), 204.0 (C1).
IR (neat) ν = 1695.4 (C=O, m), 1582.9 (m), 1473.3 (s), 1281.3 (m), 1271.1 (m),
1195.0 (m), 1125.3 (m), 1074.5 (s), 1018.9 (s), 804.6 (s) cm−1.
LC-MS: Rt = 2.18 min, m/z 240.84 [M]
+; HR-MS calculated for C10H10O2Br at
240.9864, found 240.9863 (∆ = -0.4 ppm).
Reference109
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9.32 1-Bromo-2-(3-bromopropyl)-4-
methoxybenzene, Compound
6-2
Br
Br
OMe
Chemical Formula: C10H12Br2O
Exact Mass: 305.93
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Procedure:
3-(2-Bromo-5-methoxyphenyl)propan-1-ol (6-8, 0.837 g, 3.43 mmol) was charged
to a 100 mL RBF fitted with a stirrer bar and dissolved in DCM (10.0 mL). The
solution was cooled to 0 ◦C, and PPh3 (1.082 g, 4.13 mmol) and CBr4 (1.256
g, 3.79 mmol) were charged to the RBF, which was allowed to warm to RT
and stirred overnight. The solvent was removed in vacuo and the crude material
purified by column chromatography (hexanes:EtOAc 1:1) and fractions containing
the product were combined and the solvent removed in vacuo to give the product
as a colourless oil.
Isolated yield: 0.118 g (3.86 mmol, 84%)
1H NMR (700 MHz, CDCl3): δ/ppm 2.17 (2 H, dt, J = 13.8, 6.7 Hz, H2), 2.85
(2 H, t, J = 7.5 Hz, H3), 3.42 (2 H, t, J = 6.6 Hz, H1), 3.77 (3 H, s, H10), 6.64
(1 H, dd, J = 8.8, 3.0 Hz, H7), 6.80 (1 H, d, J = 3.0 Hz, H5), 7.40 (1 H, d, J =
8.7 Hz, H8);
13C NMR (126 MHz, CDCl3): δ/ppm 32.4 (C2), 33.0 (C1), 34.7 (C3), 55.4
(C10), 113.5 (C7), 114.8 (C9), 116.3 (C5), 133.4 (C8), 140.8 (C4), 158.9 (C6).
IR (neat) ν = 1571.6 (m), 1471.5 (s), 1276.4 (m), 1255.6 (s), 1239.5 (s), 1162.2
(m), 1017.4 (m), 800.50 (m) cm−1.
LC-MS: Rt = 0.426 min, m/z 308.9 [MH]
+ (ASAP, AS+); HR-MS calculated for
C10H12Br2O at 305.9255, found 305.9258 (∆ = +1.0 ppm).
Reference110
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9.33 Ethyl 3-(3-methoxyphenyl)prop-2-enoate,
Compound 6-3
OMe
O
O
Chemical Formula: C12H14O3
Exact Mass: 206.09
1
2
3
4
5
6
7
8
9
10
11
12
Procedure:
Triethylphosphonoacetate (4.85, 24.5 mmol) and MeCN (30 mL) were charged to
a 100 mL RBF fitted with a stirrer bar. DBU (3.65 mL, 24.4 mmol) was charged
to the solution which turned a pale yellow colour. LiBr (2.507 g, 28.9 mmol)
was charged to the solution and an exotherm was observed. The RBF was fitted
with a dropping funnel, lowered into an ice bath and stirred at 0 ◦C for 10 mins.
3-Methoxybenzaldehyde (1-52, 1.25 mL, 10.2 mmol) was added dropwise to the
RBF over 15 mins. The solution was removed from the ice bath and stirred at RT
overnight. The solution was poured into a saturated aqueous solution of NH4Cl
(100 mL) and stirred for 20 mins. The biphasic solution was transferred to a
RBF and concentrated in vacuo. The solution was extracted with Et2O (3 x 20
mL), then the organic extracts were combined and washed with H2O (2 x 20 mL)
then a saturated solution of NaCl(aq) (20 mL), dried over Na2SO4, filtered and
concentrated in vacuo to give a pale yellow oil. The oil was dry-loaded onto silica
via DCM and purified by column chromatography (EtOAc:petroleum ether 1:4)
to give the product as a pale yellow oil.
Isolated yield: 1.904 g (9.42 mmol, 94%)
1H NMR (700 MHz, CDCl3): δ/ppm 1.31 (3 H, t, J = 7.2 Hz, H1), 3.78 (3 H, s,
H12), 4.24 (2 H, q, J = 7.1 Hz, H2), 6.40 (1 H, d, J = 16.0 Hz, H5), 6.89 (1 H,
dd, J = 8.6, 2.1 Hz, H9/10/11), 7.01 (1 H, s, H7), 7.08 (1 H, d, J = 7.6 Hz,
H9/10/11), 7.26 (1 H, t, J = 7.9 Hz, H9/10/11), 7.62 (1 H, d, J = 16.0 Hz,
H4);
13C NMR (176 MHz, CDCl3): δ/ppm 14.3 (C1), 55.2 (C12), 60.4 (C2), 112.9
(C7), 116.0 (C9/10/11), 118.5 (C5), 120.7 (C9/10/11), 129.8 (C9/10/11), 135.8
(C6), 144.4 (C4), 159.9 (C8), 166.8 (C3).
IR (neat) ν = 1705.9 (C=O, s), 1637.1 (m), 1579.5 (m), 1292.0 (m), 1247.2
(C-O, s), 1230.3 (C-O, s), 1160.1 (C-O, s), 979.8 (m), 781.1 (m), 697.1 (m)
cm−1.
LC-MS: Rt = 2.61 min, m/z 207.2 [MH]
+; HR-MS calculated for C12H15O3 at
121
207.1021, found 207.1032 (∆ = +5.3 ppm).
Reference111
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9.34 3-(2-Bromo-5-methoxyphenyl)prop-2-
enoate, Compound
6-4
OMe
Br
O
O
Chemical Formula: C12H13BrO3
Exact Mass: 284.00
1
2
3
4
5
6
7
8
9
10
11
12
Procedure:
Triethylphosphonoacetate (19 mL, 75.0 mmol) and MeCN (80 mL) were charged
to a 500 mL RBF fitted with a stirrer bar. DBU (19.0 mL, 127.0 mmol) was
charged to the solution which turned a pale yellow colour. LiBr (12.9 g, 148.5
mmol) was charged to the solution and an exotherm was observed. The RBF was
fitted with a dropping funnel, lowered into an ice bath and stirred at 0 ◦C for 10
mins. 2-Bromo-5-methoxybenzaldehyde (4-1, 11.097 g, 51.9 mmol) was dissolved
in MeCN (70 mL) before being added dropwise to the RBF over 15 mins. The
solution was removed from the ice bath and stirred at RT overnight. The solution
was poured into a saturated aqueous solution of NH4Cl (450 mL) and stirred for
20 mins. The biphasic solution was transferred to a RBF and concentrated in
vacuo. The solution was extracted with Et2O (3 x 75 mL), then the organic
extracts were combined and washed with H2O (2 x 100 mL) then a saturated
solution of NaCl(aq) (150 mL), dried over Na2SO4, filtered and concentrated in
vacuo to give a yellow oil (15.6 g). The oil was dry-loaded onto silica via DCM
and purified by column chromatography (Et2O:petroleum ether 1:4) to give the
product as a white solid.
Isolated yield: 12.3 g (43.4 mmol, 84%)
1H NMR (700 MHz, CDCl3): δ/ppm 1.34 (3 H, t, J = 7.1 Hz, H1), 3.80 (3 H, s,
H12), 4.28 (2 H, q, J = 7.1 Hz, H2), 6.36 (1 H, d, J = 15.9 Hz, H4), 6.80 (1 H,
dd, J = 8.8, 3.0 Hz, H9), 7.10 (1 H, d, J = 3.0 Hz, H7), 7.48 (1 H, d, J = 8.8
Hz, H10), 7.99 (1 H, d, J = 15.9 Hz, H5);
13C NMR (126 MHz, CDCl3): δ/ppm 14.3 (C1), 55.5 (C12), 60.7 (C2), 112.5
(C7), 115.9 (C11), 117.6 (C9), 121.2 (C4), 133.9 (C10), 135.1 (C6), 143.0 (C5),
159.0 (C8), 166.3 (C3).
IR (neat) ν = 1675.8 (C=O, s), 1570.1 (m), 1457.2 (s), 1278.2 (C-O, s), 928.0
(s), 864.3 (s), 819.0 (s), 646.5 (s), 597.3 (s) cm−1.
123
LC-MS: Rt = 3.18 min, m/z 285 [MH]
+; HR-MS calculated for C12H14O3Br at
285.0126, found 285.0126 (∆ = 0.0 ppm).
Melting point: 31.7-33.3 ◦C (EtOAc).
Reference112
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9.35 Ethyl 3-(3-methoxyphenyl)propanoate,
Compound 6-5
OMe
O
O
Chemical Formula: C12H16O3
Exact Mass: 208.11
1
2
3
4
5
6
7
8
9
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Procedure:
3-(3-Methoxyphenyl)prop-2-enoate (1.010 g, 4.90 mmol) was dissolved in THF
(15 mL) and stirred until all of the solid had dissolved to give a colourless solu-
tion. H2O (15 mL) was charged to the RBF to give a cloudy biphasic solution.
TsNHNH2 (2.662 g, 14.3 mmol) was gradually added to the solution, followed by
NaOAc · 3 H2O (3.1 g, 22.8 mmol). The biphasic solution was heated to reflux
overnight, then removed from the heat and allowed to cool to RT. The solution
was diluted with H2O (30 mL) then extracted with EtOAc (30 mL x 3), washed
with a saturated solution of NaCl(aq) (30 mL), dried over Na2SO4 and filtered.
The solution was concentrated in vacuo to give a colourless oil (1.310 g). The
oil was purified by column chromatography (hexanes:EtOAc 8:2), and the frac-
tions containing the product were combined and concentrated in vacuo to give a
colourless oil.
Isolated yield: 0.900 g (4.33 mmol, 88%)
1H NMR (700 MHz, CDCl3): δ/ppm 1.21-1.25 (3 H, m, H1), 2.60 (2 H, t, J =
7.8 Hz, H4), 2.91 (2 H, t, J = 7.8 Hz, H5), 3.78 (3 H, s, H12), 4.09-4.13 (2 H,
m, H2), 6.73-6.78 (3 H, m, H9+10+11), 7.18 (1 H, dd, J = 8.9, 7.6 Hz, H7);
13C NMR (126 MHz, CDCl3): δ/ppm 14.1 (C1), 31.0 (C5), 35.8 (C4), 55.1
(C12), 60.4 (C2), 111.6 (C9/10/11), 114.0 (C9/10/11), 120.6 (C9/10/11), 129.4
(C7), 142.1 (C6), 159.6 (C8), 173.0 (C3).
IR (neat) ν = 1730.5 (C=O, s), 1257.6 (C-O, s), 1151.9 (C-O, s), 1040.5 (C-O,
s), 779.3 (m), 695.0 (m) cm−1.
LC-MS: Rt = 3.00 min, m/z 209.44 [MH]
+.
Reference113
125
9.36 Ethyl
3-(2-bromo-5-methoxyphenyl)propanoate,
Compound 6-6
OMe
Br
O
O
Chemical Formula: C12H15BrO3
Exact Mass: 286.02
1
2
34
56
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8
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12
Procedure:
3-(2-Bromo-5-methoxyphenyl)prop-2-enoate (6-4, 4.0 g, 14.1 mmol) was dis-
solved in THF (100 mL) and stirred until all of the solid had dissolved to give
a colourless solution. H2O (100 mL) was charged to the RBF to give a cloudy
biphasic solution. TsNHNH2 (7.859 g, 42.2 mmol) was gradually added to the
solution, followed by NaOAc · 3 H2O (8.519 g, 62.6 mmol). The biphasic solution
was heated to reflux overnight, then removed from the heat and allowed to cool
to RT. The solution was diluted with H2O (50 mL) then extracted with EtOAc
(30 mL x 3), washed with a saturated solution of NaCl(aq) (50 mL), dried over
Na2SO4 and filtered. The solution was concentrated in vacuo to give a pale yel-
low oil (5.240 g, 18.3 mmol). The oil was purified by column chromatography
(hexanes:EtOAc 8:2), and the fractions containing the product were combined
and concentrated in vacuo to give a colourless oil.
Isolated yield: 3.957 g (13.8 mmol, 98%)
1H NMR (700 MHz, CDCl3): δ/ppm 1.23 (3 H, t, J = 7.2 Hz, H1), 2.61 (2 H, t,
J = 7.7 Hz, H4), 3.00 (2 H, t, J = 7.7 Hz, H5), 3.74 (3 H, s, H12), 4.12 (2 H, q,
J = 7.1 Hz, H2), 6.62 (1 H, dd, J = 8.7, 3.1 Hz, H9), 6.79 (1 H, d, J = 3.1 Hz,
H7), 7.38 (1 H, d, J = 8.7 Hz, H10);
13C NMR (126 MHz, CDCl3): δ/ppm 14.2 (C1), 31.6 (C5), 34.1 (C4), 55.4
(C12), 60.5 (C2), 113.6 (C9), 114.7 (C11), 116.0 (C7), 133.3 (C10), 140.7 (C6),
159.0 (C8), 172.6 (C3).
IR (neat) ν = 1729.5 (C=O, s), 1471.7 (m), 1240.3 (C-O, w), 1160.2 (C-O, s),
1020.1 (C-O, m), 802.5 (m) cm−1.
LC-MS: Rt = 3.09 min, m/z 286.91 [MH]
+; HR-MS calculated for C12H16O3Br
at 287.0283, found 287.0278 (∆ = -1.7 ppm).
Reference114
126
9.37 3-(2-Bromo-5-methoxyphenyl)propanoic
acid, Compound 6-7
OMe
Br
OH
O
Chemical Formula: C10H11BrO3
Exact Mass: 257.99
12
3
4
5
6
7
8
9
10
Procedure:
Ethyl 3-(2-bromo-5-methoxyphenyl)propanoate (6-6, 0.966 g, 3.38 mmol) was
dissolved in EtOH (12.0 mL). NaOH (0.540 g, 13.5 mmol) was charged to the
RBF and the resulting pale yellow solution was stirred at RT for 30 mins. The
solution was then heated to 30 ◦C for 30 mins. The reaction was quenched with
1M HCl (20 mL) until acidic, then extracted with Et2O (20 mL), H2O (20 mL
x 2) and a saturated solution of NaCl(aq) (20 mL). The solution was dried over
Na2SO4, filtered and concentrated in vacuo to give a white solid (0.821 g, 3.18
mmol). The solid was recrystallised from hexanes to give the product as sparkly
white needle-like crystals.
Isolated yield: 0.641 g (2.48 mmol, 74%)
1H NMR (700 MHz, CDCl3): δ/ppm 2.69 (2 H, t, J = 7.8 Hz, H2), 3.02 (2 H, t,
J = 7.8 Hz, H3), 3.76 (3 H, s, H10), 6.65 (1 H, dd, J = 8.7, 3.0 Hz, H7), 6.81 (1
H, d, J = 3.0 Hz, H5), 7.41 (1 H, d, J = 8.7 Hz, H8);
13C NMR (126 MHz, CDCl3): δ/ppm 31.3 (C3), 33.5 (C2), 55.4 (C10), 113.8
(C7), 114.6 (C9), 116.1 (C5), 133.4 (C8), 140.3 (C4), 159.0 (C6), 177.1 (C1).
IR (neat) ν = 2838.2 (O-H, br w), 1709.7 (m), 1426.2 (m), 1203.2 (s), 1051.1
(m), 866.9 (s), 814.0 (m), 603.3 (m) cm−1.
LC-MS: Rt = 2.32 min, m/z 241.30 [M-H2O]
−; HR-MS calculated for
C10H10O3Br at 256.9813, found 256.9811 (∆ = -0.8 ppm).
CHN analysis: calculated for C10H11BrO3 at C 46.36%, H 4.28%, N 0.00%;
found C 46.15%, H 4.29%, N -0.02%.
Melting point: 83.1-84.0 ◦C (hexanes), literature = 81-83 ◦C.
Reference109
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9.38 3-(2-Bromo-5-methoxyphenyl)propan-1-
ol, Compound
6-8
OH
Br
OMe
Chemical Formula: C10H13BrO2
Exact Mass: 244.01
1
2
3
4
5
6
7
8
9
10
Procedure:
Ethyl 3-(2-bromo-5-methoxyphenyl)propanoate (6-6, 0.997 g, 3.49 mmol) was
dissolved in dry THF (4.0 mL). In a separate RBF, LiAlH4 (0.136 g, 3.58 mmol)
was charged to an oven-dry RBF fitted with a stirrer bar and flushed with N2.
Dry THF (4.0 mL) was charged to this flask which was cooled in an ice bath.
The ester/ THF solution was charged to the first RBF and the resulting solution
was allowed to warm to RT and stirred for 30 mins under N2. The solution was
quenched with EtOH (10 mL), flushed with N2, filtered through silica on a scinter
and rinsed through with EtOH. The solution was concentrated in vacuo to give
a colourless oil.
Isolated yield: 0.837 g (3.43 mmol, 98%)
1H NMR (700 MHz, CDCl3): δ/ppm 1.85-1.90 (2 H, m, H2), 2.76-2.79 (2 H, m,
H3), 3.68-3.71 (2 H, m, H1), 3.76 (3 H, s, H10), 6.62 (1 H, dd, J = 8.7, 3.1 Hz,
H7), 6.78 (1 H, d, J = 3.0 Hz, H5), 7.39 (1 H, d, J = 8.7 Hz, H8);
13C NMR (126 MHz, CDCl3): δ/ppm 32.6 (C3), 32.7 (C2), 55.4 (C10), 62.1
(C1), 113.2 (C7), 114.9 (C9), 116.1 (C5), 133.3 (C8), 142.1 (C4), 158.9 (C6)..
IR (neat) ν = 3326.7 (O-H, br w), 1571.3 (m), 1371.5 (s), 1276.0 (m), 1239.4
(s), 1160.9 (m), 1053.6 (m), 1011.6 (s), 799.8 (m) cm−1.
LC-MS: Rt = 2.86 min, m/z 245 [MH]
+; HR-MS calculated for C10H12BrO
(M-H2O) at 227.0072, found 227.0062 (∆ = -4.5 ppm).
Reference115
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9.39 [3-(2-Bromo-5-
methoxyphenyl)propyl]triphenylphosphonium
bromide, Compound 6-9
P
Br
OMe
Br-
Chemical Formula: C28H27Br2OP
Exact Mass: 568.02
1
234
5
6
7
8
9
10
1112
13
14
Procedure:
1-Bromo-2-(3-bromopropyl)4-methoxybenzene (0.884 g, 2.89 mmol) was charged
to a 50 mL RBF fitted with a stirrer bar. PPh3 (0.748 g, 2.85 mmol) and toluene
(3.0 mL) were charged to the RBF and the resulting solution was refluxed for
6 h. A white precipitate formed when the solution was allowed to cool to RT.
Filtration afforded a white solid (0.839 g, 1.48 mmol) which was recrystallised
from H2O to give the product as white sparkly needle-like crystals.
Isolated yield: 0.826 g (1.45 mmol, 51%)
1H NMR (700 MHz, CDCl3): δ/ppm 1.98 (2 H, h, J = 8.4 Hz, H1), 3.13 (2 H, t,
J = 7.5 Hz, H3), 3.80 (3 H, s, H10), 3.94 (2 H, dd, J = 16.3, 12.9 Hz, H2), 6.61
(1 H, dd, J = 8.7, 3.0 Hz, H7), 7.19 (1 H, d, J = 3.0 Hz, H5), 7.29 (1 H, d, J =
8.7 Hz, H8), 7.64-7.67 (6 H, m, H12/13/14), 7.75-7.80 (9 H, m, H12/13/14);
13C NMR (126 MHz, solvent): δ/ppm 21.9d (C2), 22.4d (C1), 36.5d (C3), 56.1
(C10), 114.1 (C9), 115.2 (C7), 116.7 (C5), 118.3d (C11/12/13/14), 130.4d
(C11/12/13/14), 133.1 (C8), 133.7d (C11/12/13/14), 134.9 (C11/12/13/14),
140.5 (C4), 159.2 (C6).
IR (neat) ν = 1436.5 (P-Ph, m), 1243.1 (m), 1112.4 (m), 1105.0 (m), 740.7 (m),
731.9 (s), 723.9 (s), 690.0 (s) cm−1.
LC-MS: Rt = 0.62 min, m/z 489.1 [M-Br
−]+ (ASAP+); HR-MS calculated for
C28H27BrOP at 489.0983, found 489.0977 (∆ = -1.2 ppm).
Melting point: 173.8-174.7 ◦C (H2O), literature = 174-175
◦C.
Reference110
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9.40 3-(2-Bromo-5-methoxyphenyl)prop-2-
enoic acid, Compound
6-14
OMe
Br
OH
O
Chemical Formula: C10H9BrO3
Exact Mass: 255.97
12
3
4
5
6
7
8
9
10
Procedure:
2-Bromo-5-methoxybenzaldehyde (4-1, 20.906 g, 98 mmol) was dissolved in pyri-
dine (126 mL) in a 500 mL RBF fitted with a stirrer bar. Malonic acid (40.6 g,
391 mmol) 6.272 g, 60.27 mmol) then piperidine (6.5 mL) were charged to the so-
lution, which was heated at reflux for 4 h. The solution was quenched by pouring
into an aqueous 1 M solution of HCl (600 mL). Immediate formation of a white
precipitate was observed. The slurry was filtered and the solid washed with HCl
(20 mL x 2) then H2O. The white solid was transferred to a RBF, dissolved in
EtOAc and extracted with H2O (20 mL) before being dried over Na2SO4, filtered
and concentrated in vacuo to give a fluffy white solid.
Isolated yield: 18.014 g (70.4 mmol, 72%) 1H NMR (700 MHz, CDCl3): δ/ppm
3.78 (3 H, s, H10), 6.62 (1 H, d, J = 15.8 Hz, H2), 6.93 (1 H, dd, J = 8.8, 3.1
Hz, H7), 7.40 (1 H, d, J = 3.1 Hz, H5), 7.56 (1 H, d, J = 8.8 Hz, H8), 7.75 (1
H, d, J = 15.9 Hz, H3), 12.6 (1 H, br s, H11);
13C NMR (126 MHz, CDCl3): δ/ppm 56.1 (C10), 113.2 (C5), 115.5 (C9), 119.0
(C7), 123.2 (C2), 134.3 (C8), 134.7 (C4), 141.8 (C3), 159.4 (C6), 167.6 (C1).
IR (neat) ν = 2837.4 (br), 1675.2 (s), 1626.5 (m), 1567.1 (m), 1471.4 (m),
1417.1 (m), 1304.1 (m), 1286.9 (s), 1220.7 (s), 1201.9 (s), 1059.6 (s), 977.9 (s),
947.7 (m), 855.1 (s), 808.6 (s), 685.5 (m), 596.6 (s) cm−1.
LC-MS: Rt = 3.09 min, m/z 257.3 [MH]
+; HR-MS calculated for C10H10O3Br at
256.9813, found 256.9809 (∆ = -1.6 ppm).
CHN analysis: calculated for C10H9BrO3 at C 46.72%, H 3.53%, N 0.00%; found
C 46.73%, H 3.54%, N -0.02%.
Melting point: 190.5-191.0 ◦C, literature = 189 ◦C.
Reference116
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9.41 4-(3-Hydroxyphenyl)but-3-en-2-one
O
OH
Chemical Formula: C10H10O2
Exact Mass: 162.07
12
3
4
5
6
7
8
9
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Procedure:117
3-Hydroxybenzaldehyde (3-3, 4.90 g, 40.1 mmol) and EtOH (30 mL) were charged
to a 100 mL RBF with stirring. Acetone (15.5 mL, 211 mmol) was charged to the
flask and the reaction was stirred in an ice bath. 10% NaOH (2.99 g, 74.8 mmol,
30 mL) was charged to the flask and the solution turned yellow then orange. The
solution was stirred at RT for 2 h and monitored by TLC (Hex:EtOAc 1:1). The
solution was extracted with EtOAc (50 mL x 2), then the organic layers were
washed with a saturated aqueous solution of NaCl (30 mL), dried over MgSO4
and filtered. The solvent was removed in vacuo to give a pale yellow solid which
was recrystallised from Et2O to give the product as a fine yellow solid which was
91% pure by 1H NMR spectroscopy.
Isolated yield: 3.718 g (22.9 mmol, 57%)
1H NMR (400 MHz, d4−MeOD): δ/ppm 2.39 (3 H, s), 6.73 (1 H, d, J = 16.3
Hz), 6.87 (1 H, ddd, J = 8.2, 2.5, 1.0 Hz), 7.06 (1 H, t, J = 2.5 Hz), 7.11 (1 H,
m), 7.25 (1 H, t, J = 7.9 Hz), 7.58 (1 H, d, J = 16.3 Hz);
13C NMR (101 MHz, d4−MeOD): δ/ppm 25.9 (CH3), 114.1 (CH), 117.5 (CH),
119.7 (CH), 126.3 (CH), 129.7 (CH), 133.8 (C), 133.5 (CH), 157.7 (C), 200.0
(C=O).
IR (neat) ν = 3072.6 (OH, br), 1621.4 (C=O, s), 1576.4 (s), 1253.9 (s), 961.6
(s), 775.5 (s), 683.8 (s) cm−1.
LC-MS: Rt = 2.12 min, m/z 160.9 [M-H]
−.
Melting point: 88.1-93.4 ◦C (Et2O), literature = 94-95
◦C.
Reference117,118
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9.42 3-[3-Hydroxy-5-(3-
hydroxyphenyl)pentyl]phenol
OH
OH
OH
Chemical Formula: C17H20O3
Exact Mass: 272.14
12
3
4
5
6
7
8
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Procedure:119
1,5-Bis(3-hydroxyphenyl)penta-1,4-dien-3-one (3-2, 0.269 g, 1.01 mmol) and IPA
(5.60 mL) were charged to a 25 mL RBF fitted with a stirrer bar. The RBF was
flushed with N2, and 10% Pd/C (0.031 g, 10 wt%) was charged to the RBF. AcOH
(0.114 mL, 2.00 mmol) was charged in one portion to the RBF with stirring.
NaBH4 (0.160 g, 4.23 mmol) was charged gradually to the flask with stirring due
to the rapid evolution of gas. The solution was stirred at RT for 1 h. An aqueous
solution of 1 M HCl (2 mL) was added dropwise to the solution until no more
bubbled were observed. NaHCO3 was added dropwise to the solution until it was
basic (pH 8). The solution was extracted with Et2O (25 mL x 2) and H2O (10
mL x 2). The organic layer was dried over MgSO4, filtered through Celite and
concentrated in vacuo to give the product as a pale yellow oil.
Isolated yield: 0.215 g (0.790 mmol, 78%)
1H NMR (700 MHz, d6−DMSO): δ/ppm 1.53-1.66 (4 H, m, H2), 2.47-2.63 (4 H,
m, H3), 3.38-3.45 (1 H, m, H1), 6.52-6.60 (6 H, m, H5/8/9), 7.03 (2 H, t, J =
7.7, H7), 9.18 (2 H, s, OH);
13C NMR (176 MHz, d6−DMSO): δ/ppm 32.0 (C3), 39.5 (C2), 69.1 (C1), 112.9
(C5/8/9), 115.6 (C5/8/9), 119.4 (C5/8/9), 129.6 (C7), 144.4 (C4), 157.7 (C6).
LC-MS: Rt = 2.87 min, m/z 271 [M-H]
−.
No literature data available.
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9.43 2,4,6-Tribromo-3-hydroxybenzaldehyde
Br
CHO
OH
BrBr
Chemical Formula: C7H3Br3O2
Exact Mass: 355.77
1
2
3
45
6
7
Procedure:120
3-Hydroxybenzaldehyde (3-3, 1.275 g, 10.4 mmol) was charged to a 500 mL RBF
fitted with a stirrer bar. MeCN (200 mL) was charged to the flask and the
resulting solution was stirred for 10 mins. NBS (5.362 g, 30.1 mmol) was charged
to the flask and the solution turned pale yellow. The reaction was stirred at room
temperature for 24 h, then quenched with 10% Na2S2O3 (100 mL) and extracted
with Et2O (100 mL). The crude was washed with 10% Na2S2O3 (20 mL x 2), then
H2O (20 mL x 3). The solution was dried over MgSO4, filtered and the solvent
removed in vacuo to give the product as cream needle-like crystals.
Isolated yield: 2.954 g (8.30 mmol, 79%)
1H NMR (400 MHz, CDCl3): δ/ppm 6.37 (1 H, s, ArOH), 7.85 (1 H, s, H5),
10.17 (1 H, s, H1);
13C NMR (101 MHz, CDCl3): δ/ppm 111.6, 115.0, 115.8, 131.7, 136.6, 150.1
(C4), 190.2 (C1).
IR (neat) ν = 3348.2 (OH, br w), 1633.8 (C=O, s), 1437.0 (C-O, s), 1160.5
(C-O, s), 790.0 (s), 760.0 (m), 670.5 (s) cm−1.
LC-MS: Rt = 2.85 min, m/z 354.7 [M-H]
−; HR-MS calculated for C7H2O2Br3 at
354.7605, found 354.7605 (∆ = +0.0 ppm).
Melting point: 117.3-118.8 ◦C (AcOH), literature = 115-116 ◦C (AcOH).
Reference121
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9.44 7,7’-Dimesylate-1,1’-spirobiindane
(o-SPINOMs)
O
O
1
2
34
56
7
8
9
Chemical Formula: C19H20O6S2
Exact Mass: 408.07
10
S
O O
S
O O
Procedure from o-SPINOL:95
1,1’-Spirobiindane-7,7’-diol (o-SPINOL, 1-42) (0.030 g, 0.12 mmol) was dissolved
in dry DCM (0.150 mL) and transferred to a 5 mL RBF fitted with a stirrer bar
and septum. Dry pyridine (0.05 mL, 0.62 mmol) was charged to the RBF and
the mixture cooled to 0 ◦C. MsCl (0.05 mL, 0.64 mmol) was charged to the RBF
and the solution changed colour from dark yellow to pale yellow. The solution
was stirred in the ice bath for 4 h, then allowed to warm to RT and stirred for
30 mins. The solution was quenched with H2O (0.5 mL) and the organic phase
extracted with DCM (3 x 2 mL). The organic extracts were washed with an
aqueous solution of 1 M HCl (2 x 4 mL) and then a saturated aqueous solution of
NaCl (3 x 2 mL). The solution was dried over MgSO4, filtered and concentrated
in vacuo to give a yellow oil. Conversion to the product was 80% by 1H NMR
spectroscopy.
1H NMR (700 MHz, d6−DMSO): δ/ppm 2.08-2.21 (2 H, m, H2), 2.31-2.41 (2 H,
m, H2), 3.04 (4 H, t, J = 7.4 Hz, H3), 6.97 (2 H, d, J = 8.3 Hz, H7), 7.12 (2 H,
d, J = 8.3 Hz, H9), 7.29 (2 H, s, H8);
13C NMR (176 MHz, d6−DMSO): δ/ppm 30.6 (CH2), 37.6 (CH), 40.8 (CH2),
59.6 (C), 118.8 (CH), 121.0 (CH), 124.5 (CH), 146.2 (C), 149.4 (C).
IR (neat) ν = 2939.5 (w), 1359.5 (m), 1175.5 (C-O, s), 1121.6 (m), 932.2 (s),
904.2 (m) cm−1.
LC-MS (ASAP): Rt = 0.76 min, m/z 409.1 [M+H]
+.
No literature data available.
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9.45 1,5-Bis(2-chloro-5-nitrophenyl)penta-1,4-
dien-3-one
Cl
NO2
Chemical Formula: C17H10Cl2N2O5
Exact Mass: 392.00
12
3
4
5
6
7
8
O Cl
NO2
9
Procedure:
NaOH (1.015 g, 25.38 mmol) was charged to a 100 mL RBF fitted with a stirrer
bar. H2O (10 mL) was charged to the RBF, followed by EtOH (10 mL). 2-Chloro-
5-nitrobenzaldehyde (1.828 g, 9.85 mmol) was charged to the RBF, then stirred
for 5 mins until all the solid had dissolved to give an orange solution. Acetone
(0.38 mL, 5.18 mmol) was charged to the RBF. After 15 mins stirring at RT,
the solution was brown and viscous. After 2 h, 1 M HCl was added dropwise
until the solution was neutral. The coffee-coloured suspension was filtered over a
scinter, rinsed with H2O, and left to air-dry overnight. The crude solid was dried
in vacuo to give a pale-brown solid.
Isolated yield: 1.888 g (4.80 mmol, 96%)
1H NMR (700 MHz, CDCl3): δ/ppm 7.20 (2 H, d, J = 15.9, H2), 7.65 (2 H, d, J
= 8.8, H8), 8.12 (2 H, d, J = 15.9, H3), 8.20 (2 H, dd, J = 8.8, 2.6, H7), 8.59 (2
H, d, J = 2.6, H5);
13C NMR (176 MHz, CDCl3): δ/ppm 112.6 (C5), 125.4 (C7), 129.5 (C2), 131.4
(C8), 134.3 (C4), 137.7 (C3), 141.7 (C9), 146.8 (C6), 187.0 (C1).
IR (neat) ν = 1516.4 (m), 1346.1 (s), 1051.0 (w), 819.4 (w), 739.2 (m) cm−1.
LC-MS: Rt = 0.61 min, m/z 393.0 [MH]
+.
No literature data available.
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Part II
Continuous Flow Synthesis of
Coumalic Acid and Derivatives
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Chapter 10
Literature Review
10.1 Introduction
Coumalic acid is a valuable platform compound which can be prepared from malic
acid, a biorenewable feedstock derived from glucose. Current batch procedures
to synthesise this compound have several drawbacks, which we address here with
two flow syntheses and a new type of heated rotating flow reactor. Coumalate
derivatives can be used in inverse electron demand Diels-Alder reactions to syn-
thesise compounds with applications in molecular electronics, with the added
advantage of a metal-free preparation.
10.2 Green chemistry
Green chemistry can be defined by ‘a set of principles that reduce or eliminate
the use or generation of hazardous substances in the design, manufacture and
application of chemical products’.1
The 12 principles of green chemistry are summarised below:
1. Prevent waste
2. Atom economy
3. Less hazardous synthesis
4. Design benign chemicals
5. Benign solvents and auxiliaries
6. Design for energy efficiency
7. Use of renewable feedstocks
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8. Reduce derivatives
9. Catalysis (vs. stoichiometric)
10. Design for degradation
11. Real-time analysis for pollution prevention
12. Inherently benign chemistry for accident prevention
This project had a particular focus on Principle 7: the use of renewable feed-
stocks. The environmental and health impacts of a process and the efficacy of the
synthetic pathway must be considered when switching to an alternate feedstock
or starting material. Petroleum has historically been the most important source
of chemicals, but tends to require polluting oxidation steps to transform the hy-
drocarbons into useful starting materials. An alternative source is agricultural
and biological feedstocks. These species tend to already be highly oxygenated.
When evaluating feedstocks and starting materials, one must consider their
origin, for example, mining, refinery, synthesis, distillation, etc. and whether the
resource is renewable or depleting. The downstream implications of the choice of
feedstock must also be taken into account.
10.3 Biomass as a source of useful compounds
Biomass can be used as a source of energy (e.g. biofuels), but the more valuable
components can be used to make fine chemicals with greater added value, leading
to useful chemical building blocks.2 Biomass includes terpenes, carbohydrates,
proteins and triglycerides. Biomass carbohydrates are the most abundant renew-
able resources available, and contain lignin, cellulose and hemicellulose.3 There
are two types of sugars present in biomass: hexoses and pentoses. The two main
methods for transforming sugars into bioproducts are fermentation and chemical
processes. The conversion of biomass to commodity chemicals can proceed via
complete deoxygenation to petroleum hydrocarbons or direct conversion to oxy-
genates as platform chemicals. The products of enzymatic glucose fermentation
include lactic acid, succinic acid, 3-hydroxypropionic acid, itaconic acid, glutamic
acid and malic acid.
10.4 Malic acid as a platform molecule
In 2004, the U.S. Department of Energy published a report on ‘The Top Ten Value
Added Chemicals from Biomass’.4 This list included malic acid as a 1,4-diacid
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building block derived from sugar, along with succinic and fumaric acids. The
pathway to these building blocks from sugars is fermentation to over-produce C4
diacids from the Krebs cycle. Technical barriers to overcome include improving
the microbial biocatalyst to reduce acetic acid co-products and increase yield and
productivities, lowering the costs of the recovery process to reduce unwanted diols
and scale-up and system integration issues. The report identified three groups of
useful derivatisations, which will be described below.
1. Reductions to THF, butanediol and γ-butyrolactone families. The potential
uses of these derivatives include solvents and fibres such as Lycra R©.
2. Reductive aminations to the pyrrolidinone family via γ-butyrolactone. The
potential uses of these derivatives include green solvents and water-soluble
polymers, with applications in water treatment.
3. Direct polymerisation to straight- and branched-chain polymers. The po-
tential uses of these derivatives include fibres such as Lycra R©, among oth-
ers.
Other uses of malic acid as a platform compound include the production of sub-
stituted THF derivatives, as well as the synthesis of 3-hydroxybutyrolactone. One
possible route would proceed via cyclic reduction to malic acid to hydroxysuccinic
anhydride, followed by reduction to 3-hydroxybutyrolactone.
10.5 Methyl coumalate as a valuable
intermediate
Methyl coumalate is a doubly functional α,β-unsaturated compound. It has been
extensively used in Diels-Alder reactions,5–12 but also in pyridine synthesis and
photochemical reactions.13,14 Its utility in Diels-Alder reactions encompass both
normal and inverse electron demand as well as hetero-Diels-Alder reactions. Ad-
ditionally, it has been used in the total synthesis of natural products.11–14 A
literature survey of these reactions will be summarised below.
Coumalic acid is a common precursor to methyl coumalate, and several syn-
thetic procedures have been used to synthesise this compound from aliphatic
starting materials.
The earliest procedure for the synthesis of coumalic acid was published by
von Pechmann in 1891 and started from malic acid.15 A mixture of concentrated
sulfuric acid (97-98%) and fuming sulfuric acid were used at 70 ◦C to effect
conversion to coumalic acid. No isolated yield is given for this procedure.
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In 1963, Wiley et al. performed this reaction on a 100 g scale, using the
von Pechmann conditions allowing isolation of the product in 65-70% yield
(Scheme 10.1).16
HO
O OH
OH
O
fuming H2SO4 O
O
OHO
10-2, 65-70%
∆
2
10-1
Scheme 10.1 Synthesis of coumalic acid from malic acid.
More recently, the mechanism of this reaction was investigated by Ashworth
et al. in 2003.17 They found it proceeded via an acid-catalysed dehydration/
decarbonylation of malic acid to give an aldehyde acid enol which condenses by
Michael addition of the enol to the enone, followed by lactonisation and dehydra-
tion to give coumalic acid (Scheme 10.2). The major gaseous by-product was not
CO2, but instead was CO.
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Scheme 10.2 Mechanism of the synthesis of coumalic acid from malic acid.
Kaminski and Kirch used a more concentrated solution of sulfuric acid with
malic acid in 2008 (Scheme 10.3).18
HO
O OH
OH
O
conc H2SO4 O
O
OHO
10-2, 67%
∆
2
10-1
Scheme 10.3 Synthesis of coumalic acid from malic acid.
Since then, Kraus et al. have investigated various different reaction conditions
to synthesise coumalic acid from malic acid.19 They have varied the acid, reaction
temperature, solvent and additive, and found that the relative amounts of malic
and fumaric acid produced depends very specifically on the reaction conditions.
Fumaric acid was a by-product observed in varying amounts; the most successful
conditions are shown below (Scheme 10.4). The ratio of products shown is an
NMR yield.
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HO
O OH
OH
O
Conc. H2SO4 or CF3SO3H
Dichloroethane, 100 °C, 16 h
O
O
OHO
+ HO
O
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O
10-2, 80-86% 10-3, 4-5%10-1
Scheme 10.4 Synthesis of coumalic acid from malic acid.
Synthesis of methyl coumalate
The two main synthetic routes to methyl coumalate proceed from either aliphatic
starting materials, or more commonly, coumalic acid.
Kraus et al. synthesised methyl coumalate from methyl 3-oxo-propionate.19
They had success with either concentrated H2SO4 or trifluoromethanesulfonic
acid (Scheme 10.5).
H OMe
OO O
O
OMeO
Conc. H2SO4 or CF3SO3H
Dichloroethane, 100 °C, 16 h
10-5, 48-83%10-4
Scheme 10.5 Synthesis of methyl coumalate from methyl 3-oxo-propionate.
A related synthesis is that of ethyl coumalate. Starting from ethyl 3,3-
diethylpropionate Maeda et al. were able to synthesise ethyl coumalate and
screened a variety of Lewis acids.59 The most successful was FeCl3 · 6 H2O
(Scheme 10.6). Interestingly, they observed triethyl 1,3,5-benzenetricarboxylate
as a side-product in some of these reactions.
EtO OEt
OOEt O
O
OEtO
FeCl3.6H2O (15 mol%)
EtOH:AcOH (1:8)
90 °C, 6 h
10-7, 88%10-6
Scheme 10.6 Synthesis of ethyl coumalate from ethyl 3,3-diethoxypropionate.
Coumalic acid can be methylated by esterification to give methyl coumalate,
and several groups have performed this transformation.
The first was Boyer et al. in 1956.20 They used MeOH in concentrated H2SO4
and reported a 32-45% yield of methyl coumalate (Scheme 10.7).
O
O
OMeO
H2SO4
90 °C, 1 h
10-5, 32-45%
O
O
OHO
MeOH
10-2
Scheme 10.7 Synthesis of methyl coumalate from coumalic acid.
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Ashworth et al. experienced difficulties with this procedure, and instead at-
tempted acid chloride formation followed by reaction with MeOH, as well as mixed
anhydride formation followed by reaction with MeOH. However, once formed,
methyl coumalate decomposition was observed (Scheme 10.8).
O
O
OMeO
H+
MeOH
MeO OMe
O
OMeO
MeO OMe
O
OMeO
OMe OMe H
MeO OMe
OMeO2C
CO2Me
CO2Me
10-5
10-8
Scheme 10.8 Transformation of methyl coumalate to trimethyl 1,3,5-
benzenetricarboxylate.
A milder esterification procedure gave them methyl coumalate in good
yield, by first deprotonating coumalic acid using the non-nucleophilic N,N -
diisopropylethylamine and then reacting the coumalate anion formed with
dimethyl sulfate (Scheme 10.9).
O
O
OHO
Me2SO4
iPr2NEt
NMP
O
O
OMeO
10-5, 65%10-2
Scheme 10.9 Synthesis of methyl coumalate from coumalic acid.
Methyl coumalate in Diels-Alder reactions
The [4+2] cycloaddition known as the Diels-Alder reaction is a powerful tool
in synthetic chemistry and natural product synthesis.21 It requires a diene and
dienophile component. Methyl coumalate can be described as an electron-poor
diene because it contains two α,β-unsaturated ester units (Fig. 10.1).
O
O
OMeO
10-5
Fig. 10.1 The α,β-unsaturated esters in methyl coumalate.
This is a reversal of the normal electronic demand. With a suitable dienophile
partner (typically electron-rich), inverse electronic demand Diels-Alder reactions
are possible. In frontier molecular orbital theory, electron-withdrawing groups
(EWG) on dienes and dienophiles lower the energies of both the highest-occupied
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molecular orbital (HOMO) and lowest-unoccupied molecular orbital (LUMO).
Electron-donating groups (EDG) raise the energies of both the HOMO and
LUMO. For a better orbital overlap, the energy gap between the HOMO and
LUMO must be minimised. In normal electronic demand reactions, it is the
HOMO of the diene and the LUMO of the dienophile that react together. To
decrease the size of the HOMO-LUMO gap, there should be an EDG on the diene
and an EWG on the dienophile. It is the reverse for the inverse electronic demand
reaction, which requires the LUMO of the diene and the HOMO of the dienophile
to react. Therefore an EWG on the diene and an EDG on the dienophile will
decrease the size of the HOMO-LUMO gap (Fig. 10.2).
HOMO
LUMO
Normal e- demand
e- rich e- poor
diene dienophile
HOMO
LUMO
Inverse e- demand
e- poor
e- rich
diene dienophile
Fig. 10.2 Frontier molecular orbital theory in normal and inverse electron de-
mand Diels-Alder reactions.
Thus the most favourable inverse electron demand Diels-Alder reactions with
methyl coumalate will have an electron-donating group(s) such as alkoxy groups
and amines on the dienophile.
Several research groups have used methyl coumalate as the diene in Diels-
Alder reactions, with a variety of dienophile partners.
The Harrity group has used a variety of alkynylboronates in a series of papers
over the last ten years (Scheme 10.10).22–24
O
O
O OMe
R B
O
O
Bpin
CO2Me
R
R
CO2Me
Bpin
o-Dichlorobenzene
180 °C, 18 h
10-5 10-9 10-10 10-11
Scheme 10.10 Diels-Alder reactions of methyl coumalate with alkynyl
boronates. The ratio of products depends on the nature of the R-group.
They found that cycloaddition was more efficient for 2-pyrones if they had an
EWG at the 5-position rather than the 4-position. Aromatic boronic esters are
valuable intermediates in organic synthesis due to their stability and versatility.
Methyl coumalate has been used in Diels-Alder reactions by the Kraus group,
using a wider range of dienophiles. The procedure is a one-pot Diels-Alder/ decar-
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boxylation/ aromatisation sequence. Products formed include dimethyl tereph-
thalate and terephthalic acid, a polymerisation co-polymer.25,26 A range of ketals,
orthoesters and vinyl ethers were used as electron-rich olefinic dienophiles to give
substituted benzoate products (for example, Scheme 10.11).27
O
O
O OMe
MeO OMe
MeO
O
Toluene
200 °C, 16 h
10-13, 89%10-5 10-12
Scheme 10.11 Diels-Alder reaction of methyl coumalate with 2,2-
dimethoxypropane.
The procedure is regioselective and high-yielding.
A Diels-Alder reaction with methyl coumalate has been used by the Snyder
group as the first step in the synthesis of (+)-scholarisine A. The target compound
is a polycylic alkaloid which is isolated from the traditional Chinese medicinal
plant Alstonia scholaris (Scheme 10.12).28
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CO2Me
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O
N
O
(+)-Scholarisine A, 10-1610-15, 83%10-5 10-14
Scheme 10.12 Diels-Alder reaction of methyl coumalate used in the synthesis
of (+)-scholarisine A.
They acknowledge that this cycloaddition would appear to be unfavourable on
paper, due to the presence of electron-withdrawing groups on both components,
but that it proceeds with efficiency. Two minor components were found: one was
a separable diastereomer of the product, and the other was unknown.
Epidithiodiketopiperazines are metabolites with a range of biological activities
including antiviral, antibacterial, antiallergic, antimalarial and cytotoxic proper-
ties.29 A diastereoselective inverse electron demand Diels-Alder reaction has been
used to form a hydroindole precursor of these natural products (Scheme 10.13).
O
O
OMeO
+
Toluene
130 °CN
Boc
CO2Et O
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N
Boc
CO2Et
MeO2C H
H
N
H
CO2Et
H
HOH
O
10-18, 95%10-5 10-17 10-19
Scheme 10.13 Diels-Alder reaction of methyl coumalate used in the synthesis
of a precursor to epidithiodiketopiperazines.
The electron-rich dienophile allowed the reaction to proceed in excellent yields
with a good level of diastereoselectivity over 10:1.
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Methyl coumalate in photochemical reactions
The Baran group has used a photochemical reaction of methyl coumalate to
synthesise some members of the piperarborenine family. These compounds were
isolated from Piper arborescens, and have shown in vitro toxicity against several
cancer cell lines. They share an unsymmetrical cyclobutane core with pendant
groups that have different side chains and stereochemistry, thus presenting a
challenging target. Compounds synthesised so far include piperarborenines B,30
D (proposed structure30) and pipercyclobutanamide A (proposed structure31).
These syntheses share a common photochemical first step, and the amine in the
subsequent amide formation is varied. The example shown below is the synthesis
of piperarborenine B (Scheme 10.14).
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Piperarborenine B, 10-2110-5
Scheme 10.14 Photochemical reaction of methyl coumalate as used in the
synthesis of several piperarborenines, including piperarborenine B.
10.6 Diels-Alder derivatives and molecular
electronics
Molecular electronics is a branch of nanotechnology that uses single molecules
as components in electronic circuits, and numerous reviews have been written on
the subject.32 These molecular materials include conductive polymers and molec-
ular salts. One important family of molecules with wide ranging applications as
molecular electronic components including in the area of organic light-emitting
diodes (OLEDs) are the terphenyls.33
A critical consideration in the syntheses of such molecules is their purity,
as even low levels of contamination (ppb) can have a significant impact on their
properties. This is particularly true of residual heavy metal contamination. How-
ever, traditional syntheses of such compounds inevitably rely on reactions such
as nickel or palladium-catalysed coupling reactions.32 An alternative metal free
approach would be via the inverse electron demand Diels-Alder reaction, with
coumalic acid derivatives as the electron-poor diene, partnered with a suitable
electron-rich dienophile.5–14
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10.7 Heteropoly acids
Heteropoly acids (HPA) are a class of acids containing acidic hydrogen atoms,
oxygen, and specific metals M (e.g. W, Mo, V) and p-block non-metals X (e.g.
Si, P, As). They are strong Brønsted acid catalysts and oxidants, and have been
used in a variety of homogeneous and heterogeneous reactions.
The Keggin structure makes up the majority of heteropoly acids, with the
general formula HnXM12O40, and so will be discussed in more detail here. The
Dawson structure applies to compounds with the general formula HnX2M18O62
and is much rarer.
The Keggin structure has tetrahedral symmetry by X-ray crystallography, and
comprises a central XO4 tetrahedron surrounded by 12 MO6 octahedra.
34 These
octahedra share edges and corners, and are arranged in four groups of MO13.
The Keggin structure is retained in a concentrated solution, but in other cases,
the structure depends on pH, the solvent, the composition of the HPA and its
concentration.
The crystal structure of an HPA depends on the quantity of waters of crys-
tallisation, and many hydrates are possible. The strength of the acid increases
on dehydration.
There are three potential protonation sites, as there are three types of outer
oxygen atoms. These are the terminal oxygens of the M=O bonds, and the edge-
and corner-sharing bridging oxygen atoms of the M-O-M bonds.
The acid strength of an HPA depends on its composition: tungsten-containing
acids are stronger than molybdenum-containing acids, for example. Dissociation
constants and Hammett acidity functions have been investigated for HPAs in
solution. They are highly soluble in polar solvents such as water and methanol,
but are insoluble in non-polar solvents such as hexane. HPAs are strong, fully
dissociated acids in aqueous solution. Equimolar solutions of H2SO4 are less
strong than HPAs: for example, the pK values of H3PW12O40 are pK1 = 1.6, pK2
= 3.0 and pK3 = 4.0 whilst for H2SO4 they are pK1 = 6.6.
Homogeneous catalysis performed with HPAs has several advantages over con-
ventional mineral acids. HPAs are stronger acids, leading to higher catalytic
activity and thus requiring lower catalyst loading or temperatures. They avoid
side-reactions that can occur with mineral acids, such as sulfonation (H2SO4),
chlorination (HCl) and nitration (HNO3). They are less toxic, crystalline solids
and so are safer and easier to handle. However, the challenge of catalyst recovery
and recycling is a serious issue.
Reactions that have used HPAs as homogeneous catalysts include olefin hy-
dration (Scheme 10.15),35 esterification and condensation (Scheme 10.16).36
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H3PMo12O40
H2O
OH
10-22 10-23
Scheme 10.15 One-step industrial hydration of isobutene to synthesise t-butyl
alcohol, catalysed by H3PW12O40.
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R = -(CH2CH2CH2CHCH3)3CH3
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AcOH, 90-120 °C
-H2O
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10-26, 91%
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O R
Vitamin E, 10-2710-24 10-25
Scheme 10.16 Synthesis of vitamin E by the HPA-catalysed condensation of
isophytol with 2,3,5-trimethylhydroquinone.
Biphasic reactions with two immiscible liquid phases have also been used, for
example in the polymerisation of THF,37,38 and in esterification (Scheme 10.17).39
H3PW12O40
AcOH/ H2O OH OAc
21% conversion
90% selectivity
10-28 10-29 10-30
Scheme 10.17 Biphasic hydration and acetoxylation of dihydromyrcene catal-
ysed by H3PW12O40.
Heterogeneous catalysis avoids the major problem in homogeneous catalysis,
which is the separation of catalyst and product at the end of a reaction. However,
a new problem arises: the coking (formation of carbonaceous deposits) on the
surface of the catalyst, which leads to deactivation.
Reactions that have used HPAs as heterogeneous catalysts include alkyla-
tion of paraffins, Friedel-Crafts reactions (Scheme 10.18),40 esterification41 and
hydrolysis.
H3PW12O40
Neat
30 °C, N 2
10-32
>80 % conversion
75% selectivity
10-31 10-22
Scheme 10.18 Heterogeneous Friedel-Crafts reaction of p-xylene with 2-
methylpropene, catalysed by solid H3PW12O40.
HPAs have been immobilised on a variety of materials, including silica, meso-
porous molecular sieves, and carbon, among others.42
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10.8 Polyoxometalates
The conjugate anion of a heteropoly acid is known as a polyoxometalate (POM).
In liquid phase oxidation, a variety of metal-substituted heteropoly anions are
found. These include the Keggin-type vanadium-doped series of HPAs with
the general formula PMo12VnO40
(3+n)−, where n = 2 to 6 (HPA-n). These are
reversibly-acting oxidants which require only mild conditions, and have a step-
wise redox mechanism. A series of pH-dependent equilibria determine their state
in solution which are largely unknown, and so their mechanisms of action are not
well-understood.
The HPA-n series of anions is the most efficient and versatile POM for ox-
idation using O2. The catalytic activity of POMs is solvent-dependent. Ho-
mogeneous oxidation can be performed using a one-component HPA-n system.
Examples include oxidation of hydrocarbons, of aldehyes to carboxylic acids, of
alkylphenols, of sulfur compounds, of 2-methylnaphthalene to quinone and in the
presence of an aldehyde to effect epoxidation of olefins.43–47 Others are the de-
hydrogenation of α-terpinene to p-cymene, oxidative bromination of aromatics,
and Baeyer-Villiger oxidation of cyclic ketones to lactones.48,49
Two-component HPA-n systems can be formed by the addition of other met-
als, for example PdII. This system has had success in the oxidation of olefins,
alcohols, arenes, and other compounds. HPA-n acts as the co-catalyst, and O2
as the oxidant. It can be considered as being analogous to Wacker-type oxida-
tion with CuCl2/PdCl2. Biphasic oxidation is possible, and avoids the difficult
separation with homogeneous systems.
There is limited information about the mechanism of redox reactions catalysed
by HPA-n. Solutions of HPA-n increase in structural complexity as n increases.
31P NMR spectroscopy illustrates this, and the large number of observed peaks
correspond to the great number of polyanionic species present in solution, as well
as their positional isomers.42
Oxidation has also been performed with hydrogen peroxide as the oxidant
rather than O2, in particular by the groups of Venturello
50 and Ishii.51–58
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Chapter 11
Project Aims
The batch synthesis of coumalic acid was first verified, before beginning efforts
to transfer the reaction into flow. Factors affecting the reaction were investigated
systematically to determine critical parameters for development of the most ap-
propriate flow process. A large-scale flow process would be highly beneficial in
making coumalic acid and derivatives more accessible.
Methylation and other esterifications of coumalic acid were also investigated
in batch and then flow. The coumalate derivatives prepared were used in Diels-
Alder reactions to give terphenyls with applications in molecular electronics.
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Chapter 12
Batch Syntheses of Coumalic
Acid and Derivatives
12.1 Preliminary batch experiments
Before moving the reaction into a flow format, the reaction was first investigated
in batch. There were several literature procedures to test, which will be described
below.
Following a literature procedure by Kaminski et al., the first attempt at syn-
thesising coumalic acid in batch was on a large scale, using 200 g of malic acid
(Scheme 12.1).18
HO
O OH
OH
O
Conc. H2SO4 (5 equiv.)
75 °C, 6 h
O
O
OHO
10-1 10-2
Scheme 12.1 Synthesis of coumalic acid from malic acid.
The reaction was heated for 6 h, and significant foaming of the mixture was
observed. After quenching with ice and stirring overnight, the solid isolated
after filtration was a pale brown wet paste. After air-drying, purification by
recrystallisation from MeOH in the presence of activated carbon was attempted,
but only gave a recovery of 22%.
Kraus et al. claim in a patent that the reaction of malic acid with concentrated
sulfuric acid or triflic acid in DCE generates an 80-86% yield of coumalic acid,
and observe 4- 5% of fumaric acid side-product formation (Scheme 12.2).19
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Conc. H2SO4 or CF3SO3H
Dichloroethane, 100 °C, 16 h
O
O
OHO
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10-2, 80-86% 10-3, 4-5%10-1
Scheme 12.2 Synthesis of coumalic acid from malic acid.
The reaction with sulfuric acid gave a lower yield of coumalic acid, and a
higher composition of fumaric acid in the crude reaction mixture (Scheme 12.3).
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O OH
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Conc. H2SO4 (5.0 equiv.)
Dichloroethane, 100 °C, 20 h
O
O
OHO
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O
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10-2, 59% 10-3, 9%
Crude yield
10-1
Scheme 12.3 Synthesis of coumalic acid from malic acid.
The reaction with triflic acid gave coumalic acid in good yield but poor quality
(Scheme 12.4).
HO
O OH
OH
O
Dichloroethane, 100 °C, 16 h
O
O
OHO
10-2, 89%
CF3SO3H (5.0 equiv.)
10-1
Scheme 12.4 Synthesis of coumalic acid from malic acid.
In this latter reaction, no fumaric acid was observed by 1H NMR spectroscopy.
A one-pot, one step batch synthesis of methyl coumalate gave the ester prod-
uct in low yield (Scheme 12.5).
HO
O OH
OH
O
O
O
OMeO
1) H2SO4 (5.0 equiv.), 
90 °C, 6 h
2) MeOH (4.0 equiv.), 
reflux, 3 h
10-5, 30-40% yield10-1
Scheme 12.5 Synthesis of methyl coumalate from malic acid in a one-pot pro-
cess.
A one-pot, two step synthesis of methyl coumalate from malic acid was per-
formed (Scheme 12.6).12
HO
O OH
OH
O
1) Conc. H2SO4 (5 equiv.)
90 °C, 2 h
2) MeOH (4.0 equiv.)
0 to 90 °C, 3 h
O
O
OMeO
10-5, 27%10-1
Scheme 12.6 Synthesis of methyl coumalate from malic acid in a one-pot pro-
cess.
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The total isolated yield of methyl coumalate after recrystallisation from
EtOAc was 27%.
Methyl coumalate was synthesised from methyl-3,3-dimethoxypropionate us-
ing sulfuric acid (Scheme 12.7).
MeO
OMe
OMe
Conc. H2SO4 (5 equiv.)
Dichloroethane, 100 °C, 20 h
O
O
OMeO
10-5, 109% crude yield
O
12-1
Scheme 12.7 Synthesis of methyl coumalate from methyl-3,3-
dimethoxypropionate.
Significant impurities were observed in the 1H NMR spectrum, and the mix-
ture was not purified.
Methyl coumalate was also synthesised from methyl-3,3-dimethoxypropionate
using triflic acid (Scheme 12.8).
MeO
OMe
OMe Dichloroethane, 100 °C, 20 h
O
O
OMeO
10-5, 124% crude yield
O CF3SO3H (5.0 equiv.)
12-1
Scheme 12.8 Synthesis of methyl coumalate from methyl-3,3-
dimethoxypropionate.
Analysis by 1H NMR spectroscopy revealed the presence of significant levels
of impurities, and the mixture was not purified.
Hydrates of iron trichloride were used in the synthesis of methyl coumalate,
working from a literature procedure (Scheme 12.9).59
MeO
OMe
OMe EtOH/AcOH, 90 °C, 6 h
O
O
OMeO
10-5
When x = 0; 14%
          x = 6; 47%
O FeCl3.xH2O (15 mol%)
12-1
Scheme 12.9 Synthesis of methyl coumalate from methyl-3,3-
dimethoxypropionate.
Methyl coumalate was isolated in low yield after purification by column chro-
matography. To try and improve the yield, anhydrous iron trichloride was used
instead. In this case, a low yield of white crystalline methyl coumalate was iso-
lated after purification by column chromatography. Finally, the hexahydrate of
iron trichloride gave white crystalline methyl coumalate in a moderate yield.
An alternative to these acid catalysts is a class of compounds known as het-
eropoly acids. A vanadium-doped molybdenum-based heteropoly acid was con-
sidered as an acid catalyst in the synthesis of methyl coumalate. First, the
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heteropoly acid [H5PMo10V2O40 · xH2O] (HPMoV) was synthesised according to
a literature procedure (Scheme 12.10).60
NaVO3 (4 equiv.)
+
Na2HPO4 (1 equiv.)
1) H2O, ∆
2) H2SO4 (conc.), RT
3) Na2MoO4.2H2O (10 equiv.)/ H2O
4) H2SO4 (conc.), to RT
H5PMo10V2O40.xH2O
Scheme 12.10 Synthesis of the heteropoly acid HPMoV.
Confirmation of the product was made by comparison with literature data,
including 31P NMR spectroscopy and IR spectroscopy. The solid was dehydrated
by heating under vacuum to give the acid as an orange-green powder.
The dehydrated acid was subsequently tested in experiments with methyl-3,3-
dimethoxypropionate (MDMP) in DCE (Scheme 12.11).
MeO
OMe
OMe Dichloroethane, 100 °C, 20 h
O
O
OMeO
O H5PMo10V2O40.xH2O (y mol%)
12-1 10-5
Scheme 12.11 Reaction of MDMP with heteropoly acid.
The mol % catalyst loading was increased from 1% where no methyl coumalate
was observed, through 10 mol% to 20 mol% which gave methyl coumalate in low
yield (<20%) after purification by column chromatography.
The same heteropoly acid reaction was attempted with malic acid
(Scheme 12.12).
HO
O
Dichloroethane, 100 °C, 20 h
OH H5PMo10V2O40.xH2O (0.2 equiv.)OH
O
10-1
Scheme 12.12 Reaction of malic acid with heteropoly acid.
Only starting material was observed by 1H NMR spectroscopy.
12.2 Conclusions on batch reactions
Malic acid is the most promising starting material, even though it was possible to
access methyl coumalate in only one step from methyl-3,3-dimethoxypropionate.
Malic acid is a much cheaper and readily available feedstock.
The best choice of acid catalyst for the process is concentrated sulfuric acid.
The homogeneous process should be possible to translate into flow.
The synthesis of methyl coumalate from coumalic acid could be telescoped so
that a two-step, one-pot procedure is adapted into continuous flow.
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Chapter 13
First Flow Synthesis of Coumalic
Acid and Derivatives
13.1 Developing a flow synthesis of coumalic
acid
Moving from batch to flow, there are several factors that need to be investigated
before designing the experimental set-up.
As malic acid is not readily soluble in concentrated sulfuric acid at RT, several
solubility experiments were performed at different temperatures. Malic acid (25
g) and conc. sulfuric acid (50 mL) were combined and stirred at 360 rpm, holding
for 10 mins at each interval. The results are summarised below (Table 13.1).
Table 13.1 Solubility experiments of malic acid in conc. H2SO4 at different
temperatures.
Entry Internal tem-
perature/ ◦C
Appearance
1 20 White solid and pale yellow liquid.
2 25 White slurry.
3 32 Pale yellow slurry, frothing.
4 38 Yellow solution, with substantial foaming which dis-
sipates when stirring is stopped. No product forma-
tion is observed by 1H NMR spectroscopy.
The higher temperatures approaching 40 ◦C were required to ensure disso-
lution of the solid malic acid. Therefore the stock solutions were prepared by
stirring malic acid and conc. sulfuric acid at 40 ◦C for 10–30 mins, depending on
scale.
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An experiment was also performed to find the solubility limit of malic acid in
conc. sulfuric acid at approx. 40 ◦C. As before, malic acid (25 g) was charged
to conc. sulfuric acid (50 mL), and the mixture was heated to an external set
temperature of 45 ◦C (internal temperature = 38 ◦C) and held for 10 mins,
until all the solid had dissolved. Further portions of malic acid was added in 5
g increments. An additional 20 g of malic acid was below the solubility limit,
whereas 25 g was above the limit. Thus the solubility limit of malic acid in conc.
sulfuric acid lies between 45–50 g per L at 38 ◦C.
The Lambda Doser R© powder feeder is a powder rotary dispenser for continu-
ous addition of free-flowing solids (powders, powdery and crystalline substances).
It requires calibration with each solid to determine which settings correspond to
which addition rates. Malic acid is a free-flowing powdery white solid, and thus
is suitable for continuous addition.
The results of the calibration dosing are summarised in two graphs below, one
reporting speed versus time taken to dose 100 g of malic acid (Fig. 13.1), and the
other for speed versus the average mass dose in 1 minute (Fig. 13.2). Both were
useful when experimenting with connecting the powder doser in series with the
flow machine.
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Fig. 13.1 Calibrating the powder doser with malic acid.
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Fig. 13.2 Calibrating the powder doser speed with mass of malic acid.
Batches of malic acid in conc. sulfuric acid (100 g in 200 mL) were pre-
prepared by stirring at 40 ◦C, and were sometimes allowed to cool to RT before
use. Whether or not the stock solution was at RT or 40 ◦C when pumping did
not seem to have a significant effect on the conversion but was not specifically
investigated.
Initial scoping experiments were performed with a 10 mL heated FEP reactor
coil, starting at the relatively low temperature of 40 ◦C and increasing to 90 ◦C
whilst using the Polar Bear Plus R© reactor. A colour change was observed which
was indicative of the reaction progress. At higher temperatures, the solution turns
a dark yellow/ orange. As the mixture progresses through the reactor, the solution
can change colour from almost-colourless, to yellow through to dark orange and
eventually dark brown. The dark brown colour is a sign of ‘over-cooking’ the
reaction mixture at higher temperatures, and leads to a poorer quality product
of darker colour which is isolated in lower yields from the crude mixture. It rapidly
became apparent that the conversion was highly dependent on the temperature.
This relationship can be seen in the graph below (Fig. 13.3).
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Fig. 13.3 Temperature versus conversion in the Vapourtec R© system.
Regardless of reactor length, there is a positive correlation between tempera-
ture and conversion.
However, there is a trade-off to be made as temperatures above 120 ◦C lead
to a substantially darker solution of product, and a much lower isolated yield.
These higher temperatures ‘over-cook’ the sugar-derived reaction components.
This means the temperature is effectively capped at 120 ◦C.
The initial 10 mL heated reactor coil was doubled by the addition of a second
10 mL reactor placed in series to increase the residence time. Conversions to
coumalic acid began to increase from 19% to 71% with precipitation of coumalic
acid observed, and so these coils were exchanged for a 50 mL Polar Bear Plus R©
reactor (Scheme 13.1).
y °C
z mL
Conc. H2SO4
(3.73 mol/dm3)
x mL/min
HO
O OH
OH
O
O
O
O OH
10-2
Varying conversions
10-1
Scheme 13.1 Experiment 1: 10 mL; Experiment 2: 2 x 10 mL; Experiment 3:
50 mL
A graph of reactor size versus conversion is shown below (Fig. 13.4).
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Fig. 13.4 Reactor length versus conversion, colour-coded by temperature. The
x-axis is discrete: for example, all values clustered around the 10 mL reactor
length were collected using a 10 mL reactor.
Both the shorter and longer reactors were essentially used with lower temper-
atures (shown by colour-coding), so it is possible that these may be capable of
giving higher conversions than observed. There is a balance to be struck between
the high desired conversions, and shorter residence times, which result in greater
throughputs. Two 10 mL reactors presented a good compromise.
It should be noted that the nominal flow rate does not reflect the actual flow
rate of malic acid in conc. H2SO4 due to the high viscosity of sulfuric acid. The
viscosity of sulfuric acid depends on the temperature, and so the actual flow rate
will also depend on the temperature used (Fig. 13.5).
Fig. 13.5 Nominal flow rate versus concentration, colour-coded by tempera-
ture.
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Faster flow rates are preferred since they generate greater throughput of mate-
rial. The relationship between nominal (as specified by the Vapourtec R© pump)
and actual (based on the volume of material pumped through in a fixed time
period) flow rates is not linear.
Gas production during the reaction leads to significant segmentation of the
flow stream, with ‘slugs’ of material separated by gases proceeding through the
reactor. The pressure was monitored and found to be around 4 bar, but was not
controlled by the use of a back-pressure regulator, which is more common in a
flow process (Fig. 13.6).
Fig. 13.6 Pressure versus concentration, colour-coded by temperature.
There is no obvious relationship between the observed pressure and conversion.
It would be desirable to be able to perform the reaction at higher concentra-
tions, as this would allow a greater amount of material to be processed in a fixed
time, giving the flow process a significant advantage over the equivalent batch
reaction. Initial flow experiments indicate that the viscosity of the solution is
greatly increased, and so only a 10 mL reactor coil is required (Scheme 13.2). A
longer residence time results in an ‘over-cooked’ solution, even when operating at
the maximum nominal flow rate (‘10000’ µL min−1; actual flow rate: around 0.7
mL min−1). A stock solution was prepared using 200 g of malic acid and 200 mL
of conc. sulfuric acid. The pre-heating period required was longer, as the malic
acid took 90 mins to dissolve in the sulfuric acid at 40 ◦C at this scale.
Conc. H2SO4
(7.46 mol/dm3)
'10.0' mL/min
120 °C
10 mL
O
O
O OH
HO
O OH
OH
O
10-2
10-2
Scheme 13.2 Increasing the concentration of malic acid in conc. H2SO4.
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The high temperature somewhat decreased the viscosity of the solution, but
the residence time was greatly increased compared to the lower concentration
reaction, at over 6 mins for the single 10 mL reactor. The actual flow rate was
less than 0.1 mL min−1, even though the peristaltic pumps were operating at
their maximum nominal flow rate of 10.0 mL min−1. The material was in fact so
viscous and the residence time so extended that ‘over-cooking’ was observed to
the point where it was not possible to isolate any coumalic acid from the crude
solution. Pump failure occurred multiple times during one run.
The in-built peristaltic pumps of the Vapourtec R© system are able to pump at
a nominal maximum flow rate of 10.0 mL min−1, but in reality this is significantly
reduced for the highly viscous malic acid/ sulfuric acid solution. This places
an inherent limitation on the throughput of the process. As an alternative, an
external peristaltic Masterflex R© L/S pump was connected to the heated coil
reactors of the Vapourtec R© system.
Two chemically-compatible tubing sizes were considered, the Masterflex R©
C-Flex tubing sizes 13 and 14, with internal diameters of 0.8 and 1.6 mm respec-
tively. The internal diameter of the previously-used FEP tubing was approx. 0.5
mm.
The Masterflex R© L/S pump speeds must be calibrated for the starting mate-
rial, and so the first step was to perform the standardisation using water, sulfuric
acid as a blank and the malic acid/ sulfuric acid solution (Fig. 13.7).
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Fig. 13.7 Calibrating the Masterflex R© peristaltic pump with size 13 tubing,
with three different solutions.
The nominal pump speeds correspond linearly to actual flow rates for all three.
Unsurprisingly, the pumping of water is much easier compared to the blank of
sulfuric acid. There is an increase in viscosity on adding malic acid to sulfuric
acid. The pump was unable to handle speeds above ‘4’. A similar experiment
was performed with the size 14 tubing, but the tubing repeatedly failed and was
deemed unsafe to use in this process.
The Masterflex R© pump was connected in series to the heated coiled reactors,
and three experiments were performed at each pump speed. The average flow
rate for each pump speed was calculated, and is plotted on the graph below
(Fig. 13.8).
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Fig. 13.8 Masterflex R© pump speed versus actual flow rate.
A pump speed of ‘2’ was used in future reactions, which gave a typical flow
rate of around 0.8 mL min−1.
13.2 Semi-optimised flow synthesis of coumalic
acid
Two set-ups were semi-optimised to produce coumalic acid in flow. They differed
in the peristaltic pumping systems used: either the in-built Vapourtec R© pump,
or an external Masterflex R© pump. They were both used on larger scale syntheses,
and the results are presented below.
Malic acid (25 g) was dissolved in sulfuric acid (50 mL), and processed at 120
◦C and a nominal flow rate of ‘10’ mL min−1 (actual flow rate = 0.71 mL min−1)
using the in-built Vapourtec R© pump (Scheme 13.3).
Conc. H2SO4
(3.73 mol/dm3)
10 mL/min
120 °C
10 mL
120 °C
10 mL
O
O
O OH
HO
O OH
OH
O
10-2, 39% isolated yield
10-1
Scheme 13.3 Processing malic acid using the in-built Vapourtec R© peristaltic
pumps.
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After 70 mins, the total volume collected was 50 mL, which was quenched
with H2O (200 mL) and allowed to cool and precipitate in the freezer overnight.
After filtration and drying in vacuo, 5.1 g of crude coumalic acid (39% yield) was
isolated. This gives a throughput of 4.4 g h−1.
An attempt was made to use the powder doser (see above) to deliver the malic
acid into a flask which was receiving sulfuric acid via a dropping funnel. The two
would be mixed at 40 ◦C with the solution then pumped through the Vapourtec R©
flow reactor. Some difficulties were observed: significant foaming of the mixture
made it very difficult to withdraw only solution, and not a gas/foam mixture.
Matching the addition rates of the calibrated powder doser with the uncalibrated
dropping funnel was not precise enough, meaning that the concentration of the
solution was never known exactly. This method was abandoned in favour of
pre-mixing the two reagents and allowing the foam to dissipate before reacting.
Changing to an external Masterflex R© peristaltic pump enabled a higher
pumping speed. A run using 50 mL of starting solution took 52 mins to pro-
cess, giving 37 mL of product (a decrease of 13 mL from the starting volume)
and an average flow rate of 0.712 mL min−1 (Scheme 13.4).
Conc. H2SO4
(0.373 mol/dm3)
x mL/min
120 °C
10 mL
120 °C
10 mL
O
O
O OH
HO
O OH
OH
O
10-1
10-2
Scheme 13.4 Processing malic acid using the separate Masterflex R© peristaltic
pumping system.
13.3 Modelling the Vapourtec R© process
The Vapourtec R© flow process was modelled using the temperature, nominal flow
rate and % conversion estimated by 1H NMR spectroscopy in JMP.∗ A Design
of Experiments approach was not used here, and instead the collected data was
analysed after scoping and optimisation. Inputs such as temperature, nominal
flow rate and % conversion were used to construct model effects, by looking at
the effects of these factors, but also whether there are any interactions between
these factors. A ‘standard least squares, fit y by x’ model was used, which creates
a formula that includes these effects. The graphs shown below are leverage plots
for each effect, which show the unique effect of a term in the model. The solid red
line represents the unconstrained model with the term, and the horizontal blue
line shows the constrained model without the term. The p-value is also shown on
∗Software: JMP Pro 12.2
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the x-axis, where if p <0.05, there is strong evidence that the factor affects the
model. These details apply to all model analyses in the following chapter.
There was a strong positive correlation between temperature and % conversion
(Fig. 13.9).
Fig. 13.9 Temperature versus conversion in the Vapourtec R© model.
There was very little correlation between the nominal flow rate and the %
conversion when using the in-built Vapourtec R© peristaltic pumps (Fig. 13.10).
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Fig. 13.10 Nominal flow rate versus conversion in the Vapourtec R© model.
The accuracy of the model can be examined using the root-mean-square error
and R2 (‘RMSE’ and ‘RSq’ respectively on the x-axis). The RMSE is used as a
measure of the differences between values predicted by a model and the values
actually observed. RSq is a statistical measure of how close the data are to the
fitted regression line on a scale of 0 to 1, where a value of 1 is the maximum and
represents a perfect fit. The model was able to predict the conversion based on
the temperature and nominal flow rate with fairly high accuracy (Fig. 13.11).
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Fig. 13.11 Accuracy of the Vapourtec model predictions.
13.4 Developing a flow methylation of
coumalic acid
With a successful small-scale flow procedure for the synthesis of coumalic acid,
our attention turned to the second step in the synthesis of methyl coumalate: the
methylation.
Once the crude product solution is mixed with methanol, the viscosity was
expected to decrease. To test this hypothesis the nominal flow rate was cal-
ibrated against the actual flow rate, and the results are plotted in the graph
below (Fig. 13.12).
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Fig. 13.12 Nominal versus actual flow rate for the three different concentra-
tions.
As more methanol was added and the product solutions became more dilute,
the actual flow rates became more similar to the nominal flow rates. The gradi-
ents for all three concentrations are close to 1.00, implying that for all of these
concentrations, their nominal and actual flow rates are very similar. This makes
it much easier to determine the necessary flow rate of methanol to combine with
the product stream as it is generated.
The combination of a stream of methanol with the exiting product stream
was simulated by simply mixing the two together in a flask, then passing this
methanol/product mixture through a heated reactor coil to effect the methylation
step. The first attempt used a short coil (2.75 mL) in the Polar Bear Plus R©
reactor (Scheme 13.5). Three experiments were performed, with concentrations
of 1.99, 2.35 and 2.89 mol dm−3 as in Fig. 13.12 above. This was to determine
the volume of methanol and thus the flow rate of the methanol stream required.
The outcomes were analysed by 1H NMR spectroscopy, using the peak around
δ 8.30 ppm as a marker for methyl coumalate compared to a quartet at δ 4.25
ppm for coumalic acid, as all other aromatic peaks overlap. The results are
summarised below (Table 13.2).
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Table 13.2 Screening methanol quantities in the flow methylation of coumalic
acid.
Scheme 13.5 Initial screening of concentration using the Polar Bear reactor.
1.00 mL/min
90 °C
2.75 mL
O
O
OHO
O
O
OMeO
MeOH
x mol/dm3
Conc. H2SO4
10-2 10-5
Entry Concentration/ mol
dm−3
% coumalic acid % methyl coumalatea
1 2.89 65% 35%
2 2.35 37% 63%
3 1.99 33% 67%
aBoth % conversions estimated by 1H NMR spectroscopy
The concentration of 2.35 mol dm−3 (row 2) represents an addition rate of
0.500 mL min−1 of methanol. This value was chosen to conduct further optimi-
sation.
Coumalic acid was dissolved in conc. H2SO4, and methanol was added to
the viscous solution in an exothermic mixing process. Six experiments were
performed, varying the residence time of the reaction by altering the reactor
coils and the flow rate (Scheme 13.6). The crude solution was extracted with
toluene/H2O and dried in vacuo to give the solid product. No coumalic acid or
methyl coumalate were observed in the aqueous layer by 1H NMR spectroscopy.
The results are summarised below (Table 13.3).
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Table 13.3 Conditions used to optimise the flow synthesis of methyl coumalate.
Scheme 13.6 Optimising the flow synthesis of methyl coumalate from coumalic
acid.
x mL/min
90 °C
y mL
O
O
OHO
O
O
OMeO
MeOH (8 equiv.)
Conc. H2SO4 (10 equiv.)
10-2 10-5
Entry Flow rate/ mL
min−1
Reactor vol-
ume/ mL
Residence
time/ min
Outcomea
1 1.00 2.75 2.75 94%
2 0.500 2.75 5.50 96%
3 1.00 8.25 8.25 99%
4 1.00 11.00 11.00 99%
5 0.500 8.25 16.50 99%
6 0.500 11.00 22.00 99%
a % conversion estimated by 1H NMR spectroscopy
It can be seen in the graph below that a residence time of 8.25 mins is sufficient
to give 99% conversion of coumalic acid to methyl coumalate. The residence time
and % conversion have been plotted on the graph below (Fig. 13.13 - please note
that the graph does not begin at the origin).
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Fig. 13.13 Residence time versus conversion of coumalic acid to methyl
coumalate.
A residence time of 8.25 mins is achievable using a reactor coil which is 8.25
mL in volume, in combination with a flow rate of 1.00 mL min−1. This process
can be telescoped with the flow synthesis of coumalic acid to give a flow syn-
thesis of methyl coumalate from malic acid without isolating the coumalic acid
intermediate.
13.5 Telescoping the flow synthesis of methyl
coumalate
As established above, it is possible to perform both the synthesis of coumalic
acid from malic acid and the methylation of coumalic acid in flow. We therefore
wished to evaluate the potential telescoped process combining these two steps.
To increase the temperature, a Polar Bear Plus R© reactor with a 2.75 mL FEP
reactor maintained at 70 ◦C was used after T-piece mixing (Scheme 13.7).
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Conc. H2SO4
(3.73 mol/dm3)
0.7 mL/min MeOH
0.5 mL/min
120 °C
10 mL
120 °C
10 mL
HO
O OH
OH
O
O
O
O OH
70 °C
2.75 mL
O
O
O Me
10-1
10-2 10-5
Scheme 13.7 T-piece mixing followed by heating in the Polar Bear reactor.
A mixture of malic acid, coumalic acid and methyl coumalate was obtained, in
the ratio 14:68:17 (estimated from 1H NMR spectrum). Heating has enabled the
methylation process to occur, but higher temperatures were evidently required to
increase conversion. The gases produced in the first step remain in the reactor.
Some issues were observed with reactor blocking.
Degassing after the first step would be preferable, and could be achieved using
an open vessel to collect the intermediate, to which the methanol could be added.
The mixture could be stirred and then pumped through the Polar Bear reactor
at an increased temperature.
An experiment was performed with 5.00 g of malic acid and conc. sulfuric
acid (10 mL), running through to the methyl coumalate without isolating the
coumalic acid intermediate (Scheme 13.8).
Conc. H2SO4
(0.373 mol/dm3)
0.7 mL/min MeOH
0.5 mL/min
120 °C
10 mL
120 °C
10 mL
O
O
O OMe
HO
O OH
OH
O
10-5
Isolated yield 
47%
1.0 mL/min
90 °C
8.25 mL
O
O
O OH
10-2
(not isolated)
10-1
Scheme 13.8 Telescoping the flow synthesis of methyl coumalate from malic
acid.
After extraction with toluene/H2O, and drying in vacuo, crude methyl
coumalate was isolated (1.345 g) in 47 % yield.
A flow chart is shown below, detailing the times at which various reaction
steps were performed (Fig. 13.14).
Time/ mins
0 5 10 15 20 25 30 35 40 45 50 55
Malic acid addition
R1 + R2
MeOH addition
Intermediate collection
R3
Product collection
Cleaning
Fig. 13.14 Example timeline of the telescoped flow process, where RX refers
to Reactor X. White shading of incomplete bars indicates the residence time in
Reactor X.
From start (defined as beginning to pump the malic acid solution) to finish
(defined as the point when all of the crude product solution had left Reactor 3),
the process took 51 mins. It took 42.5 mins to pump 12.5 mL of starting material,
an effective flow rate of 0.294 mL min−1 which is slower than previously observed.
Taking this into account, the throughput of methyl coumalate is 1.58 g h−1.
13.6 Comparison between the flow and
existing batch processes
Two measures of efficiency and productivity were used to compare these processes
with the established literature protocols. Where possible, the space-time yield
has been calculated from experimental data provided in the literature.
The first of these was the throughput – the mass of coumalic acid produced
in a given time (13.1).
Throughput =
mass (g)
time (h)
(13.1)
The second is the space-time yield, or the amount of material processed in a
given time for a given reactor volume (13.2).
Space− time yield = mass (kg)
reactor volume (m3) . time (h)
(13.2)
The results are summarised below (Table 13.4).
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Table 13.4 Comparing throughputs and space-time yields of syntheses of
coumalic acid.
Reference Throughput/
g h−1
Space-time yield/
kg m−3 h−1
Wiley et al.16 17.6 55.1
Ashworth et al.17 11.8 37.1
Kraus et al.19 0.13 1.5
Batch (based on Kaminski et al.18) 6.7 6.7
Vapourtec-pumped flow process 4.4
Masterflex-pumped Vapourtec R© flow
process
11.2 560
13.7 Conclusions on the Vapourtec R© flow
process
By changing from batch to flow, the gas production and foaming is no longer an
issue, and the viscosity of sulfuric acid is reduced at these higher temperatures.
However, the pumping depends on the viscosity of the solvent which limits the
speed material can be processed, therefore restricting the throughput of material.
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Chapter 14
Development, Construction and
Testing of a Heated Rotating
Reactor to Synthesise Coumalic
Acid
14.1 Concept
Motivated by the desire to avoid the dependence on need for pumping such a
viscous solution, we considered using a gravity feed in a new design of reactor.
There are inherent limitations in the small-scale flow set-up: crucially, the
pumping efficiency depends on the viscosity of the solvent. Even when changing
to a Masterflex R© pump with tubing with a larger diameter and greater pumping
capability, the high viscosity of the concentrated sulfuric acid solution slows the
process down. We therefore considered designing a rotating heated reactor which
relied on gravity to deliver the starting material rather than a peristaltic pump.
A Kugelrohr is apparatus typically used for short-path distillation. It was
modified in this case to test the idea of a rotating heated reactor without vacuum,
and whether this would give conversion to coumalic acid (Fig. 14.1).
Fig. 14.1 Schematic of Kugelrohr apparatus adapted as a reactor.
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The solution of malic acid in concentrated sulfuric acid (3.43 mol dm−3) was
added to the left-most bulb, and a range of conditions were screened. Tempera-
ture, rotation speed and concentration of the solution were considered, and the
results are summarised below (Table 14.1).
Table 14.1 Screening conditions for the Kugelrohr proof of concept.
Entry Temperature/
◦C
Time/ mins Rotation
speed/ rpm
% Conversiona
1 120 20 10 47, 55
2 120 20 25 62, 70, 80
3 120 30 25 90
4 120 20 50 49, 52
5 130 20 25 79b
6 140 20 25 93b
aEstimated by 1H NMR spectroscopy
bOver-cooked
Higher temperatures led to ‘over-cooking’ of the reaction mixture to give a
viscous brown liquid from which no precipitation occurred when water was added
as a quench. There seems to be a trade-off between time and rotation speed. It
is possible that temperature equilibration was still occurring with the shorter
runs, since the glass bulbs are not in direct contact with the heating element.
Faster rotation speeds and longer reaction times seem to give higher conversions.
Several mixtures were prepared with high concentrations of malic acid in sulfuric
acid. Those which were more concentrated had a lower volume and thus created a
thinner reactive film on the inside of the glass bulb. This may give more efficient
heating even though the viscosity is increased. The film thickness could be a
confounding factor which is difficult to investigate. Regardless, the Kugelrohr
experiments act as a good proof of concept: it is possible to synthesis coumalic
acid from malic acid by heating in a rotating glass vessel.
14.2 Aims
The aims of this project were to design and build a heated rotating reactor sys-
tem that was compatible with concentrated sulfuric acid and temperatures up to
150 ◦C. The reactor was to be tested and easily adapted based on progressive
experimental findings. Factors affecting the conversion of malic acid would be in-
vestigated systematically. Where possible, modelling using software such as JMP
allowed us to gain further understanding of the process. High conversions of malic
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acid to coumalic acid are required to call this process successful. Additionally,
high throughputs of material are necessary as part of this process intensification.
14.3 Planning and design of the reactor
There were several components to source:
1. furnace
2. rotary drive
3. work-tube
4. delivery mechanism
5. connecting tubing
6. collection vessels
7. supports and height adjustment devices
A standard laboratory glass drying oven had three holes drilled through the
sides. The hole on the left-hand side is the entrance hole; the two holes on the
right-hand side are exit holes with angles of 2 ◦ and 11 ◦ below the plane
(Fig. 14.2). The hole diameter was constrained by the dimensions of the cutting
device available, and was therefore fixed at 50.8 mm (2 in).
Fig. 14.2 Cross-section of oven, showing the placement of holes to be drilled.
The angles below the plane were calculated using the following diagram
Fig. 14.3.
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Fig. 14.3 Schematics of the two angles possible in the oven.
Trigonometric identities were used to calculate the angles as shown:
tan θ =
17
490
∴ θ = 2◦ (14.1)
tanφ =
92
490
∴ θ = 11◦ (14.2)
A rotary evaporator (Bu¨chi Rotavapor R-124) was used as the rotary drive.
Initially, the entire evaporator (minus the water bath, chilled condenser, tension
nut for chilled condenser, collection vessel and evaporation flask) was considered
(see below).
The work-tube was custom-made by the glass-blowers in the department. The
initial specifications were that it was to be 600 mm in length, with a diameter of
44 mm, with a B29 cone and B34 socket (Fig. 14.4).
600 mm
44 mm
Fig. 14.4 The first work-tube with dimensions.
A dropping funnel was to be used as the tank for delivering material to the
work-tube. This was not automated, and was operated manually. The inner
diameter of the connecting tubing depended on the size of the dropping funnel
used. Initially, a 1 L funnel was used. This required tubing with an inner diam-
eter of 0.5 in which was compatible with concentrated sulfuric acid, which was
ordered from Masterflex R©. Round-bottomed flasks and adapters were made by
the departmental glass-blowers to be used as collection vessels. Initially, measur-
ing cylinders were used instead to allow for easy calculation of production rate
(volume/ time). This equipment resulted in the anticipated configuration shown
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below as a simplified schematic, showing the relationships between apparatus
(Fig. 14.5).
Fig. 14.5 Schematic of the planned reactor, showing components.
Several challenges became immediately apparent: the oven had to be raised
on three lab jacks to reach the required height of the rotary drive. When manoeu-
vring the oven, the base of the rotary evaporator caused problems. Eventually the
rotary drive was separated from the base, and raised on a custom-built shelving
system, with a lab jack for fine-tuning.
The fit of the work-tube through the oven was tighter than anticipated. It
was not possible to use the top hole drilled in the oven (2.1 ◦) because the rotary
drive did not align to allow for such a shallow angle. This hole was therefore
sealed. This left only the lower hole available for experimentation. The aligning
of the rotary drive and work-tube with the holes had to be exact: a fraction of a
millimetre difference could (and did) cause breakages.
The next issue to overcome was the dropping funnel/ connecting tubing po-
sitioning. Initially a combination of 1 L dropping funnel with the Masterflex R©
0.5 in tubing was tested. Ensuring a suitable union was found to be difficult.
A connect made from PTFE tubing heat-stretched to fit the tap of a 100 mL
dropping funnel was used. This arrangement was less convenient for running on
larger scale, but provided a temporary fix until a more permanent solution could
be found.
The reactor is shown below (Fig. 14.6 and Fig. 14.7). Some minor modifi-
cations were later made to the design, but the reactor design did not change
substantially from this point.
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Fig. 14.6 Photograph of the reactor in situ.
Fig. 14.7 Photograph of the reactor with the oven door opened to allow the
work-tube to be seen.
14.4 Statistical analysis
Conversion of malic acid to coumalic was estimated by 1H NMR spectroscopy,
using the peaks as shown on the scheme below (Scheme 14.1).
HO
O
OH
OH
O
O
O
OHO
2
H
δ = 4.26 ppm
H
δ = 7.77 ppm
10-1 10-2
Scheme 14.1 Synthesis of coumalic acid from malic acid.
The stoichiometry of the reaction gives the following equation which was used
to calculate the % conversion, where CA = the integral of the peak at δ = 7.77
ppm, and MA = the integral of the peak at δ = 4.26 ppm (14.3).
% Conversion =
2CA
MA+ 2CA
(14.3)
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An example spectrum is given below (Fig. 14.8).
Fig. 14.8 Example 1H NMR spectrum showing coumalic acid, malic acid, sol-
vent and acid.
14.5 Reactor development
Early experiments scoped suitable temperature ranges, rotation speeds and ad-
dition rates. Several factors were held constant: the diameter of the work tube
(44 mm), the angle of the work-tube, and the concentration of the stock solution
(3.76 mol dm−3). Raw data from all experiments can be found in the Appendices.
Over 30 samples were collected, and each sample was quenched with H2O, and
then allowed to cool. Precipitate formation on cooling is an indicator of coumalic
acid formation, and was observed in approx. half of samples. This heterogeneous
solution was analysed by 1H NMR spectroscopy, and the results are summarised
below (Fig. 14.9).
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Fig. 14.9 Temperature versus % conversion for rotation speed = 7 rpm and a
very slow addition rate.
It was apparent that a ‘critical’ temperature was reached 110-120 ◦C, at which
point the reaction began to occur. Conversions below this critical temperature
were very low.
The effects of rotation speed and addition rate were also investigated. In-
creasing the rotation speed seemed to increase the % conversion, but relatively
unreliably. It was not possible to safely rotate the work-tube faster than 28 rpm.
The addition rate did not seem to affect the percentage conversion, and so at this
point until further notice, it was recorded but not held constant.
At the end of the initial testing phase, several modifications were made to the
reactor. The weight of the work-tube as a self-supporting unit became a problem
over time, so a support bar was introduced. As the rotation speed was increased
(>14 rpm), the work-tube began to catch on the metal edges of the holes, causing
etching of the glass. Several attempts were made to re-configure the system by
moving the equipment around by increments, but it was not possible to adjust it
enough. A more radical solution was sought: new work-tubes were prepared with
smaller diameters (32 and 36 mm), which would have a looser fit with the oven
holes (Smith Scientific R/38, outer diameter = 38.0 ± 0.8 mm, inner diameter =
36 mm). They also had the added benefit of weighing slightly less, which reduced
the load on the rotary drive.
14.6 Studying the helical reactant path
During the early testing phase, it was observed that the viscous stock solution
followed a helical path, depending on reaction conditions (Fig. 14.10).
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Fig. 14.10 Photograph of a helix formed by the reactants travelling down the
work-tube as it rotates.
This helix can be described by the parameters shown in the following diagram
(Fig. 14.11).
Fig. 14.11 Model of an idealised helix, with parameters.
This helical behaviour dramatically increases the path length of the reactants,
and thus also increases the residence time of the materials within the reactor.
Several experiments were performed to ascertain at what point the helix formed,
as well as its appearance and the effect this has on the path length.
The effects of the rotation speed on the length of the helical behaviour were
examined at an addition rate of 1.0 drop/ s, and a temperature of 110 ◦C. At
rotation speeds below 7 rpm, no helix was observed. The length of the helix was
found by opening the oven door, and rapidaly measured using a tape measure.
The results of these experiments are summarised below (Fig. 14.12).
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Fig. 14.12 The effect of increasing rotation speed on the length of the helix.
As the rotation speed increases, the length of the helix increases approximately
linearly. The maximum would be 600 mm, since this is the full length of the work-
tube.
The effect of the rotation speed on the rise of the helix in one revolution
was examined for different addition rates, and the results are summarised below
(Fig. 14.13).
Fig. 14.13 The effect of changing the rotation speed on the length of each helix
revolution.
As the rotation speed increases, the helix becomes ‘tighter’, and the rise of
each helix in one revolution decreases.
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The equation to calculate the path length is as follows, where N = number
of turns; H = rise of helix in one revolution (mm); r = radius (36 mm); Lh =
length of helical behaviour (Eqn. 14.4).
Pathlength,D = N
√
H2 + (2pir)2 + (600− Lh) (14.4)
A series of manipulated helices which exhibited full helical behaviour (Lh =
600 mm) were created by changing the rotation speed and addition rate, and are
shown below (Table 14.2).
Table 14.2 Helix dimensions and path lengths.
Entry Number of
turns, N
Rise of helix in
one revolution,
H/ mm
Path length,
D/ mm
D/ 600
1 10 60 1171 1.95
2 13 46 1438 2.40
3 14 43 1531 2.55
4 60 10 6063 10.11
5 120 5 12082 20.14
For the most extreme example (Entry 5, Table 14.2), it was possible to increase
the path length by more than 20 times, so that the material will have travelled
more than 12 metres as opposed to the actual path length of the tube of 0.6 m
with no rotation.
The reduced radius of the new work-tube (36 mm compared to 44 mm) will
decrease the path length, and explains why % conversions are lower for the nar-
rower tube when other conditions are held constant. For example, if Entry 5 in
Table 14.2 had been performed with an increased radius of 44 mm and assuming
all other factors were constant, the effect can be seen in Eqn. 14.5:
Pathlength,D = 120
√
(52 + (2pi.44)2) = 33180 mm (14.5)
This is an increase by 2.75 times in path length.
14.7 Data analysis – Diameter and
concentration
Changing to a narrower work-tube affected the % conversions negatively, but
ultimately allowed the tube to be rotated at much greater speeds, more than
compensating for any loss of conversion or throughput (Fig. 14.14).
193
Fig. 14.14 The effect of changing the work-tube on the % conversion. Tem-
perature = 120 ◦C, addition rate = medium, concentration = 3.73 mol dm−3,
rotation speed = variable.
Whilst the data for the wider work-tube was less reliable, it shows a general
trend of higher conversions than the narrower work-tube. This tallies with the
helical path length depending on the radius of the tube; the wider tube will give a
longer path length, and so a longer residence time which is likely to give a greater
conversion. However, the 44 mm diameter work-tube was discarded in favour
of the 36 mm work-tube, which was able to rotate freely and was less prone to
breakages.
Running the reaction at a higher concentration would increase the throughput
of material and thus make the process much more efficient. Since this gravity-
driven system no longer depends on the pumping of a highly viscous solution, a
solution of malic acid in conc. sulfuric acid (7.46 mol dm−3) was prepared, run
and compared to the ‘standard’ 3.73 mol dm−3 solution (Fig. 14.15).
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Fig. 14.15 The effect of doubling the concentration of the solution on % con-
version.
Conversions to the product are significantly lower for the higher-concentration
solution. Subsequent experiments were all performed at a concentration of 3.73
mol dm−3.
14.8 Data analysis – Rotation speed,
temperature and addition rate
At first, it was thought that the restricted rotation speed (maximum = 28 rpm
for diameter = 44 mm) was the main factor in limiting the conversions. Several
experiments that varied both rotation speed and temperature were performed,
and are shown below (Fig. 14.16).
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Fig. 14.16 The effect of changing rotation speed on conversion, colour-coded
by temperature.
It can be seen that even at low rotation speeds of 20 rpm, high conversions
are possible if the temperature is sufficient. By examining a series at fixed tem-
perature (for example, the blue data points on the graph for 70 ◦C), there is
an approximately linear trend relating rotation speed and conversion. This fails
somewhat at higher temperatures.
It would appear that the temperature of the reaction is more important than
the rotation speed in determining the conversion (Fig. 14.17).
Fig. 14.17 The effect of changing temperature on conversion, with dot size
depending on rotation speed where the smallest dot is 20 rpm and the largest is
110 rpm.
Even though the rotation speeds vary substantially, the graph of temperature
versus conversion has a strong linear relationship. This can be described by the
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line of best fit, shown in Eqn. 14.6 and 14.7:
y = −90.1 + 1.47x (14.6)
R2 = 0.935 (14.7)
The appearance of the water-quenched solutions are striking when compared
next to each other (Fig. 14.18). It is possible to qualitatively identify which
experiments have given low and high conversions by visual inspection, based on
both colour of the solution and the degree of precipitation of the solid product.
It is worth noting in the image below that the experiments conducted at 130 ◦C
exhibit ‘over-cooking’, with a dark brown solution and only a small amount of
precipitation. It would seem that there is a narrow window of opportunity for
high conversions and high isolations, which lies between 110-130 ◦C.
Fig. 14.18 Quenched crude solutions from experiments performed at a range
of rotation speeds and temperatures.
The temperatures and rotation speeds of these experiments as well as some
additional reactions between 110-130 ◦C can be seen in the graph below, with
colour-coding indicating the conversion (Fig. 14.19).
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Fig. 14.19 Temperature versus rotation speed, colour-coded for conversion.
The trend from left to right of red to green as the conversion increases as
temperature is raised is obvious. A more subtle trend is the increase in conversion
with rotation within a temperature, as conversion now begins to exceed 80%.
An early model was developed using results from experiments at 70 ◦C to
130 ◦C increasing in 10 ◦C increments, considering the effects of temperature and
rotation speed on percentage conversion. The diameter of the work-tube, the
concentration of the stock solution, and the addition rate were all held constant.
At this point, both rotation speed and temperature were found to correlate
with conversion with statistical significance. The leverage plots can be seen be-
low. There was a strong positive correlation between temperature and percentage
conversion (Fig. 14.20).
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Fig. 14.20 Temperature versus conversion in model 1.0.
The link between rotation speed and percentage conversion was weaker, but
still positive, as can be seen in the graph below (Fig. 14.21).
Fig. 14.21 Rotation speed and conversion in model 1.0.
The predicted versus actual conversion plot can be seen below, indicating an
excellent correlation (Fig. 14.22).
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Fig. 14.22 Accuracy of model 1.0.
The prediction expression for HeRo 1.0 was found to be described by Eqn.
14.8:
% Conversion = −92.83+(1.373.Temperature (◦C))+(0.268.Rotation speed (rpm))
(14.8)
14.9 Data collection and HeRo model 2.0
A wider range of temperatures and rotation speeds were examined to cover a
larger chemical space. These experiments were built into a second refined model,
HeRo 2.0. As the model became more populated, the aim was to increase its
reliability. The strong positive correlation between temperature and conversion
remains - and is reinforced by the additional experiments which also fit the line
of best fit (Fig. 14.23).
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Fig. 14.23 Temperature versus conversion in model 2.0.
The connection between rotation speed and conversion remains weakly posi-
tive (Fig. 14.24).
Fig. 14.24 Rotation speed versus conversion in model 2.0.
The fit of this model is shown below, and appears to be excellent (Fig. 14.25).
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Fig. 14.25 Accuracy of model 2.0.
The prediction expression for HeRo 2.0 has changed only slightly from HeRo
1.0, decreasing the importance of the rotation speed coefficient, increasing the
importance of the temperature and slightly altering the intercept as shown in
Eqn. 14.9:
% Conversion = −89.47+(1.358.Temperature (◦C))+(0.208.Rotation speed (rpm))
(14.9)
14.10 Data collection and HeRo model 3.0
At this point, a further modification was made to the reactor to prevent the
rotary drive shifting around at higher rotation speeds (60 rpm and above). It
was stabilised using wedges and a curved rest. It was now possible to safely run
the reactor at speeds above 80 rpm, up to 110 rpm. The maximum speed the
rotary drive is capable of is 240 rpm.
A series of experiments run at rotary speeds above 80 rpm were performed,
and the data collected was used to build a third iteration of the model, HeRo 3.0.
The temperature was also varied.
The relationship between temperature and conversion remains strong. A
slightly wider scatter around the line of best fit is now observed (Fig. 14.26).
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Fig. 14.26 Temperature versus concentration in model 3.0.
The link between rotation speed and temperature continues to weaken
(Fig. 14.27).
Fig. 14.27 Rotation versus conversion in model 3.0.
However, the accuracy of the predictive model remains very high, with an
excellent fit (Fig. 14.28).
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Fig. 14.28 Accuracy of model 3.0.
The equation describing HeRo 3.0 is given below. The intercept has barely
changed from HeRo 2.0. The importance of the temperature variable has in-
creased, whereas the rotational speed importance has decreased substantially
(Eqn. 14.10).
% Conversion = −89.63+(1.371.Temperature (◦C))+(0.173.Rotation speed (rpm))
(14.10)
14.11 Data collection and HeRo model 4.0
The reproducibility of the data was a concern. A factorial Design of Experiments
(DOE) approach was taken to identify the experiments needed to test the repro-
ducibility of the conversion data. Temperatures from 80-120 ◦C and rotational
speeds from 40-100 rpm were taken as the boundaries. Three repeats of each set
of conditions were performed, and the results are summarised below (Fig. 14.29).
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Fig. 14.29 Reproducibility of a data sample. The closer the rings, the more
similar the results are. The size of the rings is proportional to the % conversion.
The biggest diameter difference represents a conversion difference of around ±5%.
The size of the circle is proportional to the conversion for those conditions. It
can be seen that the experiments run at lower temperatures are less reproducible,
as the circle sizes vary more. They can be seen to become more similar as the
temperature increases. There is no obvious trend in conversion when changing
the rotation speed.
In addition, the data from several previous experiments using the same con-
ditions was combined, the % conversions averaged, and plotted against rotation
speed, colour-coded by temperature. An error of ±5% can be expected from
integration data from 1H NMR spectroscopy. The results can be seen below
(Fig. 14.30).
Fig. 14.30 Rotation speed versus average conversion, colour-coded by temper-
ature.
One trend is immediately apparent: as the temperature is increased, the aver-
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age percentage conversion increases. Once a rotation speed of approx. 60 rpm has
been reached, there was little change in average percentage conversion; this held
true for all three temperatures considered here. Prior to this point, the rotation
speed was critical in determining the average percentage conversion.
It may be that the effects of rotation speed are more important than tem-
perature at lower rotation speeds, and once a ‘critical’ speed has been achieved,
temperature takes over as the dominant factor in determining percentage conver-
sion.
To investigate how the percentage conversion varied with time, a series of
experiments were designed to determine the time at which ‘steady-state’ operation
was reached for three different temperatures (Fig. 14.31). Here, ‘steady-state’ was
defined as the point at which conversion remained approximately constant.
Fig. 14.31 Conversions over the first 15 mins of product collection.
For 80 ◦C, ‘steady-state’ operation is reached after 7 mins. 100 ◦C presents
an interesting fluctuation, and the % conversion has not settled even after 15
mins. At 120 ◦C, the ‘steady-state’ point was reached after 4 mins. The trend of
increasing conversion with increasing temperature is evident here. The conversion
becomes more consistent more quickly at higher temperatures.
Up until this point, the addition rate has been disregarded from the data
analysis, although it was recorded for all experiments. Several experiments were
performed to calculate the volume of one drop of stock solution, as the number of
drops per second has been used as the measure of addition rate. The number of
drops in 10 s had previously been counted and divided by 10 to give the number
of drops/ s.
To calculate the volume of each drop, the number of drops in 10 s was varied
by changing the position of the dropping funnel tap, and the volume of stock
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solution collected in a set time which was recorded. This gave an addition rate
in mL/min, which was plotted against the number of drops (Fig. 14.32).
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Fig. 14.32 Calibration of the number of drops by addition rate.
The intercept of the line of best fit was set as zero, and the data exhibits a
linear trend. The gradient of the graph gives the average drop size in mL, and is
therefore 0.169 mL.
To examine whether the addition rate varied over time according to the height
of the stock solution in the dropping funnel, a graph of time versus volume was
plotted (Fig. 14.33).
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Fig. 14.33 Time versus volume in the dropping funnel.
The intercept of the line of best fit was again set as zero, and the data exhibits
a linear trend. This implies that the addition rate does not significantly vary with
the volume/ height of stock solution in the dropping funnel. The steady-state
behaviour persists for a large proportion of the dropping funnel’s capacity. There
did not seem to be a meaningful correlation between conversion and addition rate
in the range evaluated (1.25-3.00 mL min−1).
The observed addition rates (drops/ s) were retroactively converted into
mL/min, and overlayed onto a temperature-conversion plot to look for a pat-
tern (Fig. 14.34).
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Fig. 14.34 Addition rate versus conversion.
Visually, there did not seem to be any correlation between conversion and
addition rate. This was examined by creating a fourth and final model. The new
model examined temperature, rotation speed, addition rate and the crossings of
all of these variables.
The plot of temperature against conversion has become more chaotic, with
most data points clustered between 110-120 ◦C (Fig. 14.35). The overall correla-
tion remains positive.
Fig. 14.35 Temperature versus conversion in model 4.0.
Similarly, the plot of rotation speed versus concentration has also become
more chaotic: in this case, almost any trace of correlation has disappeared
(Fig. 14.36).
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Fig. 14.36 Rotation speed versus conversion in model 4.0.
There is little connection between addition rate and conversion (Fig. 14.37).
Fig. 14.37 Addition rate versus conversion in model 4.0.
Temperature crossed with rotation speed gives little link to conversion
(Fig. 14.38).
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Fig. 14.38 Temperature crossed with rotation speed versus conversion in model
4.0.
There is a poor link between crossed temperature/ addition rate and conver-
sion (Fig. 14.39).
Fig. 14.39 Temperature crossed with addition rate versus conversion in model
4.0.
Similarly, there is a weak correlation between crossed rotation speed/ addition
rate and conversion (Fig. 14.40).
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Fig. 14.40 Rotation speed crossed with addition rate versus conversion in
model 4.0.
Finally, the three variables crossed together against conversion show little to
no link between each of these factors (Fig. 14.41).
Fig. 14.41 Temperature crossed with rotation speed and addition rate versus
conversion in model 4.0.
The three variables do not seem to work together or have a strong effect on
each other. The accuracy of the model is still good, but with a looser fit than
seen before (Fig. 14.42).
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Fig. 14.42 Accuracy of model 4.0.
In order to run experiments for longer, the 100 mL dropping funnel was ex-
changed for a modified 500 mL dropping funnel comprising a narrowed tap, to fit
the tubing required to feed through the rotary drive into the work-tube.
Several tests were conducted to examine whether this affected the size of the
drops formed, and the behaviour of the addition rate at different filling volumes
(Fig. 14.43).
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Fig. 14.43 Number of drops in 10 seconds versus addition rate.
Two lines of best fit were calculated and their equations are shown on the
graph. The orange equation is linear, but does not fit the data as well as the
exponential line of best fit (green). It would appear that the size of the drop
depends on the addition rate. Compared to the 100 mL dropping funnel where
the average drop size was 0.169 mL, the drops from the 500 mL dropping funnel
are larger at 0.396 mL, using the gradient of the linear line of best fit (Fig. 14.44).
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Fig. 14.44 Time versus volume for the 500 mL dropping funnel.
The addition rate over time remains approximately constant since the data
fits a linear model. It could appear that there are two linear regions with different
gradients (Fig. 14.45).
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Fig. 14.45 Time versus volume for the 500 mL dropping funnel, split into two
regions.
The steeper gradient of 4.06 mL min−1 up to 10 mins implies that addition is
faster when the dropping funnel is fuller. As it empties, the addition rate slows
to 2.66 mL min−1.
A further observation was made during these experiments that different
amounts of precipitation were observed in quenched samples even when they
were shown to have the same percentage conversion by 1H NMR spectroscopy.
A hypothesis was that the degree of precipitation depended on the volume of
water added to the crude solution as an anti-solvent. To test this, seven experi-
ments were performed by adding varying quantities of water to vials containing
the crude solution. The reactions were performed at a concentration of malic
acid in sulfuric acid of 3.73 mol dm−3, with a conversion of approx. 90% by
1H NMR spectroscopy. They were allowed to precipitate overnight, filtered and
dried in vacuo to give different amounts of crude coumalic acid. The results are
summarised below (Fig. 14.46).
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Fig. 14.46 Volumes of water added versus isolated mass of coumalic acid.
There is an approximately linear relationship between the volumes of water
added and the amount of coumalic acid isolated. As the amount of water added
increases, the isolated mass of coumalic acid decreases. There is no precipitation
when water is not added. As a general rule, one volume of water was added to
the crude solution to obtain the highest recovery of coumalic acid (>50%).
14.12 Extended operation
To test the robustness of the process over longer reaction times, excess stock
solution was prepared for an 8-hour run.
The settings used for the 8-hour run were 120 ◦C (with an overnight pre-
equilibrium stage) and 60 rpm. As per the time-course experiment, stock solution
was sent through the reactor for 15 mins before collection began.
The total volume collected (1444 mL) was quenched with an equal volume of
H2O and was allowed to precipitate overnight. Filtration and drying in vacuo gave
the crude material in 65% yield (285.7 g). Efficiency calculations were performed
(see below).
14.13 Efficiency calculations
An extended version of the table first seen in Section 13.6 is now presented below
(Table 14.3).
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Table 14.3 Throughputs for various syntheses of coumalic acid.
Reference Throughput/ g h−1
Wiley et al.16 17.6
Ashworth et al.17 11.8
Kraus et al.19 0.13
Batch (based on Kaminski et al.18) 6.7
Vapourtec flow process 11.2
HeRo reactor 35.7
The HeRo reactor is capable of throughput efficiencies greater than double
that which has been previously claimed to be achievable in batch.
Several assumptions have been made to enable calculation of the reactor vol-
ume of the HeRo reactor. These are:
• The solution is homogeneous. This is known to be inaccurate, because
significant gas production is observed during the reaction.
• The film thickness is constant at 2 mm.
• The rivulet width is constant at 5 mm.
• Only a single helix is produced.
• The number of turns in the helix is 15.
• The rise of the helix in one revolution is 40 mm.
• Helical behaviour is observed for the full 600 mm of the work-tube.
The rivulet has been treated as though it is a ribbon which can be unfurled
to give a cuboid (dimensions: path length x 2 mm x 5 mm). The path length can
be found via the following calculation shown in Eqn. 14.11:
Pathlength,D = N
√
H2 + (2pir)2 + (600− Lh) = 15
√
402 + (2pi18)2 = 1.8 m
(14.11)
Therefore the volume of the rivulet (and thus the volume of the reactor),
shown in Eqn. 14.12 is:
V olume = 1.8 m · 2× 10−3 m · 5× 10−3 m = 1.8× 10−5 m3 (14.12)
Thus, the space-time yield of the HeRo process, calculated from the 8 h ex-
periment is found by the following calculation shown in Eqn. 14.13:
Space− time yield = 0.2857 kg
1.8× 10−5 m3 · 8 h = 1980 kg m
−3 h−1 (14.13)
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This is more than 3.5 times than the space-time yield of the Vapourtec R©
process, and approx. 36 times the space-time yield of the most efficient batch
process. These results are summarised below (Table 14.4).
Table 14.4 Throughputs and space-time yields for various syntheses of
coumalic acid.
Reference Throughput/ g h−1 Space-time yield/ kg
m−3 h−1
Wiley et al.16 17.6 55.1
Ashworth et al.17 11.8 37.1
Kraus et al.19 0.13 1.5
Batch (based on Kamin-
ski et al.18)
6.7 6.7
Masterflex-pumped flow
process
11.2 560
HeRo reactor 35.7 1980
14.14 Chemical engineering implications
At this point, a meeting was held with Prof Philip Gaskell and Dr Lian Gan
(School of Engineering and Computer Science, Durham University). The reactor
design and construction were discussed, as were the data collection procedures.
In engineering terms, the process can be described as a rivulet wetting the surface
of a rotating heated inclined cone. There are two phases (liquid and gaseous) and
it can be considered as an evaporation process due to the gas production. The
current set-up is too complex to model, and the helical behaviour of the rivulet
depends on too many variables.
An alternative reactor design was proposed by Prof Gaskell which transforms
the set-up into a thin-film problem which is easier to calculate and model. A cen-
tral roller made of materials which are chemically compatible with concentrated
sulfuric acid (for example: ceramic, glass, steel core with a glass coating, etc.)
would be surrounded by fixed external heaters (infra-red). The solution of malic
acid in conc. H2SO4 would be delivered to the surface of the roller, and it would
travel through the heated arc-path before being collected when the reaction is
complete, possibly by scraping the film from the roller surface (Fig. 14.47).
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Fig. 14.47 Diagram of the proposed rotating roller reactor.
The temperature, rotation speed, film thickness and roller diameter would be
optimised to achieve the maximum possible conversion/ yield and throughput.
The length of the roller gives the possibility of performing this reaction on ex-
tremely large scales. Similarly, increasing the number of rollers would scale the
reaction up even further; this can be seen in the suggested double roller system
below (Fig. 14.48).
Fig. 14.48 Diagram of the proposed double rotating roller reactor.
14.15 Conclusions
A new type of flow reactor has been developed, which we have nicknamed the
‘HeRo’ reactor. It consists of a heated rotating work-tube held at an angle into
which starting materials are dropped. The product is collected at the bottom.
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We have used it to develop an intensified process for the synthesis of coumalic
acid. It is more efficient in terms of throughput and space-time yield than any
existing batch process, or the small-scale Vapourtec-based flow process that we
have developed above. It has a lot of promise for future investigations.
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Chapter 15
Derivatising Methyl Coumalate
in Diels-Alder Reactions
The field of molecular electronics is rapidly expanding. Terphenyls are a class of
compounds with applications in this area, but there are problems with the current
literature syntheses. Even trace amounts of metals can disrupt their activity.
An alternative is the use of inverse electron demand Diels-Alder reactions, with
methyl coumalate as an electron-poor diene. An electron-rich dienophile such as
an alkyne is required.
15.1 Diels-Alder reactions with methyl
coumalate
Retrosynthetic analysis of terphenyls implies a synthetic route from methyl
coumalate and dialkynes (Scheme 15.1).
O
O
O OR
Alkyl coumalatesORO
R'
R'
δ-
δ+
Dienophile
Scheme 15.1 Retrosynthetic analysis of terphenyls.
1,3-Diethynylbenzene as a dienophile
Two dienthynyls were chosen to attempt the Diels-Alder reaction under mi-
crowave irradiation conditions. Following a literature procedure, tert-butanol was
used as an additive.61,62 The first reaction used 1,3-diethynylbenzene as a sub-
strate with methyl coumalate (Scheme 15.2). As an initial experiment, methyl
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coumalate was used in a lower ratio than required for the double Diels-Alder
reaction.
OMeO
OMe
O
O
O
OMeO
10-5
(1 equiv.)
15-1
(1 equiv.)
tBuOH (4.63 equiv.)
µW, 2 h @ 170 °C
15-2, 22% yield 
(based on methyl coumalate)
Scheme 15.2 Diels-Alder reaction of methyl coumalate and 1,3-
diethynylbenzene.
Gas formation was observed at the end of the reaction, and the pressure inside
the microwave vial had increased significantly during the reaction. This is due to
decarboxylation. The product was isolated in low yield.
1,4-Diethynylbenzene as a dienophile
Similar conditions were applied to the 1,4-isomer of diethynylbenzene
(Scheme 15.3), again with methyl coumalate as the limiting reagent.
OMeO
O
O
OMeO
10-5
(1 equiv.)
15-3
(1 equiv.)
tBuOH (3.28 equiv.)
µW, 2 h @ 170 °C
MeO O
15-4, 84% yield 
(based on methyl coumalate)
Scheme 15.3 Diels-Alder reaction of methyl coumalate and 1,4-
diethynylbenzene.
The product was isolated in moderate yield.
15.2 Conclusions
These reactions require optimisation before they could be used more widely, but
these are good examples as proof of concept. There are some benefits to this
procedure: the use of the microwave gives efficient heating and a relatively short
reaction time for what is typically regarded as a relatively difficult Diels-Alder
reaction. This assists in reducing decomposition and side-products.
Optimisation could include altering the ratio between methyl coumalate and
the diethyne, changing the amount of tert-BuOH additive, and alter the duration
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and temperature of the microwave heating conditions. The work-up could be
investigated, because both products are very insoluble in almost all common
solvents. Once optimised, a wider range of substrates could be screened.
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Chapter 16
Conclusions
Coumalic acid and its derivatives are valuable intermediates in organic synthesis,
and can be obtained from malic acid. Other starting materials such as methyl-
3,3-dimethoxypropionate were also tested, as were acid catalysts such as triflic
acid, iron trichloride, and heteropoly acids. Ultimately, the combination of malic
acid and concentrated sulfuric acid was the most promising for transfer into flow.
We have developed a flow process based on the Vapourtec reactor to synthesise
coumalic acid and methyl coumalate from malic acid in conc. sulfuric acid. This
has removed some of the problems associated with the difficult batch process,
such as gas production and foaming. However, the pumping speed (and therefore
throughput) was limited by the high viscosity of the sulfuric acid solution.
A new reactor design used a gravity feed to avoid the dependence on pumping
of this viscous solution. We nicknamed this the ‘HeRo’ reactor, and it consists
of a heated rotating work-tube held at an angle into which starting materials are
dropped. We have employed the reactor to develop an intensified process for the
synthesis of coumalic acid. The process was more efficient in terms of throughput
and space-time yield than any existing batch or flow process.
Methyl coumalate has been used with two dialkynes in test Diels-Alder reac-
tions. These triphenyl products have applications in molecular electronics, which
requires multi-phenyls as components. This metal-free synthesis has several ad-
vantages over existing literature routes.
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Chapter 17
Future Work
The next steps in developing this process include developing an industry-friendly
reactor based on the prototype HeRo reactor built here. This would allow
coumalic acid to be synthesised on a much larger scale, making it much more
readily available as a starting material for other reactions.
The Vapourtec process was telescoped to include a methylation step. This
has not yet been attempted with the HeRo reactor, but is likely to be logistically
relatively simple.
Derivatisations based on the Diels-Alder reaction have a lot of scope for devel-
opment and improvement. The two reactions shown here were first attempts, and
act as a proof of concept which requires optimisation of the reaction conditions.
Other dienophiles can be considered as well.
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Chapter 18
Experimental
18.1 Coumalic acid, Compound 10-2
O
O
OHO
Chemical Formula: C6H4O4
Exact Mass: 140.01
65
4 3
2
1
Batch procedure:
Malic acid (50.0 g, 373 mmol) was charged to a 250 mL RBF fitted with a stirrer
bar. Concentrated sulfuric acid (100 mL, 1880 mmol) was charged to the RBF.
The resulting slurry was heated at 90 ◦C with slow stirring for 6 h, during which
time significant foaming was observed. The orange solution was allowed to cool to
RT, then poured onto ice (400 mL), and stored in the freezer overnight. Formation
of a yellow precipitate was observed. After filtration and washing with H2O, the
wet solid was air-dried at approx. 50 ◦C before drying under vacuum. The crude
material was isolated as a pale yellow solid.
Isolated yield: 12.7 g (90.7 mmol, 49%)
1H NMR (700 MHz, d6−DMSO): δ/ppm 6.37 (1 H, dd, J = 9.8, 1.1 Hz, H2),
7.77 (1 H, dd, J = 9.7, 2.6 Hz, H3), 8.49 (1 H, dd, J = 2.6, 1.1 Hz, H5);
13C NMR (176 MHz, d6−DMSO): δ/ppm 112.5 (C4), 115.0 (C2), 143.0 (C3),
159.3 (C5), 160.4 (C1), 164.7 (C6).
IR (neat) ν = 2958.0 (O-H, br w), 1699.8 (C=O, s), 1544.5 (m), 1404.5 (m),
1226.3 (C-O, s), 1130.1 (m), 1097.3 (C-O, s), 952.1 (m), 847.8 (m), 772.8 (s),
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617.9 (m), 526.7 (m) cm−1.
LC-MS: Rt = 0.92 min, m/z 138.9 [M-H]
−; HR-MS calculated for C6H3O4 at
139.0031, found 139.0020 (∆ = -7.9 ppm). Decomposition by 150.0 ◦C (MeOH).
Reference18
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18.2 Methyl coumalate, Compound 10-5
O
O
OMeO
Chemical Formula: C7H6O4
Exact Mass: 154.03
65
4 3
2
1
7
One-pot, two-step batch procedure from malic acid:
Malic acid (125.0 g, 933 mmol) was charged to a 1 L RBF fitted with a stirrer
bar. Concentrated H2SO4 (250 mL, 465 mmol) was slowly charged to the RBF,
and the resulting slurry was heated to 90 ◦C for 3 h, during which time frothing
was observed. The solution was cooled to RT, then lowered into an ice bath.
MeOH (160 mL, 3960 mmol) was charged dropwise over 15 mins. The solution
was then heated at 90 ◦C for a further 2.5 h. The solution was allowed to cool
to RT, then poured over ice and left overnight. Precipitation of the product was
not observed. The orange solution was extracted with H2O and DCM (100 mL
x 3). The organic fractions were combined, and the volume reduced in vacuo to
give the crude product as a yellow solid. Recrystallisation from EtOAc gave the
product as a pale yellow solid in two crops, which were dried in vacuo.
Isolated yield: 19.130 g (124 mmol, 27%)
1H NMR (700 MHz, CDCl3): δ/ppm 3.87 (3 H, s, H7), 6.33 (1 H, dd, J = 9.8,
1.1 Hz, H2), 7.77 (1 H, dd, J = 9.8, 2.6 Hz, H3), 8.29 (1 H, dd, J = 2.6, 1.1 Hz,
H5);
13C NMR (126 MHz, CDCl3): δ/ppm 52.4 (C7), 111.9 (C4), 115.3 (C2), 141.6
(C3), 158.1 (C5), 159.8 (C1), 163.4 (C6).
IR (neat) ν = 1706.4 (C=O, s), 1544.8 (w), 1440.4 (m), 1298.8 (m), 1238.0 (s),
1084.6 (C-O, m), 948.1 (m), 839.1 (m), 815.6 (m), 773.2 (s), 630.0 (w) cm−1.
LC-MS: Rt = 1.04 min, m/z 155.3 [MH]
+; HR-MS calculated for C7H7O4 at
155.0344, found 155.0347 (∆ = +1.9 ppm).
Melting point: 65.4-69.0 ◦C (EtOAc).
Reference17
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18.3 Ethyl 2-oxo-2H-pyran-5-carboxylate -
Ethyl coumalate, Compound 10-7
O
O
OO
12
3 4 5
6
7
8
Chemical Formula: C8H8O4
Exact Mass: 168.04
Procedure:
Coumalic acid (2.603 g, 14.8 mmol) was charged to a 50 mL RBF fitted with a
stirrer bar, followed by EtOH (4.35 mL, 74.4 mmol) and conc. H2SO4 (5 mL, 93
mmol). The solution was heated at 90 ◦C for 3 h, at which point it was allowed
to cool to RT before pouring over ice. Formation of brown, oily droplets was
observed. Extraction with DCM (10 mL x 3)/H2O (10 mL x 3)/NaCl (10 mL x
3), combination of the organic layers, drying over Na2SO4 and concentrating in
vacuo gave the crude product as an orange oil.
Isolated yield: 1.650 g (9.82 mmol, 53%)
1H NMR (700 MHz, d6−DMSO): δ/ppm 1.26 (3 H, t, J = 7.1 Hz, H8), 4.25 (2
H, q, J = 7.1 Hz, H7), 6.41 (1 H, dd, J = 9.8, 1.1 Hz, H2), 7.80 (1 H, dd, J =
9.8, 2.7 Hz, H3), 8.56 (1 H, dd, J = 2.6, 1.1 Hz, H5);
13C NMR (126 MHz, d6−DMSO): δ/ppm 14.5 (C8), 61.6 (C7), 112.0 (C4),
115.2 (C2), 142.5 (C3), 159.6 (C5), 160.2 (C1), 163.2 (C6).
IR (neat) ν = 1751.3 (C=O, m), 1713.3 (C=O, s), 1288.1 (C-O, s), 1234.5
(C-O, s), 1078.2 (C-O, s), 770.3 (m) cm−1.
LC-MS: Rt = 2.37 min, m/z 169.0 [MH]
+; HR-MS calculated for C8H9O4 at
169.0501, found 169.0498 (∆ = -1.8 ppm).
Reference63
230
18.4 Propan-2-yl
2-oxo-2H-pyran-5-carboxylate - Isopropyl
coumalate
O
O
OO
Chemical Formula: C9H10O4
Exact Mass: 182.06
12
3 4 5
6 7
8
8
Procedure:
Coumalic acid (2.608 g, 14.8 mmol) was charged to a 50 mL RBF fitted with a
stirrer bar, followed by IPA (5.7 mL, 74.4 mmol) and conc. H2SO4 (5 mL, 93
mmol). The solution was heated at 90 ◦C for 3 h, at which point it was allowed
to cool to RT before pouring over ice. Formation of brown, oily droplets was
observed. Extraction with DCM (10 mL x 3)/H2O (10 mL x 3)/NaCl (10 mL
x 3), combination of the organic layers, drying over Na2SO4 and concentrating
in vacuo gave the crude product as a dark brown oil. Purification by column
chromatography (Hex: EtOAc 1: 1) gave the product as a brown oil.
Isolated yield: 1.576 g (8.66 mmol, 44%)
1H NMR (700 MHz, d6−DMSO): δ/ppm 1.26 (6 H, d, J = 6.3 Hz, H8), 5.05 (1
H, h, J = 6.3 Hz, H7), 6.39 (1 H, d, J = 10.9 Hz, H2), 7.78 (1 H, dd, J = 9.8,
2.7 Hz, H3), 8.52 (1 H, dd, J = 2.7, 1.1 Hz, H5);
13C NMR (126 MHz, d6−DMSO): δ/ppm 22.0 (C8), 69.3 (C7), 112.2 (C4),
115.2 (C2), 142.5 (C3), 159.5 (C5), 160.1 (C1), 162.7 (C6).
IR (neat) ν = 1754.8 (C=O, m), 1712.5 (C=O, s), 1289.2 (C-O, s), 1234.7
(C-O, m), 1076.9 (C-O, s), 772.9 (m) cm−1.
LC-MS: Rt = 2.61 min, m/z 183.5 [MH]
+; HR-MS calculated for C9H11O4 at
183.0657, found 183.0668 (∆ = +6.0 ppm).
No literature data available.
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18.5 Hexyl 2-oxo-2H-pyran-5-carboxylate -
Hexyl coumalate
O
O
OO
Chemical Formula: C12H16O4
Exact Mass: 224.10
12
3 4 5
6
7
108
9 11
12
Procedure:
Coumalic acid (2.609 g, 14.8 mmol) was charged to a 50 mL RBF fitted with a
stirrer bar, followed by 1-hexanol (9.3 mL, 74.4 mmol) and conc. H2SO4 (5 mL, 93
mmol). The solution was heated at 90 ◦C for 3 h, then allowed to cool to RT before
pouring over ice. Formation of brown, oily droplets was observed. Extraction with
DCM (10 mL x 3)/H2O (10 mL x 3)/NaCl (10 mL x 3), combination of the organic
layers, drying over Na2SO4 and concentrating in vacuo gave the crude product
as a dark brown oil. Purification by column chromatography (Hex: EtOAc 1: 1)
gave the product as a brown oil.
Isolated yield: 2.790 g (12.4 mmol, 64%)
1H NMR (700 MHz, d6−DMSO): δ/ppm 0.82-0.85 (3 H, m, H12), 1.14-1.30 (8
H, m, H8+9+10+11), 4.19 (2 H, t, J = 6.6 Hz, H7), 6.40 (1 H, d, J = 10.9 Hz,
H2), 7.79 (1 H, d, J = 12.4 Hz, H3), 8.55 (1 H, s, H5);
13C NMR (176 MHz, d6−DMSO): δ/ppm 14.3 (C12), 22.4 (C8/9/10/11), 26.4
(C8/9/10/11), 28.5 (C8/9/10/11), 31.3 (C8/9/10/11), 65.4 (C7), 111.9 (C4),
115.2 (C2), 142.4 (C3), 159.6 (C5), 160.1 (C1), 163.6 (C6).
IR (neat) ν = 1756/9 (C=O, s), 1289.4 (C-O, s), 1234.4 (C-O, m), 1082.0 (C-O,
s), 772.2 (m) cm−1.
LC-MS: Rt = 3.53 min, m/z 225.5 [MH]
+; HR-MS calculated for C12H17O4 at
225.1127, found 225.1129 (∆ = +0.9 ppm).
No literature data available.
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18.6 Octyl 2-oxo-2H-pyran-5-carboxylate -
Octyl coumalate
O
O
OO
12
3 4 5
6
7
8
Chemical Formula: C14H20O4
Exact Mass: 252.14
9 11 13
10 12 14
Procedure:
Coumalic acid (2.604 g, 14.8 mmol) was charged to a 50 mL RBF fitted with
a stirrer bar, followed by 1-octanol (11.7 mL, 74.4 mmol) and conc. H2SO4 (5
mL, 93 mmol). The solution was heated at 90 ◦C for 3 h, at which point it was
allowed to cool to RT before pouring over ice. Formation of brown, oily droplets
was observed. Extraction with DCM (10 mL x 3)/H2O (10 mL x 3)/NaCl (10 mL
x 3)/Et2O (10 mL x 3), combination of the organic layers, drying over Na2SO4
and concentrating in vacuo gave the crude product as a brown oil which was not
purified further due to the co-elution of octanol with the product.
Isolated yield: 7.502 g (29.8 mmol, 160% crude yield)
1H NMR (400 MHz, d6−DMSO): δ/ppm 0.84-0.86 (15 H, m, H8-14), 4.22 (2 H,
t, J = 6.6 Hz, H7), 6.44 (1 H, d, J = 10.9 Hz, H2), 7.82 (1 H, dd, J = 9.8, 2.7
Hz, H3), 8.59 (1 H, dd, J = 2.7, 1.1 Hz, H5).
IR (neat) ν = 1761.4 (C=O, m), 1724.3 (C=O, s), 1290.5 (C-O, s), 1235.3
(C-O, s), 1084.4 (C-O, s), 773.1 (m) cm−1.
No literature data available.
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18.7 Decyl 2-oxo-2H-pyran-5-carboxylate -
Decyl coumalate
O
O
OO
12
3 4 5
6
7
8
Chemical Formula: C16H24O4
Exact Mass: 280.17
9 11 13
10 12 14
15
16
Procedure:
Coumalic acid (2.610 g, 14.8 mmol) was charged to a 50 mL RBF fitted with
a stirrer bar, followed by 1-decanol (14.2 mL, 74.4 mmol) and conc. H2SO4 (5
mL, 93 mmol). The solution was heated at 90 ◦C for 3 h, at which point it was
allowed to cool to RT before pouring over ice. Formation of brown, oily droplets
was observed. Extraction with Et2O (10 mL x 3)/NaCl (10 mL x 3), combination
of the organic layers, drying over Na2SO4 and concentrating in vacuo gave the
crude product as a brown oil which was not purified further due to the co-elution
of decanol with the product.
Isolated yield: 8.030 g (28.7 mmol, 154% crude yield)
1H NMR (400 MHz, d6−DMSO): δ/ppm 0.88-0.91 (19 H, m, H8-16), 4.25-4.31
(2 H, m, H7), 6.36 (1 H, dd, J = 9.8, 1.1 Hz, H2), 7.81 (1 H, dd, J = 9.8, 2.6
Hz, H3), 8.31 (1 H, dd, J = 2.6, 1.1 Hz, H5).
IR (neat) ν = 1761.1 (C=O, m), 1724.4 (C=O, s), 1290.1 (C-O, s), 1234.9
(C-O, m), 1083.0 (C-O, s), 772.8 (m) cm−1.
No literature data available.
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18.8 H5PMo10V2O40 ·xH2O
Procedure:60
NaVO3 (24.4 g, 200 mmol) was charged to a 1 L RBF fitted with a stirrer bar.
H2O (100 mL) was added to the RBF, and stirring begun, heating to reflux for 1
h with a Vigreux column. Na2HPO4 (7.1 g, 50 mmol) was dissolved in H2O (100
mL), and the resulting solution was added to the RBF. The mixture was allowed
to cool to RT, and conc. H2SO4 (5 mL) was added to the solution, upon which
the colour changed from pale yellow to very dark red. Na2MoO4 · 2 H2O (121.0
g, 500 mmol) was dissolved in H2O (200 mL), and the solution transferred to a
dropping funnel fitted to the RBF. The solution was added dropwise over 20 mins,
and the mixture was stirred at RT for 1 h. Conc. H2SO4 (85 mL) was added
dropwise over 30 mins and an exotherm of 15 ◦C was observed. The solution was
extracted with Et2O which produced 3 layers: the lowest and fluorescent layer
was the hetereopoly etherate. The middle layer was aqueous, and the top layer
was the organic layer. The bottom layer was collected, and the Et2O allowed to
evaporate slowly. The product was a complicated dark red crystalline mixture.
Isolated yield: 33.8 g
31P NMR (162 MHz, d6−DMSO): δ/ppm -1.08, -2.89, -3.08, -3.33, -3.73, -4.06,
-4.19, -4.59 ppm.
LC-MS: Rt = 0.23 min, m/z 873 (ES
−).
Reference60
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18.9 Ethyl 3,3-dimethoxy-2-methylbutyrate
MeO
O
O
1 2
4
3
5
6
7
Chemical Formula: C9H18O4
Exact Mass: 190.12
OMe8
9
Procedure:
Ethyl 2-methylacetoacetate (15.2 mL, 108 mmol) was charged to a 3-necked 250
mL RBF fitted with a stirrer bar, condenser and two septa. MeOH (30 mL, 743
mmol) was charged to the RBF to give an orange solution. Trimethylorthoformate
(15.5 mL, 151 mmol) was charged to the RBF, followed by concentrated H2SO4,
whereupon the solution turned yellow. The solution was heated at reflux for 4.5
h, turning dark in colour. The reaction was allowed to cool to RT, then cooled in
an ice bath for 15 mins. The mixture was quenched by pouring into an aqueous
solution of KOH (0.3 g KOH in 150 mL H2O), then cooled in an ice bath for 5
mins. The solution was extracted with Et2O (30 mL), then the combined organic
layers were rinsed with brine (20 mL), dried over Na2SO4 and filtered. Removal
of the solvent in vacuo gave the crude product as an orange oil.
Isolated yield: 18.1 g (95.3 mmol, 88%)
1H NMR (700 MHz, CDCl3): δ/ppm 1.13 (3 H, d, J = 7.2 Hz, H4), 1.24 (3 H, t,
J = 7.1 Hz, H7), 1.34 (3 H, s, H1), 2.93 (1 H, q, J = 7.1 Hz, H3), 3.15 (3 H, s,
H8), 3.21 (3 H, s, H9), 4.13 (2 H, qq, J = 7.0, 3.7 Hz, H6);
13C NMR (126 MHz, CDCl3): δ/ppm 12.9 (C4), 14.1 (C7), 17.4 (C1), 44.8 (C3),
47.8 (C8), 48.4 (C9), 60.3 (C6), 102.2 (C2), 173.6 (C5).
IR (neat) ν = 2982.3 (w), 1732.7 (C=O, s), 1456.4 (w), 1373.5 (w), 1197.2
(C-O, s), 1123.0 (C-O, s), 1052.1 (C-O, s), 873.9 (m) cm−1.
Reference64
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18.10 Dimethyl
1,1’:3’,1”-terphenyl-4,4”-dicarboxylate,
Compound 15-2
OMeO
OMe
O
Chemical Formula: C22H18O4
Exact Mass: 346.12
1
2
3
8
7
69
12
11
10
4
5
Procedure:61,62
Methyl coumalate (0.156 g, 1.01 mmol) and 1,3-diethynylbenzene (0.14 mL, 1.00
mmol) were charged to a microwave vial fitted with a stirrer bar, followed by
t-BuOH (0.343 g, 4.21 mmol). The vial was capped, sealed and heated to 170 ◦C
for 2 h with 5 mins pre-stirring in the microwave. The high pressure was slowly
released, and H2O (2 mL) and EtOH (2 mL) were added to the vial. Precipitation
occurred, forming clumps of a dark orange solid. After filtration and drying in
vacuo, the crude product was obtained as a dark orange solid.
Isolated yield: 0.037 g (0.11 mmol, 22%)
1H NMR (700 MHz, CDCl3): δ/ppm 3.93 (6 H, d, J = 6.1 Hz, H1), 7.41 (1 H, t,
J = 7.8 Hz, H11), 7.51 (1 H, dt, J = 7.1, 1.3 Hz, H12), 7.59 (1 H, dt, J = 7.8,
1.4 Hz, H12), 7.63 (2 H, d, J = 8.6 Hz, H4/5/7/8), 7.71 (1 H, d, J = 8.5 Hz,
H4/5/7/8), 7.74 (1 H, t, J = 1.5 Hz, H10), 8.10 (2 H, d, J = 8.6 Hz,
H4/5/7/8), 8.13 (1 H, d, J = 8.5 Hz, H4/5/7/8);
13C NMR (176 MHz, CDCl3): δ/ppm 52.2 (C1), 122.8 (C), 127.0 (C4/5/7/8),
127.1 (C4/5/7/8), 127.7 (C12), 128.9 (C11), 130.14 (C4/5/7/8), 130.15
(C4/5/7/8), 130.9 (C10), 131.6 (C12), 140.2 (C), 144.5 (C), 166.8 (C2).
IR (neat) ν = 1712.7 (C=O, s), 1431.6 (m), 1278.4 (C-O, s), 1191.4 (m), 1109.7
(s), 765.2 (s), 700.0 (m) cm−1.
Melting point: decomposition by 100.0 ◦C (AcOH), literature = 192 ◦C
(AcOH).
Reference65
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18.11 Dimethyl
1,1’:4’,1”-terphenyl-4,4”-dicarboxylate,
Compound 15-4
O OMe
OMeO
Chemical Formula: C22H18O4
Exact Mass: 346.12
1 2
3
4
5
6
7
8
9
10 11
Procedure:61,62
Methyl coumalate (0.154 g, 1.00 mmol) and 1,4-diethynylbenzene (0.14 mL, 1.00
mmol) were charged to a microwave vial fitted with a stirrer bar, followed by
t-BuOH (0.243 g, 3.28 mmol). The vial was capped, sealed and heated to 170 ◦C
for 2 h with 5 mins pre-stirring in the microwave. The high pressure was slowly
released, and H2O (2 mL) and EtOH (2 mL) were added to the vial. Precipitation
occurred, generating brown flakes. After filtration and drying in vacuo, the crude
product was obtained as a multi-coloured brown solid, which was highly insoluble.
Isolated yield: 0.147 g (0.42 mmol, 84%)
1H NMR (700 MHz, d6−DMSO): δ/ppm 3.86 (6 H, s, H1), 7.81-7.88 (8 H, m,
H5+7+10+11), 8.03 (4 H, dd, J = 14.5, 8.4 Hz, H4+8);
IR (neat) ν = 1718.9 (C=O, s), 1432.7 (m), 1274.7 (C-O, s), 1193.3 (m), 1109.9
(s), 829.0 (s), 762.1 (s) cm−1.
Melting point: decomposition by 280.0 ◦C (DMF), literature = 315 ◦C (DMF).
Reference66
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Part III
The Darzens Reaction in Flow
243
Chapter 19
Literature Review
19.1 Introduction
Overview of the Darzens reaction
The Darzens condensation is a well-established synthetic tool to form α,β-epoxy
esters and their derivatives. It involves the reaction of a carbonyl compound with
an α-halo ester in the presence of a base to form a halohydrin-type intermediate.
A subsequent ring closure forms the glycidic ester (Scheme 19.1). There are
many methods for the formation of epoxides, but the Darzens reaction involves a
non-oxidative mechanism to give epoxides bearing electron-withdrawing groups.1
X E X E
Base R1 R2
O
R1
O-
E
X
R2
O
R1
R2
E
H
Scheme 19.1 General form of the Darzens condensation.
Although named after Auguste Darzens, the reaction was first reported in
1892 by Emil Erlenmeyer,2 who combined benzaldehyde and ethyl chloroac-
etate with sodium to form ethyl β-phenyl-α,β-epoxy propionate, a glycidic ester
(Scheme 19.2).
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OH
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KOH
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KBr H2O+ + +
19-1 19-2
Scheme 19.2 An example of Erlenmeyer’s work on epoxide formation.
Darzens later generalised this to become the classically known condensation,
with his early defining work on the reaction demonstrating the breadth of modi-
fication and adaptation that can be tolerated,3–12 which in turn has led it to be
considered as an important non-oxidative method for the synthesis of epoxides.
Risinger summarised the historical developments of the reaction in 1961.13
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The broad synthetic scope of the reaction can be ascribed to the variety
of possible reaction conditions and wide tolerance of functional groups.14 Al-
though originally the enolate was formed from simple esters, many alternative
substituents have subsequently been shown to be amenable. This expansion to
a more generalised reaction has ensured its continuing relevance, with a wide
variety of different solvents and bases providing effective conditions for the reac-
tion. The use of α,α-dihalogen epoxy esters has expanded the scope of its usage
considerably.15–18 The aza-Darzens reaction has also been reported in the forma-
tion of the nitrogen equivalent of the epoxide, the aziridine,1 but this will not be
reported on in any detail in this review.
Perhaps one of the most promising advances in the use of the reaction in re-
cent years has been in the greater control of stereoisomers and in the development
of the asymmetric reaction.19 Potential uses of a catalytic asymmetric Darzens
reaction are far-reaching, particularly within pharmaceutical chemistry.20 How-
ever, we know of no examples of syntheses of pharmaceutical compounds that
currently use the catalytic asymmetric Darzens reaction.
Although this short literature review will focus primarily on the usages of
the reaction within the pharmaceutical industry, it is important to note that
epoxides are also found in natural products such as the mosquito pheromone of
Culex pipiens fatigans (Fig. 19.1).21
O O
OAc
(S) (R)
19-3
Fig. 19.1 Pheromone of Culex pipiens fatigans.
Mechanism of the Darzens reaction
It should be noted that no definitive mechanism for the Darzens reaction has yet
been established, despite its long synthetic lifetime and extensive research.
However, it is known that the reaction proceeds via a carbanion intermedi-
ate.22 Alternative mechanisms via a carbene or ketene have been considered,23–26
but ultimately discarded.22,27–29 The mechanism is thought to proceed via an
aldol-like nucleophilic addition of the carbanion to a carbonyl compound, fol-
lowed by an internal SN2-like cyclisation to form the epoxide (Scheme 19.3).
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Scheme 19.3 The generally-accepted mechanism of the Darzens reaction.
19.2 The classical Darzens reaction
The versatility of the Darzens condensation has facilitated its incorporation into
the industrial synthesis of a number of pharmaceuticals throughout the 20th cen-
tury. Presently the reaction does not seem to be considered a primary method for
epoxide formation, and this is reflected in the limited number of recent examples.
Whether this is due to shortcomings of the reaction, or the existence of superior
alternatives will be explored in this section.
The traditional form of the reaction has been successfully implemented into
industrial scale syntheses, most notably with its involvement in the one-carbon
homologation stages of both vitamin A and ibuprofen. Additionally, a more
recent example made use of the Darzens condensation in an alternative method
to synthesise (±)-epiasarinin.
Boots synthesis of ibuprofen
In the 1960s, whilst searching for a drug to treat rheumatoid arthritis,
the Boots Company discovered and patented the compound ibuprofen (2-(4-
methylpropyl)phenylpropanoic acid).30 The process for their synthesis of ibupro-
fen is known as the ‘Boots synthesis’, and consists of six steps, including a
Darzens condensation (Scheme 19.4).31 Ibuprofen is classified as a non-steroidal
anti-inflammatory drug (NSAID) and is used to relieve pain, inflammation and
fever. The starting material for the synthesis is isobutylbenzene.
The role of the Darzens reaction is as part of a homologation step which
is achieved in the formation and subsequent opening of the oxirane ring. The
glycidic ester is formed in a classical Darzens synthesis. The ester then undergoes
saponification to generate a carboxylic acid, which is followed by a ring-opening
step and subsequent decarboxylation (Scheme 19.4).
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Scheme 19.4 Ring-opening and decarboxylation in the synthesis of ibuprofen.
The expiration of the ibuprofen patent has led to the Boots synthesis falling
out of favour. The original process was relatively atom-inefficient and has been
replaced by a ‘green synthesis’ developed by BHC32 (now BASF), with a much
greater atom economy: Boots reported an atom econommy of 40% whilst BHC
reports 77%. Part of the atomic inefficiency can be attributed to the Darzens
reaction stage, as almost all of the atoms used are not present in the final struc-
ture.
Hoffmann-La Roche synthesis of vitamin A
Vitamin A and other retinoid compounds have found a variety of medical applica-
tions, particularly in combating vitamin A deficiency in children from developing
countries.33
Both the Hoffmann-La Roche and Boots syntheses use the Darzens reaction
in mechanistically similar ways except for the migration of the carbon-carbon
double bond in β-ionone in the Hoffmann-La Roche mechanism (Scheme 19.5).34
The ability to convert a β-ionone to a β-C14 aldehyde35 has allowed the synthesis
of a number of other retinoid derivatives.36,37
Cl OEt
O
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Solvent
O O COOEt
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19-21
Scheme 19.5 Ring opening and decarboxylation in vitamin A synthesis.
The Hoffmann-La Roche reaction is still considered to be an efficient method
of producing vitamin A. However, in recent decades there has been a growth in
the number of alternative methods suitable for the industrial synthesis of vitamin
A.38 For example, the BASF protocol utilises an ylid-based reaction in place of
a Darzens condensation in addition to an alternative route to the β-ionone.
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Steel synthesis of (±)-epiasarinin
Epiasarinin is a furofuran-containing lignan-based natural product with anti-
viral, anti-oxidant, anti-cancer and immunosuppressant biological activities.39
The Steel synthesis describes an enantioselective method to synthesise the phar-
maceutical, although the stereochemistry achieved by the Darzens reaction is
irrelevant as the stereochemical information is later lost. Unusually, the electron-
withdrawing group was an α,β-unsaturated ester.39 Once formed, the epoxide
is employed in a conrotatory ring opening, followed by a disrotatory cyclisation
forming cis-dihydrofuryl ester (Scheme 19.6).
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Scheme 19.6 Darzens condensation in the synthesis of (±)-epiasarinin.
Originally the intention of the authors was to use an olefin peroxidation fol-
lowed by a Wadsworth-Emmons reaction with the epoxide formed to synthesise
the glycidic ester. This was unsuccessful, which was thought to be due to the
electron-donating effect of the substituents on the aryl group which promoted a
ring-opening reaction. The Darzens reaction avoided this problem by forming
the desired epoxide in a single step. The Darzens reaction was significantly more
high-yielding than model studies for the epoxy formation predicted.
19.3 The asymmetric Darzens reaction
In recent years the desire for single enantiomer pharmaceuticals has expanded
considerably due to a greater understanding of the marked difference in biolog-
ical properties that each isomer may possess. Therefore, the use of synthesis
routes with the ability to furnish selectively only the desired isomer has become a
key strategy in the production of many new pharmaceuticals.40 Modern advances
within the Darzens condensation have brought about a greater asymmetric capac-
ity, enabling stereoselective and stereospecific approaches, with the former using
catalysts and the latter chiral auxiliaries or reagents.
Chiral auxiliaries offer a method of selectively producing single enantiomers,
through their addition to the starting reagents in stoichiometric amounts to create
diastereotopic products. These can in turn be separated with greater ease than is
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possible with enantiomers. This is a particularly powerful tool in the asymmetric
Darzens condensation due to the relative simplicity in which the auxiliaries can
be incorporated into the starting reagents. The method has been applied in a
number of variations.
Synthesis of diltiazem hydrochloride
Diltiazem is a non-dihydropyridine calcium channel blocker used to treat hyper-
tension, angina and some arrhythmias. The (2S,3S ) diastereoisomer has been
identified as the most potent41,42 and consequently the pharmaceutical is mar-
keted as a single enantiomer. The earliest opportunity to access the single enan-
tiomer is at the glycidic ester stage. Schwartz et al. used a chiral auxiliary
strategy to furnish the desired enantiomer as the major product in 54% yield
(Scheme 19.7).43 The procedure was successfully scaled up to gram and kilogram
scales. The diastereomeric products were easily separated on the basis of their dif-
fering solubilities, and the chiral auxiliary was recyclable using a straightforward
base-mediated hydrolysis.
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Scheme 19.7 Darzens condensation in the synthesis of diltiazem hydrochloride.
Importantly, this reaction does not produce the cis-epoxides in observable
amounts. Essentially the stereochemical information is retained following a ring
opening reaction with the thiol group to form the enantiomerically pure product
(Scheme 19.8). A suggested mechanism is reported for the opening of the oxirane
ring.
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Scheme 19.8 Ring opening of the epoxide formed in the Darzens condensation
during the synthesis of diltiazem.
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It is proposed that the thiol group acts as a weak acid which protonates the
epoxide, assisting the ring-opening. This is facilitated by the p-anisyl group and
the intermediate quinone methide cation which both stabilise the configuration
through electron donation from the ring. Since no chiral inversion occurs, an
SN2-type mechanism cannot be in operation but instead an SN1-type reaction
must be taking place. It is proposed that the rate of reaction between the thiol
anion and cation must be greater than the anion migration, which is why the
thiol anion’s attack is only observed from one face.
Synthesis of (+)-mefloquine hydrochloride
Mefloquine is an anti-malarial drug but unfortunately it exhibits some serious
side effects. It is typically manufactured and administered as a racemic mixture.
However, (+)-mefloquine is at least 1.5 times more active than the (–)-enantiomer
and also is less associated with the commonly reported side effects.
Another recent example of the usage of chiral auxiliaries can be seen in the syn-
thesis of (+)-mefloquine hydrochloride, where the stereochemistry of the product
was established early in the synthesis through the use of an asymmetric Darzens
reaction (Scheme 19.9).44
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Scheme 19.9 Darzens condensation in the synthesis of (+)-mefloquine hy-
drochloride.
The synthesis reports a high diastereotopic selectivity (84% ee) for the desired
trans-glycidic ester by using N -amino cyclic carbamate chiral auxiliaries. Fur-
thermore, separating the minor cis-epoxide from the product was achieved easily
by silica gel chromatography. The trans-epoxide was isolated and transformed to
(+)-mefloquine hydrochloride by a series of steps.
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Synthesis of SK&F 104353
SK&F 104353 is a leukotriene D4 antagonist used in the potential treatment of
bronchial asthma. A synthetic strategy via the glycidic amide was proposed by
Aggarwal et al.45 The use of camphor-derived sulfonium amides has proven to be a
particularly effective enantioselective method in glycidic amide synthesis. Whilst
this could be considered to be an ylid epoxidation, it can also be considered to
be a derivation of the Darzens condensation.
The reaction is reported to proceed to the epoxide in excellent e.e. (up to
99%) with yields as high as 90%. Both the purity of the sulfonium salt diastere-
omer and the temperature of the reaction influence the selectivity and yield. The
temperature affects only the enantioselectivity and not the yield, with -20 ◦C
to -50 ◦C giving the best results. The preparation of the chiral auxiliary was
achieved in 3 steps from (+)-camphor. The subsequent Darzens reaction is per-
formed as a one-pot process with the catalyst and potassium hydroxide in ethanol
(Scheme 19.10). Addition and removal of the auxiliary occurs in situ.
SMe
OMe
1) Br
NEt2
O
2) Recrystallisation
S
OMe
NEt2
O
(CH2)8Ph
CHO
KOH/ MeOH
-30 °C, 24 h
Ph(CH2)8
CONEt2
O
19-40, 77% yield, 90% ee
Ph(CH2)8
CO2H
S
OH
CO2H
19-38 19-39
19-41
Scheme 19.10 Darzens condensation in the synthesis of SK&F 104353.
The reaction favours the trans-isomer in all observed reactions, but a better
understanding of the mechanism and enantioselectivity is required. A proposed
mechanism proceeds via reversible betaine formation, with the subsequent C-C
bond rotation being the enantio-differentiating step.
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Scheme 19.11 Reversible betaine formation followed by the enantio-
differentiating step in the synthesis of SK&F 104353.
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19.4 The catalytic asymmetric Darzens
reaction
The catalytic asymmetric Darzens reaction is an enantioselective approach to
the preparation of glycidic esters and derivatives. Both homogeneous- and
heterogeneous-catalysed reactions have been reported with high levels of enan-
tiomeric selectivity. Phase transfer catalysis is heterogeneous, and offers op-
erational simplicity, milder conditions and inexpensive, environmentally benign
reagents and solvents as benefits. These advantages make this route particularly
appealing in the pursuit of green chemistry. In addition, these positive traits
make the development of the reaction especially useful in the pharmaceutical
industry.
The catalytic asymmetric reaction has been reviewed elsewhere19 and so will
not be examined in detail here. Instead, a brief summary of the developments
will be given, starting with homogeneous catalysis before moving to heterogeneous
reactions.
Bovine serine albumin was the first homogeneous catalyst used in the asym-
metric reaction by Colonna et al.46 Lewis acid-Brønsted base catalysis,47 chiral
titanium complexes48 and chiral zirconium complexes49 have since been more
recently used.
Makosza et al.50,51 were the first to use phase-transfer catalysis in the Darzens
reaction. They and later groups used crown ethers as catalysts.52,53 Other
major families of catalysts used for phase-transfer Darzens reactions include
ephedrinium and cinchona-derived salts, although they operate by very differ-
ent mechanisms.19 For example, the Arai group has used chiral quaternary am-
monium salts derived from cinchonine54–59 in the syntheses of α,β-epoxyketones
and α,β-epoxysulfones. More recently, they have started employing a BINOL-
derived bis ammonium salt as a more effective catalyst with a greater substrate
tolerance.60
As many of these advances in this area have occurred relatively recently, few
examples therefore currently exist of the catalytic asymmetric Darzens reaction
as used in pharmaceutical synthesis.61
19.5 Advantages and disadvantages of the
Darzens reaction
Whilst demonstrating the versatility of this potential method of epoxide synthesis,
this overview has also highlighted some of the major issues with its adaptability.
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From the various potential and actual uses of the condensation in pharmaceu-
tical synthesis it is clear that there are several limitations to the reaction. The
mechanism, particularly with respect to selectivity, has not yet been absolutely
established despite various studies and proposals. The lack of understanding has
made selective reactions difficult to design.
The lack of stereoselectivity in the classical Darzens condensation means that
it is only of use when the stereochemistry of the product is unimportant. Although
great strides have been made in the development of a catalytic asymmetric reac-
tion and various other methods of enantiomeric control, this remains problematic,
with only very specific routes providing high enantioselectivity. Additionally, the
use of chiral auxiliaries brings its own problems: for example, access to the enan-
tiomerically pure auxiliary precursor, the addition of two extra synthetic steps,
and subsequent yield reduction.
These methods frequently require expensive starting materials which can be
challenging to prepare. Whilst yields are frequently high, the atom economy of the
reaction is very poor. This is only exacerbated by the use of chiral auxiliaries.
There is potential for side reactions such as self-condensation of the carbonyl
compounds and formation of halohydrins,62 which may lead to reduced yields.
The reaction has the advantage of being able to provide a multitude of syn-
thetic products through its derivations – however, alternatives to the Darzens
condensation such as organocatalytic epoxidation63 have been observed with
greater selectivity and easier preparation. Therefore, despite the ability to use
the Darzens condensation in a large range of epoxide formations, it remains a
challenge to optimise it for industrial-scale procedures.
However, there are still some advantages to the Darzens reaction. It can be
incorporated into a wide range of different synthetic routes. Whilst the tradi-
tional variant of the reaction has found the most usage, notably in one-carbon
homologation, the asymmetric condensation has far greater potential.
Generally the traditional Darzens reaction offers a direct and scalable method
in epoxide synthesis. The relatively inexpensive and easily accessible reagents and
the acceptance of electron withdrawing groups on the epoxides are also additional
advantages. The conditions of chiral auxiliary asymmetric Darzens reactions tend
to be very similar to those of the traditional reaction, as once the auxiliary is in-
corporated into the reagents, the reaction can proceed under classical conditions.
The subsequent removal of the chiral auxiliary also tends to be simple. Chiral aux-
iliary reactions offer significant advantages in providing enantiospecific products.
Additionally, the separation of the diastereoisomers is typically straightforward.
Although the variety of the possible substituents has allowed for the synthesis
of an abundance of different epoxides, perhaps the most promising advances are in
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the asymmetric Darzens reaction. Specifically, the efforts in enantioselective cat-
alysts offer an opportunity for exploitation, especially within the pharmaceutical
industry.
Further development of asymmetric heterogeneous catalysis offer several ad-
vantages over the homogeneous route in the pursuit of green chemistry, even
though it is as-yet under-developed. The use of milder reaction conditions whilst
avoiding toxic metal-based catalysts is particularly appealing.
19.6 Conclusions
Ultimately, the future of the Darzens reaction lies in whether the catalytic asym-
metric potential can be refined so as to be scalable in pharmaceutical synthesis.
The current limitations are preventing the reaction finding use in the synthesis
of many bioactive compounds. Unless these are addressed, methods such as the
Julia´-Colonna synthesis64 will take precedence as a more successfully selective
methodology.
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Chapter 20
Project Aims
The objectives of this project are as follows:
• To replicate a batch procedure for the Darzens reaction
• To develop a continuous flow protocol for the Darzens reaction
• To use this flow procedure to synthesise an industrially useful intermediate
e.g. a precursor to ibuprofen
From the literature perspective, it can be seen that the Darzens reaction is
somewhat capricious, with conditions varying widely depending on the substrate
used. The first step is to successfully perform a relevant batch reaction, and to
use these results to inform the adaptation of the batch procedure into continuous
flow.
Some changes are likely to be made on translating from batch to flow. The
scope of this flow procedure will be examined with a range of benzaldehydes.
Additional investigation of industrially relevant examples in a multi-step synthesis
of compounds such as ibuprofen or vitamin A will also be considered.
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Chapter 21
Results and Discussion
21.1 Preliminary batch experiments and early
flow attempts
Ibuprofen
According to Shasun Pharmaceuticals, they have used the Darzens reaction in
the synthesis of an intermediate towards ibuprofen on a commercial scale.∗ No
conditions or data were available, but the general reaction scheme is as shown
(Scheme 21.1).
O
O
O
Cl
O O
O
CHO
19-4 21-1 19-6
Scheme 21.1 Shasun synthesis of an ibuprofen intermediate.
Batch attempts at the Darzens reaction of isobutylacetophenone
The first experiments conducted in batch were with isobutylacetophenone and
ethyl chloroacetate, with sodium ethoxide as the base (Scheme 21.2).65 Several at-
tempts were made, starting with milder heating conditions and moving to higher
temperatures (10-15 ◦C to RT; 10-15 ◦C to 85 ◦C; reflux in EtOH).
O
Cl OEt
O NaOEt (1.1 equiv.)
19-4, (1.1 equiv.) (1.0 equiv.)
Scheme 21.2 Attempted Darzens reactions with isobutylacetophenone and
ethyl chloroacetate.
∗In correspondence with Prof Ian R. Baxendale
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The 1H NMR spectrum indicated the presence of unreacted ethyl chloroac-
etate, indicating that the base used was not strong enough to fully deprotonate
the ethyl chloroacetate.
Freshly-prepared NaOEt was made by reacting sodium in dry ethanol. When
the reaction was attempted again, a conversion of 39% from starting material was
observed in the 1H NMR spectrum (Scheme 21.3).
O
Cl OEt
O NaOEt (1.1 equiv.)
19-4, (1.1 equiv.) (1.0 equiv.)
10-15 °C to RT to 85 °C
O
OEt
O
21-2, 39% conversion
Scheme 21.3 Attempted Darzens reactions with isobutylacetophenone and
ethyl chloroacetate and freshly-prepared sodium ethoxide.
Flow attempts at the Darzens reaction of isobutylacetophenone
With the somewhat-successful batch reaction in hand, efforts were made to trans-
late it into flow. Reactions were next carried out in a Vapourtec E-MedChem R©
reactor system using the in-built peristaltic pumps.
The first attempt used a 10 mL FEP reactor at 90 ◦C with a flow rate of 0.100
mL min−1 (Scheme 21.4).
O
Cl OEt
O
19-4, (1.1 equiv.) (1.0 equiv.)
O
OEt
O
NaOEt/EtOH
(1.1 equiv.) 90 °C10 mL 21-2, 24% conversion
0.100 mL/min
Scheme 21.4 First flow attempt at the Darzens reaction with isobutylacetophe-
none.
A conversion of 24% to the product was observed by 1H NMR spectroscopy.
The flow rate was increased to 0.500 mL min−1, and then the temperature in-
creased to 100 ◦C. These changes led to a slight decrease in the overall conversions
(Scheme 21.5).
O
Cl OEt
O
19-4, (1.1 equiv.) (1.0 equiv.)
O
OEt
O
NaOEt/EtOH
(1.1 equiv.) 90, 100 °C10 mL 21-2
90 °C - 20% conversion
100 °C - 17% conversion
0.500 mL/min
Scheme 21.5 Screening temperatures and flow rates for the Darzens reaction
in flow with isobutylacetophenone.
To try and increase the conversion, a second 10 mL reactor coil was added,
and the flow rate reduced back to 0.100 mL min−1, giving a residence time of
approx. 200 mins (Scheme 21.6).
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OCl OEt
O
19-4, (1.1 equiv.) (1.0 equiv.)
O
OEt
O
NaOEt/EtOH
(1.1 equiv.) 90 °C10 mL
21-2, 23% conversion
90 °C
10 mL
0.100 mL/min
Scheme 21.6 Attempted Darzens reaction with isobutylacetophenone in flow
with two 10 mL coil reactors at 90 ◦C.
Unfortunately this did not make a difference to the conversion.
Next, the first reactor temperature was set to 25 ◦C, and the second held at
the higher temperature of 90 ◦C (Scheme 21.7).
O
Cl OEt
O
19-4 (1.1 equiv.) (1.0 equiv.)
O
OEt
O
NaOEt/EtOH
(1.1 equiv.) 25 °C10 mL
21-2, 34% conversion
90 °C
10 mL
0.100 mL/min
Scheme 21.7 Attempted Darzens reaction with isobutylacetophenone in flow
with two 10 mL coil reactors, one at 25 ◦C and the second at 90 ◦C.
This gave a modest increase to the conversion.
At this point, isobutylacetophenone was ruled out as a substrate, as it was
thought that it was proving too difficult for the deprotonated ethyl chloroacetate
to attach into the ketone carbonyl system.
Vitamin A
There are more published protocols and precedent for the successful synthesis of
the C14 aldehyde in the synthesis of vitamin A, starting from β−ionone. As
an example, the Hoffmann-La Roche synthesis of vitamin A is shown above
(Scheme 19.5).34 The Hoffmann-La Roche reaction is still considered to be an
efficient method of producing vitamin A.
Batch attempts at the Darzens reaction of β−ionone
The first attempt performed aimed to replicate the Isler procedure of 1947
(Scheme 21.8).34
O
Cl OEt
O
1) NaOEt (1.13 equiv.)
-10 °C, 4 h, N 2
2) NaOH/MeOH (15%)
5 °C, 2 h
19-8 (1.0 equiv.) (1.26 equiv.)
O
H
19-20, 12% conversion
Scheme 21.8 Isler synthesis of the aldehyde.
The conversion was measured by 1H NMR spectroscopy, using the aldehyde
peak in the 9.0-9.5 ppm region. The majority of the mixture was the β−ionone
starting material, unlike the literature procedure which reported a yield of 80%.
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Flow attempts at the Darzens reaction of β−ionone
The first flow attempt at synthesising the C14 aldehyde mimicked the Isler batch
procedure. β−Ionone and ethyl chloroacetate were pre-mixed, followed by the ad-
dition of NaOEt/EtOH. A white precipitate was formed, and the solution turned
a pale yellow, before the slurry was pumped into the Polar Bear R© reactor held
at -10 ◦C (Scheme 21.9), with no conversion of starting materials observed by 1H
NMR spectroscopy.
O
Cl OEt
O
19-8 (1.0 equiv.) (1.26 equiv.)
+
NaOEt/EtOH
-10 °C
7 mL
1.0 mL min-1
BPR SM only
Scheme 21.9 Attempted flow Isler synthesis of the aldehyde.
The second attempt used a re-calculated quantity of NaOEt, based on the
need for additional base in the form of NaOH (Scheme 21.10).
O
Cl OEt
O
19-8 (1.0 equiv.) (1.26 equiv.)
+
NaOEt (6.6 equiv.)/EtOH
-10 °C
7 mL
1.0 mL min-1
BPR SM only
Scheme 21.10 Attempted flow Isler synthesis of the aldehyde.
There were some issues with the pump blocking with precipitated NaCl when
run at 0.1 mL min−1. Only β−ionone was observed by 1H NMR spectroscopy.
The same reaction was attempted at -10 ◦C, followed by a second pass
through a 7 mL reactor housed on a Polar Bear Plus R© reactor held at +5 ◦C
(Scheme 21.11).
O
Cl OEt
O
19-8 (1.0 equiv.) (1.26 equiv.)
+
NaOEt (6.6 equiv.)/EtOH
-10 °C
7 mL
1.0 mL min-1
BPR SM only
+5 °C
7 mL
1.0 mL min-1
Scheme 21.11 Attempted flow Isler synthesis of the aldehyde.
There was no observable colour change, and only β−ionone was observed by
1H NMR spectroscopy.
The next approach was to split up the starting material components, placing
the base in a separate channel to allow for pre-cooling of the starting materials
before mixing with the sodium ethoxide (Scheme 21.12).
259
OCl OEt
O
19-8 (1.0 equiv.) (1.26 equiv.)
+
NaOEt (6.6 equiv.)/EtOH
0.1 mL min-1
-10 °C
2.75 mL
0.1 mL min-1
-10 °C
7 mL
0.1 mL min-1
Scheme 21.12 Attempted flow Isler synthesis of the aldehyde.
The crude mixture was split into two 2.5 mL portions. NaOH was added to
the first, which was stirred at room temperature. No change was observed.
The second sample was sent through the flow reactor again at a higher temper-
ature before extraction and work-up. The material isolated was a yellow-brown
oil, and 1H NMR spectroscopy indicated an absence of aldehyde, as well as the
presence of the β−ionone starting material and other impurities.
Identifying the source of the problem
A series of deprotonation and quenching experiments were performed on ethyl
chloroacetate to determine whether it was the initial deprotonation step by the
base, or the subsequent aldol-like addition into the carbonyl which was the issue.
Sodium ethoxide in EtOH was added to ethyl chloroacetate at -10 ◦C and
stirred for 30 mins. D2O was used to quench the solution. Insufficient base (0.5
equiv.) was used so that a mixture could be seen in the 1H NMR spectrum,
performed in d6−DMSO (Scheme 21.13) .
Cl OEt
O
NaOEt/ EtOH
-10 °C, 30 mins
Cl OEt
O D2O Cl OEt
O
D
Scheme 21.13 Determination of deprotonation of ethyl chloroacetate by
NaOEt in EtOH.
Integration of the 1H spectrum indicated approx. 76% deuteration (although
there was only enough NaOEt to deprotonate 45%). Therefore, the deprotonation
step was deemed not to be the problematic step in the Darzens reaction.
It would appear that the second, aldol-like addition into the carbonyl is the
problem. If it were the ring-closing, epoxide-forming step, the protons from the
ester of ethyl chloroacetate would appear in the 1H NMR spectrum, but they do
not.
Non-Isler Darzens reactions with β−ionone
Since all of the attempts at the Darzens reaction of β−ionone with ethyl chloroac-
etate using the Isler conditions failed, other literature conditions were considered.
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The first of these was from a recent patent and required N -methyl-2-
pyrrolidone in sub-stoichiometric amounts (Scheme 21.14).66
O
Cl OEt
O 1) NaOEt (1.51 equiv.)
0 °C to RT, 20 mins
2) NaOH
19-8 (1.0 equiv.) (1.23 equiv.)
N O SM only
(0.71 equiv.)
Scheme 21.14 Attempted Darzens synthesis of C14 aldehyde.
The only material isolated was β−ionone by 1H NMR spectroscopy.
The second attempt was from the same patent, using NaOMe instead of
NaOEt, and still using N -methylpyrrolidone (Scheme 21.15).
O
Cl OMe
O 1) NaOMe (1.51 equiv.)
0 °C to RT, 20 mins
2) NaOH
19-8 (1.0 equiv.) (1.23 equiv.)
N O SM only
(0.71 equiv.)
Scheme 21.15 Attempted Darzens synthesis of C14 aldehyde.
Again, by 1H NMR spectroscopy, only β−ionone was isolated.
Finally, a flow reaction with β−ionone, ethyl chloroacetate and sodium
methoxide was attempted,67 with a telescoped batch step after to add the
NaOH/MeOH (Scheme 21.16).
Cl OEt
O
19-8 (1.0 equiv.) (1.9 equiv.)
+
NaOMe (2.3 equiv.)/MeOH
0.5 mL min-1
-10 °C
2.75 mL
0.5 mL min-1
-10 °C
7 mL
0.5 mL min-1
O
Crude
NaOH
MeOH
SM only
Scheme 21.16 Attempted Darzens synthesis of C14 aldehyde.
Again, β−ionone was the only material isolated according to 1H NMR spec-
troscopy.
Benzaldehyde
Since it was thought that the addition to the carbonyl was the problem, sim-
ilar reactions were attempted using benzaldehyde as a more reactive carbonyl
functionality.
The first literature procedure68 performed employed methyl chloroacetate (2
equiv.) and sodium methoxide (2 equiv.) in MeOH at 0 ◦C. However, only
benzaldehyde was isolated.
A second modified literature procedure69 used ethyl chloroacetate (2 equiv.)
and sodium methoxide (1.5 equiv.). Again, 1H NMR spectroscopy indicated that
only benzaldehyde was isolated.
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Finally, a flow reaction using benzaldehyde, ethyl chloroacetate and sodium
methoxide was attempted (Scheme 21.17).
Cl OEt
O
21-3 (1.0 equiv.) (1.5 equiv.)
+
NaOMe (1.5 equiv.)/MeOH
0.5 mL min-1
0 °C
2.75 mL
0.5 mL min-1
RT
10 mL
0.5 mL min-1
H
O
0 °C
7 mL
0.5 mL min-1
SM only
Scheme 21.17 Attempted flow Darzens reaction between benzaldehyde and
ethyl chloroacetate.
Benzaldehyde and ethyl chloroacetate were both present by 1H NMR spec-
troscopy.
21.2 Breakthrough batch reaction
The first batch Darzens reaction that could be described as successful used KOtBu
in t-BuOH as the base, following the work of Bachelor et al.22 Benzaldehyde and
methyl chloroacetate were used as the starting materials, and the resulting white
slurry was stirred at room temperature for 2 h (Scheme 21.18).
H
O
Cl OMe
O
21-3
(1.0 equiv.)
(1.0 equiv.)
KOtBu (1.0 equiv.)
tBuOH, N2, RT
O
OMe
O
21-4, 16% yield
Scheme 21.18 Synthesis of the epoxy ester from benzaldehyde.
After purification by column chromatography, the epoxy ester was isolated
as a mixture of diastereomers, in the ratio 2.7:1. The major diastereomer was
identified as the cis isomer, based on J -values in the 1H NMR spectrum and
confirmation data from the NOESY spectrum. Both the ratio and assignment
are in agreement with the literature.22
It was examined whether evaporation of t-BuOH was necessary for a successful
aqueous work-up. It was concluded that this was only important on a larger
scale, and so therefore a simple Et2O/H2O work-up is sufficient, and enables
rapid extraction when screening flow reactions.
21.3 Benzaldehyde reactions in flow
Several possibilities for transferring the batch reaction to flow were identified.
These included a two-pump system, where the aldehyde and methyl chloroacetate
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are pre-mixed before being pumped to mix with the base stream. A preferred
option was a three-pump system, which separated the carbonyl and chloroacetate
streams. For simplicity, the 2-pump system was considered first. Many factors
were identified that could alter the conversion to product. These are described
and examined in detail below.
Several potential issues were identified with changing from a batch reaction
to a flow process. The batch reaction was performed under N2 in anhydrous
conditions, but it was not known how crucial this was. Additionally, when adding
the basic solution to the starting materials, a viscous white slurry formed rapidly
which may cause blockages in flow. Finally, the melting point of t-BuOH is 25
◦C, which imposes a limit on the lower temperature range that can be screened.
Full conversion was only observed when benzaldehyde and methyl chloroac-
etate were mixed together without additional tert-butanol. Results at higher
dilutions were not very reproducible, but show an approximate trend that as
concentration decreases, so does the conversion (Table 21.1). Running the reac-
tion at high concentrations can cause problems with blocking (if not engineered
for) due to the formation of a solid as the two reacting streams mix.
Table 21.1 Effect of substrate concentration on conversion of benzaldehyde to
epoxide.
Entry Dilution of
BA+MCA
Concentration
of BA/
mol dm−3
Flow rates
mL min−1
Pressure/
bar
Outcomea
1 Neat - B = 0.200; C =
1.000
10 100%
2 1:1 9.84 B = 0.200; C =
1.000
10 Blockage -
not resolved
3 1:2 4.92 0.500 3.0 57%
4 1:2 4.92 1.00 5.0 39%
5 1:2 4.92 1.00 5.7 57%
6 1:2 4.92 1.50 7.2 58%
7 1:3 3.28 0.500 3.5 43%
8 1:3 3.28 1.00 6.0 80%
9 1:3 3.28 1.00 5.8 78%
10 1:3 3.28 1.50 5.5 57%
11 1:5 1.97 1.00 3.5 63%
a % conversion estimated by 1H NMR spectroscopy
There is not a strong correlation between absolute flow rate and conversion
(Fig. 21.1).
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Fig. 21.1 The effect of flow rate on conversion.
Several combinations of flow rates of different streams were examined, and
the results are shown below (Fig. 21.2).
Fig. 21.2 The effect of flow rate on conversion.
There is no obvious relationship between the ratio of flow rates of streams. The
higher flow rates give slightly higher conversions, and also allow more material to
be processed and so are more efficient.
Reactions cannot be run below 25 ◦C due to the low freezing point of tert-
butanol. Two further experiments were performed to examine the effect of in-
264
creasing the temperature on the percentage conversion, and the results are sum-
marised below (Fig. 21.3).
y = -0.0085x + 1.0042
R² = 0.972
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Fig. 21.3 The effect of temperature of the reactor on conversion.
The percentage conversion decreased as the temperature was increased. This
was likely to be due to the increased formation of side-products due to reactions
of the epoxide product. Discolouration of the product stream was observed, to
orange rather than white or pale yellow.
The pressure of the reactions performed was observed, and plotted against
conversion (Fig. 21.4).
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Fig. 21.4 The effect of pressure on conversion.
There does not seem to be a connection between pressure and conversion.
When using the standard narrow tubing, blocking at the T-piece was common.
Changing to a Y-piece reduced this problem. The conversion was investigated
after mixing, before entering the reactor coil, since it was thought that the coil
may be unnecessary. It was found that there was little difference in conversion
between experiments where measurements were taken before and after the reactor
coil, and so the coil was removed. The effect of the tubing length post-mixing
was investigated below.
Narrow-bore tubing had previously been used but caused severe problems
with precipitation, over-pressure and blocking. The tubing post-mixing was ex-
changed for wider-bore tubing (inner diameter = 5.0 mm) which would reduce
the likelihood of blockages, and may lead to improved mixing.
This wider-bore tubing was obtained in several pre-cut lengths, and these were
tested with benzaldehyde, running neat or diluted in t-BuOH (Fig. 21.5).
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Fig. 21.5 The effect of tube dimensions on conversion.
The conversion of benzaldehyde was > 90 % when run neat; the length of the
wider-bore tubing did not have a large impact on this result.
21.4 Isobutylbenzaldehyde reactions in flow
Initially, the flow rates for pumps B (isobutylbenzaldehyde and methyl chloroac-
etate) and C (KOtBu and t-BuOH) were set equal, and the absolute flow rate
was varied to see if this had any effect on conversion (Fig. 21.6 and Fig. 21.7).
The impact was small (if not negligible), which is somewhat surprising because
a slower flow rate gives a longer residence time and thus a larger window for
reaction to occur, but with poorer mixing.
H
O
Cl OMe
O
(1.0 equiv.) (1.0 equiv.)
KOtBu (0.931 mol/dm3)/ tBuOH
x mL/min
x mL/min
O
OMe
O
Wide-bore
Fig. 21.6 The effect of flow rate on conversion of isobutylbenzaldehyde.
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Fig. 21.7 The effect of changing the absolute flow rate on conversion.
Next, the relative flow rates of pumps B (isobutylbenzaldehyde and methyl
chloroacetate) and C (KOtBu and t-BuOH) were changed. The results are plotted
in the graph below (Scheme 21.19 and Fig. 21.8).
H
O
Cl OMe
O
21-5, (1.0 equiv.) (1.0 equiv.)
KOtBu (0.931 mol/dm3)/ tBuOH
x mL/min
y mL/min
O
OMe
O
Wide-bore
21-6
Scheme 21.19 The effect of relative flow rate on conversion of isobutylben-
zaldehyde.
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Fig. 21.8 Effect of changing the flow rate ratios on conversion.
It would seem that there are two competing effects occurring. In the first half
(ratios up to 1:4), as the flow rate of the base increases, conversion also increases
approximately linearly. However, in the second half of the graph (ratios above
1:6), a sharp decrease in conversion is observed. This is thought to be due to the
increasing volume of t-BuOH and hence a higher dilution. It has previously been
observed that this reaction gives its highest conversions at high concentrations,
and so this is not surprising. The 1:5 flow rate ratio was also tested, but the
conversion observed was not the maximum expected. The reason for this is not
yet known.
21.5 Utilising a 3-pump system
To test whether polymerisation of methyl chloroacetate was occurring under these
conditions, it was mixed with base and without substrate (Scheme 21.20).
Cl OMe
O
(1.0 equiv.)
KOtBu (0.931 mol/dm3)/ tBuOH
0.250 mL/min
1.00 mL/min
Wide-bore
Scheme 21.20 Mixing methyl chloroacetate and the base.
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Some side-product formation was observed. One possible route for side-
product formation is shown below (Scheme 21.21).
MeO
O
Cl
Base
MeO
O
Cl
MeO
O
Cl
MeO
O
Cl
OMe
O
Scheme 21.21 Possible side-product formation from the reaction of methyl
chloroacetate with itself (wide bore: inner diameter = 5.0 mm).
Three mixing combinations between isobutylbenzaldehyde or benzaldehyde,
methyl chloroacetate and potassium tert-butoxide were considered. Mixing the
base and methyl chloroacetate gave the worst conversion, presumably because the
methyl chloroacetate started reacting with itself before it began reacting with the
aldehyde (Scheme 21.22).
H
O
Cl OMe
O
(1.0 equiv.)
(1.0 equiv.)
0.250 mL/min
O
OMe
O
Wide-bore
R
R
KOtBu (0.931 mol/dm3)/ tBuOH
Wide-bore1.00 mL/min
0.250 mL/min
7% conversion
Scheme 21.22 3-pump arrangement, with pre-mixing of methyl chloroacetate
and the base (wide bore: inner diameter = 5.0 mm).
There was little difference between mixing methyl chloroacetate and isobutyl-
benzaldehyde (Scheme 21.23), and mixing isobutylbenzaldehyde and the base
(Scheme 21.24).
H
O
Cl OMe
O
21-5, (1.0 equiv.)
(1.0 equiv.)
1.00 mL/min
O
OMe
O
Wide-bore
KOtBu (0.931 mol/dm3)/ tBuOH
Wide-bore0.250 mL/min
0.250 mL/min
22% conversion
Scheme 21.23 3-pump arrangement, with pre-mixing of methyl chloroacetate
and isobutylbenzaldehyde.
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HO
Cl OMe
O
21-5, (1.0 equiv.)
(1.0 equiv.)
0.250 mL/min
O
OMe
O
Wide-bore
KOtBu (0.931 mol/dm3)/ tBuOH
Wide-bore1.00 mL/min
0.250 mL/min
28% conversion
Scheme 21.24 3-pump arrangement, with pre-mixing of isobutylbenzaldehyde
and the base.
Finally, two injections of base were sequentially mixed with methyl chloroac-
etate and isobutylbenzaldehyde (Scheme 21.25).
H
O
Cl OMe
O
21-5, (1.0 equiv.)(1.0 equiv.)
0.500 mL/min
O
OMe
O
Wide-bore
KOtBu (0.931 mol/dm3)/ tBuOH
Wide-bore0.500 mL/min
0.250 mL/min
KOtBu (0.931 mol/dm3)/ tBuOH 28% conversion
Scheme 21.25 3-pump arrangement, with two injections of the base.
This did not improve the conversion, and so it can be concluded that the low
conversion is not due to the availability of base. These results are summarised in
the table below (Table 21.2).
Table 21.2 Effect of changing the pumping system layout.
Entry Pump system Outcomea
1 Scheme 21.22 (Benzaldehyde) 8%
2 Scheme 21.22 (IBBA) 7%
3 Scheme 21.23 (IBBA) 22%
4 Scheme 21.24 (IBBA) 28%
5 Scheme 21.25 (IBBA) 28%
a % conversion estimated by 1H NMR spectroscopy
The three-pump systems considered did not give an advantage in conversion
over the other two-pump systems. They do, however, allow aldehydes to be
changed easily so that rapid screening is possible.
21.6 Substrate screening
A range of readily-available benzaldehydes were tested under the same conditions
(Scheme 21.26). Of these, p-nitrobenzaldehyde was a solid at room temperature,
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and would not dissolve in methyl chloroacetate or t-BuOH. Therefore for this
initial screening, only benzaldehydes which are liquids at room temperature were
considered. The results are summarised below (Table 21.3).
Scheme 21.26 General flow diagram for testing a variety of aldehydes in the
Darzens reaction in flow.
H
O
Cl OMe
O
(1.0 equiv.) (1.0 equiv.)
KOtBu (0.931 mol/dm3)/ tBuOH
0.250 mL/min
1.00 mL/min
R
R
O
OMe
O
Wide-bore
Entry Starting material Outcomea
1 Isobutylbenzaldehyde 18%
2 p-Methoxybenzaldehyde 19%
3 m-Methoxybenzaldehyde 21%
4 o-Methoxybenzaldehyde 15%
5 p-Bromobenzaldehyde 47%
6 m-Bromobenzaldehyde 37%
7 o-Bromobenzaldehyde 65%
8 m-Fluorobenzaldehyde > 95%
9 o-Trifluoromethylbenzaldehyde 68%
10 o-Methylbenzaldehyde 50%
a % conversion estimated by 1H NMR spectroscopy
The resulting epoxide exhibits cis/ trans isomerism, as illustrated by the
benzaldehyde-derived epoxide shown below (Fig. 21.9).
O
OMe
O O
OMe
O
cis-epoxide trans-epoxide
H H
Fig. 21.9 cis- and trans-epoxides of benzaldehyde.
The epoxide products were separated from the aldehyde starting material
by preparative HPLC, and the cis/trans ratios were determined by 1H NMR
spectroscopy. The results are summarised below (Table 21.4).
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Table 21.4 Isomer ratios of epoxides prepared by the Darzens reaction.
Entry Starting material cis trans
1 p-Isobutylbenzaldehyde 1 2.2
2 p-Methoxybenzaldehyde 1 1.4
3 m-Methoxybenzaldehyde 1 1.8
4 o-Methoxybenzaldehyde 1 1.8
5 m-Bromobenzaldehyde 1 2.5
6 o-Bromobenzaldehyde 1 2.4
7 m-Fluorobenzaldehyde 1 3.1
8 o-Trifluoromethylbenzaldehyde 1 6.8
9 o-Methylbenzaldehyde 1 4.4
10 Benzaldehyde 1 2.5
In all cases except the trifluoromethyl-substituted epoxide, the trans isomer
is the major component. This is in line with the literature observation that steric
interactions are minimised between the substituent groups on the epoxide when
they are trans to each other.22 However, the stereochemistry and mechanism
of this reaction are not straightforward or well-understood. There are several
series of compounds in which to consider trends (Table 21.5). The methoxy-
substituted compounds show an increasing preference for the trans isomer as the
methoxy group is moved closer around the ring to the epoxide. There is little
difference for the bromo-substituted meta and ortho compounds. For the four
ortho-substituted compounds, the picture is complicated: for example, the ratios
do not tally with A-values for these substituents, used here as a measure of steric
bulk.70
Table 21.5 Isomer ratios of epoxides compared to A-values.
Starting material cis trans A-value
p-Methoxybenzaldehyde 1 1.4 0.6
m-Methoxybenzaldehyde 1 1.8
o-Methoxybenzaldehyde 1 1.8
m-Bromobenzaldehyde 1 2.5 0.38
o-Bromobenzaldehyde 1 2.4
m-Fluorobenzaldehyde 1 3.1 0.15
o-Trifluoromethylbenzaldehyde 1 6.8 2.1
o-Methylbenzaldehyde 1 4.4 1.7
The picture is a little clearer for the meta-substituted epoxides: as the steric
bulk increases, the preference for the trans- over the cis-epoxide weakens; this
is the reverse of what may be predicted on the basis of A-values alone. This
reinforces the notion that the stereochemistry of the Darzens reaction is not
simple or easy to predict.
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21.7 Isobutylbenzaldehyde in the synthesis of
ibuprofen
Ibuprofen and derivatives can be reached from isobutylbenzaldehyde according to
the following synthetic route,71 although acetophenone is a more common starting
material (Scheme 21.27).
H
O O O
OMe
H
O
OH
O
OH
O
OH
O
Ibuprofen, 19-7
Isobutylbenzaldehyde, 21-5 21-6 21-7
21-821-9
Scheme 21.27 Synthetic route from isobutylbenzaldehyde to ibuprofen.
This project has synthesised the first intermediate by the Darzens reaction
in flow, enabling access to ibuprofen. The continuous flow process will require
further optimisation.
274
Chapter 22
Conclusions
The three aims outlined at the beginning of this project will be examined here.
As expected from the literature review, the batch Darzens reaction is trou-
blesome. Early attempts to achieve the Darzens reaction in batch started from
isobutylacetophenone and β-ionone, and met with very limited success. Changing
to benzaldehyde with a tert-butoxide base gave the first epoxide product, albeit
in low yield.
This benzaldehyde batch reaction was translated into flow, and led to the dis-
covery that mixing and concentration were the two most important factors. The
use of wide-bore tubing and a T-piece gave some mixing, but there is room for
improvement. The flow rates, temperature and pressure of the reaction were less
important with this substrate. Changing to isobutylbenzaldehyde, the concentra-
tion and flow rate had two conflicting effects. The mixing is still crucial. Although
it gives medium to low yields, the main advantages of this flow procedure over
the batch process is that the residence time is many times lower (minutes rather
than hours). A wider range of aromatic benzaldehydes was screened through this
flow process, with the conversion highly dependent on the substrate. The viscos-
ity of the benzaldehyde seems to be important in determining the quality of the
mixing.
There is literature precedent for converting isobutylbenzaldehyde to ibuprofen.
The one-carbon homologated aldehyde of isobutylbenzaldehyde can be formed
from the Darzens glycidic ester intermediate. This epoxide intermediate was
reached via the flow process described herein. Conversions were typically low,
but the rapid reaction time means that viable quantities of material could be
reached in a similar amount of time to the batch process.
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Chapter 23
Future Work
The continuous flow Darzens reaction has had some success, but would benefit
from further optimisation, particularly in improving the mixing of streams.
Other substrates, such as heteroaromatic aldehydes, or other carbonyl com-
pounds could be rapidly screened using this set-up. Purification by preparative
HPLC is sufficient on a fairly small scale, but will not be sustainable on larger
quantities of material. Refining the chromatographic purification would be ad-
visable if the process were scaled up.
The ibuprofen synthesis could be completed from the epoxide intermediate to
comprehensively demonstrate the value of this process. This is a good example
of how flow chemistry can be used to synthesise valuable organic compounds.
Whilst not a resounding success, this project demonstrates the first example
of the Darzens reaction in flow. It has great potential which has yet to be fully
explored.
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Chapter 24
Experimental
24.1 General procedure A
The aromatic aldehyde (1 equiv.) and methyl chloroacetate (1 equiv.) are
pre-mixed in a vial. A stock solution of KOtBu in t-BuOH (10% by mass) is
prepared. The aldehyde/ methyl chloroacetate mixture is passed through the
Vapourtec peristaltic pump (1.0 mL min−1, RTP) and mixes with the base (1.0
mL min−1, RTP) in a wide-bore T-piece. The viscous, white slurry formed by
their exothermic mixing passes through wide-bore tubing and is collected. The
work-up consists of an aqueous/Et2O extraction, followed by removal of the
solvent in vacuo to give the crude product.
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24.2 Methyl 3-phenylglycidate, Compound
21-4
O
OMe
O O
OMe
O
Chemical Formula: C10H10O3
Exact Mass: 178.06
Chemical Formula: C10H10O3
Exact Mass: 178.06
8
7
6
5
4
3
2
1
Procedure:
Benzaldehyde (1.45 mL, 14.1 mmol) and methyl chloroacetate (1.25 mL, 13.9
mmol) were charged to a 100 mL RBF fitted with a stirrer, septum and nitrogen
balloon. KOtBu (1.63 g, 14.1 mmol) was dissolved in t-BuOH (15.0 mL), and
the solution was charged dropwise over 15 mins to the benzaldehyde mixture.
Immediate formation of a white precipitate was observed, and the solution became
a viscous slurry. The slurry was swirled at RT for 2 h. The t-BuOH was removed
in vacuo, and the residue was extracted with Et2O/H2O. The organic layer was
washed with NaCl(aq), H2O, dried over Na2SO4 and concentrated in vacuo to
give the crude product as a pale yellow oil in 30% crude yield. The oil was purified
by flash column chromatography (Hex:EtOAc 80:20 to Hex:EtOAc 98:2) to give
the product as a mixture of diastereomers, in the ratio 1:2.5 (cis :trans).
Isolated yield: 0.386 g (2.168 mmol, 16%)
Major diastereomer (trans)
1H NMR (700 MHz, CDCl3): δ/ppm 3.52 (1 H, d, J = 1.7 Hz, H3), 3.83 (3 H, s,
H1), 4.10 (1 H, d, J = 1.7 Hz, H4), 7.28-7.41 (5 H, m, H6-8);
13C NMR (126 MHz, CDCl3): δ/ppm 52.6 (C3), 56.6 (C1), 58.0 (C4), 125.8
(C6), 128.7 (C7/8), 129.0 (C7/8), 134.9 (C5), 168.7 (C2).
Minor diastereomer (cis)
1H NMR (700 MHz, CDCl3): δ/ppm 3.55 (3 H, s, H1), 3.84 (1 H, d, J = 4.6 Hz,
H3), 4.26 (1 H, d, J = 4.6 Hz, H4), 7.28-7.41 (5 H, m, H6-8);
13C NMR (126 MHz, CDCl3): δ/ppm 52.0 (C1), 55.8 (C3), 57.5 (C4), 126.6
(C6), 128.1 (C7/8), 128.5 (C7/8), 132.8 (C5), 168.7 (C2).
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Both diastereomers together
IR (neat) ν = 1749.6 (C=O, s), 1439.5 (m), 1291.6 (m), 1206.3 (C-O, s), 1183.2
(m), 758.3 (m), 695.6 (s), 599.1 (m), 516.4 (m) cm−1.
LC-MS: Rt = 2.78 min, m/z 357.6 [2M+H]
+; HR-MS calculated for C20H21O6
at 357.1338, found 357.1336 (∆ = -0.6 ppm).
Reference72
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24.3 3-[4-(2-Methylpropyl)phenyl]oxirane-2-
carboxylate, Compound
21-6
OMe
OO
Chemical Formula: C14H18O3
Exact Mass: 234.13
8
7
6
5
4
3
2
1
9
10
11
Procedure:
General procedure A. The ratio of trans to cis isomers was 2.2:1.
cis-Methyl 3-(4-isobutylphenyl)oxirane-2-carboxylate
O
OMe
O
Chemical Formula: C14H18O3
Exact Mass: 234.13
racemic
1
23
45
6
7
8
9
10
11
12
13
13
1H NMR (700 MHz, CDCl3): δ/ppm 0.87 (6 H, d, J = 6.4 Hz, H13), 1.78-1.89
(1 H, m, H12), 2.45 (2 H, d, J = 7.1 Hz, H11), 3.64 (3 H, s, H1), 4.45 (1 H, d, J
= 6.5 Hz, H3), 5.10 (1 H, d, J = 6.4 Hz, H4), 7.13 (2 H, d, J = 7.8 Hz, H7+9),
7.26 (2 H, d, J = 7.8 Hz, H6+10);
13C NMR (176 MHz, CDCl3): δ/ppm 22.3 (C13), 30.1 (C12), 45.1 (C11), 52.9
(C1), 62.9 (C3), 74.5 (C4), 126.3 (C6+10), 129.3 (C7+9), 135.3 (C8), 142.4
(C5), 168.4 (C2).
LC-MS: Rt = 4.04 min, m/z 469.3 [2M+H]
+; HR-MS calculated for C28H37O6
at 469.2590, found 469.2597 (∆ = +1.5 ppm).
trans-Methyl 3-(4-isobutylphenyl)oxirane-2-carboxylate
O
OMe
O
Chemical Formula: C14H18O3
Exact Mass: 234.13
racemic
1
23
45
6
7
8
9
10
11
12
13
13
1H NMR (700 MHz, CDCl3): δ/ppm 0.88 (6 H, d, J = 6.6 Hz, H13), 1.84 (1 H,
dt, J = 13.3, 6.7 Hz, H12), 2.46 (2 H, d, J = 7.2 Hz, H12), 3.52 (1 H, s, H3),
3.81 (3 H, s, H1), 4.06 (1 H, s, H4), 7.13 (2 H, d, J = 7.8 Hz, H7+9), 7.26 (2 H,
d, J = 8.0 Hz, H6+10);
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13C NMR (176 MHz, CDCl3): δ/ppm 22.3 (C13), 30.2 (C12), 45.1 (C11), 52.5
(C1), 56.6 (C3), 58.0 (C4), 125.6 (C6+10), 129.4 (C7+9), 132.1 (C8), 142.8
(C5), 168.7 (C2).
Literature data not available.
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24.4 Methyl 3-(4-methoxyphenyl)oxirane-2-
carboxylate
MeO
OMe
OO
Chemical Formula: C11H12O4
Exact Mass: 208.07
8
7
6
5
4
3
2
19
Procedure:
General procedure A. The ratio of trans to cis isomers was 1.4:1.
cis-Methyl 3-(4-methoxyphenyl)oxirane-2-carboxylate
O
OMe
O
Chemical Formula: C11H12O4
Exact Mass: 208.07
racemic
1
23
4
5
6
7
8
9
10
11
MeO
1H NMR (400 MHz, CDCl3): δ/ppm 3.70 (3 H, s, H1/11), 3.83 (3 H, s, H1/11),
4.45 (1 H, d, J = 6.7 Hz, H3), 5.11 (1 H, d, J = 6.7 Hz, H4), 6.91 (2 H, d, J =
8.8 Hz, H6/7/9/10), 7.38 (2 H, d, J = 8.5 Hz, H6/7/9/10);
13C NMR (101 MHz, CDCl3): δ/ppm 53.5 (C1), 61.4 (C11), 68.7 (C3), 76.4
(C4), 125.8 (C5), 128.6 (C6/7/9/10), 129.7 (C6/7/9/10), 131.9 (C6/7/9/10),
136.9 (C8), 169.0 (C2).
LC-MS: Rt = 2.89 min, m/z 250.1 [M+MeCN+H]
+.
trans-Methyl 3-(4-methoxyphenyl)oxirane-2-carboxylate
O
OMe
O
Chemical Formula: C11H12O4
Exact Mass: 208.07
racemic
1
23
4
5
6
7
8
9
10
11
MeO
1H NMR (400 MHz, CDCl3): δ/ppm 3.54 (1 H, d, J = 1.8 Hz, H3), 3.84 (3 H, s,
H1/11), 3.85 (3 H, s, H1/11), 4.07 (1 H, d, J = 1.8 Hz, H4), 6.92 (2 H, d, J =
8.8 Hz, H6/7/9/10), 7.24 (2 H, d, J = 8.7 Hz, H6/7/9/10);
13C NMR (101 MHz, CDCl3): δ/ppm 52.6 (C1), 55.4 (C11), 56.6 (C3), 58.0
(C4), 114.2 (C6/7/9/10), 126.7 (C5), 127.2 (C6/7/9/10), 160.3 (C8), 168.8
(C2).
LC-MS: Rt = 2.83 min, m/z 250.1 [M+H]
+.
Reference73
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24.5 Methyl 3-(3-methoxyphenyl)oxirane-2-
carboxylate
OMe
OO
Chemical Formula: C11H12O4
Exact Mass: 208.07
OMe
8
7
6
5
4
3
2
1
9 10
11
Procedure:
General procedure A. The ratio of trans to cis isomers was 1.8:1.
cis-Methyl 3-(3-methoxyphenyl)oxirane-2-carboxylate
O
OMe
O
Chemical Formula: C11H12O4
Exact Mass: 208.07
racemic
1
23
4
5
6
7
8
9
10
OMe
11
1H NMR (700 MHz, CDCl3): δ/ppm 3.70 (3 H, s, H1), 3.80 (3 H, s, H11), 4.46
(1 H, d, J = 6.1 Hz, H3), 5.13 (1 H, d, J = 6.1 Hz, H4), 6.86 (1 H, dd, J = 8.2,
2.5 Hz, H6/8/10), 6.90-6.96 (2 H, m, H6/8/10), 7.27 (1 H, t, J = 7.9 Hz, H9);
13C NMR (176 MHz, CDCl3): δ/ppm 53.0 (C1), 55.3 (C11), 62.7 (C3), 74.2
(C4), 112.0 (C6/8/10), 114.3 (C6/8/10), 118.7 (C6/8/10), 129.6 (C9), 139.7
(C5), 159.7 (C7), 168.4 (C2).
LC-MS: Rt = 2.70 min, m/z 250.1 [M+MeCN+H]
+; HR-MS calculated for
C13H16NO4 at 250.1079, found 250.1088 (∆ = +3.6 ppm).
trans-Methyl 3-(3-methoxyphenyl)oxirane-2-carboxylate
O
OMe
O
Chemical Formula: C11H12O4
Exact Mass: 208.07
racemic
1
23
4
5
6
7
8
9
10
OMe
11
1H NMR (700 MHz, CDCl3): δ/ppm 3.49 (1 H, d, J = 1.7 Hz, H3), 3.79 (3 H, s,
H11), 3.82 (3 H, s, H1), 4.07 (1 H, d, J = 1.6 Hz, H4), 6.79 (1 H, s, H6), 6.88 (2
H, t, J = 8.3 Hz, H8+10), 7.27 (1 H, d, J = 7.9 Hz, H9);
13C NMR (176 MHz, CDCl3): δ/ppm 52.6 (C1), 55.3 (C11), 56.4 (C3), 57.9
(C4), 110.8 (C6), 114.7 (C8/10), 118.2 (C8/10), 129.7 (C9), 136.5 (C5), 159.9
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(C7), 168.6 (C2).
LC-MS: Rt = 2.90 min, m/z 250.1 [M+MeCN+H]
+.
Literature data not available.
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24.6 Methyl 3-(2-methoxyphenyl)oxirane-2-
carboxylate
OMe
OO
Chemical Formula: C11H12O4
Exact Mass: 208.07
OMe
8
7
6 5
4
3
2
1
9
10
11
Procedure:
General procedure A. The two diastereomers were not separated from the starting
material. The ratio of trans to cis isomers was 1.8:1.
Major diastereomer (trans)
1H NMR (400 MHz, CDCl3): δ/ppm 3.42 (1 H, d, J = 1.8 Hz, H3), 3.81 (3 H, s,
H11), 3.83 (3 H, s, H1), 4.43 (1 H, d, J = 1.7 Hz, H4), 6.86-6.94 (1 H, m,
H7/8/9/10), 7.27-7.31 (3 H, m, H7/8/9/10).
Minor diastereomer (cis)
1H NMR (400 MHz, CDCl3): δ/ppm 3.73 (3 H, s, H1), 3.84 (3 H, s, H11), 4.83
(1 H, d, J = 4.4 Hz, H3), 5.47 (1 H, d, J = 4.4 Hz, H4), 6.86-6.94 (1 H, m,
H7/8/9/10), 7.13 (1 H, dd, J = 7.6, 1.7 Hz, H7/8/9/10), 7.27-7.31 (1 H, m,
H7/8/9/10).
Reference74
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24.7 Methyl
3-(3-bromophenyl)oxirane-2-carboxylate
OMe
OO
Chemical Formula: C10H9BrO3
Exact Mass: 255.97
Br
8
7
6
5
4
3
2
1
9 10
Procedure:
General procedure A. The ratio of trans to cis isomers was 2.5:1.
cis-Methyl 3-(3-bromophenyl)oxirane-2-carboxylate
O
OMe
O
Chemical Formula: C10H9BrO3
Exact Mass: 255.97
racemic
1
23
4
5
6
7
8
9
10
Br
1H NMR (700 MHz, CDCl3): δ/ppm 3.73 (3 H, s, H1), 4.43 (1 H, d, J = 5.7 Hz,
H3), 5.14 (1 H, d, J = 5.7 Hz, H4), 7.23 (1 H, t, J = 7.9 Hz, H9), 7.30 (1 H, d,
J = 7.2 Hz, H8/10), 7.46 (1 H, d, J = 8.7 Hz, H8/10), 7.55 (1 H, s, H6);
13C NMR (176 MHz, CDCl3): δ/ppm 53.2 (C1), 62.3 (C3), 73.5 (C4), 122.7
(C7), 125.1 (C8/10), 129.6 (C6), 130.0 (C9), 131.8 (C8/10), 140.4 (C5), 168.1
(C2).
trans-Methyl 3-(3-bromophenyl)oxirane-2-carboxylate
O
OMe
O
Chemical Formula: C10H9BrO3
Exact Mass: 255.97
racemic
1
23
4
5
6
7
8
9
10
Br
1H NMR (700 MHz, CDCl3): δ/ppm 3.47 (1 H, d, J = 1.7 Hz, H3), 3.82 (3 H, s,
H1), 4.06 (1 H, d, J = 1.6 Hz, H4), 7.17-7.26 (2 H, m, H8/9/10), 7.42 (1 H, s,
H6), 7.45-7.49 (1 H, m, H8/9/10);
13C NMR (176 MHz, CDCl3): δ/ppm 52.7 (C1), 56.6 (C3), 57.0 (C4), 122.8
(C7), 124.5 (C8/9/10), 128.7 (C6), 130.2 (C8/9/10), 132.1 (C8/9/10), 137.2
(C5), 168.2 (C2).
Literature data not available.
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24.8 Methyl
3-(2-bromophenyl)oxirane-2-carboxylate
OMe
OO
Chemical Formula: C10H9BrO3
Exact Mass: 255.97
Br
8
7
6 5
4
3
2
1
9
10
Procedure:
General procedure A. The ratio of trans to cis isomers was 2.4:1.
cis-Methyl 3-(2-bromophenyl)oxirane-2-carboxylate
O
OMe
O
Chemical Formula: C10H9BrO3
Exact Mass: 255.97
racemic
Br
1
23
4
5
6
7
8
9
10
1H NMR (700 MHz, CDCl3): δ/ppm 3.85 (3 H, s, H1), 4.79 (1 H, d, J = 2.8 Hz,
H3), 5.65 (1 H, d, J = 2.6 Hz, H4), 7.20 (1 H, t, J = 7.7 Hz, H8), 7.38 (1 H, t,
J = 8.0 Hz, H7), 7.53 (1 H, d, J = 8.0 Hz, H9), 7.63 (1 H, d, J = 6.4 Hz, H6);
13C NMR (176 MHz, CDCl3): δ/ppm 53.4 (C1), 60.1 (C3), 72.1 (C4), 121.3
(C10), 127.4 (C7), 129.5 (C6), 129.9 (C8), 132.6 (C9), 137.3 (C5), 169.1 (C2).
trans-Methyl 3-(2-bromophenyl)oxirane-2-carboxylate
O
OMe
O
Chemical Formula: C10H9BrO3
Exact Mass: 255.97
racemic
Br
1
23
4
5
6
7
8
9
10
1H NMR (700 MHz, CDCl3): δ/ppm 3.36 (1 H, d, J = 1.8 Hz, H3), 3.85 (3 H, s,
H1), 4.37 (1 H, d, J = 1.6 Hz, H4), 7.19-7.24 (2 H, m, H6+8), 7.31 (1 H, t, J =
7.5 Hz, H7), 7.55 (1 H, dd, J = 8.0, 0.9 Hz, H9);
13C NMR (176 MHz, CDCl3): δ/ppm 52.7 (C1), 55.9 (C3), 57.7 (C4), 122.7
(C10), 126.3 (C6), 127.7 (C7), 130.0 (C8), 132.5 (C9), 134.7 (C5), 168.3 (C2).
LC-MS: Rt = 3.30 min, m/z 298 [M+MeCN+H]
+; HR-MS calculated for
C12H13NO3Br at 298.0079, found 298.0081 (∆ = +0.7 ppm).
Reference75
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24.9 Methyl
3-(3-fluorophenyl)oxirane-2-carboxylate
OMe
OO
Chemical Formula: C10H9FO3
Exact Mass: 196.05
F
8
7
6
5
4
3
2
1
9 10
Procedure:
General procedure A. The ratio of trans to cis isomers was 3.1:1.
trans-Methyl 3-(3-fluorophenyl)oxirane-2-carboxylate
O
OMe
O
Chemical Formula: C10H9FO3
Exact Mass: 196.05
racemic
1
23
45
6
7
8
9
10
F
1H NMR (400 MHz, CDCl3): δ/ppm 3.50 (1 H, d, J = 1.7 Hz, H3), 3.85 (3 H, s,
H1), 4.12 (1 H, d, J = 1.7 Hz, H4), 6.96-7.38 (4 H, m, H6,8-10);
19F NMR (376 MHz, CDCl3): δ/ppm -112.2 (F9) ppm.
LC-MS: Rt = 2.34 min, m/z 197.2 [MH]
+.
Reference76
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24.10 Methyl
3-[2-(trifluoromethyl)phenyl]oxirane-2-
carboxylate
OMe
OO
Chemical Formula: C11H9F3O3
Exact Mass: 246.05
CF3
8
7
6 5
4
3
2
1
9
10
11
Procedure:
General procedure A. The ratio of trans to cis isomers was 1:6.75.
trans-Methyl
3-[2-(trifluoromethyl)phenyl]oxirane-2-carboxylate
O
OMe
O
Chemical Formula: C11H9F3O3
Exact Mass: 246.05
racemic
CF3
1
23
4
5
6
7
8
9
10
11
1H NMR (400 MHz, CDCl3): δ/ppm 3.85 (3 H, s, H1), 4.59 (1 H, d, J = 3.1 Hz,
H3), 5.73 (1 H, d, J = 3.0 Hz, H4), 7.49 (1 H, t, J = 7.7 Hz, H6/7/8/9),
7.60-7.75 (2 H, m, H6/7/8/9), 7.93 (1 H, d, J = 8.0 Hz, H6/7/8/9);
19F NMR (376 MHz, CDCl3): δ/ppm -100.0 (F11).
Literature data not available.
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24.11 Methyl
3-(2-methylphenyl)oxirane-2-carboxylate
OMe
OO
Chemical Formula: C11H12O3
Exact Mass: 192.08
8
7
6 5
4
3
2
1
9
10
11
Procedure:
General procedure A. The two diastereomers were not separated from the starting
material. The ratio of trans to cis isomers was 4.4:1.
Major diastereomer (trans)
1H NMR (400 MHz, CDCl3): δ/ppm 2.40 (3 H, s, H11), 3.43 (1 H, d, J = 1.9
Hz, H3), 4.24 (1 H, d, J = 1.8 Hz, H4), 7.10-7.29 (4 H, m, H6-9).
Minor diastereomer (cis)
1H NMR (400 MHz, CDCl3): δ/ppm 2.39 (3 H, s, H11), 3.67 (3 H, s, H1), 4.58
(1 H, d, J = 6.1 Hz, H3), 5.42 (1 H, d, J = 6.1 Hz, H4), 7.10-7.29 (4 H, m,
H6-9).
Reference68
290
References
[1] Aziridines and Epoxides in Organic Synthesis, ed. A. K. Yudin, Wiley-VCH,
Weinheim, 2006.
[2] E. Erlenmeyer, Annalen der Chemie, 1892, 271, 137–180.
[3] G. Darzens, Comptes Rendus de l’Acade´mie des Sciences C, 1904, 139, 1214–
1217.
[4] G. Darzens, Comptes Rendus de l’Acade´mie des Sciences C, 1905, 141, 766–
768.
[5] G. Darzens, Comptes Rendus de l’Acade´mie des Sciences C, 1906, 142, 214–
215.
[6] G. Darzens, Comptes Rendus de l’Acade´mie des Sciences C, 1906, 142, 714–
715.
[7] G. Darzens, Comptes Rendus de l’Acade´mie des Sciences C, 1907, 144, 1123–
1124.
[8] G. Darzens, Comptes Rendus de l’Acade´mie des Sciences C, 1907, 145, 1342–
1343.
[9] G. Darzens, Comptes Rendus de l’Acade´mie des Sciences C, 1910, 150, 1243–
1245.
[10] G. Darzens, Comptes Rendus de l’Acade´mie des Sciences C, 1910, 151, 758–
759.
[11] G. Darzens and H. Rost, Comptes Rendus de l’Acade´mie des Sciences C,
1911, 152, 443–436.
[12] G. Darzens and J. Sejourne´, Comptes Rendus de l’Acade´mie des Sciences C,
1911, 152, 1105–1107.
[13] G. E. Risinger, Ph.D. thesis, Iowa State University, 1961.
291
[14] T. Rosen, in Comprehensive Organic Synthesis, ed. B. Trost and I. Fleming,
Pergamon, Oxford, 1st edn., 1991, vol. 2, pp. 409–439.
[15] V. A. Mamedov, V. G. Malaev, F. G. Sibgatullina, I. A. Nuretdinov and
Y. P. Kitaev, Bulletin of the Academy of Sciences of the USSR Division of
Chemical Science, 1992, 41, 438–441.
[16] V. A. Mamedov, V. L. Polushina, F. F. Mertsalova and I. A. Nuretdinov,
Bulletin of the Academy of Sciences of the USSR Division of Chemical Sci-
ence, 1992, 41, 170–171.
[17] V. A. Mamedov, I. A. Litvinov, O. N. Kataeva, I. K. Rizvanov and I. A.
Nuretdinov, Monatshefte fuer Chemie, 1994, 125, 1427–1435.
[18] V. A. Mamedov, E. A. Berdnikov, I. A. Litvinov and L. G. Kuz’mina, Rus-
sian Chemical Bulletin, 1995, 44, 1247–1251.
[19] P. Bako, Z. Rapi and G. Keglevich, Current Organic Synthesis, 2014, 11,
361–376.
[20] W. J. Choi and C. Y. Choi, Biotechnology and Bioprocess Engineering, 2005,
10, 167–179.
[21] L. Guo-Qiang, X. Hai-Jian, W. Bi-Chi, G. Guong-Zhong and Z. Wei-Shan,
Tetrahedron Letters, 1985, 26, 1233–1236.
[22] F. W. Bachelor and R. K. Bansal, Journal of Organic Chemistry, 1968, 34,
3600–3604.
[23] C. A. Maryanoff, K. L. Sorgi and A. M. Zientek, Journal of Organic Chem-
istry, 1994, 59, 237–239.
[24] R. F. Pratt and T. C. Bruice, Journal of the American Chemical Society,
1970, 92, 5956–5964.
[25] J. Hine, Journal of the American Chemical Society, 1950, 72, 2438–2445.
[26] W. V. E. Doering and A. Kentaro Hoffman, Journal of the American Chem-
ical Society, 1954, 76, 6162–6165.
[27] H. E. Zimmerman and L. Ahramjian, Journal of the American Chemical
Society, 1960, 82, 5459–5466.
[28] D. J. Dagli, P.-S. Yu and J. Wemple, Journal of Organic Chemistry, 1975,
40, 3173–3178.
292
[29] M. Ballester and D. Perez-Blanco, Journal of Organic Chemistry, 1958, 23,
652.
[30] S. Adams, Journal of Clinical Pharmacology, 1992, 32, 317–323.
[31] J. S. Nicholson and S. Sanders Adams, Phenyl Propionic Acids, Boots Pure
Drug Company Technical Report US3385886, 1968.
[32] D. D. Lindley, T. A. Curtis, T. R. Ryan, E. M. de la Garza, C. B. Hilton
and T. M. Kenesson, Process for the produdction of 4’-isobutylacetophenone,
Hoechst Celanese Corporation Technical Report US5068448, 1990.
[33] E. Mayo-Wilson, A. Imdad, K. Herzer, M. Y. Yakoob and Z. A. Bhutta,
BMJ, 2011, 343, d5094.
[34] O. Isler, W. Huber, A. Roneo and M. Kofler, Helvetica Chimica Acta, 1947,
30, 1911–1927.
[35] N. A. Milas, S. Warren Lee, E. Sakal, H. C. Wohlers, N. S. Macdonald, F. X.
Grossi and H. F. Wright, Journal of the American Chemical Society, 1948,
70, 1584–1591.
[36] O. Isler, Pure and Applied Chemistry, 1979, 51, 447–462.
[37] P. B. S. Dawadi and J. Lugtenburg, Molecules, 2010, 15, 1825–1872.
[38] G. L. Parker, L. K. Smith and I. R. Baxendale, Tetrahedron, 2016, 72, 1645–
1652.
[39] D. J. Aldous, A. J. Dalencon and P. G. Steel, Organic Letters, 2002, 4,
1159–1162.
[40] L. A. Nguyen, H. He and C. Pham-Huy, International Journal of Biomedical
Science, 2006, 2, 85–100.
[41] R. Sato, K. Sakamoto, J. Yamazaki and T. Nagao, European Journal of
Pharmacology, 2002, 434, 125–131.
[42] S. Ikeda, J.-I. Oka and T. Nagao, European Journal of Pharmacology, 1991,
208, 199–205.
[43] A. Schwartz, P. B. Madan, E. Mohacsi, J. P. O’Brien, L. J. Todaro and D. L.
Coffen, Journal of Organic Chemistry, 1992, 57, 851–856.
[44] J. D. Knight, S. J. Sauer and D. M. Coltart, Organic Letters, 2011, 13,
3118–3121.
293
[45] V. K. Aggarwal, G. Hynd, W. Picoul and J. L. Vasse, Journal of the Amer-
ican Chemical Society, 2002, 124, 9964–9965.
[46] R. Annunziata, S. Banfi and S. Colonna, Tetrahedron Letters, 1985, 26,
2471–2474.
[47] S.-I. Watanabe, R. Hasebe, J. Ouchi, H. Nagasawa and T. Kataoka, Tetra-
hedron Letters, 2010, 51, 5778–5780.
[48] W.-J. Liu, B.-D. Lv and L.-Z. Gong, Angewandte Chemie, 2009, 48, 6625–
6628.
[49] L. He, W.-J. Liu, L. Ren, T. Lei and L.-Z. Gong, Advanced Synthesis and
Catalysis., 2010, 352, 1123–1127.
[50] A. Jonczyk, A. Kwast and M. Makosza, Journal of the Chemical Society,
Chemical Communications, 1977, 902–903.
[51] M. Fedorynski, K. Wojciechowski, Z. Matacz and M. Makosza, Journal of
Organic Chemistry, 1978, 43, 4682–4684.
[52] C. Kimura, K. Kashiwaya, K. Murai and H. Katada, Industrial and Engi-
neering Chemistry Product Research and Development, 1983, 22, 118–120.
[53] E. V. Dehmlow and J. Kinnius, Journal fuer Praktische Chemie, 1995, 337,
153–155.
[54] S. Arai, T. Ishida and T. Shioiri, Tetrahedron Letters, 1998, 39, 8299–8302.
[55] S. Arai and T. Shioiri, Tetrahedron Letters, 1998, 39, 2145–2148.
[56] S. Arai, Y. Shirai, T. Ishida and T. Shioiri, Tetrahedron, 1999, 55, 6375–
6386.
[57] S. Arai, Y. Shirai, T. Ishida and T. Shioiri, Chemical Communications, 1999,
49–50.
[58] S. Arai and T. Shioiri, Tetrahedron, 2002, 58, 1407–1413.
[59] S. Arai, Y. Suzuki, K. Tokumaru and T. Shioiri, Tetrahedron Letters, 2002,
43, 833–836.
[60] S. Arai, K. Tokumaru and T. Aoyama, Tetrahedron Letters, 2004, 45, 1845–
1848.
[61] H. Hamamoto, V. A. Mamedov, M. Kitamoto, N. Hayashi and S. Tsuboi,
Tetrahedron: Asymmetry, 2000, 11, 4485–4497.
294
[62] M. E. Krafft, S. J. R. Twiddle and J. W. Cran, Tetrahedron Letters, 2011,
52, 1277–1280.
[63] Y.-N. Xuan, H.-S. Lin and M. Yan, Organic and Biomolecular Chemistry,
2013, 11, 1815–1817.
[64] B. M. Adger, J. V. Barkley, S. Bergeron, M. W. Cappi, B. E. Flowerdew,
M. P. Jackson, R. McCague, T. C. Nugent and S. M. Roberts, Journal of
the Chemical Society, Perkin Transactions 1, 1997, 3501–3507.
[65] K. Kogure, H. Koyama and K. Nakagawa, US3959349A, 1976.
[66] J. Stangl and C. Stritt, WO2007031286A1, 2007.
[67] J. D. Surmatis, J. Maricq and A. Ofner, Journal of Organic Chemistry, 1958,
23, 157–162.
[68] C. Wei, J. Ling, H. Shen and Q. Zhu, Molecules, 2014, 19, 8067–8079.
[69] D. Wilcke and T. Bach, Organic and Biomolecular Chemistry, 2012, 10,
6498–6503.
[70] J. A. Hirsch, in Table of Conformational Energies, John Wiley Sons, Inc.,
1967, pp. 199–222.
[71] M. A. Windsor, D. J. Hermanson, P. J. Kingsley, S. Xu, B. C. Crews, W. Ho,
C. M. Keenan, S. Banerjee, K. A. Sharkey and L. J. Marnett, ACS Medicinal
Chemical Letters, 2012, 3, 759–763.
[72] F. W. Bachelor and R. K. Bansal, Journal of Organic Chemistry, 1968, 34,
3600–3604.
[73] D. Wilcke and T. Bach, Organic and Biomolecular Chemistry, 2012, 10,
6498–6503.
[74] R. P. Polniaszek and S. E. Belmont, Synthetic Communications, 1989, 19,
221–232.
[75] P. L. Minin and J. C. Walton, Organic and Biomolecular Chemistry, 2004,
2, 2471–2475.
[76] J. Li, J. Li, Y. Xu, Y. Wang, L. Zhang, L. Ding, Y. Xuan, T. Pang and
H. Lin, Natural Product Research, 2016, 30, 800–805.
295
Appendices
296
Appendix A
Raw data from the HeRo reactor
297
R
u
n
B
at
ch
C
o
n
ce
n
tr
at
io
n
Te
m
p
er
at
u
re
D
ia
m
e
te
r 
o
f 
w
o
rk
 t
u
b
e
R
o
ta
ti
o
n
 s
p
ee
d
D
ro
p
s 
p
er
 s
ec
o
n
d
P
ro
d
u
ct
io
n
 r
at
e
 O
R
 t
im
e
 s
am
p
le
 t
ak
en
 a
t
%
 c
o
n
ve
rs
io
n
A
d
d
it
io
n
 r
at
e
/ 
m
L/
m
in
1
A
3
.7
3
3
0
4
4
7
6
2
A
3
.7
3
6
0
4
4
7
6
3
A
3
.7
3
9
0
4
4
7
1
2
4
A
3
.7
3
1
0
5
4
4
7
1
7
5
A
3
.7
3
1
0
8
4
4
7
7
6
A
3
.7
3
1
2
3
4
4
7
1
1
7
A
3
.7
3
1
3
0
4
4
7
4
8
A
3
.7
3
1
3
3
4
4
7
1
7
9
A
3
.7
3
1
3
7
4
4
7
5
7
1
0
A
3
.7
3
1
4
0
4
4
7
1
9
1
1
A
3
.7
3
1
4
3
4
4
7
7
1
2
A
3
.7
3
1
4
7
4
4
7
1
3
A
3
.7
3
1
2
5
4
4
1
4
2
6
1
4
A
3
.7
3
1
2
3
4
4
1
4
5
1
1
5
A
3
.7
3
1
2
5
4
4
1
4
5
3
1
6
A
3
.7
3
1
2
5
4
4
7
3
1
1
7
A
3
.7
3
1
2
5
4
4
7
7
.5
1
4
1
8
A
3
.7
3
1
2
5
4
4
1
4
7
.5
1
7
1
9
A
3
.7
3
1
2
5
4
4
1
4
4
.3
2
8
2
0
A
3
.7
3
1
2
5
4
4
2
1
4
.3
6
2
1
A
3
.7
3
1
1
5
4
4
1
4
6
4
2
2
A
3
.7
3
1
1
5
4
4
1
4
1
0
1
1
2
3
A
3
.7
3
1
2
0
3
6
7
1
.5
6
3
3
2
4
A
3
.7
3
1
2
0
3
6
1
4
5
9
2
5
A
3
.7
3
1
2
0
3
6
2
1
6
6
2
6
A
3
.7
3
1
2
0
3
6
2
8
6
5
2
7
A
3
.7
3
1
2
0
3
6
3
5
5
9
2
8
A
3
.7
3
1
2
0
3
6
0
5
.5
6
6
2
9
A
3
.7
3
1
2
0
3
6
7
4
1
1
3
0
A
3
.7
3
1
2
0
3
6
1
4
3
.4
5
1
9
3
1
A
3
.7
3
1
2
0
3
6
2
1
2
.9
4
3
3
3
2
A
3
.7
3
1
2
0
3
6
2
8
2
.6
3
3
7
298
R
u
n
B
at
ch
C
o
n
ce
n
tr
at
io
n
Te
m
p
er
at
u
re
D
ia
m
e
te
r 
o
f 
w
o
rk
 t
u
b
e
R
o
ta
ti
o
n
 s
p
ee
d
D
ro
p
s 
p
er
 s
ec
o
n
d
P
ro
d
u
ct
io
n
 r
at
e
 O
R
 t
im
e
 s
am
p
le
 t
ak
en
 a
t
%
 c
o
n
ve
rs
io
n
A
d
d
it
io
n
 r
at
e
/ 
m
L/
m
in
3
3
A
3
.7
3
1
2
0
3
6
3
5
1
.9
2
4
7
3
4
A
3
.7
3
1
2
0
3
6
7
1
2
9
1
.6
8
9
3
5
A
3
.7
3
1
2
0
3
6
1
4
1
4
5
1
.6
8
9
3
6
A
3
.7
3
1
2
0
3
6
2
1
1
2
8
1
.6
8
9
3
7
A
3
.7
3
1
2
0
3
6
2
8
1
1
.6
8
9
3
8
A
3
.7
3
1
2
0
3
6
3
5
1
1
.6
8
9
3
9
A
3
.7
3
1
2
0
3
6
7
1
.5
9
2
.5
3
3
5
4
0
A
3
.7
3
1
2
0
3
6
1
4
1
.5
1
1
2
.5
3
3
5
4
1
A
3
.7
3
1
2
0
3
6
2
1
1
.5
7
2
.5
3
3
5
4
2
A
3
.7
3
1
2
0
3
6
2
8
1
.5
1
4
2
.5
3
3
5
4
3
B
7
.4
6
1
2
0
3
6
0
1
.1
2
1
.8
5
7
9
4
4
B
7
.4
6
1
2
0
3
6
7
1
.1
6
1
.8
5
7
9
4
5
B
7
.4
6
1
2
0
3
6
1
4
1
.1
7
1
.8
5
7
9
4
6
B
7
.4
6
1
2
0
3
6
2
1
1
.1
1
4
1
.8
5
7
9
4
7
B
7
.4
6
1
2
0
3
6
2
8
1
.1
1
4
1
.8
5
7
9
4
8
B
7
.4
6
1
2
0
3
6
3
5
1
.1
1
2
1
.8
5
7
9
4
9
B
7
.4
6
1
2
0
3
6
7
0
.4
0
.8
4
1
1
0
.6
7
5
6
5
0
B
7
.4
6
1
2
0
3
6
1
4
0
.4
0
.7
9
1
8
0
.6
7
5
6
5
1
B
7
.4
6
1
2
0
3
6
2
1
0
.4
0
.5
8
1
5
0
.6
7
5
6
5
2
B
7
.4
6
1
2
0
3
6
2
8
0
.4
0
.5
7
1
2
0
.6
7
5
6
5
3
B
7
.4
6
1
2
0
3
6
3
5
0
.4
0
.4
8
1
4
0
.6
7
5
6
5
4
B
7
.4
6
1
2
0
3
6
7
1
.8
3
7
3
.0
4
0
2
5
5
B
7
.4
6
1
2
0
3
6
1
4
1
.8
3
.3
3
7
3
.0
4
0
2
5
6
B
7
.4
6
1
2
0
3
6
2
1
1
.8
3
9
3
.0
4
0
2
5
7
B
7
.4
6
1
2
0
3
6
2
8
1
.8
3
.3
3
7
3
.0
4
0
2
5
8
B
7
.4
6
1
2
0
3
6
3
5
1
.8
2
.6
7
9
3
.0
4
0
2
5
9
B
7
.4
6
1
2
0
3
6
7
0
.9
1
.4
6
1
1
1
.5
2
0
1
6
0
B
7
.4
6
1
2
0
3
6
1
4
0
.9
1
.2
4
1
5
1
.5
2
0
1
6
1
B
7
.4
6
1
2
0
3
6
2
1
0
.9
1
.0
9
1
5
1
.5
2
0
1
6
2
B
7
.4
6
1
2
0
3
6
2
8
0
.9
1
.0
2
2
3
1
.5
2
0
1
6
3
B
7
.4
6
1
2
0
3
6
3
5
0
.9
0
.9
1
1
7
1
.5
2
0
1
6
4
A
3
.7
3
1
2
0
3
6
3
5
1
1
.9
4
4
0
1
.6
8
9
299
R
u
n
B
at
ch
C
o
n
ce
n
tr
at
io
n
Te
m
p
er
at
u
re
D
ia
m
e
te
r 
o
f 
w
o
rk
 t
u
b
e
R
o
ta
ti
o
n
 s
p
ee
d
D
ro
p
s 
p
er
 s
ec
o
n
d
P
ro
d
u
ct
io
n
 r
at
e
 O
R
 t
im
e
 s
am
p
le
 t
ak
en
 a
t
%
 c
o
n
ve
rs
io
n
A
d
d
it
io
n
 r
at
e
/ 
m
L/
m
in
6
5
A
3
.7
3
1
2
0
3
6
4
2
1
1
.5
6
3
6
1
.6
8
9
6
6
A
3
.7
3
1
2
0
3
6
4
9
1
1
.3
5
4
1
.6
8
9
6
7
A
3
.7
3
1
2
0
3
6
5
6
1
1
.1
3
7
3
1
.6
8
9
6
8
A
3
.7
3
1
2
0
3
6
6
3
1
0
.9
7
6
3
1
.6
8
9
6
9
A
3
.7
3
1
2
0
3
6
7
0
1
0
.8
8
5
4
1
.6
8
9
7
0
C
3
.7
3
7
0
3
6
2
0
1
.4
6
2
.3
6
4
6
7
1
C
3
.7
3
7
0
3
6
4
0
1
.4
1
4
2
.3
6
4
6
7
2
C
3
.7
3
7
0
3
6
6
0
1
.4
2
3
2
.3
6
4
6
7
3
C
3
.7
3
8
0
3
6
2
0
1
.4
2
1
2
.3
6
4
6
7
4
C
3
.7
3
8
0
3
6
4
0
1
.4
2
3
2
.3
6
4
6
7
5
C
3
.7
3
8
0
3
6
6
0
1
.4
3
8
2
.3
6
4
6
7
6
C
3
.7
3
9
0
3
6
2
0
1
.4
3
2
2
.3
6
4
6
7
7
C
3
.7
3
9
0
3
6
4
0
1
.4
3
5
2
.3
6
4
6
7
8
C
3
.7
3
9
0
3
6
6
0
1
.4
4
3
2
.3
6
4
6
7
9
C
3
.7
3
1
0
0
3
6
2
0
1
.4
5
4
2
.3
6
4
6
8
0
C
3
.7
3
1
0
0
3
6
4
0
1
.4
5
8
2
.3
6
4
6
8
1
C
3
.7
3
1
0
0
3
6
6
0
1
.4
6
1
2
.3
6
4
6
8
2
C
3
.7
3
1
1
0
3
6
2
0
1
.4
6
5
2
.3
6
4
6
8
3
C
3
.7
3
1
1
0
3
6
4
0
1
.4
7
4
2
.3
6
4
6
8
4
C
3
.7
3
1
1
0
3
6
6
0
1
.4
7
8
2
.3
6
4
6
8
5
C
3
.7
3
1
2
0
3
6
2
0
1
.4
8
0
2
.3
6
4
6
8
6
C
3
.7
3
1
2
0
3
6
4
0
1
.4
8
9
2
.3
6
4
6
8
7
C
3
.7
3
1
2
0
3
6
6
0
1
.4
9
1
2
.3
6
4
6
8
8
C
3
.7
3
1
3
0
3
6
2
0
1
.4
9
0
2
.3
6
4
6
8
9
C
3
.7
3
1
3
0
3
6
4
0
1
.4
9
4
2
.3
6
4
6
9
0
C
3
.7
3
1
3
0
3
6
6
0
1
.4
8
9
2
.3
6
4
6
9
1
C
3
.7
3
1
1
0
3
6
3
0
1
.4
6
6
2
.3
6
4
6
9
2
C
3
.7
3
1
1
0
3
6
5
0
1
.4
6
8
2
.3
6
4
6
9
3
C
3
.7
3
1
1
0
3
6
7
0
1
.4
7
3
2
.3
6
4
6
9
4
C
3
.7
3
1
1
0
3
6
8
0
1
.4
7
1
2
.3
6
4
6
9
5
C
3
.7
3
1
2
0
3
6
3
0
1
.4
7
9
2
.3
6
4
6
9
6
C
3
.7
3
1
2
0
3
6
5
0
1
.4
8
4
2
.3
6
4
6
300
R
u
n
B
at
ch
C
o
n
ce
n
tr
at
io
n
Te
m
p
er
at
u
re
D
ia
m
e
te
r 
o
f 
w
o
rk
 t
u
b
e
R
o
ta
ti
o
n
 s
p
ee
d
D
ro
p
s 
p
er
 s
ec
o
n
d
P
ro
d
u
ct
io
n
 r
at
e
 O
R
 t
im
e
 s
am
p
le
 t
ak
en
 a
t
%
 c
o
n
ve
rs
io
n
A
d
d
it
io
n
 r
at
e
/ 
m
L/
m
in
9
7
C
3
.7
3
1
2
0
3
6
7
0
1
.4
8
9
2
.3
6
4
6
9
8
C
3
.7
3
1
2
0
3
6
8
0
1
.4
8
8
2
.3
6
4
6
1
0
0
D
3
.7
3
1
2
0
3
6
8
5
0
.7
8
6
1
.1
8
2
3
1
0
1
D
3
.7
3
1
2
0
3
6
9
0
0
.7
9
2
1
.1
8
2
3
1
0
2
D
3
.7
3
1
2
0
3
6
9
5
0
.7
9
2
1
.1
8
2
3
1
0
3
D
3
.7
3
1
2
0
3
6
1
0
0
0
.7
9
0
1
.1
8
2
3
1
0
4
D
3
.7
3
1
2
0
3
6
1
0
5
0
.7
9
4
1
.1
8
2
3
1
0
5
D
3
.7
3
1
2
0
3
6
1
1
0
0
.7
1
0
0
1
.1
8
2
3
1
0
6
D
3
.7
3
1
2
0
3
6
8
5
0
.7
1
0
0
1
.1
8
2
3
1
0
7
D
3
.7
3
1
1
0
3
6
8
5
1
.4
7
0
2
.3
6
4
6
1
0
8
D
3
.7
3
1
1
0
3
6
9
0
1
.4
7
1
2
.3
6
4
6
1
0
9
D
3
.7
3
1
1
0
3
6
9
5
1
.4
7
8
2
.3
6
4
6
1
1
0
D
3
.7
3
1
1
0
3
6
1
0
0
1
.4
7
6
2
.3
6
4
6
1
1
1
D
3
.7
3
1
1
0
3
6
1
0
5
1
.4
7
8
2
.3
6
4
6
1
1
2
D
3
.7
3
1
1
0
3
6
1
1
0
1
.4
7
6
2
.3
6
4
6
1
1
3
D
3
.7
3
3
6
1
1
4
D
+E
3
.7
3
3
6
1
1
5
E
3
.7
3
3
6
1
1
6
E
3
.7
3
1
2
0
3
6
1
0
0
1
.7
8
4
2
.8
7
1
3
1
1
7
E
3
.7
3
1
2
0
3
6
8
0
1
.7
8
4
2
.8
7
1
3
1
1
8
E
3
.7
3
1
2
0
3
6
6
0
1
.7
8
9
2
.8
7
1
3
1
1
9
E
3
.7
3
1
2
0
3
6
4
0
1
.7
9
0
2
.8
7
1
3
1
2
0
E
3
.7
3
1
1
0
3
6
1
0
0
1
.7
6
2
2
.8
7
1
3
1
2
1
E
3
.7
3
1
1
0
3
6
8
0
1
.7
6
2
2
.8
7
1
3
1
2
2
E
3
.7
3
1
1
0
3
6
6
0
1
.7
5
8
2
.8
7
1
3
1
2
3
E
3
.7
3
1
1
0
3
6
4
0
1
.7
4
4
2
.8
7
1
3
1
2
4
E
3
.7
3
9
0
3
6
4
0
1
.7
1
2
2
.8
7
1
3
1
2
5
E
3
.7
3
7
0
3
6
4
0
1
.7
9
2
.8
7
1
3
1
2
6
E
3
.7
3
3
6
1
2
7
E
3
.7
3
3
6
1
2
8
F
3
.7
3
8
0
3
6
2
8
301
R
u
n
B
at
ch
C
o
n
ce
n
tr
at
io
n
Te
m
p
er
at
u
re
D
ia
m
e
te
r 
o
f 
w
o
rk
 t
u
b
e
R
o
ta
ti
o
n
 s
p
ee
d
D
ro
p
s 
p
er
 s
ec
o
n
d
P
ro
d
u
ct
io
n
 r
at
e
 O
R
 t
im
e
 s
am
p
le
 t
ak
en
 a
t
%
 c
o
n
ve
rs
io
n
A
d
d
it
io
n
 r
at
e
/ 
m
L/
m
in
1
2
9
F
3
.7
3
8
0
3
6
2
6
1
3
0
F
3
.7
3
8
0
3
6
1
5
1
3
1
F
3
.7
3
8
0
3
6
2
5
1
3
2
F
3
.7
3
8
0
3
6
2
9
1
3
3
F
3
.7
3
8
0
3
6
1
5
1
3
4
F
3
.7
3
8
0
3
6
3
2
1
3
5
F
3
.7
3
8
0
3
6
3
3
1
3
6
F
3
.7
3
8
0
3
6
1
9
1
3
7
F
3
.7
3
1
0
0
3
6
1
.8
5
6
3
.0
4
0
2
1
3
8
F
3
.7
3
1
0
0
3
6
6
7
1
3
9
F
3
.7
3
1
0
0
3
6
4
8
1
4
0
F
3
.7
3
1
0
0
3
6
7
3
1
4
1
F
3
.7
3
1
0
0
3
6
7
5
1
4
2
F
3
.7
3
1
0
0
3
6
6
9
1
4
3
F
3
.7
3
1
2
0
3
6
7
0
8
1
1
4
4
F
3
.7
3
1
2
0
3
6
7
0
7
6
1
4
5
F
3
.7
3
1
2
0
3
6
7
0
7
0
1
4
6
F
3
.7
3
1
0
0
3
6
7
7
1
4
7
F
3
.7
3
1
0
0
3
6
7
9
1
4
8
F
3
.7
3
1
0
0
3
6
1
4
9
F
3
.7
3
1
2
0
3
6
4
0
1
.5
7
4
2
.5
3
3
5
1
5
0
F
3
.7
3
1
2
0
3
6
4
0
7
7
1
2
1
F
3
.7
3
1
2
0
3
6
4
0
7
5
1
5
2
F
3
.7
3
1
2
0
3
6
7
0
5
0
1
5
3
F
3
.7
3
1
2
0
3
6
7
0
5
4
1
5
4
F
3
.7
3
1
2
0
3
6
7
0
4
9
1
5
5
F
3
.7
3
1
2
0
3
6
1
0
0
7
7
1
5
6
F
3
.7
3
1
2
0
3
6
1
0
0
7
0
1
5
7
F
3
.7
3
1
2
0
3
6
1
0
0
8
1
1
5
8
G
3
.7
3
1
2
0
3
6
1
0
0
0
2
1
1
5
9
G
3
.7
3
1
2
0
3
6
1
0
0
1
.4
0
.5
5
8
2
.3
6
4
6
1
6
0
G
3
.7
3
1
2
0
3
6
1
0
0
1
.4
1
6
9
2
.3
6
4
6
302
R
u
n
B
at
ch
C
o
n
ce
n
tr
at
io
n
Te
m
p
er
at
u
re
D
ia
m
e
te
r 
o
f 
w
o
rk
 t
u
b
e
R
o
ta
ti
o
n
 s
p
ee
d
D
ro
p
s 
p
er
 s
ec
o
n
d
P
ro
d
u
ct
io
n
 r
at
e
 O
R
 t
im
e
 s
am
p
le
 t
ak
en
 a
t
%
 c
o
n
ve
rs
io
n
A
d
d
it
io
n
 r
at
e
/ 
m
L/
m
in
1
6
1
G
3
.7
3
1
2
0
3
6
1
0
0
1
.4
2
8
2
2
.3
6
4
6
1
6
2
G
3
.7
3
1
2
0
3
6
1
0
0
1
.4
3
8
9
2
.3
6
4
6
1
6
3
G
3
.7
3
1
2
0
3
6
1
0
0
1
.4
5
8
2
2
.3
6
4
6
1
6
4
G
3
.7
3
1
2
0
3
6
1
0
0
1
.4
1
0
8
6
2
.3
6
4
6
1
6
5
G
3
.7
3
1
2
0
3
6
1
0
0
1
.4
1
5
9
5
2
.3
6
4
6
1
6
6
G
3
.7
3
1
2
0
3
6
5
0
8
8
1
6
7
G
3
.7
3
1
2
0
3
6
5
0
8
3
1
6
8
G
3
.7
3
1
2
0
3
6
9
0
8
9
1
6
9
G
3
.7
3
1
2
0
3
6
9
0
8
4
1
7
0
G
3
.7
3
1
2
0
3
6
7
0
8
9
1
7
1
G
3
.7
3
1
2
0
3
6
7
0
8
2
1
7
2
G
3
.7
3
1
2
0
3
6
1
0
0
8
5
1
7
3
G
3
.7
3
1
2
0
3
6
1
0
0
8
7
1
7
4
G
3
.7
3
1
0
0
3
6
5
0
1
.8
4
8
3
.0
4
0
2
1
7
5
G
3
.7
3
1
0
0
3
6
5
0
1
.8
5
0
3
.0
4
0
2
1
7
6
G
3
.7
3
1
0
0
3
6
6
0
1
.8
3
2
3
.0
4
0
2
1
7
7
G
3
.7
3
1
0
0
3
6
6
0
1
.8
3
5
3
.0
4
0
2
1
7
8
G
3
.7
3
1
0
0
3
6
9
0
1
.8
3
0
3
.0
4
0
2
1
7
9
G
3
.7
3
1
0
0
3
6
9
0
1
.8
5
0
3
.0
4
0
2
1
8
0
G
3
.7
3
8
0
3
6
5
0
1
.8
4
0
3
.0
4
0
2
1
8
1
G
3
.7
3
8
0
3
6
5
0
1
.8
3
4
3
.0
4
0
2
1
8
2
G
3
.7
3
8
0
3
6
6
0
1
.8
4
9
3
.0
4
0
2
1
8
3
G
3
.7
3
8
0
3
6
6
0
1
.8
3
.0
4
0
2
1
8
4
G
3
.7
3
8
0
3
6
9
0
1
.8
3
.0
4
0
2
1
8
5
G
3
.7
3
8
0
3
6
9
0
1
.8
3
.0
4
0
2
1
8
6
G
3
.7
3
1
0
0
3
6
1
0
0
1
.4
1
1
2
.3
6
4
6
1
8
7
G
3
.7
3
1
0
0
3
6
1
0
0
1
.4
2
.3
6
4
6
1
8
8
G
3
.7
3
1
0
0
3
6
1
0
0
1
.4
4
0
2
.3
6
4
6
1
8
9
G
3
.7
3
1
0
0
3
6
1
0
0
1
.4
4
0
2
.3
6
4
6
1
9
0
G
3
.7
3
1
0
0
3
6
1
0
0
1
.4
5
1
2
.3
6
4
6
1
9
1
G
3
.7
3
1
0
0
3
6
1
0
0
1
.4
3
2
2
.3
6
4
6
1
9
2
G
3
.7
3
1
0
0
3
6
1
0
0
1
.4
6
4
2
.3
6
4
6
303
R
u
n
B
at
ch
C
o
n
ce
n
tr
at
io
n
Te
m
p
er
at
u
re
D
ia
m
e
te
r 
o
f 
w
o
rk
 t
u
b
e
R
o
ta
ti
o
n
 s
p
ee
d
D
ro
p
s 
p
er
 s
ec
o
n
d
P
ro
d
u
ct
io
n
 r
at
e
 O
R
 t
im
e
 s
am
p
le
 t
ak
en
 a
t
%
 c
o
n
ve
rs
io
n
A
d
d
it
io
n
 r
at
e
/ 
m
L/
m
in
1
9
3
G
3
.7
3
1
0
0
3
6
1
0
0
1
.4
7
5
2
.3
6
4
6
1
9
4
G
3
.7
3
8
0
3
6
1
0
0
1
.8
6
3
.0
4
0
2
1
9
5
G
3
.7
3
8
0
3
6
1
0
0
1
.8
6
3
.0
4
0
2
1
9
6
G
3
.7
3
8
0
3
6
1
0
0
1
.8
4
3
.0
4
0
2
1
9
7
G
3
.7
3
8
0
3
6
1
0
0
1
.8
3
.0
4
0
2
1
9
8
G
3
.7
3
8
0
3
6
1
0
0
1
.8
3
0
3
.0
4
0
2
1
9
9
G
3
.7
3
8
0
3
6
1
0
0
1
.8
3
0
3
.0
4
0
2
2
0
0
G
3
.7
3
8
0
3
6
1
0
0
1
.8
3
2
3
.0
4
0
2
2
0
1
G
3
.7
3
8
0
3
6
1
0
0
1
.8
3
7
3
.0
4
0
2
2
0
2
H
3
.7
3
1
2
0
3
6
1
0
1
.6
8
3
2
.7
0
2
4
2
0
3
H
3
.7
3
1
2
0
3
6
1
0
1
.6
8
2
2
.7
0
2
4
2
0
4
H
3
.7
3
1
2
0
3
6
1
5
1
.6
8
3
2
.7
0
2
4
2
0
5
H
3
.7
3
1
2
0
3
6
1
5
1
.6
8
6
2
.7
0
2
4
2
0
6
H
3
.7
3
1
2
0
3
6
2
0
1
.6
8
1
2
.7
0
2
4
2
0
7
H
3
.7
3
1
2
0
3
6
2
0
1
.6
8
5
2
.7
0
2
4
2
0
8
H
3
.7
3
1
2
0
3
6
2
5
1
.6
8
6
2
.7
0
2
4
2
0
9
H
3
.7
3
1
2
0
3
6
2
5
1
.6
8
4
2
.7
0
2
4
2
1
0
H
3
.7
3
1
2
0
3
6
3
0
1
.6
8
6
2
.7
0
2
4
2
1
1
H
3
.7
3
1
2
0
3
6
3
0
1
.6
9
2
2
.7
0
2
4
2
1
2
H
3
.7
3
1
2
0
3
6
3
5
1
.6
8
8
2
.7
0
2
4
2
1
3
H
3
.7
3
1
2
0
3
6
3
5
1
.6
8
4
2
.7
0
2
4
2
1
4
H
3
.7
3
1
2
0
3
6
3
7
1
.6
8
6
2
.7
0
2
4
2
1
5
H
3
.7
3
1
2
0
3
6
3
7
1
.6
8
7
2
.7
0
2
4
2
1
6
H
3
.7
3
1
2
0
3
6
4
0
1
.6
8
6
2
.7
0
2
4
2
1
7
H
3
.7
3
1
2
0
3
6
4
0
1
.6
8
8
2
.7
0
2
4
304
Appendix B
% Conversion data and
calculations from the HeRo
reactor
305
R
u
n
M
A
 in
te
gr
al
C
A
 in
te
gr
al
C
o
u
m
al
ic
 a
ci
d
 in
te
gr
al
 *
 2
To
ta
l =
 M
A
 +
 2
C
A
%
 c
o
n
ve
rs
io
n
 =
 2
C
A
/ 
(M
A
 +
 2
C
A
) 
*
 1
0
0
1
1
0
.0
3
0
.0
6
1
.0
6
6
2
1
0
.0
3
0
.0
6
1
.0
6
6
3
1
0
.0
7
0
.1
4
1
.1
4
1
2
4
1
0
.1
0
.2
1
.2
1
7
5
1
0
.0
4
0
.0
8
1
.0
8
7
6
1
0
.0
6
0
.1
2
1
.1
2
1
1
7
1
0
.0
2
0
.0
4
1
.0
4
4
8
1
0
.1
0
.2
1
.2
1
7
9
1
0
.6
5
1
.3
2
.3
5
7
1
0
1
0
.1
2
0
.2
4
1
.2
4
1
9
1
1
1
0
.0
4
0
.0
8
1
.0
8
7
1
2
X
0
1
3
1
0
.1
8
0
.3
6
1
.3
6
2
6
1
4
1
0
.5
3
1
.0
6
2
.0
6
5
1
1
5
1
0
.5
7
1
.1
4
2
.1
4
5
3
1
6
1
0
.2
2
0
.4
4
1
.4
4
3
1
1
7
1
0
.0
8
0
.1
6
1
.1
6
1
4
1
8
1
0
.1
0
.2
1
.2
1
7
1
9
1
0
.1
9
0
.3
8
1
.3
8
2
8
2
0
1
0
.0
3
0
.0
6
1
.0
6
6
2
1
1
0
.0
2
0
.0
4
1
.0
4
4
2
2
1
0
.0
6
0
.1
2
1
.1
2
1
1
2
3
1
0
.2
5
0
.5
1
.5
3
3
2
4
1
0
.7
2
1
.4
4
2
.4
4
5
9
2
5
1
0
.9
6
1
.9
2
2
.9
2
6
6
2
6
1
0
.9
2
1
.8
4
2
.8
4
6
5
2
7
1
0
.7
2
1
.4
4
2
.4
4
5
9
2
8
1
0
.0
3
0
.0
6
1
.0
6
6
2
9
1
0
.0
6
0
.1
2
1
.1
2
1
1
3
0
1
0
.1
2
0
.2
4
1
.2
4
1
9
3
1
1
0
.2
5
0
.5
1
.5
3
3
3
2
1
0
.2
9
0
.5
8
1
.5
8
3
7
306
R
u
n
M
A
 in
te
gr
al
C
A
 in
te
gr
al
C
o
u
m
al
ic
 a
ci
d
 in
te
gr
al
 *
 2
To
ta
l =
 M
A
 +
 2
C
A
%
 c
o
n
ve
rs
io
n
 =
 2
C
A
/ 
(M
A
 +
 2
C
A
) 
*
 1
0
0
3
3
1
0
.4
5
0
.9
1
.9
4
7
3
4
2
.8
9
0
.6
1
.2
4
.0
9
2
9
3
5
1
0
.4
1
0
.8
2
1
.8
2
4
5
3
6
1
0
.1
9
0
.3
8
1
.3
8
2
8
3
7
X
0
3
8
X
0
3
9
1
0
.0
5
0
.1
1
.1
9
4
0
1
0
.0
6
0
.1
2
1
.1
2
1
1
4
1
1
0
.0
4
0
.0
8
1
.0
8
7
4
2
1
0
.0
8
0
.1
6
1
.1
6
1
4
4
3
1
0
.0
1
0
.0
2
1
.0
2
2
4
4
1
0
.0
3
0
.0
6
1
.0
6
6
4
5
1
0
.0
4
0
.0
8
1
.0
8
7
4
6
1
0
.0
8
0
.1
6
1
.1
6
1
4
4
7
1
0
.0
8
0
.1
6
1
.1
6
1
4
4
8
1
0
.0
7
0
.1
4
1
.1
4
1
2
4
9
1
0
.0
6
0
.1
2
1
.1
2
1
1
5
0
1
0
.1
1
0
.2
2
1
.2
2
1
8
5
1
1
0
.0
9
0
.1
8
1
.1
8
1
5
5
2
1
0
.0
7
0
.1
4
1
.1
4
1
2
5
3
1
0
.0
8
0
.1
6
1
.1
6
1
4
5
4
1
0
.0
4
0
.0
8
1
.0
8
7
5
5
1
0
.0
4
0
.0
8
1
.0
8
7
5
6
1
0
.0
5
0
.1
1
.1
9
5
7
1
0
.0
4
0
.0
8
1
.0
8
7
5
8
1
0
.0
5
0
.1
1
.1
9
5
9
1
0
.0
6
0
.1
2
1
.1
2
1
1
6
0
1
0
.0
9
0
.1
8
1
.1
8
1
5
6
1
1
0
.0
9
0
.1
8
1
.1
8
1
5
6
2
1
0
.1
5
0
.3
1
.3
2
3
6
3
1
0
.1
0
.2
1
.2
1
7
6
4
1
0
.3
4
0
.6
8
1
.6
8
4
0
307
R
u
n
M
A
 in
te
gr
al
C
A
 in
te
gr
al
C
o
u
m
al
ic
 a
ci
d
 in
te
gr
al
 *
 2
To
ta
l =
 M
A
 +
 2
C
A
%
 c
o
n
ve
rs
io
n
 =
 2
C
A
/ 
(M
A
 +
 2
C
A
) 
*
 1
0
0
6
5
1
0
.2
8
0
.5
6
1
.5
6
3
6
6
6
0
.6
4
0
.3
7
0
.7
4
1
.3
8
5
4
6
7
0
.4
1
0
.5
5
1
.1
1
.5
1
7
3
6
8
1
0
.8
6
1
.7
2
2
.7
2
6
3
6
9
0
.7
1
0
.4
2
0
.8
4
1
.5
5
5
4
7
0
1
0
.0
3
0
.0
6
1
.0
6
6
7
1
1
0
.0
8
0
.1
6
1
.1
6
1
4
7
2
1
0
.1
5
0
.3
1
.3
2
3
7
3
1
0
.1
3
0
.2
6
1
.2
6
2
1
7
4
1
0
.1
5
0
.3
1
.3
2
3
7
5
1
0
.3
1
0
.6
2
1
.6
2
3
8
7
6
1
0
.2
3
0
.4
6
1
.4
6
3
2
7
7
1
0
.2
7
0
.5
4
1
.5
4
3
5
7
8
1
0
.3
8
0
.7
6
1
.7
6
4
3
7
9
1
0
.5
8
1
.1
6
2
.1
6
5
4
8
0
1
0
.6
8
1
.3
6
2
.3
6
5
8
8
1
1
0
.7
8
1
.5
6
2
.5
6
6
1
8
2
1
0
.9
4
1
.8
8
2
.8
8
6
5
8
3
1
1
.4
4
2
.8
8
3
.8
8
7
4
8
4
1
1
.8
3
.6
4
.6
7
8
8
5
1
1
.9
8
3
.9
6
4
.9
6
8
0
8
6
1
4
.2
4
8
.4
8
9
.4
8
8
9
8
7
1
5
.2
9
1
0
.5
8
1
1
.5
8
9
1
8
8
1
4
.5
1
9
.0
2
1
0
.0
2
9
0
8
9
1
7
.5
1
1
5
.0
2
1
6
.0
2
9
4
9
0
1
4
.1
3
8
.2
6
9
.2
6
8
9
9
1
1
0
.9
6
1
.9
2
2
.9
2
6
6
9
2
1
1
.0
6
2
.1
2
3
.1
2
6
8
9
3
1
1
.3
4
2
.6
8
3
.6
8
7
3
9
4
1
1
.2
5
2
.5
3
.5
7
1
9
5
1
1
.9
3
3
.8
6
4
.8
6
7
9
9
6
1
2
.5
8
5
.1
6
6
.1
6
8
4
308
R
u
n
M
A
 in
te
gr
al
C
A
 in
te
gr
al
C
o
u
m
al
ic
 a
ci
d
 in
te
gr
al
 *
 2
To
ta
l =
 M
A
 +
 2
C
A
%
 c
o
n
ve
rs
io
n
 =
 2
C
A
/ 
(M
A
 +
 2
C
A
) 
*
 1
0
0
9
7
1
4
.1
8
.2
9
.2
8
9
9
8
1
3
.8
2
7
.6
4
8
.6
4
8
8
9
9
X
0
1
0
0
1
3
.1
7
6
.3
4
7
.3
4
8
6
1
0
1
1
5
.4
2
5
1
0
.8
5
1
1
.8
5
9
2
1
0
2
1
5
.6
4
1
1
.2
8
1
2
.2
8
9
2
1
0
3
1
4
.2
7
8
.5
4
9
.5
4
9
0
1
0
4
1
7
.6
9
1
5
.3
8
1
6
.3
8
9
4
1
0
5
0
1
2
2
1
0
0
1
0
6
0
1
2
2
1
0
0
1
0
7
1
1
.1
4
2
.2
8
3
.2
8
7
0
1
0
8
1
1
.1
9
5
2
.3
9
3
.3
9
7
1
1
0
9
1
1
.7
3
5
3
.4
7
4
.4
7
7
8
1
1
0
1
1
.5
8
5
3
.1
7
4
.1
7
7
6
1
1
1
1
1
.7
3
3
.4
6
4
.4
6
7
8
1
1
2
1
1
.5
5
5
3
.1
1
4
.1
1
7
6
1
1
3
1
0
.7
8
1
.5
6
2
.5
6
6
1
1
1
4
1
0
.8
8
1
.7
6
2
.7
6
6
4
1
1
5
1
1
.7
9
3
.5
8
4
.5
8
7
8
1
1
6
1
2
.5
5
5
.1
6
.1
8
4
1
1
7
1
2
.7
2
5
.4
4
6
.4
4
8
4
1
1
8
1
4
.2
1
8
.4
2
9
.4
2
8
9
1
1
9
1
4
.3
3
8
.6
6
9
.6
6
9
0
1
2
0
1
0
.8
3
1
.6
6
2
.6
6
6
2
1
2
1
1
0
.8
1
.6
2
.6
6
2
1
2
2
1
0
.7
1
.4
2
.4
5
8
1
2
3
1
0
.3
9
0
.7
8
1
.7
8
4
4
1
2
4
1
0
.0
7
0
.1
4
1
.1
4
1
2
1
2
5
1
0
.0
5
0
.1
1
.1
9
1
2
6
1
2
7
1
2
8
1
0
.1
9
0
.3
8
1
.3
8
2
8
309
R
u
n
M
A
 in
te
gr
al
C
A
 in
te
gr
al
C
o
u
m
al
ic
 a
ci
d
 in
te
gr
al
 *
 2
To
ta
l =
 M
A
 +
 2
C
A
%
 c
o
n
ve
rs
io
n
 =
 2
C
A
/ 
(M
A
 +
 2
C
A
) 
*
 1
0
0
1
2
9
1
0
.1
8
0
.3
6
1
.3
6
2
6
1
3
0
1
0
.0
9
0
.1
8
1
.1
8
1
5
1
3
1
1
0
.1
7
0
.3
4
1
.3
4
2
5
1
3
2
1
0
.2
0
.4
1
.4
2
9
1
3
3
1
0
.0
9
0
.1
8
1
.1
8
1
5
1
3
4
1
0
.2
3
0
.4
6
1
.4
6
3
2
1
3
5
1
0
.2
5
0
.5
1
.5
3
3
1
3
6
1
0
.1
2
0
.2
4
1
.2
4
1
9
1
3
7
1
0
.6
3
1
.2
6
2
.2
6
5
6
1
3
8
1
1
.0
2
2
.0
4
3
.0
4
6
7
1
3
9
1
0
.4
6
0
.9
2
1
.9
2
4
8
1
4
0
1
1
.3
2
2
.6
4
3
.6
4
7
3
1
4
1
1
1
.5
4
3
.0
8
4
.0
8
7
5
1
4
2
1
1
.0
9
2
.1
8
3
.1
8
6
9
1
4
3
1
2
.0
7
4
.1
4
5
.1
4
8
1
1
4
4
1
1
.5
8
3
.1
6
4
.1
6
7
6
1
4
5
1
1
.1
9
2
.3
8
3
.3
8
7
0
1
4
6
1
1
.6
6
3
.3
2
4
.3
2
7
7
1
4
7
1
1
.6
9
3
.3
8
4
.3
8
7
7
1
4
8
0
1
4
9
1
1
.4
6
2
.9
2
3
.9
2
7
4
1
5
0
1
1
.6
3
3
.2
6
4
.2
6
7
7
1
5
1
1
1
.5
1
3
.0
2
4
.0
2
7
5
1
5
2
1
0
.5
1
2
5
0
1
5
3
1
0
.5
8
1
.1
6
2
.1
6
5
4
1
5
4
1
0
.4
9
0
.9
8
1
.9
8
4
9
1
5
5
1
1
.6
4
3
.2
8
4
.2
8
7
7
1
5
6
1
1
.1
4
2
.2
8
3
.2
8
7
0
1
5
7
1
2
.0
9
4
.1
8
5
.1
8
8
1
1
5
8
1
0
.1
3
0
.2
6
1
.2
6
2
1
1
5
9
1
0
.6
8
1
.3
6
2
.3
6
5
8
1
6
0
1
1
.1
2
.2
3
.2
6
9
310
R
u
n
M
A
 in
te
gr
al
C
A
 in
te
gr
al
C
o
u
m
al
ic
 a
ci
d
 in
te
gr
al
 *
 2
To
ta
l =
 M
A
 +
 2
C
A
%
 c
o
n
ve
rs
io
n
 =
 2
C
A
/ 
(M
A
 +
 2
C
A
) 
*
 1
0
0
1
6
1
1
2
.3
4
4
.6
8
5
.6
8
8
2
1
6
2
1
3
.9
2
7
.8
4
8
.8
4
8
9
1
6
3
1
2
.3
1
4
.6
2
5
.6
2
8
2
1
6
4
1
3
.1
3
6
.2
6
7
.2
6
8
6
1
6
5
0
0
9
5
1
6
6
1
3
.6
1
7
.2
2
8
.2
2
8
8
1
6
7
1
2
.3
7
4
.7
4
5
.7
4
8
3
1
6
8
1
3
.8
9
7
.7
8
8
.7
8
8
9
1
6
9
1
2
.6
4
5
.2
8
6
.2
8
8
4
1
7
0
1
4
.0
1
8
.0
2
9
.0
2
8
9
1
7
1
1
2
.3
4
4
.6
8
5
.6
8
8
2
1
7
2
1
2
.8
3
5
.6
6
6
.6
6
8
5
1
7
3
1
3
.3
4
6
.6
8
7
.6
8
8
7
1
7
4
1
0
.4
6
0
.9
2
1
.9
2
4
8
1
7
5
1
0
.5
1
2
5
0
1
7
6
1
0
.2
4
0
.4
8
1
.4
8
3
2
1
7
7
1
0
.2
7
0
.5
4
1
.5
4
3
5
1
7
8
1
0
.2
1
0
.4
2
1
.4
2
3
0
1
7
9
1
0
.5
1
1
.0
2
2
.0
2
5
0
1
8
0
1
0
.3
4
0
.6
8
1
.6
8
4
0
1
8
1
1
0
.2
6
0
.5
2
1
.5
2
3
4
1
8
2
1
0
.4
8
0
.9
6
1
.9
6
4
9
1
8
3
0
0
1
8
4
0
0
1
8
5
0
0
1
8
6
1
0
.0
6
0
.1
2
1
.1
2
1
1
1
8
7
0
0
1
8
8
1
0
.3
3
0
.6
6
1
.6
6
4
0
1
8
9
1
0
.3
3
0
.6
6
1
.6
6
4
0
1
9
0
1
0
.5
2
1
.0
4
2
.0
4
5
1
1
9
1
1
0
.2
4
0
.4
8
1
.4
8
3
2
1
9
2
1
0
.8
7
1
.7
4
2
.7
4
6
4
311
R
u
n
M
A
 in
te
gr
al
C
A
 in
te
gr
al
C
o
u
m
al
ic
 a
ci
d
 in
te
gr
al
 *
 2
To
ta
l =
 M
A
 +
 2
C
A
%
 c
o
n
ve
rs
io
n
 =
 2
C
A
/ 
(M
A
 +
 2
C
A
) 
*
 1
0
0
1
9
3
1
1
.5
2
3
.0
4
4
.0
4
7
5
1
9
4
1
0
.0
3
0
.0
6
1
.0
6
6
1
9
5
1
0
.0
3
0
.0
6
1
.0
6
6
1
9
6
1
0
.0
2
0
.0
4
1
.0
4
4
1
9
7
0
0
1
9
8
1
0
.2
1
0
.4
2
1
.4
2
3
0
1
9
9
1
0
.2
1
0
.4
2
1
.4
2
3
0
2
0
0
1
0
.2
3
0
.4
6
1
.4
6
3
2
2
0
1
1
0
.2
9
0
.5
8
1
.5
8
3
7
2
0
2
1
2
.4
4
4
.8
8
5
.8
8
8
3
2
0
3
1
2
.2
8
4
.5
6
5
.5
6
8
2
2
0
4
1
2
.3
8
4
.7
6
5
.7
6
8
3
2
0
5
1
3
.1
4
6
.2
8
7
.2
8
8
6
2
0
6
1
2
.1
3
4
.2
6
5
.2
6
8
1
2
0
7
1
2
.9
1
5
.8
2
6
.8
2
8
5
2
0
8
1
2
.9
8
5
.9
6
6
.9
6
8
6
2
0
9
0
.7
7
2
.0
7
4
.1
4
4
.9
1
8
4
2
1
0
1
3
.0
7
6
.1
4
7
.1
4
8
6
2
1
1
1
5
.8
1
1
.6
1
2
.6
9
2
2
1
2
1
3
.7
9
7
.5
8
8
.5
8
8
8
2
1
3
1
2
.5
4
5
.0
8
6
.0
8
8
4
2
1
4
1
2
.9
9
5
.9
8
6
.9
8
8
6
2
1
5
1
3
.4
9
6
.9
8
7
.9
8
8
7
2
1
6
1
3
.1
2
6
.2
4
7
.2
4
8
6
2
1
7
1
3
.5
2
7
.0
4
8
.0
4
8
8
2
1
8
1
1
.2
4
2
.4
8
3
.4
8
7
1
2
1
9
1
1
.3
2
2
.6
4
3
.6
4
7
3
2
2
0
1
0
.7
7
1
.5
4
2
.5
4
6
1
2
2
1
1
1
.5
1
3
.0
2
4
.0
2
7
5
2
2
2
X
0
2
2
3
1
1
.8
1
3
.6
2
4
.6
2
7
8
2
2
4
X
0
312
R
u
n
M
A
 in
te
gr
al
C
A
 in
te
gr
al
C
o
u
m
al
ic
 a
ci
d
 in
te
gr
al
 *
 2
To
ta
l =
 M
A
 +
 2
C
A
%
 c
o
n
ve
rs
io
n
 =
 2
C
A
/ 
(M
A
 +
 2
C
A
) 
*
 1
0
0
2
2
5
X
-
2
2
6
X
0
2
2
7
0
.8
9
0
.7
1
1
.4
2
2
.3
1
6
1
2
2
8
X
0
2
2
9
1
1
.0
2
2
.0
4
3
.0
4
6
7
2
3
0
X
0
2
3
1
1
1
.0
3
2
.0
6
3
.0
6
6
7
2
3
2
X
0
2
3
3
1
2
.1
7
4
.3
4
5
.3
4
8
1
2
3
4
X
0
2
3
5
1
2
.0
7
4
.1
4
5
.1
4
8
1
2
3
6
X
0
313
